intt20201231

0001437749-21-006901.txt : 20210323 0001437749-21-006901.hdr.sgml : 20210323 20210323162031 ACCESSION NUMBER: 0001437749-21-006901 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 100 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210323 DATE AS OF CHANGE: 20210323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEST CORP CENTRAL INDEX KEY: 0001036262 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 222370659 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36117 FILM NUMBER: 21765020 BUSINESS ADDRESS: STREET 1: 804 EAST GATE DR., SUITE 200 CITY: MT. LAUREL STATE: NJ ZIP: 08054 BUSINESS PHONE: 856-505-8800 MAIL ADDRESS: STREET 1: 804 EAST GATE DR., SUITE 200 CITY: MT. LAUREL STATE: NJ ZIP: 08054 10-K 1 intt20201231_10k.htm FORM 10-K intt20201231_10k.htm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)

☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020
OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 1-36117

inTEST Corporation
(Exact name of registrant as specified in its charter)

DELAWARE (State or Other Jurisdiction of Incorporation or Organization)	22-2370659 (I.R.S. Employer Identification Number)

804 EAST GATE DRIVE, SUITE 200 MT. LAUREL, NEW JERSEY (Address of Principal Executive Offices)	08054 (Zip Code)

Registrant's telephone number, including area code: (856) 505-8800

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class
Common Stock, par value $0.01 per share

Trading Symbol
INTT

Name of Each Exchange on Which Registered
NYSE American

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial account standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold on June 30, 2020 (the last business day of the registrant's most recently completed second fiscal quarter), was: $33,823,258.

The number of shares outstanding of the registrant's Common Stock, as of March 15, 2021, was 10,703,056.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the definitive proxy statement of the Registrant for the Registrant's 2021 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Report, are incorporated by reference into Part III of this Report.

inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2020

INDEX

		*Page*
PART I
Item 1.	Business	4
Item 1A.	Risk Factors	14
Item 1B.	Unresolved Staff Comments	20
Item 2.	Properties	20
Item 3.	Legal Proceedings	21
Item 4.	Mine Safety Disclosures	21

PART II

Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	21
Item 6.	Selected Financial Data	22
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	22
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	30
Item 8.	Financial Statements and Supplementary Data	30
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	30
Item 9A.	Controls and Procedures	30
Item 9B.	Other Information	31

PART III

Item 10.	Directors, Executive Officers and Corporate Governance	32
Item 11.	Executive Compensation	32
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	32
Item 13.	Certain Relationships and Related Transactions, and Director Independence	32
Item 14.	Principal Accounting Fees and Services	32

PART IV

Item 15.	Exhibits, Financial Statement Schedules	33
Item 16.	Form 10-K Summary	33
	Index to Exhibits	33
	Signatures	35
	Index to Consolidated Financial Statements and Financial Statement Schedule	36

-2-

inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2020

Cautionary Statement Regarding Forward-Looking Statements

From time to time, we make written or oral "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements contained in our filings with the Securities and Exchange Commission (“SEC”) (including this Annual Report on Form 10-K (“Report”)), in our annual report to stockholders and in other communications. These statements do not convey historical information, but relate to predicted or potential future events, such as statements of our plans, strategies and intentions, or our future performance or goals, that are based on management’s current expectations. Our forward-looking statements can often be identified by the use of forward-looking terminology such as "believes," "expects," "intends," "may," “could,” "will," "should," "plans," “projects,” “forecasts,” “seeks,” “anticipates,” “goal,” “objective,” “target,” “future,” “outlook,” “vision,” or variations of such words or similar terminology. Investors and prospective investors are cautioned that such forward-looking statements are only projections based on current estimations. These statements involve risks and uncertainties and are based upon various assumptions. Such risks and uncertainties include, but are not limited to:

	●	the impact of COVID-19 on our business, liquidity, financial condition and results of operations;
	●	our ability to successfully consolidate our EMS manufacturing operations without any impact on customer shipments or quality and to realize the benefits of the consolidation;
	●	indications of a change in the market cycles in the semiconductor and automated test equipment (“ATE”) markets, collectively the “Semi Market,” or other markets we serve;
	●	developments and trends in the Semi Market, including changes in the demand for semiconductors;
	●	the loss of any one or more of our largest customers, or a reduction in orders by a major customer;
	●	changes in the rate of, and timing of, capital expenditures by our customers;
	●	the availability of materials used to manufacture our products;
	●	the impact of interruptions in our supply chain caused by external factors;
	●	the sufficiency of cash balances, lines of credit and net cash from operations;
	●	stock price fluctuations;
	●	the possibility of future acquisitions or dispositions and the successful integration of any acquired operations;
	●	the ability to borrow funds or raise capital to finance major potential acquisitions;
	●	the success of our strategy to diversify our business by entering markets outside the Semi Market, including the automotive, defense/aerospace, industrial, medical, telecommunications and other markets and changes in demand in these markets;
	●	competitive pricing pressures;
	●	the development of new products and technologies by us or our competitors;
	●	effects of exchange rate fluctuations;
	●	progress of product development programs;
	●	the anticipated market for our products;
	●	the availability of and retention of key personnel or our ability to hire personnel at anticipated costs;
	●	general economic conditions both domestically and globally; and
	●	other projections of net revenues, taxable earnings (loss), net earnings (loss), net earnings (loss) per share, capital expenditures and other financial items.

We discuss many of these risks and uncertainties and others under Item 1A "Risk Factors," in this Report, and elsewhere in this Report. These risks and uncertainties, among others, could cause our actual future results to differ materially from those described in our forward-looking statements or from our prior results. Any forward-looking statement made by us in this Report is based only on information currently available to us and speaks to circumstances only as of the date on which it is made. We are not obligated to update these forward-looking statements, even though our situation may change in the future.

-3-

PART I

Item 1.

BUSINESS

INTRODUCTION

inTEST Corporation was incorporated in New Jersey in 1981 and reincorporated in Delaware in April 1997. The consolidated entity is comprised of inTEST Corporation (parent) and our wholly-owned subsidiaries. In this report, "we," "us," "our," and the "Company" refer to inTEST Corporation and its consolidated subsidiaries.

We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We manage our business as two operating segments, Thermal Products ("Thermal”) and Electromechanical Semiconductor Products ("EMS"), which are also our reporting units. Our Thermal segment designs, manufactures and sells our thermal test and thermal process products while our EMS segment designs, manufactures and sells our semiconductor test products.

We sell our products worldwide. Within the ATE market, we sell our products both directly to major semiconductor manufacturers and semiconductor test subcontractors and indirectly through leading ATE manufacturers. In markets outside the ATE market, we sell our products directly to the end user of the product or through third party distributors. Our largest customers include Aixtron SE, Analog Devices, Inc., Emerson Electric Co., Hakuto Co. Ltd., Lockheed Martin Corporation, NXP Semiconductors N.V., QUALCOMM Incorporated, Raytheon Company, Renesas Electronics Corporation and Texas Instruments Incorporated.

COVID-19 PANDEMIC

Although we saw slightly increased order rates from our customers in the Semi Market during the second and third quarters of 2020, it was not until the fourth quarter of 2020 that we saw a significant increase in our orders from the Semi Market which we believe indicates that we have now entered the next cyclical upturn. During the fourth quarter of 2020, our orders from the Semi Market increased 53% sequentially and were 141% higher than in the fourth quarter of 2019, the low point of the prior cyclical downturn for the products that we sell. We believe the level of increase in our orders from the Semi Market during the fourth quarter of 2020 reflects a combination of increased demand in the market resulting from the interruption of the normal recovery in the Semi Market cycle caused by the onset of COVID-19 in the first half of 2020, as well as increased demand for semiconductors, generally. We believe this increase in demand is being driven both by changing technology as well as increased use of technology across all aspects of daily life, such as in devices that facilitate remote work and education, smart technology used in homes and businesses, the increase in the amount of integrated circuits (“ICs”) used in the automotive industry and changes occurring in the telecommunications and mobility markets.

As of the date of this filing, all of our operations continue to be deemed “critical and essential business operations” under the various governmental COVID-19 mandates, which has allowed us to continue to operate our business with certain modifications. These modifications include a significant number of our employees working remotely. Such employees have been provided with the tools and technology necessary to do so. Additionally, we have implemented workplace safeguards designed to protect the health and well-being of our employees. Employees who remain in our facilities are following World Health Organization (“WHO”) and Centers for Disease Control and Prevention (“CDC”) recommended safety practices, as well as state and local directives. We have had occasions where one or more employees have contracted COVID-19 and entered our facilities while infected. To date, we have managed these occurrences with minimal disruption to our business while protecting other employees, but there can be no assurances that we can avoid similar occurrences in the future or, that in such cases, we can avoid significant disruption of our operations.

The aftermarket service and support that we provide to our customers has been, and we expect may continue to be, adversely impacted by COVID-19. Specifically, the travel restrictions that remain in place, coupled with limitations on visitors into customer facilities, have resulted in the reduction or suspension of certain activities. The net revenues associated with these aftermarket service and support activities typically range from 8% to 10% of our consolidated net revenues. Although these net revenues returned to a more typical range during the third and fourth quarters of 2020, if the spread of COVID-19 or variations of the virus worsen, these revenues may be reduced in future periods.

-4-

As a result of our current level of working capital as well as the availability of our revolving credit facility, which is discussed in Note 10 to our consolidated financial statements, we currently expect to have sufficient liquidity to operate our business throughout 2021, as further described in this Report. Although our revolving credit facility will mature on April 9, 2021, we are currently in discussions with our lender to replace this facility with a three-year credit facility. We expect that facility to be put in place in conjunction with, or prior to, the expiration of our current credit facility.

MARKETS

Overview

Historically, we referred to our markets as “Semiconductor” (which included both the broader semiconductor market as well as the more specialized semiconductor ATE and wafer processing sectors within the broader semiconductor market), and “Non-Semiconductor” (which included all of the other markets we serve). In the second quarter of 2019, we began referring to the semiconductor market, including the ATE and wafer processing sectors within that market, as the “Semi Market.” All other markets, when referred to collectively, are designated as “Multimarket.” Business within our Thermal segment can fall into either the Semi Market or Multimarket, depending upon how our customers utilize our products or upon their respective applications, while business within our EMS segment is all within the Semi Market.

While the Semi Market represents the historical roots of inTEST and remains a very important component of our business, Multimarket is where we have focused our strategic growth efforts over the last several years. Our goal has been to grow our business, both organically and through acquisition, in Multimarket as we believe these markets have historically been less cyclical than the Semi Market. Moving forward, with the launch of our new strategic plan which is discussed below under “Our Strategies”, we are broadening our strategic growth efforts to target both organic and inorganic growth in all of our currently served markets, which includes the Semi Market. Our goal is to further expand our existing product lines, strengthen our positions in served markets and drive expansion into new markets.

Prior to the acquisition of Ambrell Corporation (“Ambrell”) in May 2017, we offered only highly specialized engineering solutions used for testing applications in Multimarket, the demand for which is limited and which varies significantly from period to period. Our acquisition of Ambrell not only provided expansion into new markets but also broadened our product offerings to include products sold into process or manufacturing applications. Historically, Ambrell sold its precision induction heating systems almost exclusively to customers in the industrial market but since 2018, has also had significant sales into the Semi Market. Overall, however, the acquisition of Ambrell has helped to diversify our customer base. We expect that our future orders and net revenues will be approximately equally split between the Semi Market and Multimarket. During 2020 and 2019, our net revenues from Multimarket were $27.0 million and $29.7 million, respectively, and represented 50% and 49%, respectively, of our total net revenues. In the five years prior to the acquisition of Ambrell, our net revenues from Multimarket ranged from 18% to 30% of our total net revenues.

The level of our net revenues in Multimarket varies significantly from market to market. During 2020 and 2019, our net revenues from the industrial market represented 32% and 35%, respectively, of our total net revenues, while our net revenues from the defense/aerospace market represented 12% and 8%, respectively, of our total net revenues. Our net revenues from the telecommunications market represented 3% of our total net revenues in both years. The level of our net revenues in these markets has varied significantly in the past and we expect it will vary significantly in the future as we build our presence in these markets and establish new markets for our products. One of our goals is to further expand our Multimarket sales; however, due to the highly specialized nature of many of our product offerings, we do not expect broad market penetration in many of these markets. We are continuing to evaluate buying patterns and opportunities for growth in these markets that may affect our future performance.

Outside of the Semi Market, we have developed a meaningful market share in one other market, which is the induction heating market for systems with 500kW or less of power. This market is a subset of the industrial market. In contrast to the Semi Market, where we serve a range of customers and where our business trends generally follow overall market trends within the Semi Market, in the industrial market, where induction heating products are used, we serve a limited number of market participants representing only a portion of this market. Therefore, market trends in this area do not have as material an impact on our financial results. The following discussion of our markets is, therefore, limited to the Semi Market.

-5-

Semi Market

As noted above, the Semi Market includes both the broader semiconductor market as well as the more specialized semiconductor ATE and wafer processing sectors within the broader semiconductor market. Historically, the Semi Market has been characterized by rapid technological change, wide fluctuations in demand and shortening product life cycles. Designers and manufacturers of a variety of electronic and industrial products, such as cell phones, telecom and datacom systems, Internet access devices, computers, transportation and consumer electronics, require increasingly complex ICs to provide improved end-product performance demanded by their customers. Semiconductor manufacturers generally compete based on product performance and price. We believe that testing costs represent a significant portion of the total cost of manufacturing ICs. Semiconductor manufacturers remain under pressure to maximize production yields and reduce testing costs. At the same time, the growing complexity of ICs has increased the difficulty of maximizing test yields. In order to address these market trends, semiconductor manufacturers strive for more effective utilization of ATE, smaller test areas and increased wafer level testing.

Demand for new ATE and related equipment depends upon several factors, including the test equipment utilization rates of semiconductor manufacturers, the demand for products that incorporate ICs, the increasing complexity of ICs and the emergence of new IC design, production and packaging technologies. Some of the evolutionary changes in IC technologies include the shift to 300 mm wafers in production, system-on-a-chip (“SOC”) where digital, analog and memory functions are combined on a single IC, and chip scale packaging. As a result of these factors and other advances, semiconductor manufacturers may require additional ATE not only to handle increases in production, but also to handle the more sophisticated testing requirements of ICs.

IC Test Process

Semiconductor manufacturers typically produce ICs in multiples of several hundred or more on a silicon wafer that is later separated or "diced" into individual ICs. Extended leads are then attached to the individual ICs for later connection to other electrical components. In most cases, the ICs are then encapsulated in a plastic, ceramic or other protective housing. These process steps are called "packaging."

Wafers are tested before being diced and packaged to ensure that only properly functioning ICs are packaged. This testing step has several names, including "front-end test," "wafer test," "wafer probe" or "wafer sort." In front-end test, an electronic handling device known as a wafer prober automatically positions the wafer under a probe card that is electronically connected to a "test head," which connects electrically to a test system. During front-end testing, there is a growing trend of thermally conditioning the wafer during test. Once the good ICs have been identified, they are packaged.

The packaged ICs also require testing, called "back-end test" or "final test," to determine if they meet design and performance specifications. Packaged ICs are tested after loading into another type of electronic handling device called a "package handler" or "handler," which then transfers the packaged ICs into a test socket that is attached to the test head. These handlers may be temperature controlled for testing.

Testers range in price from approximately $100,000 to over $2.0 million each, depending primarily on the complexity of the IC to be tested. Probers and handlers range in price from approximately $50,000 to $500,000 each. A typical test floor of a large semiconductor manufacturer may have 100 test heads and 100 probers or 250 handlers supplied by various vendors for use at any one time. While larger global semiconductor manufacturers typically purchase ATE to test the ICs they manufacture, there are a growing number of semiconductor manufacturers who outsource IC testing to third-party foundries, test and assembly providers.

Test head manipulators, also referred to as positioners, facilitate the movement of the test head to the electronic device handler. Docking hardware mechanically connects the test head to the wafer prober or handler. Tester interface products provide the electrical connection between the test head and the wafer or packaged IC. Traditionally, temperature management products are used in back-end test to allow a manufacturer to test packaged ICs under the extreme temperature conditions in which the IC may be required to operate. However, we believe that temperature-controlled testing will be an increasingly important part of front-end wafer testing as more parameters traditionally tested in back-end test are moved to front-end test.

Trends in IC Testing

ATE is used to identify unacceptable packaged ICs and bad die on wafers. ATE assists IC manufacturers in controlling test costs by performing IC testing in an efficient and cost-effective manner. In order to provide testing equipment that can help IC manufacturers meet these goals, we believe the ATE market must address the following issues:

-6-

Change in Technology. End-user applications are demanding ICs with increasingly higher performance, greater speeds, and smaller sizes. ICs that meet these higher standards, including SOC designs, are more complex and dense. These technology trends have significant implications for the IC testing process, including:

	●	the need for test heads of higher complexity;
	●	higher signal densities;
	●	increasing test speeds; and
	●	a new generation of testers for SOC and other technologies.

Need for Plug-Compatibility and Integration. Semiconductor manufacturers need test methodologies that will perform increasingly complex tests while lowering the overall cost of testing. This can require combining ATE manufactured by various companies into optimally performing systems. Semiconductor manufacturers have to work closely with various test hardware, software, interface and component vendors to resolve design and compatibility issues in order to make these vendors' products plug-compatible with test equipment manufactured by other vendors.

Testing Under Extreme Conditions. ICs will have to perform across a wider spectrum of temperature and environmental conditions than ever before because of the growing complexity of products in which they are deployed. In recent years, temperature testing has found an increasing role in front-end, wafer-level testing. Creating a uniform thermal profile over much larger wafer areas represents a significant engineering and design challenge for ATE manufacturers.

Demand for Higher Levels of Technical Support. As IC testing becomes more complex, semiconductor manufacturers demand higher levels of technical support on a routine basis. ATE manufacturers must commit appropriate resources to technical support in order to develop close working relationships with their customers. This level of support also requires close proximity of service and support personnel to customers' facilities.

Cost Reduction Through Increased Front-End Testing. As the cost of testing ICs increases, semiconductor manufacturers will continue to look for ways to streamline the testing process to make it more cost-effective, such as the trend to use massive parallel testing, in which semiconductor manufacturers test multiple ICs on the wafer simultaneously. We believe that this factor will lead to more front-end, wafer-level testing.

OUR SOLUTIONS

We focus our development efforts on designing and producing high quality products that provide superior performance and cost-effectiveness. We seek to address each manufacturer's individual needs through innovative and customized designs, use of the best materials available, quality manufacturing practices and personalized service. We design solutions to overcome the evolving challenges facing the Semi Market and other markets that we serve, which we believe provide the following advantages:

Temperature-Controlled Testing. Our Thermostream^(R) products are used by manufacturers in a number of markets to stress test a variety of semiconductor and electronic components, printed circuit boards and sub-assemblies. Factors motivating manufacturers to use temperature testing include design characterization, failure analysis and quality control, as well as determining performance under extreme operating temperatures, all of which contribute to manufacturing cost savings. Our thermal platforms and temperature chambers, sold under our Sigma Systems product line, can accommodate large thermal masses and are found in both laboratory and production environments. Thermonics' products provide a range of precision temperature forcing systems and have been melded into Temptronic's ATS ThermoStream product line. The Thermonics brand is now used to market a family of process chillers for test and industrial applications.

Induction Heating. Our acquisition of Ambrell added induction heating capabilities to our product offerings, which can be used by customers in process applications where precision controlled heating is needed. Customers use our induction heating products in conjunction with other technologies in various manufacturing environments to improve production efficiencies. Applications for our EKOHEAT^(R) or EASYHEAT™ induction heating products include annealing, bonding, brazing, curing, forging, heat treating, melting, shrink-fitting and testing.

Scalable, Universal, High Performance Interface Technology. Our universal test head manipulators provide a high degree of positioning flexibility with a minimum amount of effort. As a result, our products can be used in virtually any test setting. Our manipulator products are designed to accommodate the increased size of test heads. Our docking hardware products offer precise control over the connection to test sockets, probing assemblies and interface boards, reducing downtime and minimizing costly damage to fragile components. Our newest manipulator and docking hardware designs offer automated capabilities that allow for reduced downtime and increased productivity through predictable and repeatable production setup with reduced risk of operator error. Our tester interface products optimize the integrity of the signals transmitted between the test head and the device under test by being virtually transparent to the test signals. This results in increased accuracy of the test data and may thus enable improved test yields. We believe that these characteristics will gain even more significance as testing becomes even more demanding.

-7-

Compatibility and Integration. A hallmark of our products has been, and continues to be, compatibility with a wide variety of ATE. Our manipulator and docking hardware products are all designed to be used with otherwise incompatible ATE. We believe this integrated approach to ATE facilitates smooth changeover from one tester to another, longer lives for interface components, better test results, increased ATE utilization and lower overall test costs.

Worldwide Customer Service and Support. We have long recognized the need to maintain a physical presence near our customers' facilities. As of December 31, 2020, we had domestic manufacturing facilities in Massachusetts, New Jersey and New York and provided service to our customers from sales and service personnel based in the U.S., Europe and Asia. Our engineers are easily accessible to, and can work directly with, most of our customers from the time we begin developing our initial proposal, through the delivery, installation and use of the product by our customer. In this way, we are able to develop and maintain close relationships with our customers.

OUR STRATEGIES

In connection with the changes in our executive management team during the third quarter of 2020, which are discussed further in Note 3 to our consolidated financial statements, we have recently announced changes in our corporate vision and strategy. Our corporate vision is to become the supplier of choice for innovative test and process technology solutions. We are committed to becoming recognized as a leader in our markets for design and manufacturing capabilities that result in high quality and cost-effective test and process solutions combined with a customer focus that drives a high level of customer satisfaction. We intend to achieve this vision through developing unique and differentiated solutions for the customers and industries we serve while at the same time expanding our portfolio of products, services, and support to drive increased value to our customers, thereby driving increased revenue for us. Our core strategies that we believe will allow us to achieve this vision and provide sustainable long-term growth are as follows:

Global and Market Expansion. We believe we can provide significant and sustainable long-term growth through a larger installed product base. In order to achieve this objective, we intend to make investments to drive further penetration in our existing markets. This may include initiatives to increase revenue both by selling a broader array of our current portfolio of products to our existing customer base as well as by expanding our customer base within these markets. In addition, we intend to increase our global footprint and coverage to better serve new and existing customers. Finally, our strategy in this area includes targeting expansion into new markets with our existing product portfolio.

Innovation and Differentiation. We plan to continue leveraging our know-how and expertise to deliver innovative solutions which we believe our competitors cannot match. We intend to allocate increased engineering resources towards developing new and unique solutions that are broadly applicable through standardized platforms that offer late-stage configuration. We believe this focus on driving more standardization to increase market availability and lower costs can positively impact our operational results as well as increase the breadth and depth of our customer base, both of which we expect will drive long-term sustainable growth in our revenue.

Service and Support. We believe service and support activities are valuable in strengthening customer satisfaction, loyalty and retention. Through ensuring that we serve our customers’ needs, whether by expanding service coverage and decreasing response time or through expanded and enhanced service offerings, we believe we can drive revenue growth and solidify our customer relationships. We plan to achieve these objectives by adding more resources to fill areas where we have identified gaps in service and support, as well as through adding remote service capabilities which can monitor the health of our products that are onsite at customer locations. In addition, we intend to focus on expanding our product portfolio to include more consumable products. We believe that increasing the number of ways and the frequency with which we make customer contacts can drive growth in our business in the future.

Strategic Acquisitions & Partnerships. Another element of our growth strategy has been, and will continue to be, to acquire businesses, technologies or products that are complementary to our current product offerings. We have acquired several businesses that have enabled us to expand our line of product offerings and have given us the opportunity to market a broader range of products to our customer base. We intend to continue to pursue acquisitions that help build our portfolio of technologies to better serve customers. These could be acquisitions which add to an existing business by expanding its product line or geographic presence, or new businesses that would allow us to expand our customer base and our served markets. We intend to explore opportunities across both of our product segments with the goal of expanding our electronic test capabilities, widening our thermal test capabilities in areas such as environmental test, and building out around the processing technologies that Ambrell added to our product offerings.

Talent and Culture. We believe ensuring the right people are in the right roles and are empowered to deliver success is crucial to the achievement of our core strategies. In addition, we intend to create a culture and environment of openness, one that is results-oriented and drives accountability across the organization. Finally, we intend to foster diversity and inclusion and provide opportunities for career development so as to maximize employee engagement, all of which is necessary to achieving our corporate vision.

-8-

OUR SEGMENTS

As noted above, we have two operating segments, Thermal and EMS, which are also our reporting units. Our Thermal segment consists of (i) inTEST Thermal Solutions (“iTS”), which manufactures and sells products under the Temptronic, Sigma and Thermonics brand names, and (ii) Ambrell. iTS has operations in Massachusetts, Germany and Singapore. Ambrell has operations in New York, the Netherlands and the U.K. Customers use the thermal solutions produced by iTS for product development, characterization and production test or process applications. Ambrell provides customers with induction heating system solutions for conditioning, joining, and forming conductive materials in the manufacturing process. Our Thermal segment provides these solutions across an array of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications.

Our EMS segment consists of our manufacturing operations in New Jersey and, prior to December 31, 2020, our manufacturing operations in California. As discussed further in Note 3 to our consolidated financial statements, during the fourth quarter of 2020, we transitioned the manufacturing operations that had been performed in California to our operation in New Jersey. Semiconductor manufacturers use our EMS solutions in back-end testing where our mechanical and electrical products serve production testing of wafers and specialized packaged ICs. These ICs include microprocessors, digital signal processing chips, mixed signal devices, MEMS (Micro-Electro-Mechanical Systems), application specific ICs and specialized memory ICs, and are used primarily in the automotive, defense/aerospace, industrial, medical and telecommunications markets. We custom design most of our products for each customer's particular combination of ATE.

Thermal Products

ThermoStream^(R) Products: Our ThermoStream^(R) products are used in the Semi Market as a stand-alone temperature management tool, or in a variety of electronic test applications as part of our MobileTemp systems. ThermoStream^(R) products provide a source of heated and cooled air that can be directed over the component or device under test. These systems are capable of controlling temperatures to within +/- 0.1 degree Celsius over a range of -100 degrees Celsius to as high as +300 degrees Celsius within 1.0 degree Celsius of accuracy. As a stand-alone tool, ThermoStreams^(R) provide a temperature-controlled air stream to rapidly change and stabilize the temperature of packaged ICs and other devices.

Our MobileTemp Series combines our ThermoStream^(R) products with our family of exclusive, high-speed ThermoChambers to offer thermal test systems with fast, uniform temperature control in a compact package enabling temperature testing at the test location. MobileTemp Systems are designed specifically for small thermal-mass applications beyond the Semi Market and have found application in the automotive, electronic, fiber optic and oil field service markets testing such things as electronic sub-assemblies, sensor assemblies, and printed circuit boards.

Traditionally, our customers use ThermoStream^(R) products primarily in engineering, quality assurance and small-run manufacturing environments. ThermoStream^(R) and MobileTemp products range in price from approximately $15,000 to $50,000.

Thermal Chambers: Our chamber products are available in a variety of sizes, from small bench-top units to chambers with internal volumes of twenty-seven cubic feet and greater and with temperature ranges as wide as from -190 degrees Celsius to +500 degrees Celsius. Chambers can be designed to utilize liquid nitrogen or liquid carbon dioxide cooling or mechanical refrigeration, and sometimes both. These chambers can accommodate large thermal masses and are found in both laboratory and production environments. Chambers are priced from $15,000 to $150,000.

Thermal Platforms: Our platforms are available in surface sizes ranging from 7.2 square inches to 616 square inches. They provide a flat, thermally conductive, precisely temperature controllable surface that is ideal for conditioning of testing devices with a flat surface. Platforms are available with temperature ranges as broad as -100 degrees Celsius to +250 degrees Celsius. Thermal platforms can be designed to utilize either liquid nitrogen or liquid carbon dioxide cooling or mechanical refrigeration. Platforms offer virtually unimpeded access to the device under test and their easy access and compact size makes them ideal for convenient bench-top use. Platforms are priced from $6,500 to $65,000.

Thermonics^(R) Products: Our Thermonics temperature conditioning products, which include our process chillers, provide tempered gas or fluid to enable customers to maintain desired thermal conditions within their tool or process. Applications include general industrial, chemical processing, energy, electronics, automotive, defense/aerospace and semiconductor markets. Prices range from $20,000 to greater than $250,000.

EKOHEAT^(R) Products: Our EKOHEAT^(R) induction heating systems with power ratings from 10kW to 500kW are manufactured by Ambrell and are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically conductive materials in order to transform raw materials into finished parts. Prices range from $25,000 to $250,000.

EASYHEAT™ Products: Our compact EASYHEAT™ induction heating systems with power ratings from 1kW to 10kW are manufactured by Ambrell are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically conductive materials in order to transform raw materials into finished parts. Prices range from $5,000 to $25,000.

-9-

Applications for both EKOHEAT^(R) and EASYHEAT™ products include annealing, bonding, brazing, curing, forging, heat treating, melting, shrink-fitting, soldering and testing.

EMS Products

Manipulator Products. We offer three lines of manipulator products: the in2^(R), the Cobal and the LS Series. These free-standing universal manipulators can hold a variety of test heads and enable an operator to reposition a test head for alternate use with any one of several probers or handlers on a test floor.

Our manipulator products incorporate a balanced floating-head design. This design permits a test head weighing up to 1,760 pounds to be held in an effectively weightless state, so it can be moved manually or with optional powered assistance, up or down, right or left, forward or backward and rotated around each axis (known as six degrees of motion freedom) by an operator using a modest amount of force or with a computer controlled pendant. The same design features enable the operator to dock the test head without causing inadvertent damage to the fragile electrical contacts. As a result, after testing a particular production lot of ICs, the operator can quickly and easily disconnect a test head that is held in an in2^(R) or Cobal Series manipulator and equipped with our docking hardware and dock it to another electronic device handler for testing either a subsequent lot of the same packaged ICs or to test different ICs. With the LS Series manipulators, the undocking, movement of the test head and redocking can be done automatically through the pendant. Our manipulator products range in price from approximately $12,000 to $75,000.

Docking Hardware Products. We offer two lines of docking hardware products: fixed manual docking and IntelliDock pin and cup docking. Both types protect the delicate interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly or the handler's test socket as they are brought together, or "docked." Fixed manual docking includes a mechanical cam mechanism to dock and lock the test head to the prober or handler. IntelliDock is an automated docking solution that provides operator feedback for each docking step via a touchscreen display, and when coupled with the LS Series manipulator, redeployment of the test head can be done automatically and accurately via the computer pendant. Both types of docking hardware products eliminate motion of the test head relative to the prober or handler once docked. This minimizes deterioration of the interface boards, test sockets and probing assemblies that is caused by constant vibration during testing. Our docking hardware products are used primarily with floating-head universal manipulators when maximum mobility and inter-changeability of handlers and probers between test heads is required. By using our docking hardware products, semiconductor manufacturers can achieve cost savings through improved ATE utilization, improved accuracy and integrity of test results, optimized floor support and reduced repairs and replacements of expensive ATE interface products.

We believe our docking hardware products offer our customers the ability to make various competing brands of test heads compatible with various brands of probers and handlers by only changing interface boards. This is called "plug-compatibility." Plug-compatibility enables increased flexibility and utilization of test heads, probers and handlers purchased from various ATE manufacturers. We believe that because we do not compete with ATE manufacturers in the sale of probers, handlers or testers, ATE manufacturers are willing to provide us with the information that is integral to the design of plug-compatible products. Our docking hardware products range in price from approximately $2,000 to $25,000.

Interface Products. Our tester interface products provide the electrical connections between the tester and the wafer prober or IC handler to carry the electrical signals between the tester and the probe card on the prober or the test socket on the handler. Our designs optimize the integrity of the transmitted signal. Therefore, our tester interfaces can be used with high speed, high frequency, digital or mixed signal testers used in testing more complex ICs. Because our tester interface products enable the tester to provide more reliable yield data, our interfaces may also reduce IC production costs. We design standard and modular interface products to address most possible tester/prober combinations on the market today. In addition, we provide a custom design service that will allow any of our customers to use virtually any tester, prober or handler combination with any type of device, such as analog, digital, mixed signal and radio frequency. For example, our Centaur^(R) modular interface is designed to provide flexibility and scalability through the use of replaceable signal modules which can be easily changed on the test floor as our customers' testing requirements change. In addition to the Centaur^(R) modular interface, we also offer over 200 different types of tester interface models that we custom designed for our customers' specific applications. These tester interface products range in price from approximately $7,000 to $110,000.

Financial Information About Operating Segments and Geographic Areas

Please see Note 16 to the consolidated financial statements included in Item 8 of this Report on Form 10-K for additional data regarding net revenues, profit or loss and total assets of each of our segments and revenues attributable to foreign countries.

-10-

MARKETING, SALES AND CUSTOMER SUPPORT

We market and sell our products primarily in markets where semiconductors are manufactured. North American and European semiconductor manufacturers, as well as third-party foundries, test and assembly providers, have located most of their back-end factories in Southeast Asia. The front-end wafer fabrication plants of U.S. semiconductor manufacturers are primarily in the U.S. Likewise, European, Taiwanese, South Korean and Japanese semiconductor manufacturers generally have located their wafer fabrication plants in their respective countries. We have been providing a greater number of engineered solutions to markets outside the Semi Market. These are thermal-based solutions that fall into the categories of test and process, involving automotive, defense/aerospace, industrial, medical and telecommunications markets.

Thermal Products: We market our thermal products brands, Temptronic, Sigma and Thermonics, under the umbrella name of inTEST Thermal Solutions and sales to ATE manufacturers are handled directly by our own sales force. Sales to semiconductor manufacturers and customers in other markets in the U.S. are handled through independent sales representative organizations. In Singapore and Malaysia, our sales and service are handled through our internal sales and service staff. In the rest of Asia, our sales are handled through distributors. In Europe, sales managers at our office in Germany, as well as regional distributors and independent sales representatives, sell to semiconductor manufacturers and customers in other markets. We communicate with our distributors regularly and have trained them to sell and service our thermal products.

We market our EASYHEAT™ and EKOHEAT^(R) precision induction heating equipment to manufacturers who require specialized industrial heating in a wide array of industries, including automotive, aerospace and semiconductor, and are sold globally through a combination of regional sales managers, independent sales representatives and independent distributors. In North America, direct regional sales managers provide sales coverage augmented by independent sales representatives. In Europe, direct sales managers provide sales coverage augmented by independent distributors. In Asia, distributors have responsibility for sales and service of our products. We generate a significant portion of our sales leads through our website as well as through trade show attendance. However, as a result of COVID-19, the majority of the trade shows we would have normally attended were either canceled or held virtually during 2020. We believe this negatively impacted our revenue for our induction heating products during 2020. We continue to focus on other methods of lead generation and expect that trade show attendance will resume in 2021.

We also provide induction heating product support through our SmartCARE Service offering, which includes equipment repairs and training, preventative maintenance, enhanced warranties and spare parts. Our field service engineers, located in the U.S. and Europe, provide service and support globally. Additionally, a number of distributors in Europe and Asia have factory-trained service technicians.

EMS Products: In North America, we sell to semiconductor manufacturers principally through independent, commissioned sales representatives. North American sales representatives also coordinate product installation and support with our technical staff and participate in trade shows. As a result of COVID-19, the majority of the trade shows we would have normally attended were either canceled or held virtually during 2020, however, unlike for our induction heating products, our sales lead generation activities are not significantly reliant on trade show attendance.

Our internal sales account managers handle sales to ATE manufacturers and are responsible for a portfolio of customer accounts and for managing certain independent sales representatives. In addition, our sales account managers are responsible for pricing, quotations, proposals and transaction negotiations, and they assist with applications engineering and custom product design. Technical support is provided to North American customers and independent sales representatives by employees based in New Jersey, California and Texas.

In Europe, we sell to semiconductor and ATE manufacturers through our internal sales staff. Technical support is provided by our staff in the U.K. In China, Japan, the Philippines, South Korea, and Thailand, we sell through the use of independent sales representatives who are supervised by our internal sales staff. In Malaysia, Singapore and Taiwan, our sales are handled by our internal sales staff. International sales representatives are responsible for sales, installation, support and trade show participation in their geographic market areas. Technical support is provided to Asian customers primarily by employees based in Malaysia, the Philippines and Taiwan.

CUSTOMERS

We market all of our products to end users including semiconductor manufacturers, third-party foundries and test and assembly providers, as well as to original equipment manufacturers ("OEMs"), which include ATE manufacturers and their third-party outsource manufacturing partners. In the case of thermal products, we also market our products to independent testers of semiconductors, manufacturers of automotive, defense/aerospace, industrial, medical and telecommunications products, semiconductor research facilities, and manufacturers and manufacturing process integrators for a variety of industrial process applications. Our customers use our products principally in production testing or process/manufacturing applications, although our ThermoStream^(R) products traditionally have been used largely in engineering development and quality assurance. We believe that we sell to most of the major semiconductor manufacturers in the world.

-11-

During the year ended December 31, 2020, no customer accounted for 10% or more of our consolidated net revenues. During the year ended December 31, 2019, Texas Instruments Incorporated accounted for 10% of our consolidated net revenues. While both of our operating segments sold products to this customer, these revenues were primarily generated by our EMS segment. During the year ended December 31, 2019, no other customer accounted for 10% or more of our consolidated net revenues. Our ten largest customers accounted for approximately 35% and 34% of our consolidated net revenues in 2020 and 2019, respectively. The loss of any one or more of our largest customers, or a reduction in orders by a major customer, could materially reduce our net revenues or otherwise materially affect our business, financial condition or results of operations.

Our largest customers in 2020 include:

Semiconductor Manufacturers	Other
Aixtron SE	Emerson Electric Co.
Analog Devices, Inc.	Hakuto Co. Ltd.
NXP Semiconductors N.V.	Lockheed Martin Corporation
QUALCOMM Incorporated	Raytheon Company
Renesas Electronics Corporation
Texas Instruments Incorporated

MANUFACTURING AND SUPPLY

As of December 31, 2020, our principal manufacturing operations consisted of assembly and testing at our facilities in Massachusetts, New Jersey and New York. As discussed further in Note 3 to our consolidated financial statements, during the fourth quarter of 2020, we transitioned the manufacturing of our tester interface products from our facility in Fremont, California to our facility in Mt. Laurel, New Jersey. We assemble most of our products from a combination of standard components and custom parts that have been fabricated to our specifications by either third-party manufacturers or our own fabrication operation in New Jersey. Our practice is to use the highest quality raw materials and components in our products. The primary raw materials used in fabricated parts are widely available. Substantially all of our components are purchased from multiple suppliers, however certain raw materials and components are sourced from single suppliers. Although, from time to time, certain components may be in short supply due to high demand or inability of vendors to meet quality or delivery requirements, we believe that all materials and components are available in adequate amounts from other sources.

We conduct inspections of incoming raw materials, fabricated parts and components using sophisticated measurement equipment. This includes testing with coordinate measuring machines in all but one of our manufacturing facilities to ensure that products with critical dimensions meet our specifications. We have designed our inspection standards to comply with applicable MIL specifications and ANSI standards.

Our Massachusetts facility is ISO 9001:2015 certified. Our New York facility is ISO 9001:2015 certified. Our New Jersey facility manufacture products only for the semiconductor industry where ISO certification is not required. However, this location does employ the practices embodied in the ISO 9001:2008.

ENGINEERING AND PRODUCT DEVELOPMENT

Our success depends on our ability to provide our customers with products and solutions that are well engineered and to design those products and solutions before, or at least no later than, our competitors. As of December 31, 2020, we employed a total of 45 engineers engaged in engineering and product development. In addition, when the demands of engineering and product development projects exceed the capacity or knowledge of our in-house staff, we retain temporary third-party engineering and product development consultants to assist us. Our practice in many cases is to assign engineers to work with specific customers, thereby enabling us to develop the relationships and exchange of information that is most conducive to successful product development and enhancement. In addition, some of our engineers are assigned to new product research and development and have worked on such projects as the development of new types of universal manipulators, the redesign and development of new thermal products and the development of high-performance interfaces.

Since most of our products are customized, we consider substantially all of our engineering activities to be engineering and product development. We spent approximately $5.0 million in each of the years ended December 31, 2020 and 2019 on engineering and product development.

-12-

PATENTS AND OTHER PROPRIETARY RIGHTS

Our policy is to protect our technology by filing patent applications for the technologies that we consider important to our business. We also rely on trademarks, trade secrets, copyrights and unpatented know-how to protect our proprietary rights. It is our practice to require that all of our employees and third-party product development consultants assign to us all rights to inventions or other discoveries relating to our business that were made while working for us. In addition, all employees and third-party product development consultants agree not to disclose any private or confidential information relating to our technology, trade secrets or intellectual property.

As of December 31, 2020, we held 62 active U.S. patents and had two pending U.S. patent applications covering various aspects of our technology. Our U.S. patents expire at various times beginning in 2021 and extending through 2038. During 2020, two U.S. patents were issued and four U.S. patents expired. We do not believe that the upcoming expiration of certain of our patents in 2021 will have a material impact on our business. We also hold foreign patents and file foreign patent applications, in selected cases corresponding to our U.S. patents and patent applications, to the extent management deems appropriate.

While we believe that our patents and other proprietary rights are important to our business, we also believe that, due to the rapid pace of technological change in the markets we serve, the successful manufacture and sale of our products also depends upon our engineering, manufacturing, marketing and servicing skills. In the absence of patent protection, we would be vulnerable to competitors who attempt to copy or imitate our products or processes. We believe our intellectual property has value, and we have taken in the past, and will take in the future, actions we deem appropriate to protect such property from misappropriation. There can be no assurance, however, that such actions will provide meaningful protection from competition. For additional information regarding risks related to our intellectual property, see the "Risk Factors" section of this Report.

COMPETITION

We operate in an increasingly competitive environment within both of our operating segments. Some of our competitors have greater financial resources and more extensive design and production capabilities than us. Certain markets in which we operate have become more fragmented, with smaller companies entering the market. These new smaller entrants typically have much lower levels of fixed operating overhead than us, which enables them to be profitable with lower priced products. In order to remain competitive with these and other companies, we must continue to commit a significant portion of our personnel, financial resources, research and development and customer support to developing new products and maintaining customer relationships worldwide.

Our competitors include independent manufacturers, ATE manufacturers and, to a lesser extent, semiconductor manufacturers' in-house ATE interface groups. Competitive factors in the markets we serve include price, functionality, timely product delivery, customer service, applications support, product performance and reliability. We believe that our long-term relationships with our customers in the various markets we support and our commitment to, and reputation for, providing high quality products, are important elements in our ability to compete effectively in all of our markets.

Our principal competitors for Thermostream^(R) products are FTS Systems, a part of SP Industries, and MPI Corporation. Our principal competitors for environmental chambers are Cincinnati Sub-Zero Products, Inc., Espec Corp. and Thermotron Industries. Our principal competitor for thermal platforms is Environmental Stress Systems Inc. Our principal competitors for EKOHEAT^(R) and EASYHEAT™ products are Inductotherm Corporation, Park-Ohio Holdings, EFD Induction Corporation, Trumpf Huettinger GmbH, Ultraflex Power Technologies and CEIA SpA.

Our principal competitors for manipulator products are Advantest Corporation, Esmo AG, Reid-Ashman Manufacturing and Teradyne, Inc. Our principal competitors for docking hardware products include Advantest Corporation, Esmo AG, Knight Automation, Reid-Ashman Manufacturing and Teradyne, Inc. Our principal competitors for tester interface products are Advantest Corporation, Esmo AG, Reid-Ashman Manufacturing and Teradyne, Inc.

BACKLOG

At December 31, 2020, our backlog of unfilled orders for all products was $11.5 million compared with $5.5 million at December 31, 2019. Our backlog includes customer orders that we have accepted, substantially all of which we expect to deliver in 2021. While backlog is calculated on the basis of firm purchase orders, a customer may cancel an order or accelerate or postpone currently scheduled delivery dates. Our backlog may be affected by the tendency of customers to rely on shorter lead times available from suppliers, including us, in periods of depressed demand. In periods of increased demand, there is a tendency towards longer lead times, which has the effect of increasing backlog. As a result of these factors, our backlog at a particular date is not necessarily indicative of sales for any future period.

EMPLOYEES

At December 31, 2020, we had 204 employees (199 of which were full-time), including 112 in manufacturing operations, 54 in customer support/operations and 38 in administration. Substantially all of our key employees are highly skilled and trained technical personnel. None of our employees are represented by a labor union, and we have never experienced a work stoppage. From time to time, we retain third-party contractors to assist us in manufacturing operations and engineering and product development projects.

-13-

ADDITIONAL INFORMATION

Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and amendments to these reports that are filed with the SEC pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), are available free of charge through our website (www.intest.com) as soon as reasonably practicable after we electronically file them with, or furnish them to, the SEC. We also routinely post press releases, presentations, webcasts and other information regarding the Company on our website. The information posted to our website is not part of this Report.

Item 1A. RISK FACTORS

The following are some of the factors that could materially and adversely affect our future performance or could cause actual results to differ materially from those expressed or implied in our forward-looking statements. The risks and uncertainties described below are not the only risks facing us and we cannot predict every event and circumstance that may adversely affect our business. However, these risks and uncertainties are the most significant factors that we have identified at this time. If one or more of these risks actually occurs, our business, results of operations and/or financial condition could suffer, and the price of our stock could be negatively affected.

RISKS RELATED TO COVID-19

Our business, results of operations and financial condition and the market price of our common stock have been and may continue to be adversely affected by the COVID-19 pandemic.

During the first half of 2020, our business was adversely affected by the COVID-19 pandemic. During the second half of the year, the negative impact of COVID-19 on our business was reduced significantly. However, COVID-19 continues to cause disruptions, both domestically and globally, and we believe the situation will remain challenging until the spread of the virus or variants of the virus can be contained which we believe will not occur until the global dissemination and inoculation of recently introduced vaccines is substantially complete. As of the date of this filing, all of our operations continue to be deemed “critical and essential business operations” under the various governmental COVID-19 mandates which has allowed us to continue to operate our business with certain modifications. The spread of the virus or variants of the virus could worsen and one or more of our significant customers or suppliers could be impacted, or significant additional governmental regulations and restrictions could be imposed, thus negatively impacting our business in the future.

We have had occasions where one or more employees have contracted COVID-19 and entered our facilities while infected. We have managed these occurrences with minimal disruption to our business while protecting other employees, but there can be no assurances that we can avoid similar occurrences in the future or that, in such cases, we can avoid significant disruption of our operations as a result of such occurrences. Should this occur, or should we have employees who become ill or otherwise are unable to work as a result of COVID-19, we may experience limitations in employee resources or may be required to close affected facilities for a time to clean and disinfect appropriately, and allow employees to quarantine, as appropriate.

Generally, global supply chains and the timely availability of products have been materially disrupted by quarantines, factory slowdowns or shutdowns, border closings and travel restrictions resulting from COVID-19. To date, we have not experienced significant price increases or lack of availability from our normal suppliers for the materials needed to produce our products in a timely manner and/or with the level of margins we typically expect to achieve. However, if the spread of COVID-19 or its variants is not further contained and one or more of our significant suppliers is negatively impacted, we could experience delays in receipt of materials or price increases in the future which could have a material negative impact on our business, results of operations and financial condition.

-14-

The adverse effects of COVID-19 on our business could be material in future periods, particularly if there are significant and prolonged economic slowdowns in regions where we derive a significant amount of our revenue or profit, or where our suppliers are located, or if we are forced to close facilities and limit or cease manufacturing operations for extended periods of time. We could experience delays in receipt of customer orders, cancellation or postponement of existing orders. Further, as a result of COVID-19, our ability to fulfill orders within the proposed parameters at the time of order, including within the approximated timeline and estimated cost, may be negatively affected. This could lead to a reduction in revenue and/or an increase in our cost of revenues in future periods and could have a material adverse effect on our business, results of operations and financial condition. COVID-19 has also led to extreme volatility in capital markets and has adversely affected, and may adversely affect, the market price of our common stock in the future. As a result of any negative impact of COVID-19 on our business, results of operations, financial condition and cash flows, we may determine that our goodwill and long-lived assets are impaired, which would result in recording an impairment charge. The amount of any such impairment charge could be material.

RISKS RELATED TO OUR MARKETS

Our sales are affected by the cyclicality of the Semi Market, which causes our operating results to fluctuate significantly.

Our business depends in significant part upon the capital expenditures of semiconductor manufacturers. Capital expenditures by these companies depend upon, among other things, the current and anticipated market demand for semiconductors and the products that utilize them. Typically, semiconductor manufacturers curtail capital expenditures during periods of economic downturn. Conversely, semiconductor manufacturers increase capital expenditures when market demand requires the addition of new or expanded production capabilities or the reconfiguration of existing fabrication facilities to accommodate new products. These market changes have contributed in the past, and will likely continue to contribute in the future, to fluctuations in our operating results.

We seek to further diversify the markets for our thermal products in order to increase the proportion of our sales attributable to markets which are less subject to cyclicality than the Semi Market. If we are unable to do so, our future performance will remain substantially exposed to the fluctuations of the cyclicality of the Semi Market.

Since 2009, we have sold our thermal products in markets outside of the Semi Market, including the automotive, defense/aerospace, industrial, medical and telecommunications markets. We refer to these other markets collectively as Multimarket. During 2020 and 2019, our Multimarket sales were $27.0 million and $29.7 million, respectively, and represented 50% and 49% of our consolidated net revenues, respectively. Prior to our acquisition of Ambrell, we offered only highly specialized engineering solutions in Multimarket, the demand for which is limited and which we expect may vary significantly from period to period. Our goal is to increase our Multimarket sales; however, in most cases, the expansion of our thermal product sales into these new markets has occurred in the last several years, and we may experience difficulty in expanding our sales efforts further into these markets. These difficulties could include hiring sales and marketing staff with sufficient experience selling into these new markets and our ability to continue to develop products which meet the needs of customers in these markets and which are not currently offered by our competitors. In addition, due to the highly specialized nature of certain of our product offerings in Multimarket, we do not expect broad market penetration in many of these markets. If we are unable to expand our Multimarket sales, our net revenues and results of operations will remain substantially dependent upon the cycles of the Semi Market.

RISKS RELATED TO OUR BUSINESS OPERATIONS

The efficiencies or benefits we expect from the consolidation of our EMS manufacturing operations may not be realized which could result in higher-than-expected costs in future periods, a negative impact on our reputation and lost business opportunities.

On September 21, 2020, we notified employees in our Fremont, California facility of a plan to consolidate all manufacturing operations for our EMS segment into our manufacturing operations located in Mt. Laurel, New Jersey. Prior to the consolidation, our interface products were manufactured in the Fremont facility, and our manipulator and docking hardware products were manufactured in the Mt. Laurel facility. The consolidation was substantially completed during the fourth quarter of 2020. We are also currently in the process of reducing the size of our manufacturing facility in Mt. Laurel from approximately 55,000 square feet to approximately 34,000 square feet. The consolidation of manufacturing operations and footprint reduction in the Mt. Laurel facility were undertaken to better serve customers through streamlined operations and reduce the fixed annual operating costs for the EMS segment. A small engineering and sales office will be maintained in northern California. If we do not achieve the efficiencies and benefits we currently anticipate as a result of the consolidation, or if we determine that the reduction in manufacturing space is not sustainable, our costs could be higher than we currently expect in future periods.

-15-

The EMS facility consolidation resulted in the termination of certain employees at the Fremont location, including all of our interface product line assembly staff who were located at that facility. As a result of transitioning our interface manufacturing operations to New Jersey, we have hired new production staff for this product line in our Mt. Laurel facility. These new employees are being trained to assemble our products and therefore are not yet as efficient or experienced as the employees that were terminated in the Fremont location. As a result, we may experience increased lead times for our interface products for the next several months which could impact customer shipments as well as quality of our interface products. This may be further exacerbated by the recent surge in demand that we have experienced for our EMS products. If we do not meet our customers’ expectations for on-time delivery and quality, this could impact our reputation and result in lost business opportunities. Additionally, we may incur higher levels of warranty costs over the next several months as a result of the potential inability to meet customer quality requirements. This could increase our costs in future periods. The occurrence of any of these events could have a material adverse effect on our business, results of operations and financial condition in future periods.

If our suppliers do not meet product or delivery requirements, we could have reduced revenues and earnings.

Certain components of our products may be in short supply from time to time because of high demand or the inability of some vendors to consistently meet our quality or delivery requirements. A significant portion of our material purchases require some custom work, and there are not always multiple suppliers capable of performing such custom work on a timely or cost-effective basis. If any of our suppliers were to cancel commitments or fail to meet quality or delivery requirements needed to satisfy customer orders for our products, we could lose time-sensitive customer orders, have reduced revenues and earnings, and be subject to contractual penalties, any of which could have a material adverse effect on our business, results of operations and financial condition.

A breach of our operational or security systems could negatively affect our business, our reputation and results of operations.

We rely on various information technology networks and systems, some of which are managed by third parties, to process, transmit and store electronic information, including confidential data, and to carry out and support a variety of business activities, including manufacturing, research and development, supply chain management, sales and accounting. A failure in, or a breach of, our operational or security systems or infrastructure, or those of our suppliers and other service providers, including as a result of cyberattacks, could disrupt our business, result in the disclosure or misuse of proprietary or confidential information, result in litigation, damage our reputation, cause losses and significantly increase our costs. Although we have been the target of security breaches in the past, we have not experienced material losses to date related to such incidents. Nevertheless, there can be no assurance that we will not suffer such losses in the future. In addition, domestic and international regulatory agencies have implemented, and are continuing to implement, various reporting and remediation requirements that companies must comply with upon learning of a breach. While we have insurance that may protect us from incurring some of these costs, there is no assurance that such insurance coverage is adequate to cover all costs and damages incurred in connection with a cyberattack.

Our business may suffer if we are unable to attract and retain key employees or hire personnel at the costs we currently project.

Our future success will depend largely upon the continued services of our senior management and other key employees or the development of successors with commensurate skills and talents in a timely fashion and at the costs we project. If we cannot continue to increase employee salaries and maintain employee benefits commensurate with competitive opportunities, we may not be able to retain our senior management and other key employees. The loss of key personnel could adversely affect our ability to manage our business effectively and could increase our costs in future periods.

We have recently experienced difficulty in hiring personnel at the costs projected in our forecasts. This has resulted in the need to increase the labor rates offered for certain positions. If we cannot find savings in other areas or increase the price for which we sell our products in an amount sufficient to cover these additional labor costs, we may experience reduced margins in future periods.

We have experienced and may continue to experience significant variability in our effective tax rates and may have exposure to additional tax liabilities and costs.

We are subject to income taxes in the U.S. and various other countries in which we operate. Our effective tax rate is dependent on where our earnings are generated and the tax regulations and the interpretation and judgment of administrative tax or revenue entities in the U.S. and other countries. We are also subject to tax audits in the countries where we operate. Any material assessment resulting from an audit from an administrative tax or revenue entity could negatively affect our financial results.

-16-

RISKS RELATED TO OUR AQUISITION STRATEGY

We seek to grow our business through the acquisition of additional businesses. If we are unable to do so, our future rate of growth may be reduced or limited. We may incur significant expenses related to due diligence or other transaction-related expenses for a proposed acquisition that may not be completed.

A key element of our growth strategy is to acquire businesses, technologies or products that are complementary to our current product offerings. We seek to make acquisitions that will further expand our product lines as well as strengthen our positions in served markets and provide expansion into new markets. We may not be able to execute our acquisition strategy and our future growth may be limited if:

	●	we are unable to identify suitable businesses, technologies or products to acquire;
	●	we do not have sufficient cash or access to required capital at the necessary time;
	●	we are unwilling or unable to outbid larger, more resourceful companies; or
	●	we are unable to successfully close proposed acquisitions.

We may incur significant expenses related to due diligence or other transaction-related expenses for a proposed acquisition that may not be completed, which may have a material adverse effect on our financial condition and results of operations.

Our acquisition strategy involves financial and management risks which may adversely affect our results in the future.

If we acquire additional businesses, technologies or products, we will face the following additional risks:

	●	future acquisitions could divert management's attention from daily operations or otherwise require additional management, operational and financial resources;
	●	we might not be able to integrate future acquisitions into our business successfully or operate acquired businesses profitably;
	●	we may realize substantial acquisition related expenses that would reduce our net earnings in future years; and
	●	our investigation of potential acquisition candidates may not reveal problems and liabilities of the companies that we acquire.

If any of the events described above occur, our earnings could be reduced. If we issue shares of our stock or other rights to purchase our stock in connection with any future acquisitions, we would dilute our existing stockholders' interests and our earnings per share may decrease. If we issue or incur debt in connection with any future acquisitions, lenders may require that we pledge our assets to secure repayment of such debt and impose covenants on us, which could, among other things, restrict our ability to increase capital expenditures or to acquire additional businesses.

We may attempt to acquire a substantial business that would require us to issue equity or incur significant debt from third parties. If we are unable to secure sufficient financing at terms that are acceptable to us, we may not be able to close the proposed acquisition. Additionally, should we incur significant debt, we may not be able to achieve compliance with all covenants related to the debt depending on our financial results in future periods.

In connection with our acquisition strategy, we are pursuing potential acquisition opportunities that may be significant in size compared to us, which could require us to issue equity or obtain significant third-party financing to close the proposed transaction. We may encounter difficulties in securing necessary financing at terms that would be acceptable to us and may not be able to close on the proposed acquisition. In addition, should we incur significant third-party debt, our future financial results may be negatively impacted by external factors, such as an economic recession, which may impact our ability to achieve compliance with any covenants related to the debt as well as make the required payments under the terms of the indebtedness.

We may acquire businesses in the future and utilize an earnout structure as we have done in prior transactions we have closed. In connection with the earnout, we may be required to accrue significant increases or decreases to the contingent consideration liability we would establish. These adjustments to the contingent consideration liability could cause our results of operations to have increased variability, which may negatively impact our stock’s trading price.

We may utilize an earnout structure on future acquisitions as we have done in prior transactions we have closed. The initial contingent consideration liability is established as part of the accounting for the business combination. In subsequent periods, we are required to estimate the fair value of the contingent consideration associated with any earnout on a quarterly basis and record an adjustment to the contingent consideration liability in our results of operations for the period concerned. The contingent consideration adjustment we record quarterly may cause increased variability in our future results of operations, which may cause fluctuations in our stock price.

-17-

RISKS RELATED TO OUR CUSTOMER BASE

Changes in the buying patterns of our customers have affected, and may continue to affect, demand for our products and our gross and net operating margins. Such changes in patterns are difficult to predict and may not be immediately apparent.

In addition to the cyclicality of the Semi Market, demand for our products and our gross and net operating margins have also been affected by changes in the buying patterns of our customers. Some of the changes in customer buying patterns that have impacted us in the past, and may continue to do so in the future, have included customers placing heightened emphasis on shorter lead times (which places increased demands on our available engineering and production capacity and may result in increasing unit costs) and ordering in smaller quantities (which prevents us from acquiring component materials in larger volumes at lower unit costs.) We have also experienced customer supply chain management groups demanding lower prices and spreading purchases across multiple vendors. We believe some of the changes in customer buying patterns are the result of changes within the Semi Market over the last several years, including, for example, changing product requirements and longer time periods between new product offerings by OEMs. Such shifts in market practices have had, and may continue to have, varying degrees of impact on our net revenues and our gross and net operating margins. Such shifts are difficult to predict and may not be immediately apparent, and the impact of these practices is difficult to quantify from period to period. There can be no assurance that we will be successful in implementing effective strategies to counter these shifts.

We generate a large portion of our sales from a small number of customers. If we were to lose one or more of our large customers, our operating results could suffer dramatically.

During the year ended December 31, 2020, no customer accounted for 10% or more of our consolidated net revenues. During the year ended December 31, 2019, Texas Instruments Incorporated accounted for 10% of our consolidated net revenues. While both of our operating segments sold products to this customer, these revenues were primarily generated by our EMS segment. During the year ended December 31, 2019, no other customer accounted for 10% or more of our consolidated net revenues. Our ten largest customers accounted for approximately 35% and 34% of our consolidated net revenues in 2020 and 2019, respectively. The loss of any one or more of our largest customers, or a reduction in orders by a major customer could materially reduce our net revenues or otherwise materially affect our business, financial condition or results of operations.

RISKS RELATED TO COMPETITION

Our business is subject to intense competition, which has in the past and could in the future, materially adversely affect our business, financial condition and results of operations.

We face significant competition throughout the world in each of our operating segments. Some of our competitors have substantial financial resources and more extensive design and production capabilities than us. Some of our competitors are much smaller than we are, and therefore have much lower levels of overhead than us, which enables them to sell their competing products at lower prices. In order to remain competitive, we must continually commit a significant portion of our personnel and financial resources to developing new products and maintaining customer satisfaction worldwide. We expect our competitors to continue to improve the performance of their current products and introduce new products or technologies. In the recent past, in response to significant declines in global demand for our products, some competitors have reduced their product pricing significantly, which has led to intensified price-based competition, which has and could continue to materially adversely affect our business, financial condition and results of operations.

Our industry is subject to rapid technological change, and our business prospects would be negatively affected if we are unable to quickly and effectively respond to innovation in the Semi Market.

Semiconductor technology continues to become more complex as manufacturers incorporate ICs into an increasing variety of products. This trend, and the changes needed in automated testing systems to respond to developments in the semiconductor market, are likely to continue. We cannot be certain that we will be successful or timely in developing, manufacturing or selling products that will satisfy customer needs or that will attain market acceptance. Our failure to provide products that effectively and timely meet customer needs or gain market acceptance will negatively affect our business prospects.

-18-

RISKS RELATED TO INTELLECTUAL PROPERTY

Claims of intellectual property infringement by or against us could seriously harm our businesses.

From time to time, we may be forced to respond to or prosecute intellectual property infringement claims to defend or protect our rights or a customer's rights. These claims, regardless of merit, may consume valuable management time, result in costly litigation or cause product shipment delays. Any of these factors could seriously harm our business and operating results. We may have to enter into royalty or licensing agreements with third parties who claim infringement. These royalty or licensing agreements, if available, may be costly to us. If we are unable to enter into royalty or licensing agreements with satisfactory terms, our business could suffer. In instances where we have had reason to believe that we may be infringing the patent rights of others, or that someone may be infringing our patent rights, we have asked our patent counsel to evaluate the validity of the patents in question, as well as the potentially infringing conduct. If we become involved in a dispute, neither the third parties nor the courts are bound by our counsel's conclusions.

RISKS RELATED TO OUR OEPRATING RESULTS AND STOCK PRICE

Our operating results often change significantly from quarter to quarter and may cause fluctuations in our stock price.

Historically, our operating results have fluctuated significantly from quarter to quarter. We believe that these fluctuations occur primarily due to the cycles of demand in the semiconductor manufacturing industry. In addition to these changing cycles of demand, other factors that have caused our quarterly operating results to fluctuate in the past or that may cause fluctuations and losses in the future, include:

	●	the impact of COVID-19 or any other pandemic on our business;
	●	changes in demand in Multimarket including the automotive, defense/aerospace, industrial, medical and telecommunication markets;
	●	the state of the U.S. and global economies;
	●	changes in the buying patterns of our customers including any changes in the rate of, and timing of, purchases by our customers;
	●	the impact of interruptions in our supply chain caused by external factors;
	●	changes in our market share;
	●	costs related to due diligence and transaction-related expenses for a proposed acquisition that does not get completed;
	●	costs and timing of integration of our acquisitions and plant consolidations and relocations;
	●	the technological obsolescence of our inventories;
	●	quantities of our inventories greater than is reasonably likely to be utilized in future periods;
	●	fluctuations in the level of product warranty charges;
	●	competitive pricing pressures;
	●	excess manufacturing capacity;
	●	our ability to control operating costs;
	●	delays in shipments of our products;
	●	the mix of our products sold;
	●	the mix of customers and geographic regions where we sell our products;
	●	changes in the level of our fixed costs;
	●	costs associated with the development of our proprietary technology;
	●	our ability to obtain raw materials or fabricated parts when needed;
	●	increases in costs of component materials;
	●	cancellation or rescheduling of orders by our customers;
	●	changes in government regulations; and
	●	political or economic instability.

Because the market price of our common stock has tended to vary based on, and in relation to, changes in our operating results, fluctuations in the market price of our stock are likely to continue as variations in our quarterly results continue.

-19-

RISKS RELATED TO FOREIGN OPERATIONS

A substantial portion of our customers are located outside the U.S., which exposes us to foreign political and economic risks.

We have operated internationally for many years and expect to expand our international operations to continue expansion of our sales and service to our non-U.S. customers. Our foreign subsidiaries generated 14% and 15% of consolidated net revenues in 2020 and 2019, respectively. Net revenues from foreign customers totaled $31.6 million, or 59% of consolidated net revenues in 2020, and $35.4 million, or 58% of consolidated net revenues in 2019. We expect our net revenues from foreign customers will continue to represent a significant portion of total net revenues. In addition to the risks generally associated with sales and operations in the U.S., sales to customers outside the U.S. and operations in foreign countries are subject to additional risks, which may, in the future, affect our operations. These risks include:

	●	the effects of COVID-19 on markets outside the U.S.;
	●	the effects of certain foreign customers being added to the list of restricted customers by the U.S. Department of Commerce;
	●	the implementation of trade tariffs by the U.S. and other countries that would impact our products;
	●	political and economic instability in foreign countries;
	●	the imposition of financial and operational controls and regulatory restrictions by foreign governments;
	●	the need to comply with a wide variety of U.S. and foreign import and export laws;
	●	local business and cultural factors that differ from our normal standards and practices, including business practices that we are prohibited from engaging in by the Foreign Corrupt Practices Act and other anti-corruption laws and regulations;
	●	trade restrictions;
	●	changes in taxes;
	●	longer payment cycles;
	●	fluctuations in currency exchange rates; and
	●	the greater difficulty of administering business abroad.

A significant portion of our cash position is maintained overseas and we may not be able to repatriate cash from overseas when necessary, which could have an adverse effect on our financial condition.

While much of our cash is in the U.S., a significant portion is generated from and maintained by our foreign operations. As of December 31, 2020, $3.2 million, or 31%, of our cash and cash equivalents were held by our foreign subsidiaries. Our financial condition and results of operations could be adversely impacted if we are unable to maintain a sufficient level of cash flow in the U.S. to address our cash requirements and if we are unable to efficiently and timely repatriate cash from overseas. Any payment of distributions, loans or advances to us by our foreign subsidiaries could be subject to restrictions on, or taxation of, dividends or repatriation of earnings under applicable local law, monetary transfer restrictions and foreign currency exchange regulations in the jurisdictions in which our subsidiaries operate. If we are unable to repatriate the earnings of our subsidiaries, it could have an adverse impact on our ability to redeploy earnings in other jurisdictions where they could be used more profitably.

Item 1B.

UNRESOLVED STAFF COMMENTS

None.

Item 2.

PROPERTIES

At December 31, 2020, we leased seven facilities worldwide. The following chart provides information regarding each of our principal facilities that we leased at December 31, 2020:

Location	Lease Expiration	Approx. Square Footage	Principal Uses
Mansfield, MA	December 2024⁽¹⁾	52,700	Thermal segment operations (principal facility for iTS)
Mt. Laurel, NJ	April 2021⁽²⁾	54,897	Corporate headquarters and EMS segment operations
Fremont, CA	November 2025⁽³⁾	15,746	EMS segment sales and engineering
Rochester, NY	April 2028	79,150	Thermal segment operations (principal facility for Ambrell)

All of our facilities have space to accommodate our needs for the foreseeable future.

(1)

During the fourth quarter of 2020, we reduced the administrative footprint by 6,100 square feet in our Mansfield, Massachusetts corporate office associated with the reestablishment of the Mt. Laurel, New Jersey office as our corporate headquarters, as more fully discussed in Note 3 to our consolidated financial statements.

(2)

On September 22, 2020, we executed an amendment to the lease for our facility in Mt. Laurel, New Jersey, which extended the term of the existing lease for a period of 120 months commencing on May 1, 2021. In addition, effective on August 1, 2021, the leased space will be reduced to approximately 33,650 square feet.

(3)

During the fourth quarter of 2020, we consolidated all manufacturing operations for our EMS segment into our facility in Mt. Laurel, New Jersey, as more fully discussed in Note 3 to our consolidated financial statements.

-20-

Item 3.

LEGAL PROCEEDINGS

From time to time we may be a party to legal proceedings occurring in the ordinary course of business. We are not currently involved in any material legal proceedings.

Item 4.

MINE SAFETY DISCLOSURES

Not applicable.

PART II

Item 5.

MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market for Common Stock

Our common stock is traded on NYSE American LLC (“NYSE American”) under the symbol "INTT." On March 15, 2021, the closing price for our common stock as reported on the NYSE American was $10.06. As of March 15, 2021, we had 10,703,056 shares outstanding that were held by approximately 1,000 beneficial and record holders.

No dividends were paid on our common stock in the years ended December 31, 2020 or 2019. We do not currently plan to pay cash dividends in the foreseeable future. Our current policy is to use any future earnings for reinvestment in the operation and expansion of our business, including possible acquisitions of other businesses, technologies or products and, when approved by our Board of Directors, to repurchase our outstanding common stock. Payment of any future dividends will be at the discretion of our Board of Directors.

Purchases of Equity Securities

There were no shares of our common stock repurchased by us or on our behalf during the three months ended December 31, 2020.

On July 31, 2019, our Board of Directors authorized the repurchase of up to $3.0 million of our common stock from time to time on the open market, in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or in privately negotiated transactions pursuant to a newly authorized stock repurchase plan (the “2019 Repurchase Plan”). Repurchases may be made under a Rule 10b5-1 plan entered into with RW Baird & Co., which would permit shares to be repurchased when we might otherwise be precluded from doing so under insider trading laws and our internal trading windows. The 2019 Repurchase Plan does not obligate us to purchase any particular amount of common stock and may be suspended or discontinued at any time without prior notice. The 2019 Repurchase Plan is funded using our operating cash flow or available cash. Purchases began on September 18, 2019 under this plan. During the quarter ended March 31, 2020, we repurchased 13,767 shares under the 2019 Repurchase Plan at a cost of $74,000, including fees paid to our broker. On March 2, 2020, we suspended repurchases under the 2019 Repurchase Plan and no repurchases have been made since then. From September 18, 2019 through December 31, 2020, we have repurchased a total of 243,075 shares at a cost of $1.2 million, which includes fees paid to our broker of $6,000. All of the repurchased shares were retired.

In addition, on July 31, 2019, our Board of Directors terminated the 2015 Stock Repurchase Plan which had been authorized on October 27, 2015 and under which we had repurchased a total of 297,020 shares at a cost of $1.2 million. The shares were repurchased between December 2015 and January 2017. All of the repurchased shares were retired.

-21-

Item 6.

SELECTED FINANCIAL DATA

The following table contains certain selected consolidated financial data of inTEST and is qualified by the more detailed Consolidated Financial Statements and Notes thereto included elsewhere in this Report and should be read in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the other financial information included in this Annual Report on Form 10-K. On May 24, 2017, we completed the acquisition of Ambrell. This acquisition is discussed in further detail in Note 3 to the consolidated financial statements in our Form 10-K for the year ended December 31, 2018 (“2018 Form 10-K”) filed on March 26, 2019 with the Securities and Exchange Commission, including a discussion of the adjustments to our liability for contingent consideration in 2018 and 2017, which are listed below.

	Years Ended December 31,
	2020			2019		2018		2017		2016
	(in thousands, except per share data)
Condensed Consolidated Statement of Operations Data:
Net revenues	$	53,823		$	60,660	$	78,563	$	66,801	$	40,227
Gross margin		24,104			29,225		39,401		34,690		20,378
Adjustment to contingent consideration liability		-			-		6,901		6,976		-
Operating income (loss)		(1,217	)		2,549		5,180		3,611		4,146
Net earnings (loss)		(895	)		2,322		3,037		975		2,658
Net earnings (loss) per common share:
Basic	$	(0.09	)	$	0.22	$	0.29	$	0.09	$	0.26
Diluted	$	(0.09	)	$	0.22	$	0.29	$	0.09	$	0.26
Weighted average common shares outstanding:
Basic		10,257			10,373		10,348		10,285		10,314
Diluted		10,257			10,392		10,382		10,339		10,333

	As of December 31,
	2020		2019		2018		2017		2016
	(in thousands)
Condensed Consolidated Balance Sheet Data:
Cash and cash equivalents	$	10,277	$	7,612	$	17,861	$	13,290	$	28,611
Working capital		18,108		16,534		14,203		16,580		32,950
Total assets		62,030		59,715		67,187		62,493		42,844
Long-term obligations		8,422		6,520		2,889		8,786		-
Total stockholders' equity		44,752		44,834		42,880		39,288		37,788

Item 7.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

This MD&A should be read in conjunction with the accompanying consolidated financial statements.

We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We manage our business as two operating segments: Thermal and EMS. Our Thermal segment designs, manufactures and sells our thermal test and thermal process products while our EMS segment designs, manufactures and sells our semiconductor test products.

Our EMS segment sells its products to semiconductor manufacturers and third-party test and assembly houses (end user sales) and to ATE manufacturers (OEM sales), who ultimately resell our equipment with theirs to both semiconductor manufacturers and third-party test and assembly houses. These sales all fall within the ATE sector of the broader semiconductor market. Our Thermal segment sells its products to many of these same types of customers; however, it also sells to customers in the wafer processing sector within the broader semiconductor market and to customers in a variety of other markets outside the semiconductor market, including the automotive, defense/aerospace, industrial (including consumer products packaging, fiber optics and other sectors within the broader industrial market), medical and telecommunications markets.

Both of our operating segments have multiple products that we design, manufacture and market to our customers. Due to a number of factors, our products have varying levels of gross margin. These factors include, for example, the amount of engineering time required to develop the product, the market or customer to which we sell the product and the level of competing products available from other suppliers. The needs of our customers ultimately determine the products that we sell in a given time period. Therefore, the mix of products sold in a given period can change significantly when compared against the prior period. As a result, our consolidated gross margin may be significantly impacted by a change in the mix of products sold in a particular period.

-22-

Markets

Historically, we referred to our markets as “Semiconductor” (which included both the broader semiconductor market as well as the more specialized semiconductor ATE and wafer processing sectors within the broader semiconductor market), and “Non-Semiconductor” (which included all of the other markets we serve). In the second quarter of 2019, we began referring to the semiconductor market, including the ATE and wafer processing sectors within that market, as the “Semi Market.” All other markets are designated as “Multimarket.” Business within our Thermal segment can fall into either the Semi Market or Multimarket, depending upon how our customers utilize our products or upon their respective applications.

While the Semi Market represents the historical roots of inTEST and remains a very important component of our business, Multimarket is where we have focused our strategic growth efforts in the last several years. Our goal was to grow our business, both organically and through acquisition, in these markets as we believe these markets have historically been less cyclical than the Semi Market. Moving forward, with the launch of our new strategic plan which is discussed in Part 1, Item 1 under “Our Strategies”, we intend to broaden our strategic growth efforts to target both organic and inorganic growth in all of our currently served markets, which includes the Semi Market. Our goal is to further expand our existing product lines, strengthen our positions in served markets and drive expansion into new markets.

Prior to our acquisition of Ambrell Corporation (“Ambrell”) in May 2017, we offered only highly specialized engineering solutions used for testing applications in Multimarket, the demand for which is limited and which varies significantly from period to period. Our acquisition of Ambrell not only provided expansion into new markets but also broadened our product offerings to include products sold into process or manufacturing applications. Historically, Ambrell sold its precision induction heating systems almost exclusively to customers in the industrial market but since 2018, has also had significant sales into the Semi Market. Overall, however, the acquisition of Ambrell has helped to diversify our customer base.

The portion of our business that is derived from the Semi Market is substantially dependent upon the demand for ATE by semiconductor manufacturers and companies that specialize in the testing of integrated circuits or, for Ambrell, the demand for wafer processing equipment. Demand for ATE or wafer processing equipment is driven by semiconductor manufacturers that are opening new, or expanding existing, semiconductor fabrication facilities or upgrading equipment, which in turn is dependent upon the current and anticipated market demand for semiconductors and products incorporating semiconductors. Such market demand can be the result of market expansion, development of new technologies or redesigned products to incorporate new features, or the replacement of aging equipment. In addition, we continue to focus on design improvements and new approaches for our own products that contribute to our net revenues as our customers adopt these new products.

In the past, the Semi Market has been highly cyclical with recurring periods of oversupply, which often severely impact the Semi Market's demand for the products we manufacture and sell into the market. This cyclicality can cause wide fluctuations in both our orders and net revenues and, depending on our ability to react quickly to these shifts in demand, can significantly impact our results of operations. Market cycles are difficult to predict and, because they are generally characterized by sequential periods of growth or declines in orders and net revenues during each cycle, year over year comparisons of operating results may not always be as meaningful as comparisons of periods at similar points in either up or down cycles. These periods of heightened or reduced demand can shift depending on various factors impacting both our customers and the markets that they serve. In addition, during both downward and upward cycles in the Semi Market, in any given quarter, the trend in both our orders and net revenues can be erratic. This can occur, for example, when orders are canceled or currently scheduled delivery dates are accelerated or postponed by a significant customer or when customer forecasts and general business conditions fluctuate during a quarter.

Third party market share statistics are not available for the products we manufacture and sell into the Semi Market; therefore, comparisons of period over period changes in our market share are not easily determined. As a result, it is difficult to ascertain if Semi Market volatility in any period is the result of macro-economic or customer-specific factors impacting Semi Market demand, or if we have gained or lost market share to a competitor during the period.

While approximately half of our orders and net revenues are derived from the Semi Market, and our operating results generally follow the overall trend in the Semi Market, in any given period we may experience anomalies that cause the trend in our net revenues to deviate from the overall trend in the Semi Market. We believe that these anomalies may be driven by a variety of factors within the Semi Market, including, for example, changing product requirements, longer periods between new product offerings by OEMs and changes in customer buying patterns. In addition, in recent periods, we have seen instances when demand within the Semi Market is not consistent for each of our operating segments or for any given product within a particular operating segment. This inconsistency in demand can be driven by a number of factors but, in most cases, we have found that the primary reason is unique customer-specific changes in demand for certain products driven by the needs of their customers or markets served. Recently this has become more pronounced for our sales into the wafer processing sector within the broader semiconductor market due to the limited market penetration we have into this sector and the variability of orders we have experienced from the few customers we support. These shifts in market practices and customer-specific needs have had, and may continue to have, varying levels of impact on our operating results and are difficult to quantify or predict from period to period. Management has taken, and will continue to take, such actions it deems appropriate to adjust our strategies, products and operations to counter such shifts in market practices as they become evident.

-23-

As previously mentioned, as part of our ongoing strategy to grow our business, we continue to diversify our served markets to address the thermal test and thermal process requirements of several markets outside the Semi Market. These include the automotive, defense/aerospace, industrial, medical, telecommunications and other markets, which we refer to as Multimarket. We believe that these markets are usually less cyclical than the Semi Market. While market share statistics exist for some of these markets, due to the nature of our highly specialized product offerings in these markets, we do not expect broad market penetration in many of these markets and therefore do not anticipate developing meaningful market shares in most of these markets.

In addition, because of our limited market share, our Multimarket orders and net revenues in any given period do not necessarily reflect the overall trends in the markets within Multimarket. Consequently, we are continuing to evaluate buying patterns and opportunities for growth in Multimarket that may affect our performance. The level of our Multimarket orders and net revenues has varied in the past, and we expect will vary significantly in the future, as we work to build our presence in Multimarket and establish new markets for our products.

Restructuring and Other Charges

On September 21, 2020, we notified employees in our Fremont, California facility of a plan to consolidate all manufacturing for our EMS segment into our manufacturing operation located in Mt. Laurel, New Jersey. The consolidation was substantially completed during the fourth quarter of 2020 and resulted in the termination of certain employees at the Fremont location. Prior to the consolidation, our interface products were manufactured in the Fremont facility, and our manipulator and docking hardware products were manufactured in the Mt. Laurel facility. The consolidation was undertaken to better serve customers through streamlined operations and reduce the fixed annual operating costs for the EMS segment. A small engineering and sales office will be maintained in northern California. The costs related to these actions are included in restructuring and other charges on our consolidated statement of operations and are discussed in more detail in Note 3 to our consolidated financial statements.

The EMS facility consolidation resulted in the termination of certain employees at the Fremont location, including all of our interface product line assembly staff who were located at that facility. As a result of transitioning our interface manufacturing operations to New Jersey, we have hired new production staff for this product line in our Mt. Laurel facility. These new employees are being trained to assemble our products which may impact customer shipments and quality of our interface products over the next several months. In addition, we have recently experienced difficulty in hiring personnel at the costs projected in our forecasts. This has resulted in the need to increase the labor rates offered for certain positions. If we cannot find savings in other areas or increase the price for which we sell our products in an amount sufficient to cover these additional labor costs, we may experience reduced margins in future periods. See “Risks Related to Our Business Operations” in Item 1A “Risk Factors” of this Report.

During the third quarter of 2020, we made changes in our executive management team and, in connection with these actions, we reduced our administrative footprint in our Mansfield, Massachusetts facility and reestablished our corporate headquarters in our Mt. Laurel, New Jersey office. The costs related to these actions are included in restructuring and other charges on our consolidated statement of operations and are discussed in more detail in Note 3 to our consolidated financial statements.

Orders and Backlog

The following table sets forth, for the periods indicated, a breakdown of the orders received by operating segment and market (in thousands).

	Years Ended December 31,				Change
	2020		2019		$			%
*Orders:*
Thermal	$	43,014	$	39,158	$	3,856			10	%
EMS		16,726		13,655		3,071			22	%
	$	59,740	$	52,813	$	6,927			13	%

Semi Market	$	32,383	$	25,416	$	6,967			27	%
Multimarket		27,357		27,397		(40	)		-	%
	$	59,740	$	52,813	$	6,927			13	%

Total consolidated orders for the year ended December 31, 2020 were $59.7 million compared to $52.8 million in 2019, an increase of $6.9 million, or 13%. The increase reflects higher levels of demand experienced by both of our segments from customers within the Semi Market. As discussed below under “COVID-19 Pandemic,” the Semi Market, from which approximately half of our net revenues are derived, entered a cyclical downturn in the beginning of 2019. We believe the arrival of COVID-19 lengthened and deepened the level of decline in demand experienced during this downturn. During the fourth quarter of 2020, we saw a significant increase in our orders from the Semi Market which we believe indicates that we have entered the next cyclical upturn.

-24-

Multimarket orders in each of the years ended December 31, 2020 and 2019 were $27.4 million. For the year ended December 31, 2020, this represented 46% of our consolidated orders compared to 52% for the prior year. Increases in demand from customers in the automotive and defense/aerospace markets were offset by decreases from customers in the industrial and telecommunications markets. The level of our Multimarket orders has varied in the past, and we expect it will vary significantly in the future as we build our presence in these markets and establish new markets for our products.

At December 31, 2020, our backlog of unfilled orders for all products was approximately $11.5 million compared with approximately $5.5 million at December 31, 2019. The significant increase in our backlog primarily reflects the aforementioned increase in demand during the fourth quarter of 2020. Our backlog includes customer orders that we have accepted, substantially all of which we expect to deliver in 2021. While backlog is calculated on the basis of firm purchase orders, a customer may cancel an order or accelerate or postpone currently scheduled delivery dates. Our backlog may be affected by the tendency of customers to rely on short lead times available from suppliers, including us, in periods of depressed demand. In periods of increased demand, there is a tendency towards longer lead times that has the effect of increasing backlog. As a result, our backlog at a particular date is not necessarily indicative of sales for any future period.

Net Revenues

The following table sets forth, for the periods indicated, a breakdown of the net revenues by operating segment and market (in thousands).

	Years Ended December 31,				Change
	2020		2019		$			%
*Net revenues:*
Thermal	$	40,209	$	43,823	$	(3,614	)		(8	)%
EMS		13,614		16,837		(3,223	)		(19	)%
	$	53,823	$	60,660	$	(6,837	)		(11	)%

Semi Market	$	26,870	$	30,953	$	(4,083	)		(13	)%
Multimarket		26,953		29,707		(2,754	)		(9	)%
	$	53,823	$	60,660	$	(6,837	)		(11	)%

Total consolidated net revenues for the year ended December 31, 2020 were $53.8 million compared to $60.7 million in 2019, a decrease of $6.8 million or 11% as compared to 2019. The decrease in net revenues primarily reflects the aforementioned downturn in demand in the Semi Market which began in 2019. As previously mentioned, we saw a significant increase in order levels in the fourth quarter of 2020, which we believe indicates that the downturn in the Semi Market has come to an end. As a result, we expect revenue levels in the first quarter of 2021 will increase significantly from the level in the fourth quarter.

Multimarket net revenues for the year ended December 31, 2020 were $27.0 million, or 50% of total consolidated net revenues, compared to $29.7 million, or 49% of total consolidated net revenues in 2019. Our net revenues from Multimarket for the year ended December 31, 2020 declined $2.8 million or 9% from the prior period. The decline primarily reflects reductions experienced from customers in the industrial market. We believe this is a result, in part, of the impact of COVID-19 on demand for our induction heating products and their related service. The level of our Multimarket net revenues has varied in the past, and we expect it will vary significantly in the future as we build our presence in these markets and establish new markets for our products.

-25-

COVID-19 Pandemic

Our net revenues from all of the markets we serve were significantly affected by COVID-19 during the first half of 2020. The impact of COVID-19 on our net revenues from the Semi Market was intensified during the first half of the year because our business operations were also being negatively affected by a global downturn in the Semi Market at that time. The Semi Market, from which approximately half of our net revenues are derived, entered a cyclical downturn in the beginning of 2019. During the first quarter of 2020, before the spread of COVID-19, we had started to see indications that the downturn was coming to an end. These indications included increased quoting activity and order levels for the first quarter of 2020 as compared to the fourth quarter of 2019. However, we believe COVID-19 delayed the recovery in the Semi Market as the increase in activity leveled off during late March 2020. Although we saw slightly increased order rates from our customers in the Semi Market during the second and third quarters of 2020, it was not until the fourth quarter of 2020 that we saw a significant increase in our orders from the Semi Market which we believe indicates that we have now entered the next cyclical upturn. During the fourth quarter of 2020, our orders from the Semi Market increased 53% sequentially and were 141% higher than in the fourth quarter of 2019, the low point of the prior cyclical downturn for the products that we sell. We believe the level of increase in our orders from the Semi Market during the fourth quarter of 2020 reflects a combination of increased demand in the market resulting from the interruption of the normal recovery in the Semi Market cycle caused by the onset of COVID-19 in the first half of 2020, as well as increased demand for semiconductors, generally. We believe this increase in demand is being driven both by changing technology as well as increased use of technology across all aspects of daily life, such as in devices that facilitate remote work and education, smart technology used in homes and businesses, the increase in the amount of ICs used in the automotive industry and changes occurring in the telecommunications and mobility markets.

As of the date of this filing, all of our operations continue to be deemed “critical and essential business operations” under the various governmental COVID-19 mandates, which has allowed us to continue to operate our business with certain modifications. These modifications include a significant number of our employees working remotely. Such employees have been provided with the tools and technology necessary to do so. Additionally, we have implemented workplace safeguards designed to protect the health and well-being of our employees. Employees who remain in our facilities are following WHO and CDC recommended safety practices, as well as state and local directives. We have had occasions where one or more employees have contracted COVID-19 and entered our facilities while infected. To date, we have managed these occurrences with minimal disruption to our business while protecting other employees, but there can be no assurances that we can avoid similar occurrences in the future or, that in such cases, we can avoid significant disruption of our operations.

Results of Operations

The results of operations for our two operating segments are generally affected by the same factors described in the Overview section above. Separate discussions and analyses for each segment would be repetitive. The discussion and analysis that follows, therefore, is presented on a consolidated basis and includes discussion of factors unique to each operating segment where significant to an understanding of that segment.

Year Ended December 31, 2020 Compared to Year Ended December 31, 2019

Net Revenues. Net revenues were $53.8 million for the year ended December 31, 2020 compared to $60.7 million in 2019, a decrease of $6.8 million or 11%. We believe this decrease reflects the factors previously discussed in the Overview section above.

Gross Margin. Gross margin was 45% for the year ended December 31, 2020 compared to 48% in 2019. Our component material costs increased from 32% of net revenues for the year ended December 31, 2019 to 34% of net revenues for the year ended December 31, 2020. The increase in our component material costs reflects changes in product mix for both our segments. In addition, although our fixed operating costs decreased $334,000 in absolute dollar terms in 2020 as compared to 2019, as a percentage of net revenues, these costs increased from 17% of net revenues in 2019 to 18% of net revenues in 2020 as a result of not being as fully absorbed by the lower net revenues levels in 2020. The $334,000 decrease in our fixed operating costs primarily reflects a reduction in materials used in service calls and lower levels of travel, both of which are a result of the impact of COVID-19 on the level of service work we were able to perform during 2020 in our Thermal segment. To a lesser extent, there was also a reduction in the use of temporary labor and lower salary and benefits expense for our Thermal segment, reflecting the reduced business levels in 2020 and savings from headcount reductions which occurred early in the second quarter of 2020 in response to the slowdown in business. These decreases were partially offset by an increase in facility costs reflecting higher rent for our facility in Fremont, California, which took effect at the beginning of 2020, as well as the cost for additional space in our office in Mansfield, Massachusetts for our corporate headquarters which we first occupied during the fourth quarter of 2019. As previously discussed in the Overview, we closed our manufacturing operations in Fremont, California during the fourth quarter of 2020. This will result in reduced facility costs in future periods as a result of the reduction in our footprint. Costs incurred in 2020 related to this action are included in restructuring and other charges in our statement of operations and are discussed in more detail below and in Note 3 to our consolidated financial statements.

-26-

Selling Expense. Selling expense was $7.5 million for the year ended December 31, 2020 compared to $8.5 million in 2019, a decrease of $938,000 or 11%. The decrease primarily reflects lower levels of travel and trade show related costs for both our segments as a result of COVID-19. To a lesser extent, there was also a reduction in warranty expense in our Thermal segment, reflecting improved warranty claims experience and a reduction in revenues under warranty.

Engineering and Product Development Expense. Engineering and product development expense was $5.1 million for the year ended December 31, 2020 compared to $5.0 million in 2019, an increase of $106,000, or 2%. Increases in salary and benefits expense as a result of headcount additions in our Thermal segment were partially offset by a decrease in travel and lower levels of spending on third party consultants and materials used in new product development.

General and Administrative Expense. General and administrative expense was $11.4 million for the year ended December 31, 2020 compared to $13.0 million in 2019, a decrease of $1.6 million, or 12%. During 2019, we incurred $683,000 related to an acquisition opportunity that we decided not to pursue. There were no similar costs in 2020. If we had not incurred these costs in 2019, general and administrative expense would have declined $885,000 in 2020 as compared to 2019. This decrease reflects headcount reductions, primarily in corporate staff, lower levels of travel as a result of COVID-19, lower levels of stock-based compensation costs, lower fees for third-party professionals that assist us in compliance related matters and a reduction in profit-based bonus accruals in 2020.

Restructuring and Other Charges. For the year ended December 31, 2020, we recorded $1.3 million in restructuring and other charges. Of this amount, $903,000 is related to the consolidation of our EMS manufacturing operations, $189,000 is related to the reduction of the administrative footprint in our Mansfield, Massachusetts corporate office associated with the reestablishment of the Mt. Laurel, New Jersey office as our corporate headquarters, $133,000 is related to the executive management changes that occurred in the third quarter of 2020 and $60,000 is related to other restructuring actions taken during 2020. All of these actions and the related charges are discussed in more detail in Note 3 to our consolidated financial statements. During the year ended December 31, 2019, we recorded $240,000 in restructuring charges and other charges, primarily related to the consolidation of Ambrell’s European operations.

Income Tax Expense. For the year ended December 31, 2020, we recorded an income tax benefit of $336,000 compared to income tax expense of $282,000 in 2019. Our effective tax rate was 27% for 2020 compared to 11% for 2019. On a quarterly basis, we record income tax expense or benefit based on the expected annualized effective tax rate for the various taxing jurisdictions in which we operate our businesses. The increase in our effective tax rate in 2020 primarily represents the impact of changes in the expected mix of foreign and domestic source income for 2020 and other adjustments related to recently enacted tax regulations where specific application of the regulations is still evolving. See Note 10 to our consolidated financial statements for further detail of the difference between our effective tax rates in 2020 and 2019 and the statutory tax rate of 21%.

Liquidity and Capital Resources

As discussed more fully in the Overview, our business and results of operations are substantially dependent upon the demand for ATE by semiconductor manufacturers and companies that specialize in the testing of ICs. The cyclical and volatile nature of demand for ATE makes estimates of future revenues, results of operations and net cash flows difficult especially in light of COVID-19.

Our primary historical source of liquidity and capital resources has been cash flow generated by our operations and we manage our businesses to maximize operating cash flows as our primary source of liquidity. We use cash to fund growth in our operating assets, for new product research and development, for acquisitions and for stock repurchases.

Liquidity

Our cash and cash equivalents and working capital were as follows (in thousands):

	December 31,
	2020		2019
Cash and cash equivalents	$	10,277	$	7,612
Working capital	$	18,108	$	16,534

-27-

As of December 31, 2020, $3.2 million, or 31%, of our cash and cash equivalents was held by our foreign subsidiaries. We currently expect our cash and cash equivalents, in combination with the borrowing capacity available under our revolving credit facility and the anticipated net cash to be provided by our operations in the next twelve months to be sufficient to support our short-term working capital requirements and other corporate requirements. Our revolving credit facility is discussed in Note 10 to our consolidated financial statements. Although our revolving credit facility will mature on April 9, 2021, we are currently in discussions with our lender to replace this facility with a three-year credit facility. We expect that facility to be put in place in conjunction with, or prior to, the expiration of our current credit facility.

Our material short-term cash requirements include payments due under our various lease agreements, recurring payroll and benefits obligations to our employees and purchase commitments for materials that we use in the products we sell. We estimate that our minimum short-term working capital requirements currently range between $5.0 million and $7.0 million. We also anticipate making investments in our business in the next twelve months including hiring of additional staff, updates to our website and other systems and investments related to our geographic and market expansion efforts. We expect our current cash and cash equivalents, in combination with the borrowing capacity available under our revolving credit facility and the anticipated net cash to be provided by our operations to be sufficient to support these additional investments as well as our current short-term cash requirements. However, should the impact of COVID-19 on our operations, including the disruption to our business that would be caused by any unanticipated facility closures or significantly reduced demand from our customers, be more significant than we currently expect, we may need additional financial resources, including additional debt or equity financings in the long-term. There can be no assurance that any such debt or equity financings would be available on favorable terms or rates or at all.

Our current growth strategy includes pursuing acquisition opportunities for complementary businesses, technologies or products. We currently anticipate that any long-term cash requirements related to our acquisition strategy would be funded all or in part through obtaining additional third-party debt or issuing equity. If we were to obtain additional third-party debt, we do not currently know at what rates or on what terms any such debt would be available.

Cash Flows

Operating Activities. Net cash provided by operations for the year ended December 31, 2020 was $3.2 million. For the year ended December 31, 2020, we recorded a net loss of $895,000. During this same period, we had non-cash charges of $3.2 million for depreciation and amortization that included $1.3 million of amortization related to right-of-use ("ROU") assets. During the year ended December 31, 2020, we also recorded $671,000 of non-cash charges for deferred compensation expense related to stock-based awards and a $612,000 impairment charge related to our ROU assets for the leases in Fremont, California and Mansfield, Massachusetts, as discussed more fully in Note 3 to our consolidated financial statements. Accounts receivable decreased $887,000 during 2020, primarily reflecting the reduced level of shipments in 2020, while inventories increased $717,000, primarily reflecting purchasing activity in the fourth quarter for products we expect to ship in the first half of 2021. As previously discussed in the Overview, we experienced a significant increase in order levels in the fourth quarter of 2020. Operating lease liabilities decreased $1.3 million during 2020, reflecting payments made under our various lease agreements and accounts payable increased $430,000, primarily reflecting the increase in inventory purchases during the fourth quarter.

Investing Activities. During the year ended December 31, 2020, purchases of property and equipment were $658,000, and primarily reflected additions to fixed assets related to products leased to customers and leasehold improvements to our facility in Mt. Laurel, New Jersey using our working capital. During the first quarter of 2021, we expect to spend approximately $230,000 to complete the leasehold improvements to our facility in Mt. Laurel, New Jersey using our working capital. These improvements are being done in connection with reducing the size of that facility and consolidating manufacturing operations from our Fremont, California operation as discussed under the Overview section above and in Note 3 to our consolidated financial statements. We have no other significant commitments for capital expenditures in 2021; however, depending upon changes in market demand or manufacturing and sales strategies, we may make such purchases or investments as we deem necessary and appropriate. These additional cash requirements would be funded by our cash and cash equivalents, anticipated net cash to be provided by operations and our revolving credit facility.

Financing Activities. As discussed more fully in Note 13 to our consolidated financial statements in our Quarterly Report on Form 10-Q for the three months ended March 31, 2020 filed on May 13, 2020 with the Securities and Exchange Commission, during April 2020 we applied for and received loans through the Paycheck Protection Program (the “PPP”) of the Coronavirus Aid, Relief, and Economic Security Act administered by the U.S. Small Business Administration totaling $2.8 million. We repaid the full amount of the PPP loans on May 5, 2020 with the applicable interest. During the year ended December 31, 2020 we borrowed and repaid $2.8 million on our revolving credit facility. During the year ended December 31, 2020, we utilized $74,000 to repurchase 13,767 shares of our common stock under the 2019 Repurchase Plan. On March 2, 2020, we suspended repurchases under the 2019 Repurchase Plan.

-28-

New or Recently Adopted Accounting Standards

See Note 2 to the consolidated financial statements for information concerning the implementation and impact of new or recently adopted accounting standards.

Critical Accounting Estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to inventories, long-lived assets, goodwill, identifiable intangibles and deferred income tax valuation allowances. We base our estimates on historical experience and on appropriate and customary assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Some of these accounting estimates and assumptions are particularly sensitive because of their significance to our consolidated financial statements and because of the possibility that future events affecting them may differ markedly from what had been assumed when the financial statements were prepared.

Inventory Valuation

Inventories are valued at cost on a first-in, first-out basis, not in excess of market value. On a quarterly basis, we review our inventories and record excess and obsolete inventory charges based upon our established objective excess and obsolete inventory criteria. These criteria identify material that has not been used in a work order during the prior twelve months and the quantity of material on hand that is greater than the average annual usage of that material over the prior three years. In certain cases, additional excess and obsolete inventory charges are recorded based upon current market conditions, anticipated product life cycles, new product introductions and expected future use of the inventory. The excess and obsolete inventory charges we record establish a new cost basis for the related inventories. During 2020 and 2019, we recorded inventory obsolescence charges for excess and obsolete inventory of $444,000 and $391,000, respectively.

Goodwill, Intangible and Long-Lived Assets

We account for goodwill and intangible assets in accordance with Accounting Standards Codification ("ASC") Topic 350 (Intangibles- Goodwill and Other). Finite-lived intangible assets are amortized over their estimated useful economic life and are carried at cost less accumulated amortization. Goodwill is assessed for impairment at least annually in the fourth quarter, on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired. As a part of the goodwill impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount. If, as a result of our qualitative assessment, we determine this is the case, we are required to perform a goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized. The test is discussed below. If, as a result of our qualitative assessment, we determine that it is more-likely-than-not that the fair value of the reporting unit is greater than its carrying amounts, the goodwill impairment test is not required.

The quantitative goodwill impairment test, used to identify both the existence of impairment and the amount of impairment loss, compares the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The goodwill impairment assessment is based upon the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions including the selection of control premiums, discount rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge. At each of December 31, 2020 and 2019, goodwill was $13.7 million. We did not record any impairment charges related to our goodwill during 2020 or 2019.

Indefinite-lived intangible assets are assessed for impairment at least annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. As a part of the impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required; otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of the intangible asset with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. At each of December 31, 2020 and 2019, our indefinite-lived intangible assets were trademarks carried at $6.7 million. We did not record any impairment charges related to our indefinite-lived intangible assets during 2020 or 2019.

-29-

Long-lived assets, which consist of finite-lived intangible assets, property and equipment and ROU assets, are assessed for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value. The cash flow estimates used to determine the impairment, if any, contain management's best estimates using appropriate assumptions and projections at that time. At December 31, 2020 and 2019, finite-lived intangibles and long-lived assets were $14.4 million and $14.2 million, respectively. We recorded impairment charges totaling $612,000 during the year ended December 31, 2020 related to certain of our ROU assets as discussed further in Note 3 to our consolidated financial statements. We did not record any impairment charges related to our long-lived assets during 2019.

Income Taxes

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carryforwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date.

Deferred tax assets are analyzed to determine if there will be sufficient taxable income in the future in order to realize such assets. We assess all of the positive and negative evidence concerning the realizability of the deferred tax assets, including our historical results of operations for the recent past and our projections of future results of operations, in which we make subjective determinations of future events. If, after assessing all of the evidence, both positive and negative, a determination is made that the realizability of the deferred tax assets is not more likely than not, we establish a deferred tax valuation allowance for all or a portion of the deferred tax assets depending upon the specific facts. If any of the significant assumptions were changed, materially different results could occur, which could significantly change the amount of the deferred tax valuation allowance established. As of December 31, 2020 and 2019, we had a net deferred tax liability of $1.9 million and $2.3 million, respectively. Our deferred tax valuation allowance at December 31, 2020 and 2019 was $169,000 and $234,000, respectively.

Off-Balance Sheet Arrangements

There were no off-balance sheet arrangements during the year ended December 31, 2020 that have or are reasonably likely to have, a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, cash requirements or capital resources.

Item 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

This disclosure is not required for a smaller reporting company.

Item 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Consolidated financial statements are set forth in this Report beginning at page F-1 and are incorporated by reference into this Item 8.

Item 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

Item 9A.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Exchange Act. Because there are inherent limitations in all control systems, a control system, no matter how well conceived and operated, can provide only reasonable, as opposed to absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Our management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all error and all fraud. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. Accordingly, our management has designed the disclosure controls and procedures to provide reasonable assurance that the objectives of the control system were met.

-30-

CEO/CFO Conclusions about the Effectiveness of the Disclosure Controls and Procedures. As required by Rule 13a-15(b) of the Exchange Act, inTEST management, including our CEO and CFO, conducted an evaluation as of the end of the period covered by this Report, of the effectiveness of our disclosure controls and procedures, including the impact of COVID-19. Based on that evaluation, our CEO and CFO concluded that, as of the end of the period covered by this Report, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

During the period covered by this Report, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. We will continue monitoring and assessing any impacts from COVID-19 on our internal controls.

Management's Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act as a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our Board of Directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2020, including the impact of COVID-19. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) on Internal Control-Integrated 2013 Framework. Based upon this assessment, management believes that, as of December 31, 2020, our internal control over financial reporting is effective at a reasonable assurance level.

This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting, as such an attestation is not required pursuant to rules of the SEC applicable to registrants that are non-accelerated filers.

Item 9B.

OTHER INFORMATION

None.

-31-

PART III

Item 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this Item is incorporated by reference from our definitive proxy statement for our 2021 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Report.

Code of Ethics

We have adopted a Code of Ethics (the “Code”) as a guide to the standards of business conduct to which our employees, officers and directors must adhere. A copy of the Code can be found on our website at https://intestcorp.gcs-web.com/corporate-governance. We intend to satisfy the disclosure requirements of the SEC regarding amendments to, or waivers from, the Code by posting such information on the same website.

Item 11.

EXECUTIVE COMPENSATION

Item 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by Item 201(d) of Regulation S-K is set forth below. The remainder of the information required by this Item 12 is incorporated by reference from our definitive proxy statement for our 2021 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Report.

The following table shows the number of securities that may be issued pursuant to our equity compensation plans (including individual compensation arrangements) as of December 31, 2020:

Equity Compensation Plan Information

Plan Category	Number of securities to be issued upon exercise of outstanding options, warrants and rights(1)		Weighted- average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans(2)
Equity compensation plans approved by security holders		438,200	$	6.25		1,067,979
Equity compensation plans not approved by security holders		-		-		-
Total		438,200	$	6.25		1,067,979

	(1)	The securities that may be issued are shares of inTEST common stock, issuable upon exercise of outstanding stock options.
	(2)	The securities that remain available for future issuance are issuable pursuant to the Third Amended and Restated 2014 Stock Plan.

Item 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Item 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES

-32-

PART IV

Item 15.

EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)

The documents filed as part of this Annual Report on Form 10-K are:

(i)     Our consolidated financial statements and notes thereto as well as the applicable report of our independent registered public accounting firm are included in Part II, Item 8 of this Annual Report on Form 10-K.
(ii)    The following financial statement schedule should be read in conjunction with the consolidated financial statements set forth in Part II, Item 8 of this Annual Report on Form 10-K:
                Schedule II -- Valuation and Qualifying Accounts
(iii)   The exhibits required by Item 601 of Regulation S-K are included under Item 15(b) of this Annual Report on Form 10-K.

(b)

Exhibits required by Item 601 of Regulation S-K:

A list of the Exhibits which are required by Item 601 of Regulation S-K and filed with this Report is set forth in the Exhibit Index immediately preceding the signature page, which Exhibit Index is incorporated herein by reference.

Item 16.

FORM 10-K SUMMARY

None.

Index to Exhibits

Exhibit Number	Description of Exhibit
3.1		Certificate of Incorporation. (1)
3.2		Bylaws as amended and restated on April 23, 2018. (2)
4.1		Description of Securities (1).
10.1		Lease Agreement between Exeter 804 East Gate, LLC and the Company dated May 10, 2010. (3)
10.2		First Amendment to Lease Agreement, dated September 22, 2020, by and between inTEST Corporation and Exeter 804 East Gate 2018, LLC (4)
10.3		Lease Agreement between AMB-SGP Seattle/Boston, LLC and Temptronic Corporation (a subsidiary of the Company), dated October 25, 2010. (5)
10.4		Second Amendment to Lease between James Campbell Company, LLC and Temptronic Corporation dated April 8, 2019 (6).
10.5		Lease Agreement between Columbia California Warm Springs Industrial, LLC and inTEST Silicon Valley Corporation dated January 9, 2012. (7)
10.6		First Amendment to Lease Agreement between Columbia California Warm Springs Industrial, LLC and inTEST Silicon Valley Corporation dated November 18, 2016. (8)
10.7		Second Amendment to Standard Lease Agreement, dated January 23, 2020, by and between inTEST Silicon Valley Corporation and Fremont Business Center, LLC. (9)
10.8		Guaranty Agreements between Columbia California Warm Springs Industrial, LLC and inTEST Corporation dated January 9, 2012. (7)
10.9		Lease Agreement between Maguire Family Properties, Inc. and Ambrell Corporation dated December 19, 2017 (10)
10.10		Guaranty of Lease between Maguire Family Properties, Inc. and Ambrell Corporation dated December 19, 2017 (10)
10.11		Loan and Security Agreement, dated April 10, 2020, by inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation and M&T Bank (11)
10.12		Patents, Trademarks, Copyrights and Licenses Security Agreement, dated April 10, 2020, by inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation and M&T Bank (11)
10.13		Surety Agreement, dated April 10, 2020, by Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation and M&T Bank (11)
10.14		Revolver Note, dated April 10, 2020 (11)
10.15		Form of Indemnification Agreement (12)(*)
10.16		inTEST Corporation Third Amended and Restated 2014 Stock Plan (13)(*)
10.17		inTEST Corporation 2007 Stock Plan. (14)(*)

-33-

10.18		Separation and Consulting Agreement between the Company and James Pelrin dated August 6, 2020 (15)(*)
10.19		Letter Agreement between the Company and Richard N. Grant, Jr. dated July 24, 2020 (15)(*)
10.20		Change of Control Agreement dated August 11, 2020 between the Company and Richard N. Grant, Jr. (13)(*)
10.21		Amended and Restated Change of Control Agreement dated April 29, 2020 between the Company and Hugh T. Regan, Jr. (16)(*)
10.22		Amended and Restated Change of Control Agreement dated April 29, 2020 between the Company and James Pelrin (16)(*)
10.23		2020 Executive Compensation Plan. (17)(*)
10.24		2021 Executive Compensation Plan. (18)(*)
10.25		Form of Restricted Stock Award Agreement for Employees. (13)(*)
10.26		Form of Restricted Stock Award Agreement for Directors. (13)(*)
10.27		Form of Non-Qualified Stock Option Agreement. (18)(*)
10.28		Form of Incentive Stock Option Agreement. (18)(*)
10.29		Compensatory Arrangements of Directors. (*)
21		Subsidiaries of the Company.
23		Consent of RSM US LLP.
31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a).
31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a).
32.1		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Taxonomy Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

(1)	Previously filed by the Company as an exhibit to the Company’s Form 10-K for the year ended December 31, 2019, File No. 001-36117, filed March 23, 2020, and incorporated herein by reference.
(2)	Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated April 23, 2018, File No. 001-36117, filed April 25, 2018, and incorporated herein by reference.
(3)	Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated May 10, 2010, File No. 000-22529, filed May 13, 2010, and incorporated herein by reference.
(4)	Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated September 22, 2020, File No. 001-36117, filed September 24, 2020, and incorporated herein by reference.
(5)	Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated October 27, 2010, File No. 000-22529, filed October 29, 2010, and incorporated herein by reference.
(6)	Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated April 8, 2019, File No. 001-36117, filed April 12, 2019, and incorporated herein by reference.
(7)	Previously filed by the Company as an exhibit to the Company's Form 10-Q Amendment No. 1 for the quarter ended March 31, 2012, File No. 000-22529, filed May 15, 2012, and incorporated herein by reference.
(8)	Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated November 18, 2016, File No. 001-36117, filed November 22, 2016, and incorporated herein by reference.
(9)	Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated January 23, 2020, File No. 001-36117, filed January 28, 2020, and incorporated herein by reference.
(10)	Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated December 19, 2017, File No. 001-36117, filed December 22, 2017, and incorporated herein by reference.
(11)	Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated April 10, 2020, File No. 001-36117, filed April 15, 2020, and incorporated herein by reference.
(12)	Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated June 24, 2020, File No. 001-36117, filed June 29, 2020, and incorporated herein by reference.
(13)	Previously filed by the Company as an exhibit to the Company’s Form 10-Q for the quarter ended September 30, 2020, File No. 001-36117, filed November 12, 2020, and incorporated herein by reference.
(14)	Previously filed by the Company as an exhibit to the Company’s Form 10-K for the year ended December 31, 2017, File No. 001-36117, filed March 28, 2018, and incorporated herein by reference.
(15)	Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated August 6, 2020, File No. 001-36117, filed August 11, 2020, and incorporated herein by reference.
(16)	Previously filed by the Company as an exhibit to the Company’s Form 10-Q for the quarter ended March 31, 2020, File No. 001-36117, filed May 13, 2020, and incorporated herein by reference.
(17)	Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated March 9, 2020, File No. 001-36117, filed March 11, 2020, and incorporated herein by reference.
(18)	Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated March 10, 2021, File No. 001-36117, filed March 16, 2021, and incorporated herein by reference.
(*)	Indicates a management contract or compensatory plan, contract or arrangement in which directors or executive officers participate.

-34-

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

inTEST Corporation


By:	/s/ Richard N. Grant, Jr.	March 23, 2021
	Richard N. Grant, Jr.
	President and Chief Executive Officer

Pursuant to the requirements of Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.




/s/ Richard N. Grant, Jr. Richard N. Grant, Jr., President, Chief Executive Officer and Director (Principal Executive Officer)	March 23, 2021



/s/ Hugh T. Regan, Jr. Hugh T. Regan, Jr., Treasurer, Chief Financial Officer and Secretary (Principal Financial Officer)	March 23, 2021



/s/ Joseph W. Dews IV Joseph W. Dews IV, Chairman	March 23, 2021



/s/ Steven J. Abrams Steven J. Abrams, Esq., Director	March 23, 2021



/s/ Jeffrey A. Beck Jeffrey A. Beck, Director	March 23, 2021



/s/ Gerald J. Maginnis Gerald J. Maginnis, Director	March 23, 2021

-35-

inTEST CORPORATION

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND
FINANCIAL STATEMENT SCHEDULE

	Page

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	F - 1

CONSOLIDATED FINANCIAL STATEMENTS

Consolidated Balance Sheets as of December 31, 2020 and 2019	F - 3

Consolidated Statements of Operations for the years ended December 31, 2020 and 2019	F - 4

Consolidated Statements of Comprehensive Earnings for the years ended December 31, 2020 and 2019	F - 5

Consolidated Statements of Stockholders' Equity for the years ended December 31, 2020 and 2019	F - 6

Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019	F - 7

Notes to Consolidated Financial Statements	F - 8

FINANCIAL STATEMENT SCHEDULE

Schedule II - Valuation and Qualifying Accounts	F - 30

-36-

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of inTEST Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of inTEST Corporation and its subsidiaries (the Company) as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive earnings (loss), stockholders' equity and cash flows for the years then ended, and the related notes to the consolidated financial statements and schedule (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Valuation of Goodwill

As disclosed in Notes 2 and 4 to the Company’s consolidated financial statements, the Company has two operating segments which are also its reporting units - Thermal and EMS. As of December 31, 2020, the Company’s goodwill balance of approximately $13.8 million was allocated to the Company’s Thermal reporting unit. The Company evaluates its goodwill for impairment annually in the fourth quarter, or more frequently whenever events or changes in circumstances indicate that it is more likely than not that the carrying value of goodwill may not be recoverable. The Company performed its annual goodwill impairment test as of December 31, 2020 using a quantitative approach.

We identified goodwill impairment as a critical audit matter because of the significant, subjective assumptions used and judgments made by management in developing the discounted cash flow model used to estimate the fair value of the Thermal reporting unit. As a result, we performed audit procedures to test the Company’s discounted cash flow model, including significant assumptions related to the revenue growth rate, operating margins, and the discount rate that are affected by expected future market or economic conditions. In addition, we used professionals with specialized skill and knowledge in valuation methods to assist us in performing these procedures.

F-1

Addressing the potential impairment of goodwill involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others:

●

Obtaining an understanding of management’s process for developing the fair value estimate;

●

Testing management’s process for developing the fair value estimate;

●

Testing the completeness, accuracy, and relevance of certain underlying data used in the discounted cash flow model;

●

Assessing management’s methodologies, evaluating the appropriateness of the discounted cash flow model, and performing tests on the significant assumptions used by management. This included evaluating the Company’s financial forecast by comparing the significant assumptions used to current industry and economic trends, changes in the Company’s business model, the current customer base and the Company’s product mix;

●

Comparing and assessing the historical accuracy of management’s estimates, including forecasted revenue streams, to identify, understand, and evaluate the reasonableness of forecasts as compared to the Company’s historical results;

●

Performing a sensitivity analysis of the significant assumptions used to evaluate changes in the fair value estimate resulting from changes in the assumptions; and

●

Utilizing a valuation specialist to assist us in evaluating certain key inputs including, but not limited to, the discount rate, risk premiums, and control premiums used in determining the fair value of the Thermal reporting unit and its reconciliation to the Company’s market capitalization.

/s/ RSM US LLP

We have served as the Company's auditor since 2008.

Blue Bell, Pennsylvania
March 23, 2021

F-2

inTEST CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)

	December 31,
	2020			2019
ASSETS
Current assets:
Cash and cash equivalents	$	10,277		$	7,612
Trade accounts receivable, net of allowance for doubtful accounts of $212 and $211, respectively		8,435			9,296
Inventories		7,476			7,182
Prepaid expenses and other current assets		776			805
Total current assets		26,964			24,895

Property and equipment:
Machinery and equipment		5,356			5,269
Leasehold improvements		2,636			2,424
Gross property and equipment		7,992			7,693
Less: accumulated depreciation		(5,642	)		(5,273	)
Net property and equipment		2,350			2,420

Right of use assets, net		6,387			4,842
Goodwill		13,738			13,738
Intangible assets, net		12,421			13,654
Restricted certificates of deposit		140			140
Other assets		30			26
Total assets	$	62,030		$	59,715

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	2,424		$	1,984
Accrued wages and benefits		1,944			2,007
Accrued professional fees		776			805
Customer deposits and deferred revenue		396			456
Accrued sales commission		472			442
Current portion of operating lease liabilities		1,215			1,302
Domestic and foreign income taxes payable		825			868
Other current liabilities		804			497
Total current liabilities		8,856			8,361
Operating lease liabilities, net of current portion		6,050			3,794
Deferred tax liabilities		1,922			2,263
Other liabilities		450			463
Total liabilities		17,278			14,881

Commitments and Contingencies (Note 12)

Stockholders' equity:
Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding		-			-
Common stock, $0.01 par value; 20,000,000 shares authorized; 10,562,200 and 10,413,982 shares issued, respectively		106			104
Additional paid-in capital		26,851			26,256
Retained earnings		17,110			18,005
Accumulated other comprehensive earnings		889			673
Treasury stock, at cost; 33,077 shares		(204	)		(204	)
Total stockholders' equity		44,752			44,834
Total liabilities and stockholders' equity	$	62,030		$	59,715

See accompanying Notes to Consolidated Financial Statements.

F-3

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)

	Years Ended December 31,
	2020			2019

Net revenues	$	53,823		$	60,660
Cost of revenues		29,719			31,435
Gross margin		24,104			29,225

Operating expenses:
Selling expense		7,522			8,460
Engineering and product development expense		5,070			4,964
General and administrative expense		11,444			13,012
Restructuring and other charges		1,285			240
Total operating expenses		25,321			26,676

Operating income (loss)		(1,217	)		2,549
Other income (loss)		(14	)		55

Earnings (loss) before income tax expense (benefit)		(1,231	)		2,604
Income tax expense (benefit)		(336	)		282

Net earnings (loss)	$	(895	)	$	2,322

Net earnings (loss) per common share – basic	$	(0.09	)	$	0.22

Weighted average common shares outstanding – basic		10,256,560			10,373,164

Net earnings (loss) per common share – diluted	$	(0.09	)	$	0.22

Weighted average common shares and common share equivalents outstanding – diluted		10,256,560			10,391,975

See accompanying Notes to Consolidated Financial Statements.

F-4

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(In thousands)

	Years Ended December 31,
	2020			2019

Net earnings (loss)	$	(895	)	$	2,322

Foreign currency translation adjustments		216			(110	)

Comprehensive earnings (loss)	$	(679	)	$	2,212

See accompanying Notes to Consolidated Financial Statements

F-5

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands, except share data)

													Accumulated
							Additional						Other						Total
	Common Stock						Paid-In			Retained			Comprehensive			Treasury			Stockholders'
	Shares			Amount			Capital			Earnings			Earnings			Stock			Equity

Balance, January 1, 2019		10,523,035		$	105		$	26,513		$	15,683		$	783		$	(204	)	$	42,880

Net earnings		-			-			-			2,322			-			-			2,322
Other comprehensive loss		-			-			-			-			(110	)		-			(110	)
Amortization of deferred compensation related to stock-based awards		-			-			884			-			-			-			884
Issuance of unvested shares of restricted stock		132,580			1			(1	)		-			-			-			-
Forfeiture of unvested shares of restricted stock		(12,325	)		-			-			-			-			-			-
Repurchase and retirement of common stock		(229,308	)		(2	)		(1,140	)		-			-			-			(1,142	)

Balance, December 31, 2019		10,413,982		$	104		$	26,256		$	18,005		$	673		$	(204	)	$	44,834

Net loss		-			-			-			(895	)		-			-			(895	)
Other comprehensive earnings		-			-			-			-			216			-			216
Amortization of deferred compensation related to stock-based awards		-			-			671			-			-			-			671
Issuance of unvested shares of restricted stock		229,110			2			(2	)		-			-			-			-
Forfeiture of unvested shares of restricted stock		(67,125	)		-			-			-			-			-			-
Repurchase and retirement of common stock		(13,767	)		-			(74	)		-			-			-			(74	)

Balance, December 31, 2020		10,562,200		$	106		$	26,851		$	17,110		$	889		$	(204	)	$	44,752

See accompanying Notes to Consolidated Financial Statements

F-6

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

	Years Ended December 31,
	2020			2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings (loss)	$	(895	)	$	2,322
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		3,174			3,193
Impairment of right of use assets		612			-
Payment of earnout related to Ambrell acquisition		-			(12,167	)
Provision for excess and obsolete inventory		444			391
Foreign exchange loss		26			3
Amortization of deferred compensation related to stock-based awards		671			884
Proceeds from sale of demonstration equipment, net of gain		82			167
Loss on disposal of property and equipment		22			55
Deferred income tax benefit		(341	)		(426	)
Changes in assets and liabilities:
Trade accounts receivable		887			1,244
Inventories		(717	)		(1,058	)
Prepaid expenses and other current assets		35			(129	)
Restricted certificates of deposit		-			35
Other assets		(4	)		(1	)
Accounts payable		430			197
Accrued wages and benefits		(70	)		(912	)
Accrued professional fees		(31	)		31
Customer deposits and deferred revenue		(62	)		(797	)
Accrued sales commission		29			(261	)
Operating lease liabilities		(1,297	)		(1,378	)
Domestic and foreign income taxes payable		(48	)		171
Other current liabilities		301			31
Net cash provided by (used in) operating activities		3,248			(8,405	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(658	)		(620	)
Proceeds from sale of property and equipment		10			-
Net cash used in investing activities		(648	)		(620	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Paycheck Protection Program loans		2,829			-
Repayments of Paycheck Protection Program loans		(2,829	)		-
Proceeds from revolving credit facility		2,800			-
Repayments of revolving credit facility		(2,800	)		-
Repurchases of common stock		(74	)		(1,142	)
Net cash used in financing activities		(74	)		(1,142	)

Effects of exchange rates on cash		139			(82	)
Net cash provided by (used in) all activities		2,665			(10,249	)
Cash and cash equivalents at beginning of period		7,612			17,861
Cash and cash equivalents at end of period	$	10,277		$	7,612
Cash payments for:
Domestic and foreign income taxes	$	54		$	535

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of unvested shares of restricted stock	$	971		$	837
Forfeiture of unvested shares of restricted stock		(405	)		(88	)

See accompanying Notes to Consolidated Financial Statements.

F-7

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

(1)

NATURE OF OPERATIONS

We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We manage our business as two operating segments which are also our reportable segments and reporting units: Thermal Products ("Thermal") and Electromechanical Solutions ("EMS"). Our Thermal segment designs, manufactures and sells our thermal test and thermal process products while our EMS segment designs, manufactures and sells our semiconductor test products. We manufacture our products in the U.S. Marketing and support activities are conducted worldwide from our facilities in the U.S., Germany, Singapore, the Netherlands and the U.K. The consolidated entity is comprised of inTEST Corporation and our wholly-owned subsidiaries.

Our EMS segment sells its products to semiconductor manufacturers and third-party test and assembly houses (end user sales) and to automated test equipment (“ATE”) manufacturers (original equipment manufacturer (“OEM”) sales), who ultimately resell our equipment with theirs to both semiconductor manufacturers and third-party test and assembly houses. These sales all fall within the ATE sector of the broader semiconductor market. Our Thermal segment sells its products to many of these same types of customers; however, it also sells to customers in the wafer processing sector within the broader semiconductor market and to customers in a variety of other markets outside the semiconductor market, including the automotive, defense/aerospace, industrial (including consumer products packaging, fiber optics and other sectors within the broader industrial market), medical and telecommunications markets.

Both of our operating segments have multiple products that we design, manufacture and market to our customers. Due to a number of factors, our products have varying levels of gross margin. The mix of products we sell in any period is ultimately determined by our customers' needs. Therefore, the mix of products sold in any given period can change significantly from the prior period. As a result, our consolidated gross margin can be significantly impacted in any given period by a change in the mix of products sold in that period.

Historically, we referred to our markets as “Semiconductor” (which included both the broader semiconductor market as well as the more specialized ATE and wafer processing sectors within the broader semiconductor market), and “Non-Semiconductor” (which included all of the other markets we serve). Starting in the second quarter of 2019, we began referring to the broader semiconductor market, including the ATE and wafer processing sectors within that market, as the “Semi Market.” All other markets are designated as “Multimarket.” The Semi Market, which is the principal market in which we operate, is characterized by rapid technological change, competitive pricing pressures and cyclical as well as seasonal market patterns. This market is subject to significant economic downturns at various times.

Our financial results are affected by a wide variety of factors, including, but not limited to, general economic conditions worldwide and in the markets in which we operate, economic conditions specific to the Semi Market and the other markets we serve, our ability to safeguard patented technology and intellectual property in a rapidly evolving market, downward pricing pressures from customers, and our reliance on a relatively few number of customers for a significant portion of our sales. In addition, we are exposed to the risk of obsolescence of our inventory depending on the mix of future business and technological changes within the markets that we serve. Part of our strategy for growth includes potential acquisitions that may cause us to incur substantial expense in reviewing and evaluating potential transactions. We may or may not be successful in locating suitable businesses to acquire and in closing acquisitions of businesses we pursue. In addition, we may not be able to successfully integrate any business we do acquire with our existing business and we may not be able to operate the acquired business profitably. As a result of these or other factors, we may experience significant period-to-period fluctuations in future operating results.

F-8

COVID-19 Pandemic

Our net revenues from all of the markets we serve were significantly affected by COVID-19 during the first half of 2020. The impact of COVID-19 on our net revenues from the Semi Market was intensified during the first half of the year because our business operations were also being negatively affected by a global downturn in the Semi Market at that time. The Semi Market, from which approximately half of our net revenues are derived, entered a cyclical downturn in the beginning of 2019. During the first quarter of 2020, before the spread of COVID-19, we had started to see indications that the downturn was coming to an end. These indications included increased quoting activity and order levels for the first quarter of 2020 as compared to the fourth quarter of 2019. However, we believe COVID-19 delayed the recovery in the Semi Market as the increase in activity leveled off during late March 2020. Although we saw slightly increased order rates from our customers in the Semi Market during the second and third quarters of 2020, it was not until the fourth quarter of 2020 that we saw a significant increase in our orders from the Semi Market which we believe indicates that we have now entered the next cyclical upturn. During the fourth quarter of 2020, our orders from the Semi Market increased 53% sequentially and were 141% higher than in the fourth quarter of 2019, the low point of the prior cyclical downturn for the products that we sell. We believe the level of increase in our orders from the Semi Market during the fourth quarter of 2020 reflects a combination of increased demand in the market resulting from the interruption of the normal recovery in the Semi Market cycle caused by the onset of COVID-19 in the first half of 2020, as well as increased demand for semiconductors, generally. We believe this increase in demand is being driven both by changing technology as well as increased use of technology across all aspects of daily life, such as in devices that facilitate remote work and education, smart technology used in homes and businesses, the increase in the amount of integrated circuits used in the automotive industry and changes occurring in the telecommunications and mobility markets.

While the negative impact of COVID-19 on our business was reduced significantly in the second half of 2020, the spread of the virus or variants of the virus could worsen and one or more of our significant customers or suppliers could be impacted, or significant additional governmental regulations and restrictions could be imposed, thus negatively impacting our business in the future. As a result of our current level of working capital as well as the availability of our revolving credit facility, which is discussed in Note 10 to our consolidated financial statements, we currently expect to have sufficient liquidity to operate our business throughout 2021, as further described in this Report. Our revolving credit facility will mature on April 9, 2021.

(2)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Use of Estimates

The accompanying consolidated financial statements include our accounts and those of our wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated upon consolidation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Certain of our accounts, including inventories, long-lived assets, goodwill, identifiable intangibles and deferred tax assets and liabilities including related valuation allowances, are particularly impacted by estimates.

Reclassification

Certain prior year amounts have been reclassified to be comparable with the current year's presentation.

Subsequent Events

We have made an assessment of our operations and determined that there were no material subsequent events requiring adjustment to, or disclosure in, our consolidated financial statements for the year ended December 31, 2020.

F-9

Business Combinations

Acquired businesses are accounted for using the purchase method of accounting, which requires that the purchase price be allocated to the net assets acquired at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Fair values of intangible assets are estimated by valuation models prepared by our management and third-party advisors. The assets purchased and liabilities assumed have been reflected in our consolidated balance sheets, and the operating results are included in the consolidated statements of operations and consolidated statements of cash flows from the date of acquisition. Any change in the fair value of acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, will be recognized in the consolidated statement of operations in the period of the estimated fair value change. Acquisition-related transaction costs, including legal and accounting fees and other external costs directly related to the acquisition, are recognized separately from the acquisition and expensed as incurred in general and administrative expense in the consolidated statements of operations.

Restructuring and Other Charges

In accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 420 (Exit or Disposal Cost Obligations), we recognize a liability for restructuring costs at fair value only when the liability is incurred. Workforce-related charges are accrued when it is determined that a liability has been incurred, which is generally after individuals have been notified of their termination dates and expected severance benefits. Depending on the timing of the termination dates, these charges may be recognized upon notification or ratably over the remaining required service period of the employees. Plans to consolidate excess facilities may result in lease termination fees and impairment charges related to our right-of-use (“ROU”) assets that are associated with the leases for these facilities. Other long-lived assets that may be impaired as a result of restructuring consist of property and equipment, goodwill and intangible assets. Asset impairment charges included in restructuring and other charges are based on an estimate of the amounts and timing of future cash flows related to the expected future remaining use and ultimate sale or disposal of the asset, and, in the case of our ROU assets, would include expected future sublease rental income, if applicable. These estimates are derived using the guidance in ASC Topic 842 (Leases), ASC Topic 360 (Property, Plant and Equipment) and ASC Topic 350 (Intangibles - Goodwill and Other).

Cash and Cash Equivalents

Short-term investments that have maturities of three months or less when purchased are considered to be cash equivalents and are carried at cost, which approximates fair value. Our cash balances, which are deposited with highly reputable financial institutions, at times may exceed the federally insured limits. We have not experienced any losses related to these cash balances and believe the credit risk to be minimal.

Trade Accounts Receivable and Allowance for Doubtful Accounts

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. We grant credit to customers and generally require no collateral. To minimize our risk, we perform ongoing credit evaluations of our customers' financial condition. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience and the aging of such receivables, among other factors. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. We do not have any significant off-balance sheet credit exposure related to our customers. There was no bad debt expense recorded for the year ended December 31, 2020. We recorded bad debt expense of $3 for the year ended December 31, 2019. Cash flows from accounts receivable are recorded in operating cash flows.

Fair Value of Financial Instruments

Our financial instruments, principally accounts receivable and accounts payable, are carried at cost which approximates fair value, due to the short maturities of the accounts.

Goodwill, Intangible and Long-Lived Assets

We have two operating segments which are also our reporting units: Thermal and EMS. We account for goodwill and intangible assets in accordance with Accounting Standards Codification (“ASC”) Topic 350 (Intangibles - Goodwill and Other). Finite-lived intangible assets are amortized over their estimated useful economic life and are carried at cost less accumulated amortization. Goodwill is assessed for impairment annually in the fourth quarter on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired. Goodwill is considered to be impaired if the fair value of a reporting unit is less than its carrying amount. As a part of the goodwill impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount. If, as a result of our qualitative assessment, we determine that it is more-likely-than-not that the fair value of the reporting unit is greater than its carrying amount, a quantitative goodwill impairment test is not required. However, if, as a result of our qualitative assessment, we determine it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, or, if we choose not to perform a qualitative assessment, we are required to perform a quantitative goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized.

F-10

The quantitative goodwill impairment test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss will be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The goodwill impairment assessment is based upon the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions including the selection of control premiums, discount rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge.

Indefinite-lived intangible assets are assessed for impairment annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. As a part of the impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required; otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of the intangible asset with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.

Long-lived assets, which consist of finite-lived intangible assets, property and equipment and right-of-use (“ROU”) assets, are assessed for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value. The cash flow estimates used to determine the impairment, if any, contain management's best estimates using appropriate assumptions and projections at that time.

Revenue Recognition

We recognize revenue in accordance with the guidance in ASC Topic 606 (Revenue from Contracts with Customers). We recognize revenue for the sale of products or services when our performance obligations under the terms of a contract with a customer are satisfied and control of the product or service has been transferred to the customer. Generally, this occurs when we ship a product or perform a service. In certain cases, recognition of revenue is deferred until the product is received by the customer or at some other point in the future when we have determined that we have satisfied our performance obligations under the contract. Our contracts with customers may include a combination of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. In addition to the sale of products and services, we also lease certain of our equipment to customers under short-term lease agreements. We recognize revenue from equipment leases on a straight-line basis over the lease term.

Revenue is recorded in an amount that reflects the consideration we expect to receive in exchange for those products or services. We do not have any material variable consideration arrangements, or any material payment terms with our customers other than standard payment terms which generally range from net 30 to net 90 days. We generally do not provide a right of return to our customers. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

Nature of Products and Services

We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We sell thermal management products including ThermoStreams, ThermoChambers and process chillers, which we sell under our Temptronic, Sigma and Thermonics product lines, and Ambrell’s precision induction heating systems, including EKOHEAT and EASYHEAT products. We sell semiconductor ATE interface solutions which include manipulators, docking hardware and electrical interface products. We provide post-warranty service and support for the equipment we sell. We sell semiconductor ATE interface solutions and certain thermal management products to the Semi Market. We also sell our thermal management products to various other markets including the automotive, defense/aerospace, industrial, medical and telecommunications markets.

F-11

We lease certain of our equipment under short-term leasing agreements with original lease terms of six months or less. Our lease agreements do not contain purchase options.

Types of Contracts with Customers

Our contracts with customers are generally structured as individual purchase orders which specify the exact products or services being sold or equipment being leased along with the selling price, service fee or monthly lease amount for each individual item on the purchase order. Payment terms and any other customer-specific acceptance criteria are also specified on the purchase order. We generally do not have any customer-specific acceptance criteria, other than that the product performs within the agreed upon specifications. We test substantially all products manufactured as part of our quality assurance process to determine that they comply with specifications prior to shipment to a customer.

Contract Balances

We record accounts receivable at the time of invoicing. Accounts receivable, net of the allowance for doubtful accounts, is included in current assets on our balance sheet. To the extent that we do not recognize revenue at the same time as we invoice, we record a liability for deferred revenue. In certain instances, we also receive customer deposits in advance of invoicing and recording of accounts receivable. Deferred revenue and customer deposits are included in current liabilities on our consolidated balance sheets.

The allowance for doubtful accounts reflects our best estimate of probable losses inherent in the accounts receivable balance. We determine the allowance based on known troubled accounts, if any, historical experience, and other currently available evidence.

Costs to Obtain a Contract with a Customer

The only costs we incur associated with obtaining contracts with customers are sales commissions that we pay to our internal sales personnel or third-party sales representatives. These costs are calculated based on set percentages of the selling price of each product or service sold. Commissions are considered earned by our internal sales personnel at the time we recognize revenue for a particular transaction. Commissions are considered earned by third-party sales representatives at the time that revenue is recognized for a particular transaction. We record commission expense in our consolidated statements of operations at the time the commission is earned. Commissions earned but not yet paid are included in current liabilities on our balance sheets.

Product Warranties

In connection with the sale of our products, we generally provide standard one- or two-year product warranties which are detailed in our terms and conditions and communicated to our customers. Our standard warranties are not offered for sale separately from our products; therefore, there is not a separate performance obligation related to our standard warranties. We record estimated warranty expense for our standard warranties at the time of sale based upon historical claims experience. In very limited cases, we offer customers an option to separately purchase an extended warranty for certain of our products. In the case of extended warranties, we recognize revenue in the amount of the sale price for the extended warranty on a straight-line basis over the extended warranty period. We record costs incurred to provide service under an extended warranty at the time the service is provided. Warranty expense is included in selling expense in our consolidated statements of operations.

See Notes 5 and 16 for further information about our revenue from contracts with customers.

Inventories

Inventories are valued at cost on a first-in, first-out basis, not in excess of market value. Cash flows from the sale of inventories are recorded in operating cash flows. On a quarterly basis, we review our inventories and record excess and obsolete inventory charges based upon our established objective excess and obsolete inventory criteria. These criteria identify material that has not been used in a work order during the prior twelve months and the quantity of material on hand that is greater than the average annual usage of that material over the prior three years. In certain cases, additional excess and obsolete inventory charges are recorded based upon current market conditions, anticipated product life cycles, new product introductions and expected future use of the inventory. The excess and obsolete inventory charges we record establish a new cost basis for the related inventories. We incurred excess and obsolete inventory charges of $444 and $391 for the years ended December 31, 2020 and 2019, respectively.

Property and Equipment

Machinery and equipment are stated at cost, except for machinery and equipment acquired in a business combination, which are stated at fair value at the time of acquisition. As previously discussed above under "Goodwill, Intangible and Long-Lived Assets," machinery and equipment that has been determined to be impaired is written down to its fair value at the time of the impairment. Depreciation is based upon the estimated useful life of the assets using the straight-line method. The estimated useful lives range from one to ten years. Leasehold improvements are recorded at cost and amortized over the shorter of the lease term or the estimated useful life of the asset. Total depreciation expense was $630 and $685 for the years ended December 31, 2020 and 2019, respectively.

F-12

Leases

We account for leases in accordance with ASC Topic 842 (Leases). We determine if an arrangement is a lease at inception. A lease contract is within scope if the contract has an identified asset (property, plant or equipment) and grants the lessee the right to control the use of the asset during the lease term. The identified asset may be either explicitly or implicitly specified in the contract. In addition, the supplier must not have any practical ability to substitute a different asset and would not economically benefit from doing so for the lease contract to be in scope. The lessee’s right to control the use of the asset during the term of the lease must include the ability to obtain substantially all of the economic benefits from the use of the asset as well as decision-making authority over how the asset will be used. Leases are classified as either operating leases or finance leases based on the guidance in ASC Topic 842. Operating leases are included in operating lease ROU assets and operating lease liabilities in our consolidated balance sheets. Finance leases are included in property and equipment and financing lease liabilities. We do not currently have any financing leases.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. None of our leases provide an implicit rate; therefore, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease. We include these options in the determination of the amount of the ROU asset and lease liability when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Certain of our operating leases contain predetermined fixed escalations of minimum rentals and rent holidays during the original lease terms. Rent holidays are periods during which we have control of the leased facility but are not obligated to pay rent. For these leases, our ROU asset and lease liability are calculated including any rent holiday in the determination of the life of the lease.

We have lease agreements which contain both lease and non-lease components, which are generally accounted for separately. In addition to the monthly rental payments due, most of our leases for our offices and warehouse facilities include non-lease components representing our portion of the common area maintenance, property taxes and insurance charges incurred by the landlord for the facilities which we occupy. These amounts are not included in the calculation of the ROU assets and lease liabilities as they are based on actual charges incurred in the periods to which they apply.

Operating lease payments are included in cash outflows from operating activities on our consolidated statements of cash flows. Amortization of right of use assets is presented separately from the change in operating lease liabilities and is included in Depreciation and Amortization on our consolidated statements of cash flows.

We have made an accounting policy election not to apply the recognition requirements of ASC Topic 842 to short-term leases (leases with a term of one year or less at the commencement date of the lease). Lease expense for short-term lease payments is recognized on a straight-line basis over the lease term.

See “Effect of Recently Adopted Amendments to Authoritative Accounting Guidance” below and Note 8 for further disclosures regarding our leases.

Contingent Liability for Repayment of State and Local Grant Funds Received

In connection with leasing a new facility in Rochester, New York, which our subsidiary, Ambrell, occupied in May 2018, we entered into agreements with the city of Rochester and the state of New York under which we received grants totaling $463 to help offset a portion of the cost of the leasehold improvements we have made to this facility. In exchange for the funds we received under these agreements, we are required to create and maintain specified levels of employment in this location through various dates ending in 2023. If we fail to meet these employment targets, we may be required to repay a proportionate share of the proceeds. As of December 31, 2020, $423 of the total proceeds received could still be required to be repaid if we do not meet the targets. We have recorded this amount as a contingent liability which is included in other liabilities on our balance sheet. Those portions of the proceeds which are no longer subject to repayment are reclassified to deferred grant proceeds and amortized to income on a straight-line basis over the remaining lease term for the Rochester facility. Deferred grant proceeds are included in other current liabilities and other liabilities on our balance sheet and totaled $27 at December 31, 2020.

F-13

As of December 31, 2020, we were not in compliance with the employment targets as specified in the grant agreement with the city of Rochester. We applied for and received a waiver of this requirement for the year ended December 31, 2020. We have until December 31, 2021 to come into compliance with the targets as outlined in the waiver received for the year ended December 31, 2020. If we do not achieve compliance, we will need to apply for an additional waiver or we may be required to repay a proportionate share of the proceeds.

Stock-Based Compensation

We account for stock-based compensation in accordance with ASC Topic 718 (Compensation - Stock Compensation) which requires that employee share-based equity awards be accounted for under the fair value method and requires the use of an option pricing model for estimating fair value of stock options, which is then amortized to expense over the service periods. See further disclosures related to our stock-based compensation plans in Note 13.

Engineering and Product Development

Engineering and product development costs, which consist primarily of the salary and related benefits costs of our technical staff, as well as the cost of materials used in product development, are expensed as incurred.

Foreign Currency

For our foreign subsidiaries whose functional currencies are not the U.S. dollar, assets and liabilities are translated using the exchange rate in effect at the balance sheet date. The results of operations are translated using an average exchange rate for the period. The effects of rate fluctuations in translating assets and liabilities of these international operations into U.S. dollars are included in accumulated other comprehensive earnings in stockholders' equity. Transaction gains or losses are included in net earnings. For the years ended December 31, 2020 and 2019, foreign currency transaction losses were $26 and $3, respectively.

Income Taxes

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carryforwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets if it is more likely than not that such assets will not be realized. See Note 11 for additional information regarding income taxes.

Net Earnings (Loss) Per Common Share

Net earnings (loss) per common share - basic is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding during each period. Net earnings (loss) per common share - diluted is computed by dividing net earnings (loss) by the weighted average number of common shares and common share equivalents outstanding during each period. Common share equivalents represent unvested shares of restricted stock and stock options and are calculated using the treasury stock method. Common share equivalents are excluded from the calculation if their effect is anti-dilutive.

The table below sets forth, for the periods indicated, a reconciliation of weighted average common shares outstanding - basic to weighted average common shares and common share equivalents outstanding - diluted and the average number of potentially dilutive securities that were excluded from the calculation of diluted earnings (loss) per share because their effect was anti-dilutive:

	Years Ended December 31,
	2020		2019

Weighted average common shares outstanding–basic		10,256,560		10,373,164
Potentially dilutive securities:
Unvested shares of restricted stock and employee stock options		-		18,811
Weighted average common shares and common share equivalents outstanding–diluted		10,256,560		10,391,975
Average number of potentially dilutive securities excluded from calculation		717,015		523,485

F-14

Effect of Recently Issued Amendments to Authoritative Accounting Guidance

In June 2016, the Financial Accounting Standards Board (“FASB”) issued amendments to the guidance for accounting for credit losses. In November 2019, the FASB deferred the effective date of these amendments for certain companies, including smaller reporting companies. As a result of the deferral, the amendments are effective for us for reporting periods beginning after December 15, 2022. The amendments replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires the use of a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. The amendments require a modified retrospective approach through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. We plan to adopt the amendments when they become effective for us on January 1, 2023. We are currently evaluating the impact the adoption of these amendments will have on our consolidated financial statements.

In December 2019, the FASB issued amendments to the accounting for income taxes, which add new guidance to simplify the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 (Income Taxes) and changing the accounting for certain income tax transactions. The amendments are effective for us as of January 1, 2021. Early adoption is permitted. We plan to adopt the amendments when they become effective for us on January 1, 2021. We do not expect these amendments to have a material impact on our consolidated financial statements.

(3)

RESTRUCTURING AND OTHER CHARGES

EMS Segment Restructuring and Facility Consolidation

On September 21, 2020, we notified employees in our Fremont, California facility of a plan to consolidate all manufacturing for our EMS segment into our manufacturing operations located in Mt. Laurel, New Jersey. The consolidation was substantially completed during the fourth quarter of 2020 and resulted in the termination of certain employees at the Fremont location. Prior to the consolidation, our interface products were manufactured in the Fremont facility, and our manipulator and docking hardware products were manufactured in the Mt. Laurel facility. The consolidation was undertaken to better serve customers through streamlined operations and reduce the fixed annual operating costs for the EMS segment. A small engineering and sales office will be maintained in northern California.

As a result of this action, we incurred charges for severance and other one-time termination benefits, other associated costs, including moving and production start-up costs, and charges related to exiting the facility, including an impairment charge related to the ROU asset for the lease of the Fremont facility. The total costs incurred in 2020 related to this action were $903. We expect to incur additional charges in the first half of 2021 as we finalize the integration of the manufacturing operations. These additional costs are expected to range from $100 to $150. We intend to try to sublease our facility located in Fremont, California. When manufacturing operations ceased in the Fremont facility on December 28, 2020, we recorded a non-cash impairment charge of $522 related to the ROU asset for the lease of the Fremont facility as we do not currently expect to sublet the facility for the full remaining term of the lease. As of December 31, 2020, after recording the impairment charge, the ROU asset related to this facility totaled $597.

Details of the cash and non-cash charges recorded during the year ended December 31, 2020 related to the EMS segment restructuring and facility consolidation are below. These costs are included in restructuring and other charges on our consolidated statement of operations for the year ended December 31. 2020.

	Cash Charges		Non-Cash Charges		Total Charges
Severance and other one-time termination benefits	$	69	$	-	$	69
Other associated costs		159		-		159
Impairment of ROU asset		-		522		522
Costs related to subletting the Fremont, CA facility		153		-		153
Total	$	381	$	522	$	903

Executive Management Changes

On August 6, 2020, James Pelrin resigned as President and Chief Executive Officer (“CEO”) and as a director. In connection with his resignation, we entered into a Separation and Consulting Agreement (the “Separation Agreement”) with Mr. Pelrin dated August 6, 2020 pursuant to which Mr. Pelrin agreed to provide consulting services for three months, subject to an extension of up to an additional three months at our option. The Separation Agreement also provides that Mr. Pelrin is entitled to severance and other benefits. The Separation Agreement is included as Exhibit 10.1 to our Current Report on Form 8-K (“8-K”) filed on August 11, 2020 with the SEC.

F-15

On August 6, 2020, our Board of Directors approved, effective as of August 24, 2020 (the “Start Date”), the appointment of Richard N. Grant, Jr. to the position of President and CEO and to fill the vacancy on our Board of Directors left by Mr. Pelrin’s resignation. We entered into a letter agreement with Mr. Grant, subject to his appointment as our President, CEO and a director, which appointments occurred on August 6, 2020 and became effective as of the Start Date. The letter agreement is included as Exhibit 10.2 to our 8-K filed on August 11, 2020 with the SEC.

Total costs incurred during the year ended December 31, 2020 related to these executive management changes were $514, which consisted of fees for the executive management search firm, legal fees related to the transition, and severance and consulting fees paid to our former CEO. These costs were partially offset by the reversal of $117 of expense related to stock-based compensation awards forfeited at his termination date by our former CEO.

In addition, in connection with these actions, we have reduced the administrative footprint in our Mansfield, Massachusetts corporate office associated with the reestablishment of the Mt. Laurel, New Jersey office as our corporate headquarters. We recorded a non-cash impairment charge of $90 during the fourth quarter of 2020 related to the ROU asset associated with the lease of the corporate space in Mansfield and a cash charge of $99 for other costs related to reducing the size of this facility. We intend to try to sublease this space, but we do not currently expect to sublet it for the full remaining term of the lease. As of December 31, 2020, after recording the impairment charge, the ROU asset related to this space totaled $139. We do not expect to incur any additional costs related to these actions after December 31, 2020.

Details of the cash and non-cash charges recorded during the year ended December 31, 2020 related to these actions are below. These severance and one-time termination benefits, the impairment charge and the costs associated with subletting the facility in Mansfield are included in restructuring and other charges on our consolidated statement of operations for the year ended December 31. 2020. The other associated costs in the table below are included in general and administrative expense on our consolidated statement of operations for the year ended December 31, 2020.

	Cash Charges		Non-Cash Charges		Total Charges
Severance and other one-time termination benefits	$	133	$	-	$	133
Other associated costs		381		-		381
Impairment of ROU asset		-		90		90
Costs related to subletting the Mansfield, MA facility		99		-		99
Total	$	613	$	90	$	703

Other Charges

In addition to the charges discussed above, during 2020, we recorded cash charges for severance and other one-time termination benefits of $46 and other costs of $14 related to headcount reductions and employee relocation. The headcount reductions were primarily in our Thermal segment as a result of a slow-down in business activity early in the year. These costs are included in restructuring and other charges on our consolidated statement of operations for the year ended December 31. 2020.

Consolidation of Ambrell’s European Operations

During the year ended December 31, 2019, we recorded $240 of restructuring and other charges which were primarily related to the consolidation of Ambrell’s European operations. These costs included severance and other one-time termination benefits of $137 and other costs related to the consolidation of $103.

Accrued Restructuring

The liability for accrued restructuring charges is included in other current liabilities on our consolidated balance sheet. Changes in the amount of the liability for accrued restructuring for the years ended December 31, 2020 and 2019 are as follows:

Balance - January 1, 2019	$	-
Accruals for severance and other one-time termination benefits		137
Accruals for costs related to the consolidation of Ambrell’s European operations		103
Cash payments		(240	)
Balance - December 31, 2019		-
Accruals for severance and other one-time termination benefits		248
Accruals for costs related to subletting the Fremont, CA facility		153
Accruals for costs related to subletting the Mansfield, MA facility		98
Cash payments		(159	)
Balance - December 31, 2020	$	340

F-16

(4)

GOODWILL AND INTANGIBLE ASSETS

We have two operating segments which are also our reporting units: Thermal and EMS. Goodwill and intangible assets on our balance sheets are the result of our acquisitions of Sigma Systems Corp. ("Sigma") in October 2008, Thermonics, Inc. ("Thermonics") in January 2012 and Ambrell in May 2017. All of our goodwill and intangible assets are allocated to our Thermal segment.

Goodwill

Goodwill totaled $13,738 at both December 31, 2020 and 2019 and was comprised of the following:

Sigma	$	1,656
Thermonics		50
Ambrell		12,032
Total	$	13,738

Intangible Assets

Changes in the amount of the carrying value of finite-lived intangible assets for the years ended December 31, 2020 and 2019 are as follows:

Balance - January 1, 2019	$	8,201
Amortization		(1,257	)
Balance - December 31, 2019		6,944
Amortization		(1,233	)
Balance - December 31, 2020	$	5,711

The following tables provide further detail about our intangible assets as of December 31, 2020 and 2019:

	December 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	10,480	$	4,912	$	5,568
Technology		600		477		123
Patents		590		570		20
Software		270		270		-
Trade name		140		140		-
Total finite-lived intangible assets		12,080		6,369		5,711
Indefinite-lived intangible assets:
Trademarks		6,710		-		6,710
Total intangible assets	$	18,790	$	6,369	$	12,421

	December 31, 2019
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	10,480	$	3,805	$	6,675
Technology		600		380		220
Patents		590		541		49
Software		270		270		-
Trade name		140		140		-
Total finite-lived intangible assets		12,080		5,136		6,944
Indefinite-lived intangible assets:
Trademarks		6,710		-		6,710
Total intangible assets	$	18,790	$	5,136	$	13,654

F-17

We generally amortize our finite-lived intangible assets over their estimated useful lives on a straight-line basis, unless an alternate amortization method can be reliably determined. Any such alternate amortization method would be based on the pattern in which the economic benefits of the intangible asset are expected to be consumed. None of our intangible assets have any residual value.

The following table sets forth the estimated annual amortization expense for each of the next five years:

2021	$	1,227
2022	$	1,167
2023	$	1,067
2024	$	980
2025	$	905

Impairment of Goodwill and Indefinite Life Intangible Assets

During December 2020 and 2019, we assessed our goodwill and indefinite life intangible asset for impairment in accordance with the requirements of ASC Topic 350 using a quantitative approach. Our goodwill impairment assessment is based upon the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The discount rate used in 2020 and 2019 for the discounted cash flows was 20.0%. The selection of the rate in each year was based upon our analysis of market-based estimates of capital costs and discount rates. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions including the selection of control premiums, discount rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge.

During the goodwill impairment assessment in both 2020 and 2019, we compared the fair value of our Thermal reporting unit with its carrying value. This assessment indicated no impairment existed as the fair value of the reporting unit exceeded its carrying value in both 2020 and 2019.

During the indefinite life intangible asset impairment assessment in both 2020 and 2019, we compared the fair value of our indefinite life intangible assets with their carrying values. This assessment indicated no impairment existed as the fair value of the indefinite life intangible assets exceeded their carrying values in both 2020 and 2019.

Impairment of Long-Lived Assets and Finite-lived Intangible Assets

During 2020 and 2019, we did not review any of our long-lived assets for impairment other than the ROU assets related to the leases for our facilities in Fremont, CA and Mansfield, MA as discussed further in Notes 3 and 8. There were no events or changes in business circumstances that would indicate an impairment might exist other than the events identified and discussed in Note 3 related to these specific long-lived assets.

F-18

(5)

REVENUE FROM CONTRACTS WITH CUSTOMERS

The following tables provide additional information about our revenue from contracts with customers, including revenue by customer and product type and revenue by market. See also Note 16 for information about revenue by operating segment and geographic region.

	Years Ended December 31,
	2020		2019
*Net revenues by customer type:*
End user	$	48,041	$	55,074
OEM/Integrator		5,782		5,586
	$	53,823	$	60,660
*Net revenues by product type:*
Thermal test	$	15,768	$	17,631
Thermal process		18,966		20,079
Semiconductor test		13,112		16,273
Service/other		5,977		6,677
	$	53,823	$	60,660
*Net revenues by market:*
Semi Market	$	26,870	$	30,953
Industrial		17,341		21,231
Defense/aerospace		6,314		4,842
Telecommunications		1,715		1,845
Other Multi Markets		1,583		1,789
	$	53,823	$	60,660

Changes in the amount of the allowance for doubtful accounts for the years ended December 31, 2020 and 2019 are as follows:

Balance - January 1, 2019	$	233
Bad debt expense		3
Write-offs		(25	)
Balance - December 31, 2019		211
Bad debt expense		-
Write-offs		-
Foreign currency translation adjustments		1
Balance - December 31, 2020	$	212

(6)

MAJOR CUSTOMERS

(7)

INVENTORIES

Inventories held at December 31 were comprised of the following:

	2020		2019
Raw materials	$	5,371	$	5,369
Work in process		1,085		949
Inventory consigned to others		45		54
Finished goods		975		810
Total inventories	$	7,476	$	7,182

F-19

(8)

LEASES

As previously discussed in Note 2, we account for our leases in accordance with the guidance in ASC Topic 842. We lease our offices, warehouse facilities and certain equipment under non-cancellable operating leases that expire at various dates through 2031. Total operating lease and short-term lease costs for the years ended December 31, 2020 and 2019, respectively, were as follows:

	Years Ended December 31,
	2020		2019

Operating lease cost	$	1,583	$	1,476
Short-term lease cost	$	47	$	51

The following is additional information about our leases as of December 31, 2020:

Range of remaining lease terms (in years)	0.1	to	10.0
Weighted average remaining lease term (in years)		6.4
Weighted average discount rate		4.3%

Maturities of lease liabilities as of December 31, 2020 were as follows:

2021	$	1,481
2022		1,405
2023		1,416
2024		1,395
2025		722
Thereafter		1,845
Total lease payments	$	8,264
Less imputed interest		(999	)
Total	$	7,265

F-20

Cash Flow Information

Total amortization of right of use assets for the years ended December 31, 2020 and 2019 was $1,294 and $1,251, respectively.

ROU Asset Impairment Charges

During the fourth quarter of 2020, we recorded charges for non-cash impairments related to certain of our ROU assets as discussed further in Note 3. The total of these charges was $612. In determining whether our ROU assets were impaired, we considered the intended future use of the assets, including whether we expect to be able to sublease the related facilities. In both cases, we expect to eventually be able to sublease the facilities, but we currently do not expect to successfully negotiate a sublease for either facility in 2021. Our projected future cash inflows from sublease income reflect this expectation. In order to determine whether an impairment existed, we compared all future cash outflows related to the lease for the underlying ROU asset and compared this with our projected future cash inflows from the sublease. We developed several scenarios to model the expected timing and amount of sublease income we expect to receive. In all cases, the future cash outflows exceeded the expected future cash inflows, resulting in the conclusion that the ROU assets were impaired. We then discounted the projected deficit in each scenario using our estimated cost of capital and probability weighted the results to determine the amount of the impairment charge to record. To the extent that our estimate of future cash inflows exceeds the amount we ultimately receive from any sublease we enter into for these facilities, we may need to record an additional impairment charge related to these ROU assets in a future period.

Lease Modifications and Additions

Supplemental cash flow information related to leases for the years ended December 31, 2020 and 2019 was as follows:

Year ended December 31, 2020
Non-cash increases (decreases) in operating lease liabilities and ROU assets as a result of lease modifications and the execution of new leases:
Modification to lease for facility in Fremont, California	$	1,176
Modification to lease for facility in Mt. Laurel, New Jersey	$	2,051
Modification to lease for Ambrell’s Netherlands facility	$	133
Additions to automobile leases	$	91

On January 23, 2020, we executed an amendment to the lease for our EMS facility in Fremont, California, which extended the term for a period of 61 months commencing on November 1, 2020 and expiring on November 30, 2025. At the effective date of this modification, we recorded an increase in our ROU assets and operating lease liabilities of approximately $1,176.

On September 22, 2020, we executed an amendment to the lease for our EMS facility in Mt. Laurel, New Jersey, which extended the term of the existing lease for a period of 120 months commencing on May 1, 2021. At the effective date of this modification, we recorded an increase in our ROU assets and operating lease liabilities of approximately $2,051. In addition, effective on August 1, 2021, the leased space will be reduced to approximately 33,650 square feet.

On October 1, 2020, the lease for Ambrell’s Netherlands facility automatically renewed for an additional three years. At the effective date of this modification, we recorded an increase in our ROU assets and operating lease liabilities of approximately $133.

During the fourth quarter of 2020, we executed new leases for automobiles for certain of our employees in Europe. At the dates of execution, we recorded increases in our ROU assets and operating lease liabilities. The total increase recorded in 2020 related to these new leases was approximately $91.

F-21

Year ended December 31, 2019
Non-cash increases (decreases) in operating lease liabilities and ROU assets as a result of lease modifications:
Modification to lease for Ambrell’s U.K. facility	$	(486	)
Modification to lease for facility in Mansfield, Massachusetts	$	1,811
Modification to lease for Ambrell’s Netherlands facility	$	(48	)

The lease for Ambrell’s U.K. facility had an original term of 15 years, which extended through August 2029. The lease included the option to terminate the lease at specified points in time without penalty. We exercised this option in March 2019, and the lease expired in September 2019. At the effective date of this modification, we recorded a reduction in our ROU assets and operating lease liabilities of approximately $486.

On April 8, 2019, we executed an amendment to the lease for our facility in Mansfield, Massachusetts that extended the term of the lease for an additional forty months to December 31, 2024 and expanded the amount of leased space by approximately 6,100 square feet. The current rate per square foot that is in place through August 31, 2021 (the original expiration date of the lease) did not change. After August 31, 2021, there are predetermined fixed escalations of the rate as outlined in the amendment. As a result of this modification, we recorded an increase in our ROU assets and operating lease liabilities of approximately $1,811.

During the third quarter of 2019, the lease for a portion of Ambrell’s facility in the Netherlands was modified to reduce the term of that lease to expire in September 2019 as that portion of the space was no longer needed. At the effective date of this modification, we recorded a reduction in our ROU assets and operating lease liabilities of approximately $48.

(9)

OTHER CURRENT LIABILITIES

Other current liabilities at December 31 were comprised of the following:

	2020		2019
Accrued restructuring	$	340	$	-
Accrued warranty		235		334
Other		229		163
Total other current liabilities	$	804	$	497

(10)

DEBT

Letters of Credit

We have issued letters of credit as the security deposits for certain of our domestic leases. These letters of credit are secured by pledged certificates of deposit which are classified as Restricted Certificates of Deposit on our balance sheets. The terms of our leases require us to renew these letters of credit at least 30 days prior to their expiration dates for successive terms of not less than one year until lease expiration. In accordance with the terms of our lease, the letter of credit related to our facility in Mt. Laurel, New Jersey was reduced from $125 to $90 on April 1, 2019. Our outstanding letters of credit at December 31, 2020 and 2019 consisted of the following:

L/C

Lease

Letters of Credit
Amount Outstanding

Facility

Original L/C
Issue Date

Expiration
Date

Dec. 31
2020

Dec. 31
2019

Mt. Laurel, NJ

3/29/2010

4/30/2021

4/30/2031

Mansfield, MA

10/27/2010

12/31/2024

140

Line of Credit

On April 10, 2020 (the “Closing Date”) we entered into a Loan and Security Agreement (the “Agreement”) with M&T Bank (“M&T”) which was amended on December 16, 2020. Under the terms of the amended Agreement, M&T has provided us with a $7,500 revolving credit facility under which our domestic subsidiaries, Ambrell, inTEST EMS LLC (“EMS LLC”), Temptronic Corporation (“Temptronic”) and inTEST Silicon Valley Corporation (“Silicon Valley”), are guarantors (collectively, the “Guarantors”). The revolving credit facility has a 364-day contract period that began on the Closing Date and expires on April 9, 2021 (the “Contract Period”). The principal balance of the revolving credit facility accrues interest at the LIBOR rate plus 2.0%. In the event the current LIBOR rate is no longer available or representative, the Agreement includes a mechanism for providing an alternate benchmark. Interest payments are due on a monthly basis, and principal payments are due, along with any accrued and unpaid interest thereon, on the earlier of (a) the expiration of the Contract Period, or (b) on demand upon the occurrence of an event of default that is continuing. As of December 31, 2020, we had $7,500 available to borrow under this facility.

F-22

The Agreement contains customary events of default including, but not limited to, the failure by us to repay obligations when due, violation of provisions or representations provided in the Agreement, bankruptcy of inTEST Corporation, suspension of the business of inTEST Corporation or any of our subsidiaries and certain material judgments. After expiration of the Contract Period, or if during the continuance of an event of default, interest will accrue on the principal balance at a rate of 2% in excess of the then applicable non-default interest rate. Our obligations under the Agreement are secured by liens on substantially all our tangible and intangible assets. The Agreement includes customary affirmative, negative and financial covenants, including a maximum ratio of assets to liabilities and a fixed charge coverage ratio.

This facility was put in place to provide us with additional liquidity in response to the business environment, as a result of COVID-19. During the three months ended June 30, 2020, we drew down $2,800 on our revolving credit facility. This amount was fully repaid during this same period. We did not borrow under this revolving credit facility at any other time during 2020.

Paycheck Protection Program Loans

As discussed more fully in Note 13 to our consolidated financial statements in our Quarterly Report on Form 10-Q for the three months ended March 31, 2020 filed on May 13, 2020 with the Securities and Exchange Commission, during April 2020 we applied for and received loans through the Paycheck Protection Program (the “PPP”) of the Coronavirus Aid, Relief, and Economic Security Act administered by the U.S. Small Business Administration totaling $2,829. We repaid the full amount of the PPP loans on May 5, 2020 with the applicable interest.

(11)

INCOME TAXES

We are subject to Federal and certain state income taxes. In addition, we are taxed in certain foreign countries.

Earnings (loss) before income taxes was as follows:

	Years Ended December 31,
	2020			2019
Domestic	$	(2,017	)	$	1,804
Foreign		786			800
Total	$	(1,231	)	$	2,604

Income tax expense (benefit) was as follows:

	Years Ended December 31,
	2020			2019
Current
Domestic – Federal	$	(182	)	$	510
Domestic – state		53			101
Foreign		135			97
Total	$	6		$	708
Deferred
Domestic – Federal	$	(299	)	$	(413	)
Domestic – state		(7	)		(13	)
Foreign		(36	)		-
Total		(342	)		(426	)
Income tax expense	$	(336	)	$	282

F-23

Deferred income taxes reflect the net tax effect of net operating loss and tax credit carryforwards as well as temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following is a summary of the significant components of our deferred tax assets and liabilities as of December 31, 2020 and 2019:

	December 31,
	2020			2019
Deferred tax assets:
Operating lease liabilities	$	1,601		$	1,123
Inventories		321			247
Accrued vacation pay and stock-based compensation		252			279
Net operating loss (state and foreign)		241			280
Allowance for doubtful accounts		44			44
Accrued warranty		13			19
Acquisition costs		10			12
Tax credit carryforwards		5			112
Other		71			13
Total		2,558			2,129
Valuation allowance		(169	)		(234	)
Deferred tax assets		2,389			1,895
Deferred tax liabilities:
Net intangible assets		(2,697	)		(2,923	)
Right of use assets		(1,400	)		(1,066	)
Depreciation of property and equipment		(214	)		(169	)
Deferred tax liabilities		(4,311	)		(4,158	)
Net deferred tax liabilities	$	(1,922	)	$	(2,263	)

The net change in the valuation allowance for the years ended December 31, 2020 and 2019 was a decrease of $65 and $7, respectively. In assessing the ability to realize the deferred tax assets, we consider whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. In order to fully realize the total deferred tax assets, we will need to generate future taxable income prior to the expiration of net operating loss and tax credit carryforwards which expire in various years through 2040.

An analysis of the effective tax rate for the years ended December 31, 2020 and 2019 and a reconciliation from the expected statutory rate of 21% is as follows:

	Years Ended December 31,
	2020			2019
Expected income tax expense (benefit) at U.S. statutory rate	$	(259	)	$	547
Increase (decrease) in tax from:
Dividend from foreign subsidiaries		83			97
NOL carryforwards utilized		64			32
Restricted stock compensation		62			114
Global intangible low taxed income		35			30
Nondeductible expenses		8			4
Current year tax credits (foreign and research)		(82	)		(234	)
Domestic tax benefit, net of Federal benefit		(68	)		(184	)
Changes in valuation allowance		(65	)		(7	)
Foreign income tax rate differences		(34	)		(51	)
Section 250 foreign derived intangible income deduction		(9	)		(145	)
Other		(71	)		79
Income tax expense (benefit)	$	(336	)	$	282

In accounting for income taxes, we follow the guidance in ASC Topic 740 (Income Taxes) regarding the recognition and measurement of uncertain tax positions in our financial statements. Recognition involves a determination of whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information. Our policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of December 31, 2020 and 2019, we did not have an accrual for uncertain tax positions.

We file U.S. income tax returns and multiple state and foreign income tax returns. With few exceptions, the U.S. and state income tax returns filed for the tax years ended December 31, 2017 and thereafter are subject to examination by the relevant taxing authorities.

F-24

(12)

LEGAL PROCEEDINGS

From time to time we may be a party to legal proceedings occurring in the ordinary course of business. We are not currently involved in any legal proceedings the resolution of which we believe could have a material effect on our business, financial position, results of operations or long-term liquidity.

(13)

STOCK-BASED COMPENSATION PLAN

As of December 31, 2020, we have unvested restricted stock awards and stock options outstanding which were granted under the inTEST Corporation Third Amended and Restated 2014 Stock Plan (the "2014 Stock Plan"). The 2014 Stock Plan was originally approved at our annual meeting of stockholders held on June 25, 2014 and permitted the granting of stock options, restricted stock, stock appreciation rights or restricted stock units for up to 500,000 shares of our common stock to directors, officers, other key employees and consultants. On June 27, 2018, our stockholders approved the amendment and restatement of the 2014 Stock Plan to increase the number of shares of common stock that may be delivered pursuant to awards granted under the 2014 Stock Plan from 500,000 to 1,000,000 shares. On June 19, 2019, our stockholders approved the amendment and restatement of the 2014 Stock Plan to increase the number of shares of common stock that may be delivered pursuant to awards granted under the 2014 Stock Plan from 1,000,000 to 2,000,000 shares. As of December 31, 2020, there were 1,067,979 aggregate shares available to grant under the 2014 Plan.

Our unvested restricted stock awards and stock options are accounted for based on their grant date fair value. As of December 31, 2020, total compensation expense to be recognized in future periods is $1,353. The weighted average period over which this expense is expected to be recognized is 2.6 years.

The following table summarizes the compensation expense we recorded during 2020 and 2019, related to unvested shares of restricted stock and stock options:

	Years Ended December 31,
	2020		2019
Cost of revenues	$	-	$	-
Selling expense		12		8
Engineering and product development expense		42		35
General and administrative expense		617		841
	$	671	$	884

There was no compensation expense capitalized in 2020 or 2019.

Stock Options

We record compensation expense for stock options based on the fair market value of the options as of the grant date. No option may be granted with an exercise period in excess of ten years from the date of grant. Generally, stock options will be granted with an exercise price equal to the fair market value of our stock on the date of grant and will vest over four years.

The fair value for stock options granted during 2020 and 2019 was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

	2020			2019
Risk-free interest rate		0.46	%		2.35	%
Dividend yield		0.00	%		0.00	%
Expected common stock market price volatility factor		.44			.42
Weighted average expected life of stock options (years)		6.25			6.25

The per share weighted average fair value of stock options issued during 2020 and 2019 was $1.48 and $2.75, respectively.

F-25

The following table summarizes the activity related to stock options for the two years ended December 31, 2020:

	Number of Shares			Weighted Average Exercise Price
Options outstanding, January 1, 2019		264,400			7.54
Granted		249,460			6.25
Exercised		-			-
Canceled		(7,050	)		8.45
Options outstanding, December 31, 2019 (87,900 exercisable)		506,810			6.89
Granted		113,980			3.49
Exercised		-			-
Canceled		(182,590	)		6.31
Options outstanding, December 31, 2020 (204,630 exercisable)		438,200			6.25

Restricted Stock Awards

We record compensation expense for restricted stock awards based on the quoted market price of our stock at the grant date and amortize the expense over the vesting period. Restricted stock awards generally vest over four years for employees and over one year for our independent directors (25% at each of March 31, June 30, September 30, and December 31 of the year in which they were granted).

On August 24, 2020, our new President and CEO received two restricted stock awards totaling 141,610 shares valued at $650 as of the date of grant, which was also his hire date. Of the total shares awarded, 66,448 shares vest over 4 years (25% at each anniversary) and 75,162 vest on the third anniversary of the grant date at a vesting percentage that could range from 0% to 150% of the number of shares awarded on August 24, 2020. The final vesting percentage will be based on the achievement of certain performance metrics, including net revenue compound annual growth rate and diluted earnings per share excluding amortization of intangibles, for specified time periods as determined by the Compensation Committee of our Board of Directors. As of December 31, 2020, we have estimated that these shares will vest at 100% of the original amount awarded and are recording expense based on this estimate on a straight-line basis over the three year vesting period. Our estimate of the final expected vesting percentage will be reassessed and adjusted, as needed, at the end of each reporting period.

The following table summarizes the activity related to unvested restricted stock awards for the two years ended December 31, 2020:

	Number of Shares			Weighted Average Grant Date Fair Value
Unvested shares outstanding, January 1, 2019		114,750			6.92
Granted		132,580			6.31
Vested		(69,974	)		6.60
Forfeited		(12,325	)		7.14
Unvested shares outstanding, December 31, 2019		165,031			6.55
Granted		229,110			4.24
Vested		(89,861	)		5.32
Forfeited		(67,125	)		6.03
Unvested shares outstanding, December 31, 2020		237,155			4.93

The total fair value of the restricted stock awards that vested during the years ended December 31, 2020 and 2019 was $357 and $426, respectively, as of the vesting dates of these awards.

(14)

STOCK REPURCHASE PLANS

On July 31, 2019, our Board of Directors authorized the repurchase of up to $3,000 of our common stock from time to time on the open market, in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or in privately negotiated transactions pursuant to a newly authorized stock repurchase plan (the “2019 Repurchase Plan”). Repurchases may be made under a Rule 10b5-1 plan entered into with RW Baird & Co., which would permit shares to be repurchased when we might otherwise be precluded from doing so under insider trading laws and our internal trading windows. The 2019 Repurchase Plan does not obligate us to purchase any particular amount of common stock and may be suspended or discontinued at any time without prior notice. The 2019 Repurchase Plan is funded using our operating cash flow or available cash. Purchases began on September 18, 2019 under this plan. During the quarter ended March 31, 2020, we repurchased 13,767 shares under the 2019 Repurchase Plan at a cost of $74, including fees paid to our broker. On March 2, 2020, we suspended repurchases under the 2019 Repurchase Plan. For the term of the 2019 Repurchase Plan through December 31, 2020, we have repurchased a total of 243,075 shares at a cost of $1,216, which includes fees paid to our broker of $6. All of the repurchased shares were retired.

F-26

In addition, on July 31, 2019, our Board of Directors terminated the 2015 Stock Repurchase Plan which had been authorized on October 27, 2015 and under which we had repurchased a total of 297,020 shares at a cost of $1,195. The shares were repurchased between December 2015 and January 2017. All of the repurchased shares were retired.

(15)

EMPLOYEE BENEFIT PLANS

We have defined contribution 401(k) plans for our employees who work in the U.S. All permanent employees of inTEST Corporation, EMS LLC, Temptronic and Silicon Valley who are at least 18 years of age are eligible to participate in the inTEST Corporation Incentive Savings Plan. We match employee contributions dollar for dollar up to 10% of the employee's annual compensation, with a maximum limit of $5. Employer contributions vest ratably over four years. Matching contributions are discretionary. For the years ended December 31, 2020 and 2019 we recorded $331 and $382 of expense for matching contributions, respectively.

All permanent employees of Ambrell are immediately eligible to participate in the Ambrell Corporation Savings & Profit Sharing Plan (the "Ambrell Plan") upon employment and are eligible for employer matching contributions after completing six months of service, as defined in the Ambrell Plan. The Ambrell Plan allows eligible employees to make voluntary contributions up to 100% of compensation, up to the federal government contribution limits. We will make a matching contribution of 50% of each employee's contributions up to a maximum of 10% of the employee's deferral with a maximum limit of $5. For the years ended December 31, 2020 and 2019 we recorded $62 and $49 of expense for matching contributions, respectively.

(16)

SEGMENT INFORMATION

We have two reportable segments, Thermal and EMS, which are also our reporting units. Thermal includes the operations of Temptronic, Thermonics, Sigma, inTEST Thermal Solutions GmbH (Germany), inTEST Pte, Limited (Singapore) and Ambrell. Sales of this segment consist primarily of temperature management systems which we design, manufacture and market under our Temptronic, Thermonics and Sigma product lines, and precision induction heating systems which are designed, manufactured and marketed by Ambrell. In addition, this segment provides post-warranty service and support. EMS includes the operations of our manufacturing facilities in Mt. Laurel, New Jersey and Fremont, California. Sales of this segment consist primarily of manipulator, docking hardware and tester interface products, which we design, manufacture and market. See Note 3 for information related to the planned closure of our manufacturing facility in Fremont, California.

We operate our business worldwide and sell our products both domestically and internationally. Both of our segments sell to semiconductor manufacturers, third-party test and assembly houses and ATE manufacturers. Thermal also sells into a variety of markets outside of the Semi Market, including the automotive, defense/aerospace, industrial, medical, telecommunications and other markets.

	Years Ended December 31,
	2020			2019
*Net revenues from unaffiliated customers:*
Thermal	$	40,209		$	43,823
EMS		13,614			16,837
	$	53,823		$	60,660
*Depreciation/amortization:*
Thermal	$	1,727		$	1,810
EMS		109			118
Corporate		27			14
	$	1,863		$	1,942
*Operating income (loss):*
Thermal	$	325		$	2,334
EMS		(1,113	)		1,725
Corporate		(429	)		(1,510	)
	$	(1,217	)	$	2,549
*Earnings (loss) before income tax expense (benefit):*
Thermal	$	306		$	2,370
EMS		(1,077	)		1,767
Corporate		(460	)		(1,533	)
	$	(1,231	)	$	2,604
*Income tax expense (benefit):*
Thermal	$	84		$	257
EMS		(294	)		194
Corporate		(126	)		(169	)
	$	(336	)	$	282
*Net earnings (loss):*
Thermal	$	222		$	2,113
EMS		(783	)		1,573
Corporate		(334	)		(1,364	)
	$	(895	)	$	2,322
*Capital expenditures:*
Thermal	$	371		$	501
EMS		284			46
Corporate		3			73
	$	658		$	620

F-27

	December 31,
	2020		2019
*Identifiable assets:*
Thermal	$	50,782	$	51,621
EMS		9,667		7,319
Corporate		1,581		775
	$	62,030	$	59,715

The following table provides information about our geographic areas of operation. Net revenues from unaffiliated customers are based on the location to which the goods are shipped.

	Years Ended December 31,
	2020		2019
*Net revenues from unaffiliated customers:*
U.S.	$	22,211	$	25,283
Foreign		31,612		35,377
	$	53,823	$	60,660

	December 31,
	2020		2019
*Property and equipment:*
U.S.	$	2,053	$	2,163
Foreign		297		257
	$	2,350	$	2,420

F-28

(17)

QUARTERLY CONSOLIDATED FINANCIAL DATA (Unaudited)

The following tables present certain unaudited consolidated quarterly financial information for each of the eight quarters ended December 31, 2020. In our opinion, this quarterly information has been prepared on the same basis as the consolidated financial statements and includes all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the information for the periods presented. The results of operations for any quarter are not necessarily indicative of results for the full year or for any future period.

Year-over-year quarterly comparisons of our results of operations may not be as meaningful as the sequential quarterly comparisons set forth below that tend to reflect the cyclical and seasonal activity of the Semi Market. Quarterly fluctuations in expenses are related directly to sales activity and volume and may also reflect the timing of operating expenses incurred throughout the year.

	Quarters Ended
	3/31/20⁽¹⁾			6/30/20⁽²⁾		9/30/20⁽³⁾			12/31/20⁽⁴⁾			Total
Net revenues	$	11,230		$	13,275	$	14,443		$	14,875		$	53,823
Gross margin		4,867			6,067		6,450			6,720			24,104
Earnings (loss) before income tax expense (benefit)		(1,393	)		183		433			(454	)		(1,231	)
Income tax expense (benefit)		(250	)		13		(25	)		(74	)		(336	)
Net earnings (loss)		(1,143	)		170		458			(380	)		(895	)

Net earnings (loss) per common share – basic	$	(0.11	)	$	0.02	$	0.04		$	(0.04	)	$	(0.09	)
Weighted average common shares outstanding – basic		10,220,853			10,252,490		10,269,995			10,282,903			10,256,560
Net earnings (loss) per common share – diluted	$	(0.11	)	$	0.02	$	0.04		$	(0.04	)	$	(0.09	)
Weighted average common shares outstanding – diluted		10,220,853			10,258,917		10,287,562			10,282,903			10,256,560

	Quarters Ended
	3/31/19		6/30/19⁽⁵⁾			9/30/19⁽⁶⁾		12/31/19			Total
Net revenues	$	18,062	$	14,352		$	14,632	$	13,614		$	60,660
Gross margin		8,836		6,719			7,205		6,465			29,225
Earnings (loss) before income tax expense (benefit)		1,462		(300	)		794		648			2,604
Income tax expense (benefit)		324		(113	)		147		(76	)		282
Net earnings (loss)		1,138		(187	)		647		724			2,322

Net earnings (loss) per common share – basic	$	0.11	$	(0.02	)	$	0.06	$	0.07		$	0.22
Weighted average common shares outstanding – basic		10,385,017		10,411,276			10,421,383		10,274,980			10,373,164
Net earnings (loss) per common share – diluted	$	0.11	$	(0.02	)	$	0.06	$	0.07		$	0.22
Weighted average common shares outstanding – diluted		10,414,330		10,411,276			10,429,536		10,298,535			10,391,975

	(1)	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
	(2)	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
	(3)	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
	(4)	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3
	(5)	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.
	(6)	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.

F-29

inTEST CORPORATION
SCHEDULE II -- VALUATION AND QUALIFYING ACCOUNTS
(in thousands)

	Balance at Beginning of Period		Expense (Recovery)		Deductions			Foreign Currency Translation Adjustments		Balance at End of Period

Year Ended December 31, 2020
Allowance for doubtful accounts	$	211	$	-	$	-		$	1	$	212
Warranty reserve		334		32		(131	)		-		235

Year Ended December 31, 2019
Allowance for doubtful accounts	$	233	$	3	$	(25	)		-	$	211
Warranty reserve		346		243		(255	)		-		334

F-30

EX-10.29 2 ex_234686.htm EXHIBIT 10.29 ex_234686.htm

EXHIBIT 10.29

COMPENSATORY ARRANGEMENTS OF DIRECTORS

Directors who are not also our officers (each a "non-employee director") currently receive an annual retainer of $25,000. The Chairman of the Board of Directors (the "Board") is paid an additional annual retainer of $40,000. The Chair of each of the committees of the Board are paid an additional annual fee as follows: the Chair of the Audit Committee is paid an additional annual fee of $20,000; the Chair of the Compensation Committee is paid an additional annual fee of $10,000; and the Chair of the Nominating and Corporate Governance Committee is paid an additional annual fee of $10,000. The members of the committees, other than the Chair, are paid additional annual fees as follows: members of the Audit Committee are paid an additional annual fee of $10,000, members of the Compensation Committee are paid an additional annual fee of $5,000, and members of the Nominating and Corporate Governance Committee are paid an additional annual fee of $5,000. Non-employee directors also receive a one-time award of restricted stock after their initial election to the Board that vests over four years and an annual award of restricted stock that vests fully in the year awarded, both of which are granted under our Third Amended and Restated 2014 Stock Plan. In addition, we reimburse non-employee directors' travel expenses and other costs associated with attending Board or committee meetings. We do not pay compensation to our executive officers for their service as directors.

EX-21 3 ex_234687.htm EXHIBIT 21 ex_234687.htm

EXHIBIT 21

Subsidiaries of the Registrant

Name of Subsidiaries	Jurisdiction of Incorporation

Ambrell Corporation	Delaware
inTEST EMS LLC (a)	Delaware
inTEST Silicon Valley Corporation (a)	Delaware
Temptronic Corporation (b)	Delaware
Ambrell B.V.	Netherlands
Ambrell Limited	U.K.
inTEST PTE, Ltd.	Singapore
inTEST Thermal Solutions GmbH	Germany

(a)	Doing business as inTEST EMS.

(b)	Doing business as inTEST Thermal Solutions Corp.

EX-23 4 ex_235504.htm EXHIBIT 23 ex_235504.htm

EXHIBIT 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements (Nos. 333-145176, 333-197858, 333-226815, and 333-233297) on Form S-8 and the Registration Statement (No. 333-250047) on Form S-3 of inTEST Corporation of our report dated March 23, 2021, relating to the consolidated financial statements and the financial statement schedule of inTEST Corporation, appearing in this Annual Report on Form 10-K of inTEST Corporation for the year ended December 31, 2020.

/s/ RSM US LLP

Blue Bell, Pennsylvania
March 23, 2021

EX-31.1 5 ex_234688.htm EXHIBIT 31.1 ex_234688.htm

EXHIBIT 31.1

CERTIFICATION

I, Richard N. Grant, Jr., certify that:

1. I have reviewed this annual report on Form 10-K of inTEST Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	March 23, 2021	/s/Richard N. Grant, Jr.
		Richard N. Grant, Jr.
		President and Chief Executive Officer

EX-31.2 6 ex_234690.htm EXHIBIT 31.2 ex_234690.htm

EXHIBIT 31.2

CERTIFICATION

I, Hugh T. Regan, Jr., certify that:

1. I have reviewed this annual report on Form 10-K of inTEST Corporation;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	March 23, 2021	/s/ Hugh T. Regan, Jr.
		Hugh T. Regan, Jr.
		Secretary, Treasurer and Chief Financial Officer

EX-32.1 7 ex_234691.htm EXHIBIT 32.1 ex_234691.htm

EXHIBIT 32.1

inTEST CORPORATION

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of inTEST Corporation (the "Company") on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Richard N. Grant, Jr., President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	March 23, 2021	/s/ Richard N. Grant, Jr.
		Richard N. Grant, Jr.
		President and Chief Executive Officer

EX-32.2 8 ex_234692.htm EXHIBIT 32.2 ex_234692.htm

EXHIBIT 32.2

inTEST CORPORATION

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of inTEST Corporation (the "Company") on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Hugh T. Regan, Jr., Secretary, Treasurer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	March 23, 2021	/s/ Hugh T. Regan, Jr.
		Hugh T. Regan, Jr.
		Secretary, Treasurer and Chief Financial Officer

EX-101.INS 9 intt-20201231.xml XBRL INSTANCE DOCUMENT false --12-31 FY 2020 2020-12-31 10-K 0001036262 10703056 Yes false Non-accelerated Filer Yes 33823258 INTEST CORP false true No No Common Stock, par value $0.01 per share intt 1000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Basis of Presentation and Use of Estimates</div></div></div><br /> <br /> The accompanying consolidated financial statements include our accounts and those of our wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated upon consolidation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Certain of our accounts, including inventories, long-lived assets, goodwill, identifiable intangibles and deferred tax assets and liabilities including related valuation allowances, are particularly impacted by estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 12167000 463000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Contingent Liability for Repayment of State and Local Grant Funds Received </div></div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In connection with leasing a new facility in Rochester, New York, which our subsidiary, Ambrell, occupied in <div style="display: inline; font-style: italic; font: inherit;"> May 2018, </div>we entered into agreements with the city of Rochester and the state of New York under which we received grants totaling <div style="display: inline; font-style: italic; font: inherit;">$463</div> to help offset a portion of the cost of the leasehold improvements we have made to this facility. In exchange for the funds we received under these agreements, we are required to create and maintain specified levels of employment in this location through various dates ending in <div style="display: inline; font-style: italic; font: inherit;">2023.</div> If we fail to meet these employment targets, we <div style="display: inline; font-style: italic; font: inherit;"> may </div>be required to repay a proportionate share of the proceeds. As of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div><div style="display: inline; font-style: italic; font: inherit;">$423</div> of the total proceeds received could still be required to be repaid if we do <div style="display: inline; font-style: italic; font: inherit;">not</div> meet the targets. We have recorded this amount as a contingent liability which is included in other liabilities on our balance sheet. Those portions of the proceeds which are <div style="display: inline; font-style: italic; font: inherit;">no</div> longer subject to repayment are reclassified to deferred grant proceeds and amortized to income on a straight-line basis over the remaining lease term for the Rochester facility. Deferred grant proceeds are included in other current liabilities and other liabilities on our balance sheet and totaled <div style="display: inline; font-style: italic; font: inherit;">$27</div> at <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">As of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>we were <div style="display: inline; font-style: italic; font: inherit;">not</div> in compliance with the employment targets as specified in the grant agreement with the city of Rochester. We applied for and received a waiver of this requirement for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>We have until <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2021 </div>to come into compliance with the targets as outlined in the waiver received for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>If we do <div style="display: inline; font-style: italic; font: inherit;">not</div> achieve compliance, we will need to apply for an additional waiver or we <div style="display: inline; font-style: italic; font: inherit;"> may </div>be required to repay a proportionate share of the proceeds.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 99000 99000 153000 153000 423000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 15%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 64%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accrued restructuring</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">340</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accrued warranty</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Other</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">229</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">163</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total other current liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">804</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">497</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div> 486000 48000 486000 48000 27000 10000 12000 1601000 1123000 1400000 1066000 P4Y 5000 0.2 0.2 -405000 -88000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Goodwill, Intangible and Long-Lived Assets</div></div></div><br /> <br /> We have <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">two</div></div> operating segments which are also our reporting units: Thermal and EMS. We account for goodwill and intangible assets in accordance with Accounting Standards Codification (“ASC”) Topic <div style="display: inline; font-style: italic; font: inherit;">350</div> (Intangibles - Goodwill and Other). Finite-lived intangible assets are amortized over their estimated useful economic life and are carried at cost less accumulated amortization. Goodwill is assessed for impairment annually in the <div style="display: inline; font-style: italic; font: inherit;">fourth</div> quarter on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill <div style="display: inline; font-style: italic; font: inherit;"> may </div>be impaired. Goodwill is considered to be impaired if the fair value of a reporting unit is less than its carrying amount. As a part of the goodwill impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> that the fair value of a reporting unit is less than its carrying amount. If, as a result of our qualitative assessment, we determine that it is more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> that the fair value of the reporting unit is greater than its carrying amount, a quantitative goodwill impairment test is <div style="display: inline; font-style: italic; font: inherit;">not</div> required. However, if, as a result of our qualitative assessment, we determine it is more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> that the fair value of a reporting unit is less than its carrying amount, or, if we choose <div style="display: inline; font-style: italic; font: inherit;">not</div> to perform a qualitative assessment, we are required to perform a quantitative goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized. </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The quantitative goodwill impairment test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered <div style="display: inline; font-style: italic; font: inherit;">not</div> impaired. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss will be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The goodwill impairment assessment is based upon the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions including the selection of control premiums, discount rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Indefinite-lived intangible assets are assessed for impairment annually in the <div style="display: inline; font-style: italic; font: inherit;">fourth</div> quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. As a part of the impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> that an indefinite-lived intangible asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> that the fair value of the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required; otherwise, <div style="display: inline; font-style: italic; font: inherit;">no</div> further testing is required. The quantitative impairment test consists of a comparison of the fair value of the intangible asset with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Long-lived assets, which consist of finite-lived intangible assets, property and equipment and right-of-use (“ROU”) assets, are assessed for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets <div style="display: inline; font-style: italic; font: inherit;"> may </div><div style="display: inline; font-style: italic; font: inherit;">not</div> be fully recoverable or that the useful lives of these assets are <div style="display: inline; font-style: italic; font: inherit;">no</div> longer appropriate. Each impairment test is based on a comparison of the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value. The cash flow estimates used to determine the impairment, if any, contain management's best estimates using appropriate assumptions and projections at that time. </div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 83000 97000 -64000 -32000 35000 30000 -9000 -145000 -31000 31000 29000 -261000 -1297000 -1378000 1176000 2051000 133000 91000 1811000 1176000 133000 91000 1811000 0 0 6100 P36D P10Y 6000 2829000 82000 167000 1285000 240000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Restructuring and Other Charges</div></div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In accordance with the guidance in Accounting Standards Codification (“ASC”) Topic <div style="display: inline; font-style: italic; font: inherit;">420</div> (Exit or Disposal Cost Obligations), we recognize a liability for restructuring costs at fair value only when the liability is incurred. Workforce-related charges are accrued when it is determined that a liability has been incurred, which is generally after individuals have been notified of their termination dates and expected severance benefits. Depending on the timing of the termination dates, these charges <div style="display: inline; font-style: italic; font: inherit;"> may </div>be recognized upon notification or ratably over the remaining required service period of the employees. Plans to consolidate excess facilities <div style="display: inline; font-style: italic; font: inherit;"> may </div>result in lease termination fees and impairment charges related to our right-of-use (“ROU”) assets that are associated with the leases for these facilities. Other long-lived assets that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be impaired as a result of restructuring consist of property and equipment, goodwill and intangible assets. Asset impairment charges included in restructuring and other charges are based on an estimate of the amounts and timing of future cash flows related to the expected future remaining use and ultimate sale or disposal of the asset, and, in the case of our ROU assets, would include expected future sublease rental income, if applicable. These estimates are derived using the guidance in ASC Topic <div style="display: inline; font-style: italic; font: inherit;">842</div> (Leases), ASC Topic <div style="display: inline; font-style: italic; font: inherit;">360</div> (Property, Plant and Equipment) and ASC Topic <div style="display: inline; font-style: italic; font: inherit;">350</div> (Intangibles - Goodwill and Other).</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 15%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 82%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - January 1, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8,201</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,257</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,944</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,233</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - December 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,711</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - January 1, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">233</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Bad debt expense</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Write-offs</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">211</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Bad debt expense</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Write-offs</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Foreign currency translation adjustments</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - December 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">212</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31, 2020 </div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Gross</div><br /> <div style="display: inline; font-weight: bold;">Carrying</div><br /> <div style="display: inline; font-weight: bold;">Amount</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Accumulated </div></div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Net</div><br /> <div style="display: inline; font-weight: bold;">Carrying</div><br /> <div style="display: inline; font-weight: bold;">Amount</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Finite-lived intangible assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Customer relationships</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,480</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4,912</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5,568</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Technology</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">600</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">477</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">123</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Patents</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">590</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">570</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Software</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Trade name</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total finite-lived intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12,080</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,369</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5,711</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Indefinite-lived intangible assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Trademarks</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,710</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,710</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">18,790</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,369</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">12,421</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31, 2019 </div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Gross</div><br /> <div style="display: inline; font-weight: bold;">Carrying</div><br /> <div style="display: inline; font-weight: bold;">Amount</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Accumulated </div></div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Net</div><br /> <div style="display: inline; font-weight: bold;">Carrying</div><br /> <div style="display: inline; font-weight: bold;">Amount</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Finite-lived intangible assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Customer relationships</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,480</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3,805</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,675</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Technology</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">600</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">380</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">220</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Patents</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">590</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">541</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">49</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Software</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Trade name</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total finite-lived intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12,080</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5,136</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,944</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Indefinite-lived intangible assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Trademarks</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,710</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,710</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">18,790</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,136</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">13,654</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="margin-right: auto; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 42%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 10%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;">L/C</div></div> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;">Lease</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 14%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Letters of Credit</div><br /> <div style="display: inline; font-weight: bold;">Amount Outstanding</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 42%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Facility</div></div></div> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%; border-bottom: thin solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;">Original L/C</div><br /> <div style="display: inline; font-weight: bold;">Issue Date</div></div> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: thin solid rgb(0, 0, 0); width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;">Expiration</div><br /> <div style="display: inline; font-weight: bold;">Date </div></div> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: thin solid rgb(0, 0, 0); width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;">Expiration</div><br /> <div style="display: inline; font-weight: bold;">Date </div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Dec. 31</div><br /> <div style="display: inline; font-weight: bold;">2020 </div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Dec. 31</div><br /> <div style="display: inline; font-weight: bold;">2019 </div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 42%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Mt. Laurel, NJ</div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3/29/2010</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4/30/2021</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4/30/2031</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">90</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">90</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 42%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Mansfield, MA</div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10/27/2010</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12/31/2024</div></div> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 10%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12/31/2024</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 42%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 10%;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 10%;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 10%;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div> 69000 69000 133000 133000 0 1.5 650000 117000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font: inherit;">14</div>)</div> </div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">STOCK REPURCHASE PLANS</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">On <div style="display: inline; font-style: italic; font: inherit;"> July 31, 2019, </div>our Board of Directors authorized the repurchase of up to <div style="display: inline; font-style: italic; font: inherit;">$3,000</div> of our common stock from time to time on the open market, in compliance with Rule <div style="display: inline; font-style: italic; font: inherit;">10b</div>-<div style="display: inline; font-style: italic; font: inherit;">18</div> under the Securities Exchange Act of <div style="display: inline; font-style: italic; font: inherit;">1934,</div> as amended (the “Exchange Act”), or in privately negotiated transactions pursuant to a newly authorized stock repurchase plan (the <div style="display: inline; font-style: italic; font: inherit;">“2019</div> Repurchase Plan”). Repurchases <div style="display: inline; font-style: italic; font: inherit;"> may </div>be made under a Rule <div style="display: inline; font-style: italic; font: inherit;">10b5</div>-<div style="display: inline; font-style: italic; font: inherit;">1</div> plan entered into with RW Baird & Co., which would permit shares to be repurchased when we might otherwise be precluded from doing so under insider trading laws and our internal trading windows. The <div style="display: inline; font-style: italic; font: inherit;">2019</div> Repurchase Plan does <div style="display: inline; font-style: italic; font: inherit;">not</div> obligate us to purchase any particular amount of common stock and <div style="display: inline; font-style: italic; font: inherit;"> may </div>be suspended or discontinued at any time without prior notice. The <div style="display: inline; font-style: italic; font: inherit;">2019</div> Repurchase Plan is funded using our operating cash flow or available cash. Purchases began on <div style="display: inline; font-style: italic; font: inherit;"> September 18, 2019 </div>under this plan. During the quarter ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020, </div>we repurchased <div style="display: inline; font-style: italic; font: inherit;">13,767</div> shares under the <div style="display: inline; font-style: italic; font: inherit;">2019</div> Repurchase Plan at a cost of <div style="display: inline; font-style: italic; font: inherit;">$74,</div> including fees paid to our broker. On <div style="display: inline; font-style: italic; font: inherit;"> March 2, 2020, </div>we suspended repurchases under the <div style="display: inline; font-style: italic; font: inherit;">2019</div> Repurchase Plan. For the term of the <div style="display: inline; font-style: italic; font: inherit;">2019</div> Repurchase Plan through <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>we have repurchased a total of <div style="display: inline; font-style: italic; font: inherit;">243,075</div> shares at a cost of <div style="display: inline; font-style: italic; font: inherit;">$1,216,</div> which includes fees paid to our broker of <div style="display: inline; font-style: italic; font: inherit;">$6.</div> All of the repurchased shares were retired.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In addition, on <div style="display: inline; font-style: italic; font: inherit;"> July 31, 2019, </div>our Board of Directors terminated the <div style="display: inline; font-style: italic; font: inherit;">2015</div> Stock Repurchase Plan which had been authorized on <div style="display: inline; font-style: italic; font: inherit;"> October 27, 2015 </div>and under which we had repurchased a total of <div style="display: inline; font-style: italic; font: inherit;">297,020</div> shares at a cost of <div style="display: inline; font-style: italic; font: inherit;">$1,195.</div> The shares were repurchased between <div style="display: inline; font-style: italic; font: inherit;"> December 2015 </div>and <div style="display: inline; font-style: italic; font: inherit;"> January 2017. </div>All of the repurchased shares were retired.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 36pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="4" style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">Year ended December 31, 2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="4" style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">Non-cash increases (decreases) in operating lease liabilities and ROU assets as a result of lease modifications and the execution of new leases:</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 84%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Modification to lease for facility in Fremont, California</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,176</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Modification to lease for facility in Mt. Laurel, New Jersey</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,051</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Modification to lease for Ambrell's Netherlands facility</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">133</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Additions to automobile leases</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">91</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 36pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="4" style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">Year ended December 31, 2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="4" style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">Non-cash increases (decreases) in operating lease liabilities and ROU assets as a result of lease modifications:</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 84%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Modification to lease for Ambrell's U.K. facility</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(486</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Modification to lease for facility in Mansfield, Massachusetts</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,811</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Modification to lease for Ambrell's Netherlands facility</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(48</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at</div><br /> <div style="display: inline; font-weight: bold;">Beginning</div><br /> <div style="display: inline; font-weight: bold;">of Period</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Expense</div><br /> <div style="display: inline; font-weight: bold;">(Recovery)</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Deductions</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div><br /> <div style="display: inline; font-weight: bold;">Currency</div><br /> <div style="display: inline; font-weight: bold;">Translation</div><br /> <div style="display: inline; font-weight: bold;">Adjustments</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at</div><br /> <div style="display: inline; font-weight: bold;">End of</div><br /> <div style="display: inline; font-weight: bold;">Period</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 35%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year Ended December 31, 2020</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">211</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">212</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Warranty reserve</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(131</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year Ended December 31, 2019</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">233</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">211</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Warranty reserve</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">346</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">243</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(255</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;">inTEST CORPORATION</div><br /> <div style="display: inline; font-weight: bold;">SCHEDULE II -- VALUATION AND QUALIFYING ACCOUNTS</div><br /> (in thousands)</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at</div><br /> <div style="display: inline; font-weight: bold;">Beginning</div><br /> <div style="display: inline; font-weight: bold;">of Period</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Expense</div><br /> <div style="display: inline; font-weight: bold;">(Recovery)</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Deductions</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div><br /> <div style="display: inline; font-weight: bold;">Currency</div><br /> <div style="display: inline; font-weight: bold;">Translation</div><br /> <div style="display: inline; font-weight: bold;">Adjustments</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance at</div><br /> <div style="display: inline; font-weight: bold;">End of</div><br /> <div style="display: inline; font-weight: bold;">Period</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 35%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year Ended December 31, 2020</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">211</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">212</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Warranty reserve</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(131</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year Ended December 31, 2019</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">233</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">211</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Warranty reserve</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">346</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">243</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(255</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div></div>

2424000

1984000

8435000

9296000

776000

805000

472000

442000

5642000

5273000

889000

673000

26851000

26256000

884000

671000

12000

8000

42000

35000

617000

841000

671000

884000

233000

211000

212000

211000

3000

25000

1257000

1233000

717015

523485

33650

62030000

59715000

50782000

51621000

9667000

7319000

1581000

775000

26964000

24895000

10277000

7612000

17861000

10277000

2665000

-10249000

0.01

20000000

10562200

10413982

10523035

10413982

10562200

106000

104000

-679000

2212000

0.1

396000

456000

29719000

31435000

-182000

510000

135000

97000

6000

708000

53000

101000

0.02

-299000

-413000

-36000

-341000

-426000

4311000

4158000

1922000

2263000

-7000

-13000

2558000

2129000

321000

247000

2389000

1895000

241000

280000

71000

13000

5000

112000

252000

279000

44000

13000

19000

169000

234000

1922000

2263000

2697000

2923000

214000

169000

331000

382000

62000

49000

0.1

0.5

5000

630000

685000

1727000

1810000

109000

118000

27000

14000

1863000

1942000

3174000

3193000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font: inherit;">13</div>)</div> </div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">STOCK-BASED COMPENSATION PLAN</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">As of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>we have unvested restricted stock awards and stock options outstanding which were granted under the inTEST Corporation Third Amended and Restated <div style="display: inline; font-style: italic; font: inherit;">2014</div> Stock Plan (the <div style="display: inline; font-style: italic; font: inherit;">"2014</div> Stock Plan"). The <div style="display: inline; font-style: italic; font: inherit;">2014</div> Stock Plan was originally approved at our annual meeting of stockholders held on <div style="display: inline; font-style: italic; font: inherit;"> June 25, 2014 </div>and permitted the granting of stock options, restricted stock, stock appreciation rights or restricted stock units for up to <div style="display: inline; font-style: italic; font: inherit;">500,000</div> shares of our common stock to directors, officers, other key employees and consultants. On <div style="display: inline; font-style: italic; font: inherit;"> June 27, 2018, </div>our stockholders approved the amendment and restatement of the <div style="display: inline; font-style: italic; font: inherit;">2014</div> Stock Plan to increase the number of shares of common stock that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be delivered pursuant to awards granted under the <div style="display: inline; font-style: italic; font: inherit;">2014</div> Stock Plan from <div style="display: inline; font-style: italic; font: inherit;">500,000</div> to <div style="display: inline; font-style: italic; font: inherit;">1,000,000</div> shares. On <div style="display: inline; font-style: italic; font: inherit;"> June 19, 2019, </div>our stockholders approved the amendment and restatement of the <div style="display: inline; font-style: italic; font: inherit;">2014</div> Stock Plan to increase the number of shares of common stock that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be delivered pursuant to awards granted under the <div style="display: inline; font-style: italic; font: inherit;">2014</div> Stock Plan from <div style="display: inline; font-style: italic; font: inherit;">1,000,000</div> to <div style="display: inline; font-style: italic; font: inherit;">2,000,000</div> shares. As of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>there were <div style="display: inline; font-style: italic; font: inherit;">1,067,979</div> aggregate shares available to grant under the <div style="display: inline; font-style: italic; font: inherit;">2014</div> Plan.<br /> <br /> Our unvested restricted stock awards and stock options are accounted for based on their grant date fair value. As of <div style="display: inline; font-style: italic; font: inherit;"> December </div><div style="display: inline; font-style: italic; font: inherit;">31,</div> <div style="display: inline; font-style: italic; font: inherit;">2020,</div> total compensation expense to be recognized in future periods is <div style="display: inline; font-style: italic; font: inherit;">$1,353.</div> The weighted average period over which this expense is expected to be recognized is <div style="display: inline; font-style: italic; font: inherit;">2.6</div> years.</div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The following table summarizes the compensation expense we recorded during <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> related to unvested shares of restricted stock and stock options:</div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Cost of revenues</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Selling expense</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Engineering and product development expense</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">42</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">35</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">General and administrative expense</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">617</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">841</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">671</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">884</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">There was <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">no</div></div> compensation expense capitalized in <div style="display: inline; font-style: italic; font: inherit;">2020</div> or <div style="display: inline; font-style: italic; font: inherit;">2019.</div> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Stock Options</div></div></div><br /> <br /> We record compensation expense for stock options based on the fair market value of the options as of the grant date. <div style="display: inline; font-style: italic; font: inherit;">No</div> option <div style="display: inline; font-style: italic; font: inherit;"> may </div>be granted with an exercise period in excess of <div style="display: inline; font-style: italic; font: inherit;">ten</div> years from the date of grant. Generally, stock options will be granted with an exercise price equal to the fair market value of our stock on the date of grant and will vest over <div style="display: inline; font-style: italic; font: inherit;">four</div> years.<br /> <br /> The fair value for stock options granted during <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019</div> was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:</div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.46</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.35</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Dividend yield</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Expected common stock market price volatility factor</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">.44</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">.42</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average expected life of stock options (years)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The per share weighted average fair value of stock options issued during <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019</div> was <div style="display: inline; font-style: italic; font: inherit;">$1.48</div> and <div style="display: inline; font-style: italic; font: inherit;">$2.75,</div> respectively.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The following table summarizes the activity related to stock options for the <div style="display: inline; font-style: italic; font: inherit;">two</div> years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020:</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div><br /> <div style="display: inline; font-weight: bold;">of Shares</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div><br /> <div style="display: inline; font-weight: bold;">Average</div><br /> <div style="display: inline; font-weight: bold;">Exercise Price</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Options outstanding, January 1, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">264,400</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">7.54</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">249,460</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Canceled</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(7,050</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8.45</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Options outstanding, December 31, 2019 (87,900 exercisable)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">506,810</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.89</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">113,980</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3.49</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Canceled</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(182,590</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.31</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Options outstanding, December 31, 2020 (204,630 exercisable)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">438,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Restricted Stock Awards</div></div></div><br /> <br /> We record compensation expense for restricted stock awards based on the quoted market price of our stock at the grant date and amortize the expense over the vesting period. Restricted stock awards generally vest over <div style="display: inline; font-style: italic; font: inherit;">four</div> years for employees and over <div style="display: inline; font-style: italic; font: inherit;">one</div> year for our independent directors (<div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">25%</div></div></div></div> at each of <div style="display: inline; font-style: italic; font: inherit;"> March 31, </div><div style="display: inline; font-style: italic; font: inherit;"> June 30, </div><div style="display: inline; font-style: italic; font: inherit;"> September 30, </div>and <div style="display: inline; font-style: italic; font: inherit;"> December 31 </div>of the year in which they were granted).</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">On <div style="display: inline; font-style: italic; font: inherit;"> August 24, 2020, </div>our new President and CEO received <div style="display: inline; font-style: italic; font: inherit;">two</div> restricted stock awards totaling <div style="display: inline; font-style: italic; font: inherit;">141,610</div> shares valued at <div style="display: inline; font-style: italic; font: inherit;">$650</div> as of the date of grant, which was also his hire date. Of the total shares awarded, <div style="display: inline; font-style: italic; font: inherit;">66,448</div> shares vest over <div style="display: inline; font-style: italic; font: inherit;">4</div> years (<div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">25%</div></div></div></div> at each anniversary) and <div style="display: inline; font-style: italic; font: inherit;">75,162</div> vest on the <div style="display: inline; font-style: italic; font: inherit;">third</div> anniversary of the grant date at a vesting percentage that could range from <div style="display: inline; font-style: italic; font: inherit;">0%</div> to <div style="display: inline; font-style: italic; font: inherit;">150%</div> of the number of shares awarded on <div style="display: inline; font-style: italic; font: inherit;"> August 24, 2020. </div>The final vesting percentage will be based on the achievement of certain performance metrics, including net revenue compound annual growth rate and diluted earnings per share excluding amortization of intangibles, for specified time periods as determined by the Compensation Committee of our Board of Directors. As of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>we have estimated that these shares will vest at <div style="display: inline; font-style: italic; font: inherit;">100%</div> of the original amount awarded and are recording expense based on this estimate on a straight-line basis over the <div style="display: inline; font-style: italic; font: inherit;">three</div> year vesting period. Our estimate of the final expected vesting percentage will be reassessed and adjusted, as needed, at the end of each reporting period.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The following table summarizes the activity related to unvested restricted stock awards for the <div style="display: inline; font-style: italic; font: inherit;">two</div> years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020:</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div><br /> <div style="display: inline; font-weight: bold;">of Shares</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div><br /> <div style="display: inline; font-weight: bold;">Average</div><br /> <div style="display: inline; font-weight: bold;">Grant Date</div><br /> <div style="display: inline; font-weight: bold;">Fair Value</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Unvested shares outstanding, January 1, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">114,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.92</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">132,580</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.31</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Vested</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(69,974</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.60</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Forfeited</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(12,325</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">7.14</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Unvested shares outstanding, December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">165,031</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.55</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">229,110</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4.24</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Vested</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(89,861</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5.32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Forfeited</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(67,125</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Unvested shares outstanding, December 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">237,155</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4.93</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The total fair value of the restricted stock awards that vested during the years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> was <div style="display: inline; font-style: italic; font: inherit;">$357</div> and <div style="display: inline; font-style: italic; font: inherit;">$426,</div> respectively, as of the vesting dates of these awards. </div></div>

-0.11

0.02

0.04

-0.04

-0.09

0.11

-0.02

0.06

0.07

0.22

-0.11

0.02

0.04

-0.04

-0.09

0.11

-0.02

0.06

0.07

0.22

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Net Earnings (Loss) Per Common Share</div></div></div><br /> <br /> Net earnings (loss) per common share - basic is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding during each period. Net earnings (loss) per common share - diluted is computed by dividing net earnings (loss) by the weighted average number of common shares and common share equivalents outstanding during each period. Common share equivalents represent unvested shares of restricted stock and stock options and are calculated using the treasury stock method. Common share equivalents are excluded from the calculation if their effect is anti-dilutive.<br /> <br /> The table below sets forth, for the periods indicated, a reconciliation of weighted average common shares outstanding - basic to weighted average common shares and common share equivalents outstanding - diluted and the average number of potentially dilutive securities that were excluded from the calculation of diluted earnings (loss) per share because their effect was anti-dilutive:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 68%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding–basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,256,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,373,164</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Potentially dilutive securities:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Unvested shares of restricted stock and employee stock options</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">18,811</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares and common share equivalents outstanding–diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">10,256,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">10,391,975</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Average number of potentially dilutive securities excluded from calculation</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">717,015</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">523,485</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>

139000

-82000

0.21

1944000

2007000

1353000

P2Y219D

4912000

477000

570000

270000

140000

6369000

3805000

380000

541000

270000

140000

5136000

1227000

905000

980000

1067000

1167000

10480000

600000

590000

270000

140000

12080000

10480000

600000

590000

270000

140000

12080000

8201000

6944000

5711000

5568000

123000

20000

6675000

220000

49000

-26000

-3000

-22000

-55000

11444000

13012000

13738000

1656000

50000

12032000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font: inherit;">4</div>)</div></div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">GOODWILL AND INTANGIBLE ASSETS</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We have <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">two</div></div> operating segments which are also our reporting units: Thermal and EMS. Goodwill and intangible assets on our balance sheets are the result of our acquisitions of Sigma Systems Corp. ("Sigma") in <div style="display: inline; font-style: italic; font: inherit;"> October 2008, </div>Thermonics, Inc. ("Thermonics") in <div style="display: inline; font-style: italic; font: inherit;"> January 2012 </div>and Ambrell in <div style="display: inline; font-style: italic; font: inherit;"> May 2017. </div>All of our goodwill and intangible assets are allocated to our Thermal segment.<br /> <br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Goodwill</div></div></div><br /> <br /> Goodwill totaled <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">$13,738</div></div> at both <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> and was comprised of the following:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 15%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 82%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Sigma</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,656</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermonics</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Ambrell</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">12,032</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">13,738</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Intangible Assets</div></div></div><br /> <br /> Changes in the amount of the carrying value of finite-lived intangible assets for the years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> are as follows:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 15%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 82%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - January 1, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8,201</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,257</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,944</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,233</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - December 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,711</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The following tables provide further detail about our intangible assets as of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019:</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31, 2020 </div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Gross</div><br /> <div style="display: inline; font-weight: bold;">Carrying</div><br /> <div style="display: inline; font-weight: bold;">Amount</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Accumulated </div></div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Net</div><br /> <div style="display: inline; font-weight: bold;">Carrying</div><br /> <div style="display: inline; font-weight: bold;">Amount</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Finite-lived intangible assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Customer relationships</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,480</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4,912</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5,568</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Technology</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">600</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">477</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">123</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Patents</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">590</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">570</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Software</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Trade name</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total finite-lived intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12,080</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,369</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5,711</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Indefinite-lived intangible assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Trademarks</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,710</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,710</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">18,790</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,369</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">12,421</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31, 2019 </div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Gross</div><br /> <div style="display: inline; font-weight: bold;">Carrying</div><br /> <div style="display: inline; font-weight: bold;">Amount</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Accumulated </div></div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Net</div><br /> <div style="display: inline; font-weight: bold;">Carrying</div><br /> <div style="display: inline; font-weight: bold;">Amount</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Finite-lived intangible assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Customer relationships</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,480</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3,805</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,675</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Technology</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">600</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">380</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">220</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Patents</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">590</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">541</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">49</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Software</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Trade name</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">140</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total finite-lived intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12,080</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5,136</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,944</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Indefinite-lived intangible assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Trademarks</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,710</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,710</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">18,790</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,136</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">13,654</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We generally amortize our finite-lived intangible assets over their estimated useful lives on a straight-line basis, unless an alternate amortization method can be reliably determined. Any such alternate amortization method would be based on the pattern in which the economic benefits of the intangible asset are expected to be consumed. <div style="display: inline; font-style: italic; font: inherit;">None</div> of our intangible assets have any residual value.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The following table sets forth the estimated annual amortization expense for each of the next <div style="display: inline; font-style: italic; font: inherit;">five</div> years:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,227</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,167</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,067</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">980</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">905</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Impairment of Goodwill and Indefinite Life Intangible Assets</div></div></div><br /> <br /> During <div style="display: inline; font-style: italic; font: inherit;"> December 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> we assessed our goodwill and indefinite life intangible asset for impairment in accordance with the requirements of ASC Topic <div style="display: inline; font-style: italic; font: inherit;">350</div> using a quantitative approach. Our goodwill impairment assessment is based upon the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The discount rate used in <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019</div> for the discounted cash flows was <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">20.0%</div>.</div> The selection of the rate in each year was based upon our analysis of market-based estimates of capital costs and discount rates. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions including the selection of control premiums, discount rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge.</div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">During the goodwill impairment assessment in both <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> we compared the fair value of our Thermal reporting unit with its carrying value. This assessment indicated <div style="display: inline; font-style: italic; font: inherit;">no</div> impairment existed as the fair value of the reporting unit exceeded its carrying value in both <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019.</div><br /> <br /> During the indefinite life intangible asset impairment assessment in both <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> we compared the fair value of our indefinite life intangible assets with their carrying values. This assessment indicated <div style="display: inline; font-style: italic; font: inherit;">no</div> impairment existed as the fair value of the indefinite life intangible assets exceeded their carrying values in both <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019.</div> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Impairment of Long-Lived Assets and Finite-lived Intangible Assets</div></div></div><br /> <br /> During <div style="display: inline; font-style: italic; font: inherit;">2020</div> and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> we did <div style="display: inline; font-style: italic; font: inherit;">not</div> review any of our long-lived assets for impairment other than the ROU assets related to the leases for our facilities in Fremont, CA and Mansfield, MA as discussed further in Notes <div style="display: inline; font-style: italic; font: inherit;">3</div> and <div style="display: inline; font-style: italic; font: inherit;">8.</div> There were <div style="display: inline; font-style: italic; font: inherit;">no</div> events or changes in business circumstances that would indicate an impairment might exist other than the events identified and discussed in Note <div style="display: inline; font-style: italic; font: inherit;">3</div> related to these specific long-lived assets.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div></div>

4867000

6067000

6450000

6720000

24104000

8836000

6719000

7205000

6465000

29225000

-2017000

1804000

-1231000

2604000

786000

800000

-1231000

2604000

-1393000

183000

433000

-454000

1462000

-300000

794000

648000

306000

2370000

-1077000

1767000

-460000

-1533000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font: inherit;">11</div>)</div> </div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">INCOME TAXES </div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We are subject to Federal and certain state income taxes. In addition, we are taxed in certain foreign countries.<br /> <br /> Earnings (loss) before income taxes was as follows:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Domestic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(2,017</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,804</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Foreign</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">786</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">800</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,231</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,604</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Income tax expense (benefit) was as follows:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Current</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Domestic – Federal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(182</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">510</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Domestic – state</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">53</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">101</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Foreign</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">135</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">97</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">708</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Deferred</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Domestic – Federal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(299</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(413</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Domestic – state</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(7</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Foreign</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(36</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(342</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(426</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Income tax expense</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(336</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">282</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Deferred income taxes reflect the net tax effect of net operating loss and tax credit carryforwards as well as temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following is a summary of the significant components of our deferred tax assets and liabilities as of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019:</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax assets:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Operating lease liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,601</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,123</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Inventories</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">321</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">247</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Accrued vacation pay and stock-based compensation</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">252</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">279</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net operating loss (state and foreign)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">241</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">280</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">44</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">44</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Accrued warranty</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">19</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Acquisition costs</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Tax credit carryforwards</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">112</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Other</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,558</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,129</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Valuation allowance</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(234</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,389</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,895</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax liabilities:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net intangible assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(2,697</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(2,923</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Right of use assets</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,400</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,066</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Depreciation of property and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(214</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(4,311</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(4,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net deferred tax liabilities</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,922</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(2,263</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The net change in the valuation allowance for the years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> was a decrease of <div style="display: inline; font-style: italic; font: inherit;">$65</div> and <div style="display: inline; font-style: italic; font: inherit;">$7,</div> respectively. In assessing the ability to realize the deferred tax assets, we consider whether it is more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> that some portion or all of the deferred tax assets will <div style="display: inline; font-style: italic; font: inherit;">not</div> be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. In order to fully realize the total deferred tax assets, we will need to generate future taxable income prior to the expiration of net operating loss and tax credit carryforwards which expire in various years through <div style="display: inline; font-style: italic; font: inherit;">2040.</div> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">An analysis of the effective tax rate for the years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> and a reconciliation from the expected statutory rate of <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">21%</div></div> is as follows:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Expected income tax expense (benefit) at U.S. statutory rate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(259</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">547</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Increase (decrease) in tax from:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Dividend from foreign subsidiaries</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">83</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">97</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">NOL carryforwards utilized</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">64</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Restricted stock compensation</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">62</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">114</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Global intangible low taxed income</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">35</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">30</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Nondeductible expenses</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Current year tax credits (foreign and research)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(82</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(234</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Domestic tax benefit, net of Federal benefit</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(184</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Changes in valuation allowance</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(65</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(7</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Foreign income tax rate differences</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(34</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(51</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Section 250 foreign derived intangible income deduction</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(9</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(145</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Other</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">79</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(336</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">282</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In accounting for income taxes, we follow the guidance in ASC Topic <div style="display: inline; font-style: italic; font: inherit;">740</div> (Income Taxes) regarding the recognition and measurement of uncertain tax positions in our financial statements. Recognition involves a determination of whether it is more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information. Our policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> we did <div style="display: inline; font-style: italic; font: inherit;">not</div> have an accrual for uncertain tax positions.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We file U.S. income tax returns and multiple state and foreign income tax returns. With few exceptions, the U.S. and state income tax returns filed for the tax years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2017 </div>and thereafter are subject to examination by the relevant taxing authorities.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div></div>

-336000

282000

-250000

13000

-25000

-74000

324000

-113000

147000

-76000

84000

257000

-294000

194000

-126000

-169000

-65000

-7000

-34000

-51000

-259000

547000

8000

4000

62000

114000

-71000

79000

-68000

-184000

82000

234000

54000

535000

430000

197000

-887000

-1244000

-48000

171000

-62000

-797000

-70000

-912000

717000

1058000

301000

31000

4000

1000

-35000

129000

-35000

18811

6710000

18790000

12421000

13654000

975000

810000

7476000

7182000

5371000

5369000

1085000

949000

444000

391000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="margin-right: auto; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 68%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 17%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended December 31,</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 68%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="width: 68%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Operating lease cost</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,583</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,476</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Short-term lease cost</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">51</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="margin-right: auto; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 90%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Range of remaining lease terms (in years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; text-align: right;"> </td> <td style="width: 2%; font-family: "Times New Roman", Times, serif; font-size: 10pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">0.1</div></td> <td style="width: 5%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font: inherit;">to</div></td> <td nowrap="nowrap" style="width: 2%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10.0</div></td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 90%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average remaining lease term (in years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 2%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="width: 5%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font: inherit;">6.4</div></td> <td nowrap="nowrap" style="width: 2%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 90%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average discount rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 2%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="width: 5%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font: inherit;">4.3%</div></td> <td nowrap="nowrap" style="width: 2%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> </tr> </table></div>

2031-04-30

2024-12-31

2636000

2424000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="margin-right: auto; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,481</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,405</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,416</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,395</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">722</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,845</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total lease payments</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8,264</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Less imputed interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(999</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">7,265</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div>

8264000

1845000

1481000

722000

1395000

1416000

1405000

999000

P5Y30D

P10Y

P3Y

P3Y120D

P15Y

90000

50000

140000

17278000

14881000

62030000

59715000

8856000

8361000

7500000

2021-04-30

2024-12-31

2010-03-29

2010-10-27

125000

7500000

5356000

5269000

-74000

-1142000

-648000

-620000

3248000

-8405000

-895000

2322000

-1143000

170000

458000

-380000

1138000

-187000

647000

724000

222000

2113000

-783000

1573000

-334000

-1364000

2322000

-895000

25321000

26676000

-1217000

2549000

325000

2334000

-1113000

1725000

-429000

-1510000

1583000

1476000

522000

90000

612000

522000

90000

612000

7265000

1215000

1302000

6050000

3794000

597000

139000

6387000

4842000

1294000

1251000

0.043

P6Y146D

229000

163000

30000

26000

216000

-110000

216000

45000

54000

804000

497000

450000

463000

-14000

55000

99000

46000

14000

159000

381000

74000

1142000

240000

159000

658000

620000

371000

501000

284000

46000

3000

73000

0.01

5000000

776000

805000

2829000

2800000

10000

235000

334000

7992000

7693000

2350000

2420000

2053000

2163000

297000

257000

P1Y

P10Y

3000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font: inherit;">17</div>)</div> </div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">QUARTERLY CONSOLIDATED FINANCIAL DATA (Unaudited) </div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The following tables present certain unaudited consolidated quarterly financial information for each of the <div style="display: inline; font-style: italic; font: inherit;">eight</div> quarters ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>In our opinion, this quarterly information has been prepared on the same basis as the consolidated financial statements and includes all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the information for the periods presented. The results of operations for any quarter are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of results for the full year or for any future period.  </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Year-over-year quarterly comparisons of our results of operations <div style="display: inline; font-style: italic; font: inherit;"> may </div><div style="display: inline; font-style: italic; font: inherit;">not</div> be as meaningful as the sequential quarterly comparisons set forth below that tend to reflect the cyclical and seasonal activity of the Semi Market. Quarterly fluctuations in expenses are related directly to sales activity and volume and <div style="display: inline; font-style: italic; font: inherit;"> may </div>also reflect the timing of operating expenses incurred throughout the year.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Quarters Ended</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">3/31/20</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(1)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6/30/20</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(2)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">9/30/20</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(3)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">12/31/20</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(4)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 35%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net revenues</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">11,230</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13,275</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14,443</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">53,823</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Gross margin</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4,867</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,067</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,450</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,720</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">24,104</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Earnings (loss) before income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,393</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">183</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">433</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(454</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,231</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(250</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(74</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(336</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">170</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">458</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(380</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(895</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss) per common share – basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.09</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding – basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,220,853</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,252,490</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,269,995</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,282,903</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,256,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss) per common share – diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.09</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding – diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,220,853</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,258,917</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,287,562</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,282,903</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,256,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Quarters Ended</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">3/31/19</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6/30/19</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(5)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">9/30/19</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(6)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">12/31/19</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 35%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net revenues</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">18,062</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14,352</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14,632</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13,614</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">60,660</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Gross margin</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8,836</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,719</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">7,205</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,465</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">29,225</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Earnings (loss) before income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,462</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(300</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">794</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">648</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,604</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">324</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(113</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">147</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(76</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">282</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,138</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(187</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">647</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">724</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,322</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss) per common share – basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.06</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.22</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding – basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,385,017</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,411,276</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,421,383</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,274,980</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,373,164</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss) per common share – diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.06</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.22</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding – diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,414,330</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,411,276</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,429,536</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,298,535</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,391,975</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> </td> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">(<div style="display: inline; font-style: italic; font: inherit;">1</div>)</div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">The quarter ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>includes <div style="display: inline; font-style: italic; font: inherit;">$8</div> of restructuring and other charges which are discussed in Note <div style="display: inline; font-style: italic; font: inherit;">3.</div></div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 27pt;"> </td> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">(<div style="display: inline; font-style: italic; font: inherit;">2</div>)</div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">The quarter ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>includes <div style="display: inline; font-style: italic; font: inherit;">$38</div> of restructuring and other charges which are discussed in Note <div style="display: inline; font-style: italic; font: inherit;">3.</div></div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 27pt;"> </td> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">(<div style="display: inline; font-style: italic; font: inherit;">3</div>)</div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">The quarter ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020 </div>includes <div style="display: inline; font-style: italic; font: inherit;">$161</div> of restructuring and other charges which are discussed in Note <div style="display: inline; font-style: italic; font: inherit;">3.</div></div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 27pt;"> </td> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">(<div style="display: inline; font-style: italic; font: inherit;">4</div>)</div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">The quarter ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>includes <div style="display: inline; font-style: italic; font: inherit;">$1,078</div> of restructuring and other charges which are discussed in Note <div style="display: inline; font-style: italic; font: inherit;">3</div></div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 27pt;"> </td> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">(<div style="display: inline; font-style: italic; font: inherit;">5</div>)</div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">The quarter ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2019 </div>includes <div style="display: inline; font-style: italic; font: inherit;">$223</div> of restructuring and other charges which are discussed in Note <div style="display: inline; font-style: italic; font: inherit;">3.</div></div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 27pt;"> </td> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">(<div style="display: inline; font-style: italic; font: inherit;">6</div>)</div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">The quarter ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2019 </div>includes <div style="display: inline; font-style: italic; font: inherit;">$17</div> of restructuring and other charges which are discussed in Note <div style="display: inline; font-style: italic; font: inherit;">3.</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div></div>

2800000

2829000

5070000

4964000

140000

903000

100000

150000

514000

240000

137000

103000

8000

38000

161000

1078000

223000

17000

137000

248000

153000

98000

381000

522000

903000

613000

90000

703000

340000

17110000

18005000

11230000

13275000

14443000

14875000

53823000

18062000

14352000

14632000

13614000

60660000

48041000

55074000

5782000

5586000

15768000

17631000

18966000

20079000

13112000

16273000

5977000

6677000

26870000

30953000

17341000

21231000

6314000

4842000

1715000

1845000

1583000

1789000

40209000

43823000

13614000

16837000

22211000

25283000

31612000

35377000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Revenue Recognition</div></div></div><br /> <br /> We recognize revenue in accordance with the guidance in ASC Topic <div style="display: inline; font-style: italic; font: inherit;">606</div> (Revenue from Contracts with Customers). We recognize revenue for the sale of products or services when our performance obligations under the terms of a contract with a customer are satisfied and control of the product or service has been transferred to the customer. Generally, this occurs when we ship a product or perform a service. In certain cases, recognition of revenue is deferred until the product is received by the customer or at some other point in the future when we have determined that we have satisfied our performance obligations under the contract. Our contracts with customers <div style="display: inline; font-style: italic; font: inherit;"> may </div>include a combination of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. In addition to the sale of products and services, we also lease certain of our equipment to customers under short-term lease agreements. We recognize revenue from equipment leases on a straight-line basis over the lease term.</div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Revenue is recorded in an amount that reflects the consideration we expect to receive in exchange for those products or services. We do <div style="display: inline; font-style: italic; font: inherit;">not</div> have any material variable consideration arrangements, or any material payment terms with our customers other than standard payment terms which generally range from net <div style="display: inline; font-style: italic; font: inherit;">30</div> to net <div style="display: inline; font-style: italic; font: inherit;">90</div> days. We generally do <div style="display: inline; font-style: italic; font: inherit;">not</div> provide a right of return to our customers. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Nature of Products and Services</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We sell thermal management products including ThermoStreams, ThermoChambers and process chillers, which we sell under our Temptronic, Sigma and Thermonics product lines, and Ambrell's precision induction heating systems, including EKOHEAT and EASYHEAT products. We sell semiconductor ATE interface solutions which include manipulators, docking hardware and electrical interface products. We provide post-warranty service and support for the equipment we sell. We sell semiconductor ATE interface solutions and certain thermal management products to the Semi Market. We also sell our thermal management products to various other markets including the automotive, defense/aerospace, industrial, medical and telecommunications markets.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We lease certain of our equipment under short-term leasing agreements with original lease terms of <div style="display: inline; font-style: italic; font: inherit;">six</div> months or less. Our lease agreements do <div style="display: inline; font-style: italic; font: inherit;">not</div> contain purchase options.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Types of Contracts with Customers</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Our contracts with customers are generally structured as individual purchase orders which specify the exact products or services being sold or equipment being leased along with the selling price, service fee or monthly lease amount for each individual item on the purchase order. Payment terms and any other customer-specific acceptance criteria are also specified on the purchase order. We generally do <div style="display: inline; font-style: italic; font: inherit;">not</div> have any customer-specific acceptance criteria, other than that the product performs within the agreed upon specifications. We test substantially all products manufactured as part of our quality assurance process to determine that they comply with specifications prior to shipment to a customer.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Contract Balances</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We record accounts receivable at the time of invoicing. Accounts receivable, net of the allowance for doubtful accounts, is included in current assets on our balance sheet. To the extent that we do <div style="display: inline; font-style: italic; font: inherit;">not</div> recognize revenue at the same time as we invoice, we record a liability for deferred revenue. In certain instances, we also receive customer deposits in advance of invoicing and recording of accounts receivable. Deferred revenue and customer deposits are included in current liabilities on our consolidated balance sheets.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The allowance for doubtful accounts reflects our best estimate of probable losses inherent in the accounts receivable balance. We determine the allowance based on known troubled accounts, if any, historical experience, and other currently available evidence.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Costs to Obtain a Contract with a Customer</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The only costs we incur associated with obtaining contracts with customers are sales commissions that we pay to our internal sales personnel or <div style="display: inline; font-style: italic; font: inherit;">third</div>-party sales representatives. These costs are calculated based on set percentages of the selling price of each product or service sold. Commissions are considered earned by our internal sales personnel at the time we recognize revenue for a particular transaction. Commissions are considered earned by <div style="display: inline; font-style: italic; font: inherit;">third</div>-party sales representatives at the time that revenue is recognized for a particular transaction. We record commission expense in our consolidated statements of operations at the time the commission is earned. Commissions earned but <div style="display: inline; font-style: italic; font: inherit;">not</div> yet paid are included in current liabilities on our balance sheets.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Product Warranties</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In connection with the sale of our products, we generally provide standard <div style="display: inline; font-style: italic; font: inherit;">one</div>- or <div style="display: inline; font-style: italic; font: inherit;">two</div>-year product warranties which are detailed in our terms and conditions and communicated to our customers. Our standard warranties are <div style="display: inline; font-style: italic; font: inherit;">not</div> offered for sale separately from our products; therefore, there is <div style="display: inline; font-style: italic; font: inherit;">not</div> a separate performance obligation related to our standard warranties. We record estimated warranty expense for our standard warranties at the time of sale based upon historical claims experience. In very limited cases, we offer customers an option to separately purchase an extended warranty for certain of our products. In the case of extended warranties, we recognize revenue in the amount of the sale price for the extended warranty on a straight-line basis over the extended warranty period. We record costs incurred to provide service under an extended warranty at the time the service is provided. Warranty expense is included in selling expense in our consolidated statements of operations.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">See Notes <div style="display: inline; font-style: italic; font: inherit;">5</div> and <div style="display: inline; font-style: italic; font: inherit;">16</div> for further information about our revenue from contracts with customers.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Quarters Ended</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">3/31/20</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(1)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6/30/20</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(2)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">9/30/20</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(3)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">12/31/20</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(4)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 35%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net revenues</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">11,230</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13,275</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14,443</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">53,823</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Gross margin</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">4,867</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,067</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,450</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,720</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">24,104</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Earnings (loss) before income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,393</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">183</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">433</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(454</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,231</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(250</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(74</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(336</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">170</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">458</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(380</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(895</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss) per common share – basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.09</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding – basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,220,853</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,252,490</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,269,995</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,282,903</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,256,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss) per common share – diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.09</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding – diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,220,853</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,258,917</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,287,562</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,282,903</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,256,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Quarters Ended</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">3/31/19</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6/30/19</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(5)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">9/30/19</div><div style="display: inline; font-family:Times New Roman;font-size:9pt;"><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align:top;line-height:120%;font-size:pt">(6)</div></div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">12/31/19</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 35%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net revenues</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">18,062</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14,352</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14,632</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13,614</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">60,660</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Gross margin</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8,836</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,719</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">7,205</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6,465</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">29,225</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Earnings (loss) before income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,462</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(300</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">794</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">648</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,604</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">324</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(113</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">147</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(76</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">282</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,138</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(187</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">647</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">724</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,322</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss) per common share – basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.06</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.22</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding – basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,385,017</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,411,276</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,421,383</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,274,980</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,373,164</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net earnings (loss) per common share – diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.06</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.22</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding – diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,414,330</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,411,276</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,429,536</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,298,535</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,391,975</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 15%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 82%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - January 1, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accruals for severance and other one-time termination benefits</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">137</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accruals for costs related to the consolidation of Ambrell's European operations</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">103</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Cash payments</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(240</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accruals for severance and other one-time termination benefits</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">248</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accruals for costs related to subletting the Fremont, CA facility</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">153</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accruals for costs related to subletting the Mansfield, MA facility</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">98</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Cash payments</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(159</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Balance - December 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">340</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Net revenues from unaffiliated customers:</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">40,209</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">43,823</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">13,614</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">16,837</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">53,823</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">60,660</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Depreciation/amortization:</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,727</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,810</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">109</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">118</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">27</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">14</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,863</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,942</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Operating income (loss):</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">325</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,113</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,725</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(429</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,510</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,217</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,549</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Earnings (loss) before income tax expense (benefit):</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">306</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,370</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,077</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,767</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(460</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,533</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,231</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,604</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Income tax expense (benefit): </div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">257</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(294</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">194</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(126</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(336</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">282</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Net earnings (loss):</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">222</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,113</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(783</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,573</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,364</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(895</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,322</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Capital expenditures:</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">371</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">501</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">284</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">46</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">3</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">73</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">658</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">620</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font: inherit;">16</div>)</div> </div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">SEGMENT INFORMATION</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We have <div style="display: inline; font-style: italic; font: inherit;">two</div> reportable segments, Thermal and EMS, which are also our reporting units. Thermal includes the operations of Temptronic, Thermonics, Sigma, inTEST Thermal Solutions GmbH (Germany), inTEST Pte, Limited (Singapore) and Ambrell. Sales of this segment consist primarily of temperature management systems which we design, manufacture and market under our Temptronic, Thermonics and Sigma product lines, and precision induction heating systems which are designed, manufactured and marketed by Ambrell. In addition, this segment provides post-warranty service and support. EMS includes the operations of our manufacturing facilities in Mt. Laurel, New Jersey and Fremont, California. Sales of this segment consist primarily of manipulator, docking hardware and tester interface products, which we design, manufacture and market. See Note <div style="display: inline; font-style: italic; font: inherit;">3</div> for information related to the planned closure of our manufacturing facility in Fremont, California.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We operate our business worldwide and sell our products both domestically and internationally. Both of our segments sell to semiconductor manufacturers, <div style="display: inline; font-style: italic; font: inherit;">third</div>-party test and assembly houses and ATE manufacturers. Thermal also sells into a variety of markets outside of the Semi Market, including the automotive, defense/aerospace, industrial, medical, telecommunications and other markets.</div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Net revenues from unaffiliated customers:</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">40,209</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">43,823</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">13,614</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">16,837</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">53,823</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">60,660</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Depreciation/amortization:</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,727</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,810</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">109</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">118</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">27</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">14</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,863</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,942</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Operating income (loss):</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">325</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,113</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,725</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(429</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,510</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,217</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,549</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Earnings (loss) before income tax expense (benefit):</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">306</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,370</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(1,077</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,767</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(460</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,533</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,231</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,604</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Income tax expense (benefit): </div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">257</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(294</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">194</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(126</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(336</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">282</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Net earnings (loss):</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">222</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,113</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(783</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,573</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1,364</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(895</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,322</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Capital expenditures:</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">371</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">501</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">284</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">46</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">3</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">73</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">658</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">620</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Identifiable assets: </div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Thermal</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">50,782</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">51,621</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">EMS</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">9,667</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">7,319</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Corporate</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,581</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">775</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">62,030</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">59,715</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The following table provides information about our geographic areas of operation. Net revenues from unaffiliated customers are based on the location to which the goods are shipped.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Net revenues from unaffiliated customers:</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">U.S.</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">22,211</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">25,283</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Foreign</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">31,612</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">35,377</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">53,823</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">60,660</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Property and equipment:</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">U.S.</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,053</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,163</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Foreign</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">297</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">257</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,350</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,420</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div></div>

7522000

8460000

671000

884000

P4Y

P1Y

P4Y

P3Y

12325

67125

7.14

6.03

141610

66448

75162

132580

229110

6.31

4.24

114750

165031

237155

6.92

6.55

4.93

69974

89861

357000

426000

6.60

5.32

0.0044

0.0042

0.0046

0.0235

500000

1000000

2000000

1067979

87900

204630

8.45

6.31

7050

182590

249460

113980

1.48

2.75

264400

506810

438200

7.54

6.89

6.25

3.49

0.25

P10Y

P6Y91D

47000

51000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font: inherit;">2</div>) </div></div> </td> <td> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Basis of Presentation and Use of Estimates</div></div></div><br /> <br /> The accompanying consolidated financial statements include our accounts and those of our wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated upon consolidation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Certain of our accounts, including inventories, long-lived assets, goodwill, identifiable intangibles and deferred tax assets and liabilities including related valuation allowances, are particularly impacted by estimates.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Reclassification</div></div></div><br /> <br /> Certain prior year amounts have been reclassified to be comparable with the current year's presentation.</div> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Subsequent Events</div></div></div><br /> <br /> We have made an assessment of our operations and determined that there were <div style="display: inline; font-style: italic; font: inherit;">no</div> material subsequent events requiring adjustment to, or disclosure in, our consolidated financial statements for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020.</div></div><div style="display: inline; font-style: italic; font: inherit;"></div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Business Combinations</div></div></div><br /> <br /> Acquired businesses are accounted for using the purchase method of accounting, which requires that the purchase price be allocated to the net assets acquired at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Fair values of intangible assets are estimated by valuation models prepared by our management and <div style="display: inline; font-style: italic; font: inherit;">third</div>-party advisors. The assets purchased and liabilities assumed have been reflected in our consolidated balance sheets, and the operating results are included in the consolidated statements of operations and consolidated statements of cash flows from the date of acquisition. Any change in the fair value of acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, will be recognized in the consolidated statement of operations in the period of the estimated fair value change. Acquisition-related transaction costs, including legal and accounting fees and other external costs directly related to the acquisition, are recognized separately from the acquisition and expensed as incurred in general and administrative expense in the consolidated statements of operations.</div><br /> <br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div></div> <div style="display: inline; font-style: italic; font: inherit;"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Restructuring and Other Charges</div></div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In accordance with the guidance in Accounting Standards Codification (“ASC”) Topic <div style="display: inline; font-style: italic; font: inherit;">420</div> (Exit or Disposal Cost Obligations), we recognize a liability for restructuring costs at fair value only when the liability is incurred. Workforce-related charges are accrued when it is determined that a liability has been incurred, which is generally after individuals have been notified of their termination dates and expected severance benefits. Depending on the timing of the termination dates, these charges <div style="display: inline; font-style: italic; font: inherit;"> may </div>be recognized upon notification or ratably over the remaining required service period of the employees. Plans to consolidate excess facilities <div style="display: inline; font-style: italic; font: inherit;"> may </div>result in lease termination fees and impairment charges related to our right-of-use (“ROU”) assets that are associated with the leases for these facilities. Other long-lived assets that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be impaired as a result of restructuring consist of property and equipment, goodwill and intangible assets. Asset impairment charges included in restructuring and other charges are based on an estimate of the amounts and timing of future cash flows related to the expected future remaining use and ultimate sale or disposal of the asset, and, in the case of our ROU assets, would include expected future sublease rental income, if applicable. These estimates are derived using the guidance in ASC Topic <div style="display: inline; font-style: italic; font: inherit;">842</div> (Leases), ASC Topic <div style="display: inline; font-style: italic; font: inherit;">360</div> (Property, Plant and Equipment) and ASC Topic <div style="display: inline; font-style: italic; font: inherit;">350</div> (Intangibles - Goodwill and Other).</div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Cash and Cash Equivalents</div></div></div><br /> <br /> Short-term investments that have maturities of <div style="display: inline; font-style: italic; font: inherit;">three</div> months or less when purchased are considered to be cash equivalents and are carried at cost, which approximates fair value. Our cash balances, which are deposited with highly reputable financial institutions, at times <div style="display: inline; font-style: italic; font: inherit;"> may </div>exceed the federally insured limits. We have <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced any losses related to these cash balances and believe the credit risk to be minimal.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Trade Accounts Receivable and Allowance for Doubtful Accounts</div></div></div><br /> <br /> Trade accounts receivable are recorded at the invoiced amount and do <div style="display: inline; font-style: italic; font: inherit;">not</div> bear interest. We grant credit to customers and generally require <div style="display: inline; font-style: italic; font: inherit;">no</div> collateral. To minimize our risk, we perform ongoing credit evaluations of our customers' financial condition. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience and the aging of such receivables, among other factors. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. We do <div style="display: inline; font-style: italic; font: inherit;">not</div> have any significant off-balance sheet credit exposure related to our customers. There was <div style="display: inline; font-style: italic; font: inherit;">no</div> bad debt expense recorded for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>We recorded bad debt expense of <div style="display: inline; font-style: italic; font: inherit;">$3</div> for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019. </div>Cash flows from accounts receivable are recorded in operating cash flows.</div><br /> <br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Fair Value of Financial Instruments</div></div></div><br /> <br /> Our financial instruments, principally accounts receivable and accounts payable, are carried at cost which approximates fair value, due to the short maturities of the accounts.</div><br /> <br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div></div> <div style="display: inline; font-style: italic; font: inherit;"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Goodwill, Intangible and Long-Lived Assets</div></div></div><br /> <br /> We have <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">two</div></div> operating segments which are also our reporting units: Thermal and EMS. We account for goodwill and intangible assets in accordance with Accounting Standards Codification (“ASC”) Topic <div style="display: inline; font-style: italic; font: inherit;">350</div> (Intangibles - Goodwill and Other). Finite-lived intangible assets are amortized over their estimated useful economic life and are carried at cost less accumulated amortization. Goodwill is assessed for impairment annually in the <div style="display: inline; font-style: italic; font: inherit;">fourth</div> quarter on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill <div style="display: inline; font-style: italic; font: inherit;"> may </div>be impaired. Goodwill is considered to be impaired if the fair value of a reporting unit is less than its carrying amount. As a part of the goodwill impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> that the fair value of a reporting unit is less than its carrying amount. If, as a result of our qualitative assessment, we determine that it is more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> that the fair value of the reporting unit is greater than its carrying amount, a quantitative goodwill impairment test is <div style="display: inline; font-style: italic; font: inherit;">not</div> required. However, if, as a result of our qualitative assessment, we determine it is more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> that the fair value of a reporting unit is less than its carrying amount, or, if we choose <div style="display: inline; font-style: italic; font: inherit;">not</div> to perform a qualitative assessment, we are required to perform a quantitative goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized. </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The quantitative goodwill impairment test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered <div style="display: inline; font-style: italic; font: inherit;">not</div> impaired. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss will be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The goodwill impairment assessment is based upon the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions including the selection of control premiums, discount rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Indefinite-lived intangible assets are assessed for impairment annually in the <div style="display: inline; font-style: italic; font: inherit;">fourth</div> quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. As a part of the impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> that an indefinite-lived intangible asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> that the fair value of the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required; otherwise, <div style="display: inline; font-style: italic; font: inherit;">no</div> further testing is required. The quantitative impairment test consists of a comparison of the fair value of the intangible asset with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Long-lived assets, which consist of finite-lived intangible assets, property and equipment and right-of-use (“ROU”) assets, are assessed for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets <div style="display: inline; font-style: italic; font: inherit;"> may </div><div style="display: inline; font-style: italic; font: inherit;">not</div> be fully recoverable or that the useful lives of these assets are <div style="display: inline; font-style: italic; font: inherit;">no</div> longer appropriate. Each impairment test is based on a comparison of the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value. The cash flow estimates used to determine the impairment, if any, contain management's best estimates using appropriate assumptions and projections at that time. </div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div></div> <div style="display: inline; font-style: italic; font: inherit;"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Revenue Recognition</div></div></div><br /> <br /> We recognize revenue in accordance with the guidance in ASC Topic <div style="display: inline; font-style: italic; font: inherit;">606</div> (Revenue from Contracts with Customers). We recognize revenue for the sale of products or services when our performance obligations under the terms of a contract with a customer are satisfied and control of the product or service has been transferred to the customer. Generally, this occurs when we ship a product or perform a service. In certain cases, recognition of revenue is deferred until the product is received by the customer or at some other point in the future when we have determined that we have satisfied our performance obligations under the contract. Our contracts with customers <div style="display: inline; font-style: italic; font: inherit;"> may </div>include a combination of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. In addition to the sale of products and services, we also lease certain of our equipment to customers under short-term lease agreements. We recognize revenue from equipment leases on a straight-line basis over the lease term.</div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Revenue is recorded in an amount that reflects the consideration we expect to receive in exchange for those products or services. We do <div style="display: inline; font-style: italic; font: inherit;">not</div> have any material variable consideration arrangements, or any material payment terms with our customers other than standard payment terms which generally range from net <div style="display: inline; font-style: italic; font: inherit;">30</div> to net <div style="display: inline; font-style: italic; font: inherit;">90</div> days. We generally do <div style="display: inline; font-style: italic; font: inherit;">not</div> provide a right of return to our customers. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Nature of Products and Services</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We sell thermal management products including ThermoStreams, ThermoChambers and process chillers, which we sell under our Temptronic, Sigma and Thermonics product lines, and Ambrell's precision induction heating systems, including EKOHEAT and EASYHEAT products. We sell semiconductor ATE interface solutions which include manipulators, docking hardware and electrical interface products. We provide post-warranty service and support for the equipment we sell. We sell semiconductor ATE interface solutions and certain thermal management products to the Semi Market. We also sell our thermal management products to various other markets including the automotive, defense/aerospace, industrial, medical and telecommunications markets.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We lease certain of our equipment under short-term leasing agreements with original lease terms of <div style="display: inline; font-style: italic; font: inherit;">six</div> months or less. Our lease agreements do <div style="display: inline; font-style: italic; font: inherit;">not</div> contain purchase options.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Types of Contracts with Customers</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Our contracts with customers are generally structured as individual purchase orders which specify the exact products or services being sold or equipment being leased along with the selling price, service fee or monthly lease amount for each individual item on the purchase order. Payment terms and any other customer-specific acceptance criteria are also specified on the purchase order. We generally do <div style="display: inline; font-style: italic; font: inherit;">not</div> have any customer-specific acceptance criteria, other than that the product performs within the agreed upon specifications. We test substantially all products manufactured as part of our quality assurance process to determine that they comply with specifications prior to shipment to a customer.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Contract Balances</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We record accounts receivable at the time of invoicing. Accounts receivable, net of the allowance for doubtful accounts, is included in current assets on our balance sheet. To the extent that we do <div style="display: inline; font-style: italic; font: inherit;">not</div> recognize revenue at the same time as we invoice, we record a liability for deferred revenue. In certain instances, we also receive customer deposits in advance of invoicing and recording of accounts receivable. Deferred revenue and customer deposits are included in current liabilities on our consolidated balance sheets.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The allowance for doubtful accounts reflects our best estimate of probable losses inherent in the accounts receivable balance. We determine the allowance based on known troubled accounts, if any, historical experience, and other currently available evidence.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Costs to Obtain a Contract with a Customer</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">The only costs we incur associated with obtaining contracts with customers are sales commissions that we pay to our internal sales personnel or <div style="display: inline; font-style: italic; font: inherit;">third</div>-party sales representatives. These costs are calculated based on set percentages of the selling price of each product or service sold. Commissions are considered earned by our internal sales personnel at the time we recognize revenue for a particular transaction. Commissions are considered earned by <div style="display: inline; font-style: italic; font: inherit;">third</div>-party sales representatives at the time that revenue is recognized for a particular transaction. We record commission expense in our consolidated statements of operations at the time the commission is earned. Commissions earned but <div style="display: inline; font-style: italic; font: inherit;">not</div> yet paid are included in current liabilities on our balance sheets.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-style: italic;">Product Warranties</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In connection with the sale of our products, we generally provide standard <div style="display: inline; font-style: italic; font: inherit;">one</div>- or <div style="display: inline; font-style: italic; font: inherit;">two</div>-year product warranties which are detailed in our terms and conditions and communicated to our customers. Our standard warranties are <div style="display: inline; font-style: italic; font: inherit;">not</div> offered for sale separately from our products; therefore, there is <div style="display: inline; font-style: italic; font: inherit;">not</div> a separate performance obligation related to our standard warranties. We record estimated warranty expense for our standard warranties at the time of sale based upon historical claims experience. In very limited cases, we offer customers an option to separately purchase an extended warranty for certain of our products. In the case of extended warranties, we recognize revenue in the amount of the sale price for the extended warranty on a straight-line basis over the extended warranty period. We record costs incurred to provide service under an extended warranty at the time the service is provided. Warranty expense is included in selling expense in our consolidated statements of operations.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">See Notes <div style="display: inline; font-style: italic; font: inherit;">5</div> and <div style="display: inline; font-style: italic; font: inherit;">16</div> for further information about our revenue from contracts with customers.</div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Inventories</div></div></div><br /> <br /> Inventories are valued at cost on a <div style="display: inline; font-style: italic; font: inherit;">first</div>-in, <div style="display: inline; font-style: italic; font: inherit;">first</div>-out basis, <div style="display: inline; font-style: italic; font: inherit;">not</div> in excess of market value. Cash flows from the sale of inventories are recorded in operating cash flows. On a quarterly basis, we review our inventories and record excess and obsolete inventory charges based upon our established objective excess and obsolete inventory criteria. These criteria identify material that has <div style="display: inline; font-style: italic; font: inherit;">not</div> been used in a work order during the prior <div style="display: inline; font-style: italic; font: inherit;">twelve</div> months and the quantity of material on hand that is greater than the average annual usage of that material over the prior <div style="display: inline; font-style: italic; font: inherit;">three</div> years. In certain cases, additional excess and obsolete inventory charges are recorded based upon current market conditions, anticipated product life cycles, new product introductions and expected future use of the inventory. The excess and obsolete inventory charges we record establish a new cost basis for the related inventories. We incurred excess and obsolete inventory charges of <div style="display: inline; font-style: italic; font: inherit;">$444</div> and <div style="display: inline; font-style: italic; font: inherit;">$391</div> for the years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> respectively.</div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Property and Equipment</div></div></div><br /> <br /> Machinery and equipment are stated at cost, except for machinery and equipment acquired in a business combination, which are stated at fair value at the time of acquisition. As previously discussed above under "Goodwill, Intangible and Long-Lived Assets," machinery and equipment that has been determined to be impaired is written down to its fair value at the time of the impairment. Depreciation is based upon the estimated useful life of the assets using the straight-line method. The estimated useful lives range from <div style="display: inline; font-style: italic; font: inherit;">one</div> to <div style="display: inline; font-style: italic; font: inherit;">ten</div> years. Leasehold improvements are recorded at cost and amortized over the shorter of the lease term or the estimated useful life of the asset. Total depreciation expense was <div style="display: inline; font-style: italic; font: inherit;">$630</div> and <div style="display: inline; font-style: italic; font: inherit;">$685</div> for the years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> respectively.</div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div></div> <div style="display: inline; font-style: italic; font: inherit;"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Leases</div></div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We account for leases in accordance with ASC Topic <div style="display: inline; font-style: italic; font: inherit;">842</div> (Leases). We determine if an arrangement is a lease at inception. A lease contract is within scope if the contract has an identified asset (property, plant or equipment) and grants the lessee the right to control the use of the asset during the lease term. The identified asset <div style="display: inline; font-style: italic; font: inherit;"> may </div>be either explicitly or implicitly specified in the contract. In addition, the supplier must <div style="display: inline; font-style: italic; font: inherit;">not</div> have any practical ability to substitute a different asset and would <div style="display: inline; font-style: italic; font: inherit;">not</div> economically benefit from doing so for the lease contract to be in scope. The lessee's right to control the use of the asset during the term of the lease must include the ability to obtain substantially all of the economic benefits from the use of the asset as well as decision-making authority over how the asset will be used. Leases are classified as either operating leases or finance leases based on the guidance in ASC Topic <div style="display: inline; font-style: italic; font: inherit;">842.</div> Operating leases are included in operating lease ROU assets and operating lease liabilities in our consolidated balance sheets. Finance leases are included in property and equipment and financing lease liabilities. We do <div style="display: inline; font-style: italic; font: inherit;">not</div> currently have any financing leases.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. <div style="display: inline; font-style: italic; font: inherit;">None</div> of our leases provide an implicit rate; therefore, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms <div style="display: inline; font-style: italic; font: inherit;"> may </div>include options to extend or terminate the lease. We include these options in the determination of the amount of the ROU asset and lease liability when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Certain of our operating leases contain predetermined fixed escalations of minimum rentals and rent holidays during the original lease terms. Rent holidays are periods during which we have control of the leased facility but are <div style="display: inline; font-style: italic; font: inherit;">not</div> obligated to pay rent. For these leases, our ROU asset and lease liability are calculated including any rent holiday in the determination of the life of the lease.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We have lease agreements which contain both lease and non-lease components, which are generally accounted for separately. In addition to the monthly rental payments due, most of our leases for our offices and warehouse facilities include non-lease components representing our portion of the common area maintenance, property taxes and insurance charges incurred by the landlord for the facilities which we occupy. These amounts are <div style="display: inline; font-style: italic; font: inherit;">not</div> included in the calculation of the ROU assets and lease liabilities as they are based on actual charges incurred in the periods to which they apply.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Operating lease payments are included in cash outflows from operating activities on our consolidated statements of cash flows. Amortization of right of use assets is presented separately from the change in operating lease liabilities and is included in Depreciation and Amortization on our consolidated statements of cash flows.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">We have made an accounting policy election <div style="display: inline; font-style: italic; font: inherit;">not</div> to apply the recognition requirements of ASC Topic <div style="display: inline; font-style: italic; font: inherit;">842</div> to short-term leases (leases with a term of <div style="display: inline; font-style: italic; font: inherit;">one</div> year or less at the commencement date of the lease). Lease expense for short-term lease payments is recognized on a straight-line basis over the lease term.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">See “Effect of Recently Adopted Amendments to Authoritative Accounting Guidance” below and Note <div style="display: inline; font-style: italic; font: inherit;">8</div> for further disclosures regarding our leases.</div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div></div> <div style="display: inline; font-style: italic; font: inherit;"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Contingent Liability for Repayment of State and Local Grant Funds Received </div></div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In connection with leasing a new facility in Rochester, New York, which our subsidiary, Ambrell, occupied in <div style="display: inline; font-style: italic; font: inherit;"> May 2018, </div>we entered into agreements with the city of Rochester and the state of New York under which we received grants totaling <div style="display: inline; font-style: italic; font: inherit;">$463</div> to help offset a portion of the cost of the leasehold improvements we have made to this facility. In exchange for the funds we received under these agreements, we are required to create and maintain specified levels of employment in this location through various dates ending in <div style="display: inline; font-style: italic; font: inherit;">2023.</div> If we fail to meet these employment targets, we <div style="display: inline; font-style: italic; font: inherit;"> may </div>be required to repay a proportionate share of the proceeds. As of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div><div style="display: inline; font-style: italic; font: inherit;">$423</div> of the total proceeds received could still be required to be repaid if we do <div style="display: inline; font-style: italic; font: inherit;">not</div> meet the targets. We have recorded this amount as a contingent liability which is included in other liabilities on our balance sheet. Those portions of the proceeds which are <div style="display: inline; font-style: italic; font: inherit;">no</div> longer subject to repayment are reclassified to deferred grant proceeds and amortized to income on a straight-line basis over the remaining lease term for the Rochester facility. Deferred grant proceeds are included in other current liabilities and other liabilities on our balance sheet and totaled <div style="display: inline; font-style: italic; font: inherit;">$27</div> at <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">As of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>we were <div style="display: inline; font-style: italic; font: inherit;">not</div> in compliance with the employment targets as specified in the grant agreement with the city of Rochester. We applied for and received a waiver of this requirement for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>We have until <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2021 </div>to come into compliance with the targets as outlined in the waiver received for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>If we do <div style="display: inline; font-style: italic; font: inherit;">not</div> achieve compliance, we will need to apply for an additional waiver or we <div style="display: inline; font-style: italic; font: inherit;"> may </div>be required to repay a proportionate share of the proceeds.</div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Stock-Based Compensation</div></div></div><br /> <br /> We account for stock-based compensation in accordance with ASC Topic <div style="display: inline; font-style: italic; font: inherit;">718</div> (Compensation - Stock Compensation) which requires that employee share-based equity awards be accounted for under the fair value method and requires the use of an option pricing model for estimating fair value of stock options, which is then amortized to expense over the service periods. See further disclosures related to our stock-based compensation plans in Note <div style="display: inline; font-style: italic; font: inherit;">13.</div></div><div style="display: inline; font-style: italic; font: inherit;"></div><br /> <br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Engineering and Product Development</div></div></div><br /> <br /> Engineering and product development costs, which consist primarily of the salary and related benefits costs of our technical staff, as well as the cost of materials used in product development, are expensed as incurred.</div><br /> <br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Foreign Currency</div></div></div><br /> <br /> For our foreign subsidiaries whose functional currencies are <div style="display: inline; font-style: italic; font: inherit;">not</div> the U.S. dollar, assets and liabilities are translated using the exchange rate in effect at the balance sheet date. The results of operations are translated using an average exchange rate for the period. The effects of rate fluctuations in translating assets and liabilities of these international operations into U.S. dollars are included in accumulated other comprehensive earnings in stockholders' equity. Transaction gains or losses are included in net earnings. For the years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> foreign currency transaction losses were <div style="display: inline; font-style: italic; font: inherit;">$26</div> and <div style="display: inline; font-style: italic; font: inherit;">$3,</div> respectively.</div><br /> <br /> <div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Income Taxes</div></div></div><br /> <br /> The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carryforwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets if it is more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> that such assets will <div style="display: inline; font-style: italic; font: inherit;">not</div> be realized. See Note <div style="display: inline; font-style: italic; font: inherit;">11</div> for additional information regarding income taxes.</div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div></div> <div style="display: inline; font-style: italic; font: inherit;"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Net Earnings (Loss) Per Common Share</div></div></div><br /> <br /> Net earnings (loss) per common share - basic is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding during each period. Net earnings (loss) per common share - diluted is computed by dividing net earnings (loss) by the weighted average number of common shares and common share equivalents outstanding during each period. Common share equivalents represent unvested shares of restricted stock and stock options and are calculated using the treasury stock method. Common share equivalents are excluded from the calculation if their effect is anti-dilutive.<br /> <br /> The table below sets forth, for the periods indicated, a reconciliation of weighted average common shares outstanding - basic to weighted average common shares and common share equivalents outstanding - diluted and the average number of potentially dilutive securities that were excluded from the calculation of diluted earnings (loss) per share because their effect was anti-dilutive:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 27pt; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Years Ended</div><br /> <div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 68%;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding–basic</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,256,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">10,373,164</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Potentially dilutive securities:</div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Unvested shares of restricted stock and employee stock options</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">18,811</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares and common share equivalents outstanding–diluted</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">10,256,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">10,391,975</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Average number of potentially dilutive securities excluded from calculation</div> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">717,015</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">523,485</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div></div> <div> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"></div></div></div></div> <div style="display: inline; font-style: italic; font: inherit;"><div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Effect of Recently Issued Amendments to Authoritative Accounting Guidance</div></div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In <div style="display: inline; font-style: italic; font: inherit;"> June 2016, </div>the Financial Accounting Standards Board (“FASB”) issued amendments to the guidance for accounting for credit losses. In <div style="display: inline; font-style: italic; font: inherit;"> November 2019, </div>the FASB deferred the effective date of these amendments for certain companies, including smaller reporting companies. As a result of the deferral, the amendments are effective for us for reporting periods beginning after <div style="display: inline; font-style: italic; font: inherit;"> December 15, 2022. </div>The amendments replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires the use of a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. The amendments require a modified retrospective approach through a cumulative-effect adjustment to retained earnings as of the beginning of the <div style="display: inline; font-style: italic; font: inherit;">first</div> reporting period in which the guidance is effective. We plan to adopt the amendments when they become effective for us on <div style="display: inline; font-style: italic; font: inherit;"> January 1, 2023. </div>We are currently evaluating the impact the adoption of these amendments will have on our consolidated financial statements.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In <div style="display: inline; font-style: italic; font: inherit;"> December 2019, </div>the FASB issued amendments to the accounting for income taxes, which add new guidance to simplify the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic <div style="display: inline; font-style: italic; font: inherit;">740</div> (Income Taxes) and changing the accounting for certain income tax transactions. The amendments are effective for us as of <div style="display: inline; font-style: italic; font: inherit;"> January 1, 2021. </div>Early adoption is permitted. We plan to adopt the amendments when they become effective for us on <div style="display: inline; font-style: italic; font: inherit;"> January 1, 2021. </div>We do <div style="display: inline; font-style: italic; font: inherit;">not</div> expect these amendments to have a material impact on our consolidated financial statements. </div></div></div>

971000

837000

12325

67125

132580

229110

1000

2000

3000000

13767

243075

297020

229308

13767

74000

1216000

1195000

2000

1140000

1142000

74000

44752000

44834000

105000

26513000

15683000

783000

-204000

42880000

104000

26256000

18005000

673000

-204000

106000

26851000

17110000

889000

-204000

825000

868000

33077

204000

-65000

-7000

1000

211000

212000

334000

235000

233000

346000

32000

3000

243000

131000

25000

255000

10220853

10258917

10287562

10282903

10256560

10414330

10411276

10429536

10298535

10391975

10220853

10252490

10269995

10282903

10256560

10385017

10411276

10421383

10274980

10373164

The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3. The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3. The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3. The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3. The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3. The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3. xbrli:shares xbrli:pure utr:sqft iso4217:USD iso4217:USD xbrli:shares 0001036262 2015-10-27 2019-07-31 0001036262 2015-10-27 2020-12-31 0001036262 2019-01-01 2019-03-31 0001036262 intt:LeaseAgreementAmbrellsUKMember 2019-01-01 2019-09-30 0001036262 2019-01-01 2019-12-31 0001036262 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001036262 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0001036262 us-gaap:RestrictedStockMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001036262 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-12-31 0001036262 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001036262 us-gaap:RestrictedStockMember us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-12-31 0001036262 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intt:TexasInstrumentsIncorporatedMember 2019-01-01 2019-12-31 0001036262 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0001036262 us-gaap:OperatingSegmentsMember intt:EMSMember 2019-01-01 2019-12-31 0001036262 us-gaap:OperatingSegmentsMember intt:ThermalTestingProductsMember 2019-01-01 2019-12-31 0001036262 intt:DefenseAerospaceMember 2019-01-01 2019-12-31 0001036262 intt:IndustrialMarketMember 2019-01-01 2019-12-31 0001036262 intt:OtherMultiMarketsMember 2019-01-01 2019-12-31 0001036262 intt:SemiconductorMarketMember 2019-01-01 2019-12-31 0001036262 intt:TelecommunicationsMarketMember 2019-01-01 2019-12-31 0001036262 intt:LeaseAgreementAmbrellsNetherlandsFacilityMember 2019-01-01 2019-12-31 0001036262 intt:LeaseAgreementAmbrellsUKMember 2019-01-01 2019-12-31 0001036262 intt:LeaseForFacilityInMansfieldMassachusettsMember 2019-01-01 2019-12-31 0001036262 intt:EndUserMember 2019-01-01 2019-12-31 0001036262 intt:OEMAndIntegratorsMember 2019-01-01 2019-12-31 0001036262 intt:SemiconductorProductionTestProductsMember 2019-01-01 2019-12-31 0001036262 intt:ServiceAndOtherProductsMember 2019-01-01 2019-12-31 0001036262 intt:ThermalProcessMember 2019-01-01 2019-12-31 0001036262 intt:ThermalTestingProductsMember 2019-01-01 2019-12-31 0001036262 us-gaap:FacilityClosingMember intt:AmbrellEuropeanOperationsConsolidationMember 2019-01-01 2019-12-31 0001036262 intt:SeveranceAndOtherOnetimeTerminationBenefitsMember 2019-01-01 2019-12-31 0001036262 intt:SeveranceAndOtherOnetimeTerminationBenefitsMember intt:AmbrellEuropeanOperationsConsolidationMember 2019-01-01 2019-12-31 0001036262 intt:AmbrellEuropeanOperationsConsolidationMember 2019-01-01 2019-12-31 0001036262 intt:The401KPlanMember 2019-01-01 2019-12-31 0001036262 intt:TheAmbrellPlanMember 2019-01-01 2019-12-31 0001036262 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001036262 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001036262 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001036262 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001036262 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001036262 us-gaap:NonUsMember 2019-01-01 2019-12-31 0001036262 country:US 2019-01-01 2019-12-31 0001036262 us-gaap:AllowanceForCreditLossMember 2019-01-01 2019-12-31 0001036262 us-gaap:WarrantyReservesMember 2019-01-01 2019-12-31 0001036262 2019-04-01 2019-06-30 0001036262 intt:MansfieldMassachusettsMember 2019-04-08 2019-04-08 0001036262 2019-07-01 2019-09-30 0001036262 intt:LeaseAgreementAmbrellsNetherlandsFacilityMember 2019-07-01 2019-09-30 0001036262 2019-10-01 2019-12-31 0001036262 2020-01-01 2020-03-31 0001036262 us-gaap:RestrictedStockMember intt:IndependentDirectorsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-03-31 0001036262 us-gaap:RestrictedStockMember intt:IndependentDirectorsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-01-01 2020-06-30 0001036262 us-gaap:RestrictedStockMember intt:IndependentDirectorsMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2020-01-01 2020-09-30 0001036262 intt:LeaseAgreementEMSFacilityInFremontCaliforniaMember 2020-01-01 2020-09-30 0001036262 2020-01-01 2020-12-31 0001036262 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember intt:RestrictedStockVestingInThreeYearsMember srt:PresidentMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember intt:EmployeesMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember intt:IndependentDirectorsMember 2020-01-01 2020-12-31 0001036262 us-gaap:RestrictedStockMember intt:IndependentDirectorsMember intt:ShareBasedCompensationAwardTrancheFourMember 2020-01-01 2020-12-31 0001036262 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001036262 us-gaap:OperatingSegmentsMember intt:EMSMember 2020-01-01 2020-12-31 0001036262 us-gaap:OperatingSegmentsMember intt:ThermalTestingProductsMember 2020-01-01 2020-12-31 0001036262 us-gaap:LetterOfCreditMember intt:MansfieldMember 2020-01-01 2020-12-31 0001036262 us-gaap:LetterOfCreditMember intt:MtLaurelMember 2020-01-01 2020-12-31 0001036262 intt:DefenseAerospaceMember 2020-01-01 2020-12-31 0001036262 intt:IndustrialMarketMember 2020-01-01 2020-12-31 0001036262 intt:OtherMultiMarketsMember 2020-01-01 2020-12-31 0001036262 intt:SemiconductorMarketMember 2020-01-01 2020-12-31 0001036262 intt:TelecommunicationsMarketMember 2020-01-01 2020-12-31 0001036262 intt:AutomobileLeasesMember 2020-01-01 2020-12-31 0001036262 intt:LeaseAgreementAmbrellsNetherlandsFacilityMember 2020-01-01 2020-12-31 0001036262 intt:LeaseAgreementEMSFacilityInFremontCaliforniaMember 2020-01-01 2020-12-31 0001036262 intt:LeaseAgreementEmsFacilityInMtLaurelNewJerseyMember 2020-01-01 2020-12-31 0001036262 intt:EndUserMember 2020-01-01 2020-12-31 0001036262 intt:OEMAndIntegratorsMember 2020-01-01 2020-12-31 0001036262 intt:SemiconductorProductionTestProductsMember 2020-01-01 2020-12-31 0001036262 intt:ServiceAndOtherProductsMember 2020-01-01 2020-12-31 0001036262 intt:ThermalProcessMember 2020-01-01 2020-12-31 0001036262 intt:ThermalTestingProductsMember 2020-01-01 2020-12-31 0001036262 srt:MaximumMember 2020-01-01 2020-12-31 0001036262 srt:MinimumMember 2020-01-01 2020-12-31 0001036262 intt:CashChargesMember intt:EMSSegmentRestructuringAndFacilityConsolidationMember 2020-01-01 2020-12-31 0001036262 intt:CashChargesMember intt:ExecutiveManagementChangesMember 2020-01-01 2020-12-31 0001036262 us-gaap:EmployeeRelocationMember intt:OtherRestructuringActionsMember 2020-01-01 2020-12-31 0001036262 intt:FacilitySizeReductionMember intt:ExecutiveManagementChangesMember 2020-01-01 2020-12-31 0001036262 intt:HeadcountReductionsAndEmployeeRelocationMember intt:OtherRestructuringActionsMember 2020-01-01 2020-12-31 0001036262 intt:NonCashChargesMember intt:EMSSegmentRestructuringAndFacilityConsolidationMember 2020-01-01 2020-12-31 0001036262 intt:NonCashChargesMember intt:ExecutiveManagementChangesMember 2020-01-01 2020-12-31 0001036262 intt:SeveranceAndOtherOnetimeTerminationBenefitsMember 2020-01-01 2020-12-31 0001036262 intt:SublettingCostsOfTheFremontCaFacilityMember 2020-01-01 2020-12-31 0001036262 intt:SublettingCostsOfTheMansfieldMAFacilityMember 2020-01-01 2020-12-31 0001036262 intt:EMSSegmentRestructuringAndFacilityConsolidationMember 2020-01-01 2020-12-31 0001036262 intt:ExecutiveManagementChangesMember 2020-01-01 2020-12-31 0001036262 intt:The401KPlanMember 2020-01-01 2020-12-31 0001036262 intt:TheAmbrellPlanMember 2020-01-01 2020-12-31 0001036262 intt:AssetMember 2020-01-01 2020-12-31 0001036262 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001036262 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001036262 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001036262 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001036262 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001036262 us-gaap:NonUsMember 2020-01-01 2020-12-31 0001036262 country:US 2020-01-01 2020-12-31 0001036262 us-gaap:AllowanceForCreditLossMember 2020-01-01 2020-12-31 0001036262 us-gaap:WarrantyReservesMember 2020-01-01 2020-12-31 0001036262 2020-04-01 2020-04-30 0001036262 2020-04-01 2020-06-30 0001036262 us-gaap:RevolvingCreditFacilityMember intt:MTMember 2020-04-01 2020-06-30 0001036262 us-gaap:RevolvingCreditFacilityMember intt:MTMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-04-10 2020-04-10 0001036262 2020-07-01 2020-09-30 0001036262 us-gaap:RestrictedStockMember intt:RestrictedStockVestingInFourYearsMember srt:PresidentMember 2020-08-24 2020-08-24 0001036262 us-gaap:RestrictedStockMember intt:RestrictedStockVestingInFourYearsMember srt:PresidentMember intt:ShareBasedCompensationAwardTrancheFourMember 2020-08-24 2020-08-24 0001036262 us-gaap:RestrictedStockMember intt:RestrictedStockVestingInFourYearsMember srt:PresidentMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-08-24 2020-08-24 0001036262 us-gaap:RestrictedStockMember intt:RestrictedStockVestingInFourYearsMember srt:PresidentMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2020-08-24 2020-08-24 0001036262 us-gaap:RestrictedStockMember intt:RestrictedStockVestingInFourYearsMember srt:PresidentMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-08-24 2020-08-24 0001036262 us-gaap:RestrictedStockMember intt:RestrictedStockVestingInThreeYearsMember srt:PresidentMember 2020-08-24 2020-08-24 0001036262 us-gaap:RestrictedStockMember intt:RestrictedStockVestingInThreeYearsMember srt:PresidentMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-08-24 2020-08-24 0001036262 us-gaap:RestrictedStockMember srt:PresidentMember 2020-08-24 2020-08-24 0001036262 intt:LeaseAgreementAmbrellsNetherlandsFacilityMember 2020-10-01 2020-10-01 0001036262 2020-10-01 2020-12-31 0001036262 intt:AutomobileLeasesMember 2020-10-01 2020-12-31 0001036262 intt:ExecutiveManagementChangesMember 2020-10-01 2020-12-31 0001036262 intt:EMSSegmentRestructuringAndFacilityConsolidationMember 2020-12-28 2020-12-28 0001036262 srt:MaximumMember intt:EMSSegmentRestructuringAndFacilityConsolidationMember srt:ScenarioForecastMember 2021-01-01 2021-06-30 0001036262 srt:MinimumMember intt:EMSSegmentRestructuringAndFacilityConsolidationMember srt:ScenarioForecastMember 2021-01-01 2021-06-30 0001036262 intt:StockPlan2014Member 2014-06-25 0001036262 intt:StockPlan2014Member 2018-06-27 0001036262 2018-12-31 0001036262 us-gaap:RestrictedStockMember 2018-12-31 0001036262 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001036262 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001036262 us-gaap:CommonStockMember 2018-12-31 0001036262 us-gaap:RetainedEarningsMember 2018-12-31 0001036262 us-gaap:TreasuryStockMember 2018-12-31 0001036262 us-gaap:AllowanceForCreditLossMember 2018-12-31 0001036262 us-gaap:WarrantyReservesMember 2018-12-31 0001036262 intt:LeaseAgreementAmbrellsUKMember 2019-03-31 0001036262 us-gaap:RevolvingCreditFacilityMember intt:MTMember 2019-04-01 0001036262 intt:MansfieldMassachusettsMember 2019-04-08 0001036262 intt:StockPlan2014Member 2019-06-19 0001036262 2019-07-31 0001036262 2019-12-31 0001036262 us-gaap:RestrictedStockMember 2019-12-31 0001036262 us-gaap:CorporateNonSegmentMember 2019-12-31 0001036262 us-gaap:LetterOfCreditMember 2019-12-31 0001036262 us-gaap:LetterOfCreditMember intt:MansfieldMember 2019-12-31 0001036262 us-gaap:LetterOfCreditMember intt:MtLaurelMember 2019-12-31 0001036262 us-gaap:ComputerSoftwareIntangibleAssetMember 2019-12-31 0001036262 us-gaap:CustomerRelationshipsMember 2019-12-31 0001036262 us-gaap:PatentedTechnologyMember 2019-12-31 0001036262 us-gaap:PatentsMember 2019-12-31 0001036262 us-gaap:TradeNamesMember 2019-12-31 0001036262 us-gaap:TrademarksMember 2019-12-31 0001036262 intt:EMSMember 2019-12-31 0001036262 intt:ThermalTestingProductsMember 2019-12-31 0001036262 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001036262 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001036262 us-gaap:CommonStockMember 2019-12-31 0001036262 us-gaap:RetainedEarningsMember 2019-12-31 0001036262 us-gaap:TreasuryStockMember 2019-12-31 0001036262 us-gaap:NonUsMember 2019-12-31 0001036262 country:US 2019-12-31 0001036262 us-gaap:AllowanceForCreditLossMember 2019-12-31 0001036262 us-gaap:WarrantyReservesMember 2019-12-31 0001036262 intt:LeaseAgreementEMSFacilityInFremontCaliforniaMember 2020-01-23 0001036262 us-gaap:RevolvingCreditFacilityMember intt:MTMember 2020-04-10 0001036262 2020-06-30 0001036262 intt:LeaseAgreementEmsFacilityInMtLaurelNewJerseyMember 2020-09-22 0001036262 intt:LeaseAgreementAmbrellsNetherlandsFacilityMember 2020-10-01 0001036262 2020-12-31 0001036262 us-gaap:RestrictedStockMember 2020-12-31 0001036262 intt:AmbrellMember 2020-12-31 0001036262 intt:SigmaMember 2020-12-31 0001036262 intt:ThermonicsMember 2020-12-31 0001036262 us-gaap:CorporateNonSegmentMember 2020-12-31 0001036262 intt:CityOfRochesterAndStateOfNewYorkMember 2020-12-31 0001036262 us-gaap:LetterOfCreditMember 2020-12-31 0001036262 us-gaap:LetterOfCreditMember intt:MansfieldMember 2020-12-31 0001036262 us-gaap:LetterOfCreditMember intt:MtLaurelMember 2020-12-31 0001036262 us-gaap:RevolvingCreditFacilityMember intt:MTMember 2020-12-31 0001036262 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-12-31 0001036262 us-gaap:CustomerRelationshipsMember 2020-12-31 0001036262 us-gaap:PatentedTechnologyMember 2020-12-31 0001036262 us-gaap:PatentsMember 2020-12-31 0001036262 us-gaap:TradeNamesMember 2020-12-31 0001036262 us-gaap:TrademarksMember 2020-12-31 0001036262 intt:LeaseAgreementEmsFacilityInMtLaurelNewJerseyMember 2020-12-31 0001036262 intt:StockPlan2014Member 2020-12-31 0001036262 intt:EMSSegmentRestructuringAndFacilityConsolidationMember 2020-12-31 0001036262 intt:EMSMember 2020-12-31 0001036262 intt:ThermalTestingProductsMember 2020-12-31 0001036262 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001036262 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001036262 us-gaap:CommonStockMember 2020-12-31 0001036262 us-gaap:RetainedEarningsMember 2020-12-31 0001036262 us-gaap:TreasuryStockMember 2020-12-31 0001036262 us-gaap:NonUsMember 2020-12-31 0001036262 country:US 2020-12-31 0001036262 us-gaap:AllowanceForCreditLossMember 2020-12-31 0001036262 us-gaap:WarrantyReservesMember 2020-12-31 0001036262 2021-03-15

EX-101.SCH 10 intt-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Comprehensive Earnings (Loss) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 1 - Nature of Operations link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 3 - Restructuring and Other Charges link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 4 - Goodwill and Intangible Assets link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 5 - Revenue From Contracts With Customers link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 6 - Major Customers link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 7 - Inventories link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 8 - Leases link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 9 - Other Current Liabilities link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 10 - Debt link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 11 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 12 - Legal Proceedings link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 13 - Stock-based Compensation Plan link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 14 - Stock Repurchase Plans link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 15 - Employee Benefit Plans link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 16 - Segment Information link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 17 - Quarterly Consolidated Financial Data (Unaudited) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 3 - Restructuring and Other Charges (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 4 - Goodwill and Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 5 - Revenue From Contracts With Customers (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 7 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 8 - Leases (Tables) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 9 - Other Current Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 10 - Debt (Tables) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 11 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 13 - Stock-based Compensation Plan (Tables) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 16 - Segment Information (Tables) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 17 - Quarterly Consolidated Financial Data (Unaudited) (Tables) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 1 - Nature of Operations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Weighted Average Common Shares (Details) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 3 - Restructuring and Other Charges (Details Textual) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 3 - Restructuring and Other Charges - Changes in Accrued Restructuring (Details) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 4 - Goodwill and Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 4 - Goodwill and Intangible Assets - Component of Goodwill (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 4 - Goodwill and Intangible Assets - Changes in the Amount of the Carrying Value of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 4 - Goodwill and Intangible Assets - Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 4 - Goodwill and Intangible Assets - Future Amortization Expense (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 5 - Revenue From Contracts With Customers - Disaggregation of Revenues (Details) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 5 - Revenue From Contracts With Customers - Changes in Allowance for Doubtful Accounts (Details) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 6 - Major Customers (Details Textual) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 7 - Inventories - Inventories Held (Details) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 8 - Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 8 - Leases - Lease Costs (Details) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 8 - Leases - Maturities of Lease Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 8 - Leases - Lease Modifications (Details) link:calculationLink link:definitionLink link:presentationLink 058 - Disclosure - Note 9 - Other Current Liabilities - Other Current Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 059 - Disclosure - Note 10 - Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 060 - Disclosure - Note 10 - Debt - Outstanding Letters of Credit (Details) link:calculationLink link:definitionLink link:presentationLink 061 - Disclosure - Note 11 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 062 - Disclosure - Note 11 - Income Taxes - Earnings Before Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink 063 - Disclosure - Note 11 - Income Taxes - Income Tax Expense (Benefit) (Details) link:calculationLink link:definitionLink link:presentationLink 064 - Disclosure - Note 11 - Income Taxes - Deferred Tax Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 065 - Disclosure - Note 11 - Income Taxes - Effective Tax Rate Analysis and Reconciliation of Expected Statutory Rate (Details) link:calculationLink link:definitionLink link:presentationLink 066 - Disclosure - Note 13 - Stock-based Compensation Plan (Details Textual) link:calculationLink link:definitionLink link:presentationLink 067 - Disclosure - Note 13 - Stock-based Compensation Plan - Allocation of Share-based Compensation Expense (Details) link:calculationLink link:definitionLink link:presentationLink 068 - Disclosure - Note 13 - Stock-based Compensation Plan - Stock Options Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 069 - Disclosure - Note 13 - Stock-based Compensation Plan - Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 070 - Disclosure - Note 13 - Stock-based Compensation Plan - Stock Option Activity (Details) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 071 - Disclosure - Note 13 - Stock-based Compensation Plan - Unvested Stock Activity (Details) link:calculationLink link:definitionLink link:presentationLink 072 - Disclosure - Note 14 - Stock Repurchase Plans (Details Textual) link:calculationLink link:definitionLink link:presentationLink 073 - Disclosure - Note 15 - Employee Benefit Plans (Details Textual) link:calculationLink link:definitionLink link:presentationLink 074 - Disclosure - Note 16 - Segment Information - Segment Information (Details) link:calculationLink link:definitionLink link:presentationLink 075 - Disclosure - Note 16 - Segment Information - Identifiable Assets (Details) link:calculationLink link:definitionLink link:presentationLink 076 - Disclosure - Note 16 - Segment Information - Net Revenue From Unaffiliated Customers (Details) link:calculationLink link:definitionLink link:presentationLink 077 - Disclosure - Note 16 - Segment Information - Long-lived Assets by Geographical Area (Details) link:calculationLink link:definitionLink link:presentationLink 078 - Disclosure - Note 17 - Quarterly Consolidated Financial Data (Unaudited) (Details Textual) link:calculationLink link:definitionLink link:presentationLink 079 - Disclosure - Note 17 - Quarterly Consolidated Financial Data (Unaudited) - Quarterly Consolidated Financial Data (Details) link:calculationLink link:definitionLink link:presentationLink 080 - Disclosure - Schedule II Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 11 intt-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 12 intt-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 13 intt-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Dividend yield Note To Financial Statement Details Textual Significant Accounting Policies Note 2 - Summary of Significant Accounting Policies Expected income tax expense (benefit) at U.S. statutory rate Note 3 - Restructuring and Other Charges Risk-free interest rate Note 4 - Goodwill and Intangible Assets Note 5 - Revenue From Contracts With Customers Note 7 - Inventories Note 8 - Leases Note 9 - Other Current Liabilities Note 10 - Debt Income Tax Disclosure [Text Block] Note 11 - Income Taxes Note 13 - Stock-based Compensation Plan Note 16 - Segment Information Note 17 - Quarterly Consolidated Financial Data (Unaudited) Expected common stock market price volatility factor Schedule II - Valuation and Qualifying Accounts us-gaap_LiabilitiesCurrent Total current liabilities Automobile Leases [Member] Information pertaining to automobile leases. Note 2 - Summary of Significant Accounting Policies - Weighted Average Common Shares (Details) Note 3 - Restructuring and Other Charges - Restructuring and Related Costs (Details) Note 3 - Restructuring and Other Charges - Changes in Accrued Restructuring (Details) Note 4 - Goodwill and Intangible Assets - Component of Goodwill (Details) Other current liabilities Total other current liabilities Weighted average expected life of stock options (years) (Year) Note 4 - Goodwill and Intangible Assets - Changes in the Amount of the Carrying Value of Intangible Assets (Details) Note 4 - Goodwill and Intangible Assets - Intangible Assets (Details) Note 4 - Goodwill and Intangible Assets - Future Amortization Expense (Details) intt_AllowanceForDoubtfulAccountsReceivableForeignCurrencyTranslation Foreign currency translation adjustments Amount of foreign currency translation gain (loss) which (increases) decreases allowance for credit loss on accounts receivable. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Note 5 - Revenue From Contracts With Customers - Disaggregation of Revenues (Details) Note 5 - Revenue From Contracts With Customers - Changes in Allowance for Doubtful Accounts (Details) Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Note 7 - Inventories - Inventories Held (Details) Note 8 - Leases - Lease Costs (Details) Note 8 - Leases - Maturities of Lease Liabilities (Details) Note 8 - Leases - Lease Modifications (Details) Note 9 - Other Current Liabilities - Other Current Liabilities (Details) Share-based Payment Arrangement, Option, Activity [Table Text Block] Note 10 - Debt - Outstanding Letters of Credit (Details) Note 11 - Income Taxes - Earnings Before Income Taxes (Details) Granted, weighted average exercise price (in dollars per share) us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Foreign currency translation adjustments Note 11 - Income Taxes - Income Tax Expense (Benefit) (Details) Vested, weighted average exercise price (in dollars per share) Note 11 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Forfeited, weighted average exercise price (in dollars per share) Note 11 - Income Taxes - Effective Tax Rate Analysis and Reconciliation of Expected Statutory Rate (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Unvested shares outstanding, weighted average exercise price (in dollars per share) Unvested shares outstanding, weighted average exercise price (in dollars per share) Note 13 - Stock-based Compensation Plan - Allocation of Share-based Compensation Expense (Details) Note 13 - Stock-based Compensation Plan - Stock Options Valuation Assumptions (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Forfeited, number of shares (in shares) Note 13 - Stock-based Compensation Plan - Stock Option Activity (Details) Note 13 - Stock-based Compensation Plan - Stock Option Activity (Details) (Parentheticals) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Unvested shares outstanding (in shares) Unvested shares outstanding (in shares) Note 13 - Stock-based Compensation Plan - Unvested Stock Activity (Details) us-gaap_GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment, Total Schedule of Nonvested Share Activity [Table Text Block] Note 16 - Segment Information - Segment Information (Details) Note 16 - Segment Information - Identifiable Assets (Details) Granted, number of shares (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) Note 16 - Segment Information - Net Revenue From Unaffiliated Customers (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Vested, number of shares (in shares) Note 16 - Segment Information - Long-lived Assets by Geographical Area (Details) Note 17 - Quarterly Consolidated Financial Data (Unaudited) - Quarterly Consolidated Financial Data (Details) Schedule II Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) Notes To Financial Statements Notes To Financial Statements [Abstract] Options exercisable (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) Facility Size Reduction [Member] Information pertaining to the facility reduction in size. Retirement Plan Name [Axis] Retirement Plan Name [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Options outstanding, weighted average exercise price (in dollars per share) Options outstanding, weighted average exercise price (in dollars per share) Customer deposits and deferred revenue us-gaap_ContractWithCustomerLiabilityCurrent Canceled, weighted average exercise price (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Goodwill [Table Text Block] Granted, weighted average exercise price (in dollars per share) us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Domestic and foreign income taxes payable Accrued wages and benefits Lessee, Operating Leases [Text Block] intt_ContingentLiabilityRepaymentOfStateAndLocalGrantFundsReceived Contingent Liability, Repayment of State and Local Grant Funds Received Amount of liability recognized arising from contingent for repayment of state and local grant funds received. Accounts payable Revolving Credit Facility [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Options outstanding, number of shares (in shares) Options outstanding, number of shares (in shares) Credit Facility [Axis] Proceeds from sale of property and equipment Credit Facility [Domain] Other Trademarks [Member] us-gaap_PolicyTextBlockAbstract Accounting Policies City of Rochester and State of New York [Member] Represents information related to city of Rochester and state of New York. Accrued warranty Trade Names [Member] us-gaap_AccruedSalesCommissionCurrent Accrued sales commission us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) Issuance of unvested shares of restricted stock us-gaap_StockIssued1 Accrued professional fees Indefinite-lived Intangible Assets [Axis] Contingent Liability, Repayment of State and Local Grant Funds Received, Policy [Policy Text Block] Disclosure of accounting policy for contingent liability for repayment of state and local grant funds received. Indefinite-lived Intangible Assets, Major Class Name [Domain] Capital expenditures us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchase of property and equipment Unvested shares of restricted stock and employee stock options (in shares) SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] intt_DiscountedCashFlowsDiscountRate Discounted Cash Flows, Discount Rate Discount rate used by discounted cash flows. us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Share-based Payment Arrangement, Tranche Three [Member] Current liabilities: Vesting [Axis] Vesting [Domain] Patented Technology [Member] Share-based Payment Arrangement, Tranche One [Member] Share-based Payment Arrangement, Tranche Two [Member] Cash payments for: us-gaap_Assets Total assets Identifiable Assets Impairment of right of use assets Impairment of ROU asset Operating Lease, Impairment Loss Restructuring, Impairment, and Other Activities Disclosure [Text Block] intt_PaymentsForStockRepurchasedBrokerFees Payments for Stock Repurchased Broker Fees The cash outflow for broker fees incurred with the stock repurchased. Patents [Member] Plan Name [Axis] Plan Name [Domain] Property and equipment: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Goodwill Intangible And Long Lived Assets [Policy Text Block] The policy disclosure of goodwill intangible and long lived assets. us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) Customer Relationships [Member] Legal Matters and Contingencies [Text Block] us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized Computer Software, Intangible Asset [Member] Share-based Payment Arrangement [Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] us-gaap_IncreaseDecreaseOfRestrictedInvestments Restricted certificates of deposit Award Type [Domain] Global intangible low taxed income Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to global intangible low taxed income. Award Type [Axis] Net earnings (loss) Net earnings (loss) Net earnings (loss) Net earnings (loss) intt_IncomeTaxReconciliationSection250ForeignDerivedIntangibleIncomeDeduction Section 250 foreign derived intangible income deduction Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to section 250, foreign derived intangible income deduction. Finite-lived, Accumulated Amortization Net Carrying Amount Balance Balance Intangible assets, net Net Carrying Amount Finite-lived, Gross Carrying Amount Restricted Stock [Member] Share-based Payment Arrangement, Option [Member] Schedule Of Intangible Assets [Table Text Block] The tabular disclosure of the intangible assets. Ambrell [Member] Related to the acquisition of Ambrell. Net Carrying Amount us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived, Gross Carrying Amount us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less: accumulated depreciation us-gaap_PropertyPlantAndEquipmentNet Net property and equipment Property and Equipment Goodwill Goodwill, Ending Balance us-gaap_PropertyPlantAndEquipmentGross Gross property and equipment Machinery and equipment Leasehold improvements Operating lease liabilities The amount of increase (decrease) in operating lease liabilities. EMS [Member] Represents the information pertaining to inTEST Electromechanical Semiconductor Products (EMS). Accrued professional fees intt_IncreaseDecreaseInAccruedProfessionalFees The amount of increase (decrease) in accrued professional fees. Acquisition costs intt_DeferredTaxAssetsAcquisitionCosts Amount before allocation of valuation allowances of deferred tax asset attributable to deductible acquisition costs. Lease for Facility in Mansfield, Massachusetts [Member] Related to a lease. Employees [Member] Related to employees. CASH FLOWS FROM INVESTING ACTIVITIES Range of remaining lease terms (in years) (Year) The remaining lease term of operating leases. Share-based Compensation Award, Tranche Four [Member] Fourth portion of share-based compensation award differentiated by a particular vesting feature, including, but not limited to, performance measure or service period. us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable Domestic and foreign income taxes payable Letter of Credit [Member] us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities Accrued wages and benefits Earnings (loss) before income tax expense (benefit) us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Total Earnings (loss) before income tax expense (benefit) Income tax expense (benefit) Income tax expense (benefit) Income tax expense (benefit) Income tax expense (benefit) The Ambrell Plan [Member] Related to the Ambrell defined contribution retirement plan. Other Restructuring Actions [Member] Represents other restructuring actions. Severance and other one-time termination benefits Represents severance and other one-time termination benefits. us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable us-gaap_OperatingExpenses Total operating expenses Restricted certificates of deposit us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount General and administrative expense us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount Restructuring and other charges intt_RestructuringAndOtherCharges Amount of expenses associated with exit or disposal activities pursuant to an authorized plan and other charges. Excludes expenses related to a discontinued operation or an asset retirement obligation. us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match Cash and cash equivalents EX-101.PRE 14 intt-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 15 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2020	Mar. 15, 2021	Jun. 30, 2020
Document Information [Line Items]
Entity Registrant Name	INTEST CORP
Entity Central Index Key	0001036262
Trading Symbol	intt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		10,703,056
Entity Public Float			$ 33,823,258
Entity Shell Company	false
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	false
Title of 12(b) Security	Common Stock, par value $0.01 per share

XML 16 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 10,277	$ 7,612
Trade accounts receivable, net of allowance for doubtful accounts of $212 and $211, respectively	8,435	9,296
Inventories	7,476	7,182
Prepaid expenses and other current assets	776	805
Total current assets	26,964	24,895
Property and equipment:
Machinery and equipment	5,356	5,269
Leasehold improvements	2,636	2,424
Gross property and equipment	7,992	7,693
Less: accumulated depreciation	(5,642)	(5,273)
Net property and equipment	2,350	2,420
Right of use assets, net	6,387	4,842
Goodwill	13,738	13,738
Intangible assets, net	12,421	13,654
Restricted certificates of deposit	140	140
Other assets	30	26
Total assets	62,030	59,715
Current liabilities:
Accounts payable	2,424	1,984
Accrued wages and benefits	1,944	2,007
Accrued professional fees	776	805
Customer deposits and deferred revenue	396	456
Accrued sales commission	472	442
Current portion of operating lease liabilities	1,215	1,302
Domestic and foreign income taxes payable	825	868
Other current liabilities	804	497
Total current liabilities	8,856	8,361
Operating lease liabilities, net of current portion	6,050	3,794
Deferred tax liabilities	1,922	2,263
Other liabilities	450	463
Total liabilities	17,278	14,881
Commitments and Contingencies (Note 12)
Stockholders' equity:
Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.01 par value; 20,000,000 shares authorized; 10,562,200 and 10,413,982 shares issued, respectively	106	104
Additional paid-in capital	26,851	26,256
Retained earnings	17,110	18,005
Accumulated other comprehensive earnings	889	673
Treasury stock, at cost; 33,077 shares	(204)	(204)
Total stockholders' equity	44,752	44,834
Total liabilities and stockholders' equity	$ 62,030	$ 59,715

XML 17 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Allowance for doubtful accounts	$ 212	$ 211
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	10,562,200	10,413,982
Treasury stock, shares (in shares)	33,077	33,077

XML 18 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Net revenues	$ 53,823	$ 60,660
Cost of revenues	29,719	31,435
Gross margin	24,104	29,225
Operating expenses:
Selling expense	7,522	8,460
Engineering and product development expense	5,070	4,964
General and administrative expense	11,444	13,012
Restructuring and other charges	1,285	240
Total operating expenses	25,321	26,676
Operating income (loss)	(1,217)	2,549
Other income (loss)	(14)	55
Earnings (loss) before income tax expense (benefit)	(1,231)	2,604
Income tax expense (benefit)	(336)	282
Net earnings (loss)	$ (895)	$ 2,322
Net earnings (loss) per common share – basic (in dollars per share)	$ (0.09)	$ 0.22
Weighted average common shares outstanding – basic (in shares)	10,256,560	10,373,164
Net earnings (loss) per common share – diluted (in dollars per share)	$ (0.09)	$ 0.22
Weighted average common shares and common share equivalents outstanding – diluted (in shares)	10,256,560	10,391,975

XML 19 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Comprehensive Earnings (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Net earnings (loss)	$ (895)	$ 2,322
Foreign currency translation adjustments	216	(110)
Comprehensive earnings (loss)	$ (679)	$ 2,212

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

XML 20 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Total
Balance (in shares) at Dec. 31, 2018	10,523,035
Balance at Dec. 31, 2018	$ 105	$ 26,513	$ 15,683	$ 783	$ (204)	$ 42,880
Net earnings (loss)			2,322			2,322
Other comprehensive earnings (loss)				(110)		(110)
Amortization of deferred compensation related to stock-based awards		884				884
Issuance of unvested shares of restricted stock (in shares)	132,580
Issuance of unvested shares of restricted stock	$ 1	1
Issuance of unvested shares of restricted stock	$ (1)	(1)
Forfeiture of unvested shares of restricted stock (in shares)	(12,325)
Repurchase and retirement of common stock (in shares)	(229,308)
Repurchase and retirement of common stock	$ (2)	(1,140)				$ (1,142)
Balance (in shares) at Dec. 31, 2019	10,413,982					10,413,982
Balance at Dec. 31, 2019	$ 104	26,256	18,005	673	(204)	$ 44,834
Net earnings (loss)			(895)			(895)
Other comprehensive earnings (loss)				216		216
Amortization of deferred compensation related to stock-based awards		671				671
Issuance of unvested shares of restricted stock (in shares)	229,110
Issuance of unvested shares of restricted stock	$ 2	2
Issuance of unvested shares of restricted stock	$ (2)	(2)
Forfeiture of unvested shares of restricted stock (in shares)	(67,125)
Repurchase and retirement of common stock (in shares)	(13,767)
Repurchase and retirement of common stock		(74)				$ (74)
Balance (in shares) at Dec. 31, 2020	10,562,200					10,562,200
Balance at Dec. 31, 2020	$ 106	$ 26,851	$ 17,110	$ 889	$ (204)	$ 44,752

XML 21 R7.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings (loss)	$ (895)	$ 2,322
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	3,174	3,193
Impairment of right of use assets	612
Payment of earnout related to Ambrell acquisition		(12,167)
Provision for excess and obsolete inventory	444	391
Foreign exchange loss	26	3
Amortization of deferred compensation related to stock-based awards	671	884
Proceeds from sale of demonstration equipment, net of gain	82	167
Loss on disposal of property and equipment	22	55
Deferred income tax benefit	(341)	(426)
Changes in assets and liabilities:
Trade accounts receivable	887	1,244
Inventories	(717)	(1,058)
Prepaid expenses and other current assets	35	(129)
Restricted certificates of deposit		35
Other assets	(4)	(1)
Accounts payable	430	197
Accrued wages and benefits	(70)	(912)
Accrued professional fees	(31)	31
Customer deposits and deferred revenue	(62)	(797)
Accrued sales commission	29	(261)
Operating lease liabilities	(1,297)	(1,378)
Domestic and foreign income taxes payable	(48)	171
Other current liabilities	301	31
Net cash provided by (used in) operating activities	3,248	(8,405)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(658)	(620)
Proceeds from sale of property and equipment	10
Net cash used in investing activities	(648)	(620)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Paycheck Protection Program loans	2,829
Repayments of Paycheck Protection Program loans	(2,829)
Proceeds from revolving credit facility	2,800
Repayments of revolving credit facility	(2,800)
Repurchases of common stock	(74)	(1,142)
Net cash used in financing activities	(74)	(1,142)
Effects of exchange rates on cash	139	(82)
Net cash provided by (used in) all activities	2,665	(10,249)
Cash and cash equivalents at beginning of period	7,612	17,861
Cash and cash equivalents at end of period	10,277	7,612
Cash payments for:
Domestic and foreign income taxes	54	535
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of unvested shares of restricted stock	971	837
Forfeiture of unvested shares of restricted stock	$ (405)	$ (88)

XML 22 R8.htm IDEA: XBRL DOCUMENT

Note 1 - Nature of Operations

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Nature of Operations [Text Block]

(

)

NATURE OF OPERATIONS

two

operating segments which are also our reportable segments and reporting units: Thermal Products ("Thermal") and Electromechanical Solutions ("EMS"). Our Thermal segment designs, manufactures and sells our thermal test and thermal process products while our EMS segment designs, manufactures and sells our semiconductor test products. We manufacture our products in the U.S. Marketing and support activities are conducted worldwide from our facilities in the U.S., Germany, Singapore, the Netherlands and the U.K. The consolidated entity is comprised of inTEST Corporation and our wholly-owned subsidiaries.

Our EMS segment sells its products to semiconductor manufacturers and

third

-party test and assembly houses (end user sales) and to automated test equipment (“ATE”) manufacturers (original equipment manufacturer (“OEM”) sales), who ultimately resell our equipment with theirs to both semiconductor manufacturers and

third

-party test and assembly houses. These sales all fall within the ATE sector of the broader semiconductor market. Our Thermal segment sells its products to many of these same types of customers; however, it also sells to customers in the wafer processing sector within the broader semiconductor market and to customers in a variety of other markets outside the semiconductor market, including the automotive, defense/aerospace, industrial (including consumer products packaging, fiber optics and other sectors within the broader industrial market), medical and telecommunications markets.

Both of our operating segments have multiple products that we design, manufacture and market to our customers. Due to a number of factors, our products have varying levels of gross margin. The mix of products we sell in any period is ultimately determined by our customers' needs. Therefore, the mix of products sold in any given period can change significantly from the prior period. As a result, our consolidated gross margin can be significantly impacted in any given period by a change in the mix of products sold in that period.

second

quarter of

2019,

we began referring to the broader semiconductor market, including the ATE and wafer processing sectors within that market, as the “Semi Market.” All other markets are designated as “Multimarket.” The Semi Market, which is the principal market in which we operate, is characterized by rapid technological change, competitive pricing pressures and cyclical as well as seasonal market patterns. This market is subject to significant economic downturns at various times.

Our financial results are affected by a wide variety of factors, including, but

not

limited to, general economic conditions worldwide and in the markets in which we operate, economic conditions specific to the Semi Market and the other markets we serve, our ability to safeguard patented technology and intellectual property in a rapidly evolving market, downward pricing pressures from customers, and our reliance on a relatively few number of customers for a significant portion of our sales. In addition, we are exposed to the risk of obsolescence of our inventory depending on the mix of future business and technological changes within the markets that we serve. Part of our strategy for growth includes potential acquisitions that

may

cause us to incur substantial expense in reviewing and evaluating potential transactions. We

may

not

be successful in locating suitable businesses to acquire and in closing acquisitions of businesses we pursue. In addition, we

may

not

be able to successfully integrate any business we do acquire with our existing business and we

may

not

be able to operate the acquired business profitably. As a result of these or other factors, we

may

experience significant period-to-period fluctuations in future operating results.

COVID-

Pandemic

Our net revenues from all of the markets we serve were significantly affected by COVID-

during the

first

half of

2020.

The impact of COVID-

on our net revenues from the Semi Market was intensified during the

first

half of the year because our business operations were also being negatively affected by a global downturn in the Semi Market at that time. The Semi Market, from which approximately half of our net revenues are derived, entered a cyclical downturn in the beginning of

2019.

During the

first

quarter of

2020,

before the spread of COVID-

19,

we had started to see indications that the downturn was coming to an end. These indications included increased quoting activity and order levels for the

first

quarter of

2020

as compared to the

fourth

quarter of

2019.

However, we believe COVID-

delayed the recovery in the Semi Market as the increase in activity leveled off during late

March 2020.

Although we saw slightly increased order rates from our customers in the Semi Market during the

second

and

third

quarters of

2020,

it was

not

until the

fourth

quarter of

2020

that we saw a significant increase in our orders from the Semi Market which we believe indicates that we have now entered the next cyclical upturn. During the

fourth

quarter of

2020,

our orders from the Semi Market increased

53%

sequentially and were

141%

higher than in the

fourth

quarter of

2019,

the low point of the prior cyclical downturn for the products that we sell. We believe the level of increase in our orders from the Semi Market during the

fourth

quarter of

2020

reflects a combination of increased demand in the market resulting from the interruption of the normal recovery in the Semi Market cycle caused by the onset of COVID-

in the

first

half of

2020,

as well as increased demand for semiconductors, generally. We believe this increase in demand is being driven both by changing technology as well as increased use of technology across all aspects of daily life, such as in devices that facilitate remote work and education, smart technology used in homes and businesses, the increase in the amount of integrated circuits used in the automotive industry and changes occurring in the telecommunications and mobility markets.

As of the date of this filing, all of our operations continue to be deemed “critical and essential business operations” under the various governmental COVID-

mandates, which has allowed us to continue to operate our business with certain modifications. These modifications include a significant number of our employees working remotely. Such employees have been provided with the tools and technology necessary to do so. Additionally, we have implemented workplace safeguards designed to protect the health and well-being of our employees. Employees who remain in our facilities are following World Health Organization (“WHO”) and Centers for Disease Control and Prevention (“CDC”) recommended safety practices, as well as state and local directives. We have had occasions where

one

or more employees have contracted COVID-

and entered our facilities while infected. To date, we have managed these occurrences with minimal disruption to our business while protecting other employees, but there can be

assurances that we can avoid similar occurrences in the future or, that in such cases, we can avoid significant disruption of our operations.

The aftermarket service and support that we provide to our customers has been, and we expect

may

continue to be, adversely impacted by COVID-

19.

Specifically, the travel restrictions that remain in place, coupled with limitations on visitors into customer facilities, have resulted in the reduction or suspension of certain activities. The net revenues associated with these aftermarket service and support activities typically range from

10%

of our consolidated net revenues. Although these net revenues returned to a more typical range during the

third

and

fourth

quarters of

2020,

if the spread of COVID-

or variations of the virus worsen, these revenues

may

be reduced in future periods.

While the negative impact of COVID-

on our business was reduced significantly in the

second

half of

2020,

the spread of the virus or variants of the virus could worsen and

one

or more of our significant customers or suppliers could be impacted, or significant additional governmental regulations and restrictions could be imposed, thus negatively impacting our business in the future. As a result of our current level of working capital as well as the availability of our revolving credit facility, which is discussed in Note

to our consolidated financial statements, we currently expect to have sufficient liquidity to operate our business throughout

2021,

as further described in this Report. Our revolving credit facility will mature on

April 9, 2021.

XML 23 R9.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Significant Accounting Policies [Text Block]

(

)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Use of Estimates

The accompanying consolidated financial statements include our accounts and those of our wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated upon consolidation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Certain of our accounts, including inventories, long-lived assets, goodwill, identifiable intangibles and deferred tax assets and liabilities including related valuation allowances, are particularly impacted by estimates.

Reclassification

Certain prior year amounts have been reclassified to be comparable with the current year's presentation.

Subsequent Events

We have made an assessment of our operations and determined that there were

material subsequent events requiring adjustment to, or disclosure in, our consolidated financial statements for the year ended

December 31, 2020.

Business Combinations

Acquired businesses are accounted for using the purchase method of accounting, which requires that the purchase price be allocated to the net assets acquired at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Fair values of intangible assets are estimated by valuation models prepared by our management and

third

-party advisors. The assets purchased and liabilities assumed have been reflected in our consolidated balance sheets, and the operating results are included in the consolidated statements of operations and consolidated statements of cash flows from the date of acquisition. Any change in the fair value of acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, will be recognized in the consolidated statement of operations in the period of the estimated fair value change. Acquisition-related transaction costs, including legal and accounting fees and other external costs directly related to the acquisition, are recognized separately from the acquisition and expensed as incurred in general and administrative expense in the consolidated statements of operations.

Restructuring and Other Charges

In accordance with the guidance in Accounting Standards Codification (“ASC”) Topic

420

(Exit or Disposal Cost Obligations), we recognize a liability for restructuring costs at fair value only when the liability is incurred. Workforce-related charges are accrued when it is determined that a liability has been incurred, which is generally after individuals have been notified of their termination dates and expected severance benefits. Depending on the timing of the termination dates, these charges

may

be recognized upon notification or ratably over the remaining required service period of the employees. Plans to consolidate excess facilities

may

result in lease termination fees and impairment charges related to our right-of-use (“ROU”) assets that are associated with the leases for these facilities. Other long-lived assets that

may

be impaired as a result of restructuring consist of property and equipment, goodwill and intangible assets. Asset impairment charges included in restructuring and other charges are based on an estimate of the amounts and timing of future cash flows related to the expected future remaining use and ultimate sale or disposal of the asset, and, in the case of our ROU assets, would include expected future sublease rental income, if applicable. These estimates are derived using the guidance in ASC Topic

842

(Leases), ASC Topic

360

(Property, Plant and Equipment) and ASC Topic

350

(Intangibles - Goodwill and Other).

Cash and Cash Equivalents

Short-term investments that have maturities of

three

months or less when purchased are considered to be cash equivalents and are carried at cost, which approximates fair value. Our cash balances, which are deposited with highly reputable financial institutions, at times

may

exceed the federally insured limits. We have

not

experienced any losses related to these cash balances and believe the credit risk to be minimal.

Trade Accounts Receivable and Allowance for Doubtful Accounts

Trade accounts receivable are recorded at the invoiced amount and do

not

bear interest. We grant credit to customers and generally require

collateral. To minimize our risk, we perform ongoing credit evaluations of our customers' financial condition. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience and the aging of such receivables, among other factors. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. We do

not

have any significant off-balance sheet credit exposure related to our customers. There was

bad debt expense recorded for the year ended

December 31, 2020.

We recorded bad debt expense of

for the year ended

December 31, 2019.

Cash flows from accounts receivable are recorded in operating cash flows.

Fair Value of Financial Instruments

Our financial instruments, principally accounts receivable and accounts payable, are carried at cost which approximates fair value, due to the short maturities of the accounts.

Goodwill, Intangible and Long-Lived Assets

We have

two

operating segments which are also our reporting units: Thermal and EMS. We account for goodwill and intangible assets in accordance with Accounting Standards Codification (“ASC”) Topic

350

(Intangibles - Goodwill and Other). Finite-lived intangible assets are amortized over their estimated useful economic life and are carried at cost less accumulated amortization. Goodwill is assessed for impairment annually in the

fourth

quarter on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill

may

be impaired. Goodwill is considered to be impaired if the fair value of a reporting unit is less than its carrying amount. As a part of the goodwill impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more-likely-than-

not

that the fair value of a reporting unit is less than its carrying amount. If, as a result of our qualitative assessment, we determine that it is more-likely-than-

not

that the fair value of the reporting unit is greater than its carrying amount, a quantitative goodwill impairment test is

not

required. However, if, as a result of our qualitative assessment, we determine it is more-likely-than-

not

that the fair value of a reporting unit is less than its carrying amount, or, if we choose

not

to perform a qualitative assessment, we are required to perform a quantitative goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized.

not

impaired. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss will be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The goodwill impairment assessment is based upon the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions including the selection of control premiums, discount rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge.

Indefinite-lived intangible assets are assessed for impairment annually in the

fourth

quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. As a part of the impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more likely than

not

that an indefinite-lived intangible asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-

not

that the fair value of the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required; otherwise,

further testing is required. The quantitative impairment test consists of a comparison of the fair value of the intangible asset with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.

may

not

be fully recoverable or that the useful lives of these assets are

longer appropriate. Each impairment test is based on a comparison of the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value. The cash flow estimates used to determine the impairment, if any, contain management's best estimates using appropriate assumptions and projections at that time.

Revenue Recognition

We recognize revenue in accordance with the guidance in ASC Topic

606

(Revenue from Contracts with Customers). We recognize revenue for the sale of products or services when our performance obligations under the terms of a contract with a customer are satisfied and control of the product or service has been transferred to the customer. Generally, this occurs when we ship a product or perform a service. In certain cases, recognition of revenue is deferred until the product is received by the customer or at some other point in the future when we have determined that we have satisfied our performance obligations under the contract. Our contracts with customers

may

include a combination of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. In addition to the sale of products and services, we also lease certain of our equipment to customers under short-term lease agreements. We recognize revenue from equipment leases on a straight-line basis over the lease term.

Revenue is recorded in an amount that reflects the consideration we expect to receive in exchange for those products or services. We do

not

have any material variable consideration arrangements, or any material payment terms with our customers other than standard payment terms which generally range from net

to net

days. We generally do

not

provide a right of return to our customers. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

Nature of Products and Services

We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We sell thermal management products including ThermoStreams, ThermoChambers and process chillers, which we sell under our Temptronic, Sigma and Thermonics product lines, and Ambrell's precision induction heating systems, including EKOHEAT and EASYHEAT products. We sell semiconductor ATE interface solutions which include manipulators, docking hardware and electrical interface products. We provide post-warranty service and support for the equipment we sell. We sell semiconductor ATE interface solutions and certain thermal management products to the Semi Market. We also sell our thermal management products to various other markets including the automotive, defense/aerospace, industrial, medical and telecommunications markets.

We lease certain of our equipment under short-term leasing agreements with original lease terms of

six

months or less. Our lease agreements do

not

contain purchase options.

Types of Contracts with Customers

not

have any customer-specific acceptance criteria, other than that the product performs within the agreed upon specifications. We test substantially all products manufactured as part of our quality assurance process to determine that they comply with specifications prior to shipment to a customer.

Contract Balances

We record accounts receivable at the time of invoicing. Accounts receivable, net of the allowance for doubtful accounts, is included in current assets on our balance sheet. To the extent that we do

not

recognize revenue at the same time as we invoice, we record a liability for deferred revenue. In certain instances, we also receive customer deposits in advance of invoicing and recording of accounts receivable. Deferred revenue and customer deposits are included in current liabilities on our consolidated balance sheets.

Costs to Obtain a Contract with a Customer

The only costs we incur associated with obtaining contracts with customers are sales commissions that we pay to our internal sales personnel or

third

-party sales representatives. These costs are calculated based on set percentages of the selling price of each product or service sold. Commissions are considered earned by our internal sales personnel at the time we recognize revenue for a particular transaction. Commissions are considered earned by

third

-party sales representatives at the time that revenue is recognized for a particular transaction. We record commission expense in our consolidated statements of operations at the time the commission is earned. Commissions earned but

not

yet paid are included in current liabilities on our balance sheets.

Product Warranties

In connection with the sale of our products, we generally provide standard

one

- or

two

-year product warranties which are detailed in our terms and conditions and communicated to our customers. Our standard warranties are

not

offered for sale separately from our products; therefore, there is

not

a separate performance obligation related to our standard warranties. We record estimated warranty expense for our standard warranties at the time of sale based upon historical claims experience. In very limited cases, we offer customers an option to separately purchase an extended warranty for certain of our products. In the case of extended warranties, we recognize revenue in the amount of the sale price for the extended warranty on a straight-line basis over the extended warranty period. We record costs incurred to provide service under an extended warranty at the time the service is provided. Warranty expense is included in selling expense in our consolidated statements of operations.

See Notes

and

for further information about our revenue from contracts with customers.

Inventories

Inventories are valued at cost on a

first

-in,

first

-out basis,

not

in excess of market value. Cash flows from the sale of inventories are recorded in operating cash flows. On a quarterly basis, we review our inventories and record excess and obsolete inventory charges based upon our established objective excess and obsolete inventory criteria. These criteria identify material that has

not

been used in a work order during the prior

twelve

months and the quantity of material on hand that is greater than the average annual usage of that material over the prior

three

years. In certain cases, additional excess and obsolete inventory charges are recorded based upon current market conditions, anticipated product life cycles, new product introductions and expected future use of the inventory. The excess and obsolete inventory charges we record establish a new cost basis for the related inventories. We incurred excess and obsolete inventory charges of

$444

and

$391

for the years ended

December 31, 2020

and

2019,

respectively.

Property and Equipment

Machinery and equipment are stated at cost, except for machinery and equipment acquired in a business combination, which are stated at fair value at the time of acquisition. As previously discussed above under "Goodwill, Intangible and Long-Lived Assets," machinery and equipment that has been determined to be impaired is written down to its fair value at the time of the impairment. Depreciation is based upon the estimated useful life of the assets using the straight-line method. The estimated useful lives range from

one

ten

years. Leasehold improvements are recorded at cost and amortized over the shorter of the lease term or the estimated useful life of the asset. Total depreciation expense was

$630

and

$685

for the years ended

December 31, 2020

and

2019,

respectively.

Leases

We account for leases in accordance with ASC Topic

842

(Leases). We determine if an arrangement is a lease at inception. A lease contract is within scope if the contract has an identified asset (property, plant or equipment) and grants the lessee the right to control the use of the asset during the lease term. The identified asset

may

be either explicitly or implicitly specified in the contract. In addition, the supplier must

not

have any practical ability to substitute a different asset and would

not

economically benefit from doing so for the lease contract to be in scope. The lessee's right to control the use of the asset during the term of the lease must include the ability to obtain substantially all of the economic benefits from the use of the asset as well as decision-making authority over how the asset will be used. Leases are classified as either operating leases or finance leases based on the guidance in ASC Topic

842.

Operating leases are included in operating lease ROU assets and operating lease liabilities in our consolidated balance sheets. Finance leases are included in property and equipment and financing lease liabilities. We do

not

currently have any financing leases.

None

of our leases provide an implicit rate; therefore, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms

may

include options to extend or terminate the lease. We include these options in the determination of the amount of the ROU asset and lease liability when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Certain of our operating leases contain predetermined fixed escalations of minimum rentals and rent holidays during the original lease terms. Rent holidays are periods during which we have control of the leased facility but are

not

obligated to pay rent. For these leases, our ROU asset and lease liability are calculated including any rent holiday in the determination of the life of the lease.

not

included in the calculation of the ROU assets and lease liabilities as they are based on actual charges incurred in the periods to which they apply.

We have made an accounting policy election

not

to apply the recognition requirements of ASC Topic

842

to short-term leases (leases with a term of

one

year or less at the commencement date of the lease). Lease expense for short-term lease payments is recognized on a straight-line basis over the lease term.

See “Effect of Recently Adopted Amendments to Authoritative Accounting Guidance” below and Note

for further disclosures regarding our leases.

Contingent Liability for Repayment of State and Local Grant Funds Received

In connection with leasing a new facility in Rochester, New York, which our subsidiary, Ambrell, occupied in

May 2018,

we entered into agreements with the city of Rochester and the state of New York under which we received grants totaling

$463

to help offset a portion of the cost of the leasehold improvements we have made to this facility. In exchange for the funds we received under these agreements, we are required to create and maintain specified levels of employment in this location through various dates ending in

2023.

If we fail to meet these employment targets, we

may

be required to repay a proportionate share of the proceeds. As of

December 31, 2020,

$423

of the total proceeds received could still be required to be repaid if we do

not

meet the targets. We have recorded this amount as a contingent liability which is included in other liabilities on our balance sheet. Those portions of the proceeds which are

longer subject to repayment are reclassified to deferred grant proceeds and amortized to income on a straight-line basis over the remaining lease term for the Rochester facility. Deferred grant proceeds are included in other current liabilities and other liabilities on our balance sheet and totaled

$27

December 31, 2020.

As of

December 31, 2020,

we were

not

in compliance with the employment targets as specified in the grant agreement with the city of Rochester. We applied for and received a waiver of this requirement for the year ended

December 31, 2020.

We have until

December 31, 2021

to come into compliance with the targets as outlined in the waiver received for the year ended

December 31, 2020.

If we do

not

achieve compliance, we will need to apply for an additional waiver or we

may

be required to repay a proportionate share of the proceeds.

Stock-Based Compensation

We account for stock-based compensation in accordance with ASC Topic

718

(Compensation - Stock Compensation) which requires that employee share-based equity awards be accounted for under the fair value method and requires the use of an option pricing model for estimating fair value of stock options, which is then amortized to expense over the service periods. See further disclosures related to our stock-based compensation plans in Note

13.

Engineering and Product Development

Engineering and product development costs, which consist primarily of the salary and related benefits costs of our technical staff, as well as the cost of materials used in product development, are expensed as incurred.

Foreign Currency

For our foreign subsidiaries whose functional currencies are

not

the U.S. dollar, assets and liabilities are translated using the exchange rate in effect at the balance sheet date. The results of operations are translated using an average exchange rate for the period. The effects of rate fluctuations in translating assets and liabilities of these international operations into U.S. dollars are included in accumulated other comprehensive earnings in stockholders' equity. Transaction gains or losses are included in net earnings. For the years ended

December 31, 2020

and

2019,

foreign currency transaction losses were

$26

and

$3,

respectively.

Income Taxes

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carryforwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets if it is more likely than

not

that such assets will

not

be realized. See Note

for additional information regarding income taxes.

Net Earnings (Loss) Per Common Share

Net earnings (loss) per common share - basic is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding during each period. Net earnings (loss) per common share - diluted is computed by dividing net earnings (loss) by the weighted average number of common shares and common share equivalents outstanding during each period. Common share equivalents represent unvested shares of restricted stock and stock options and are calculated using the treasury stock method. Common share equivalents are excluded from the calculation if their effect is anti-dilutive.

The table below sets forth, for the periods indicated, a reconciliation of weighted average common shares outstanding - basic to weighted average common shares and common share equivalents outstanding - diluted and the average number of potentially dilutive securities that were excluded from the calculation of diluted earnings (loss) per share because their effect was anti-dilutive:

	Years Ended December 31,
	2020		2019

Weighted average common shares outstanding–basic		10,256,560		10,373,164
Potentially dilutive securities:
Unvested shares of restricted stock and employee stock options		-		18,811
Weighted average common shares and common share equivalents outstanding–diluted		10,256,560		10,391,975
Average number of potentially dilutive securities excluded from calculation		717,015		523,485

Effect of Recently Issued Amendments to Authoritative Accounting Guidance

June 2016,

the Financial Accounting Standards Board (“FASB”) issued amendments to the guidance for accounting for credit losses. In

November 2019,

the FASB deferred the effective date of these amendments for certain companies, including smaller reporting companies. As a result of the deferral, the amendments are effective for us for reporting periods beginning after

December 15, 2022.

The amendments replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires the use of a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. The amendments require a modified retrospective approach through a cumulative-effect adjustment to retained earnings as of the beginning of the

first

reporting period in which the guidance is effective. We plan to adopt the amendments when they become effective for us on

January 1, 2023.

We are currently evaluating the impact the adoption of these amendments will have on our consolidated financial statements.

December 2019,

the FASB issued amendments to the accounting for income taxes, which add new guidance to simplify the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic

740

(Income Taxes) and changing the accounting for certain income tax transactions. The amendments are effective for us as of

January 1, 2021.

Early adoption is permitted. We plan to adopt the amendments when they become effective for us on

January 1, 2021.

We do

not

expect these amendments to have a material impact on our consolidated financial statements.

XML 24 R10.htm IDEA: XBRL DOCUMENT

Note 3 - Restructuring and Other Charges

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Restructuring, Impairment, and Other Activities Disclosure [Text Block]

(

)

RESTRUCTURING AND OTHER CHARGES

EMS Segment Restructuring and Facility Consolidation

September 21, 2020,

we notified employees in our Fremont, California facility of a plan to consolidate all manufacturing for our EMS segment into our manufacturing operations located in Mt. Laurel, New Jersey. The consolidation was substantially completed during the

fourth

quarter of

2020

and resulted in the termination of certain employees at the Fremont location. Prior to the consolidation, our interface products were manufactured in the Fremont facility, and our manipulator and docking hardware products were manufactured in the Mt. Laurel facility. The consolidation was undertaken to better serve customers through streamlined operations and reduce the fixed annual operating costs for the EMS segment. A small engineering and sales office will be maintained in northern California.

As a result of this action, we incurred charges for severance and other

one

-time termination benefits, other associated costs, including moving and production start-up costs, and charges related to exiting the facility, including an impairment charge related to the ROU asset for the lease of the Fremont facility. The total costs incurred in

2020

related to this action were

$903.

We expect to incur additional charges in the

first

half of

2021

as we finalize the integration of the manufacturing operations. These additional costs are expected to range from

$100

$150.

We intend to try to sublease our facility located in Fremont, California. When manufacturing operations ceased in the Fremont facility on

December 28, 2020,

we recorded a non-cash impairment charge of

$522

related to the ROU asset for the lease of the Fremont facility as we do

not

currently expect to sublet the facility for the full remaining term of the lease. As of

December 31, 2020,

after recording the impairment charge, the ROU asset related to this facility totaled

$597.

Details of the cash and non-cash charges recorded during the year ended

December 31, 2020

related to the EMS segment restructuring and facility consolidation are below. These costs are included in restructuring and other charges on our consolidated statement of operations for the year ended

December 31. 2020.

	Cash Charges		Non-Cash Charges		Total Charges
Severance and other one-time termination benefits	$	69	$	-	$	69
Other associated costs		159		-		159
Impairment of ROU asset		-		522		522
Costs related to subletting the Fremont, CA facility		153		-		153
Total	$	381	$	522	$	903

Executive Management Changes

August 6, 2020,

James Pelrin resigned as President and Chief Executive Officer (“CEO”) and as a director. In connection with his resignation, we entered into a Separation and Consulting Agreement (the “Separation Agreement”) with Mr. Pelrin dated

August 6, 2020

pursuant to which Mr. Pelrin agreed to provide consulting services for

three

months, subject to an extension of up to an additional

three

months at our option. The Separation Agreement also provides that Mr. Pelrin is entitled to severance and other benefits. The Separation Agreement is included as Exhibit

10.1

to our Current Report on Form

-K (

“8

-K”) filed on

August 11, 2020

with the SEC.

August 6, 2020,

our Board of Directors approved, effective as of

August 24, 2020 (

the “Start Date”), the appointment of Richard N. Grant, Jr. to the position of President and CEO and to fill the vacancy on our Board of Directors left by Mr. Pelrin's resignation. We entered into a letter agreement with Mr. Grant, subject to his appointment as our President, CEO and a director, which appointments occurred on

August 6, 2020

and became effective as of the Start Date. The letter agreement is included as Exhibit

10.2

to our

-K filed on

August 11, 2020

with the SEC.

Total costs incurred during the year ended

December 31, 2020

related to these executive management changes were

$514,

which consisted of fees for the executive management search firm, legal fees related to the transition, and severance and consulting fees paid to our former CEO. These costs were partially offset by the reversal of

$117

of expense related to stock-based compensation awards forfeited at his termination date by our former CEO.

$90

during the

fourth

quarter of

2020

related to the ROU asset associated with the lease of the corporate space in Mansfield and a cash charge of

$99

for other costs related to reducing the size of this facility. We intend to try to sublease this space, but we do

not

currently expect to sublet it for the full remaining term of the lease. As of

December 31, 2020,

after recording the impairment charge, the ROU asset related to this space totaled

$139.

We do

not

expect to incur any additional costs related to these actions after

December 31, 2020.

Details of the cash and non-cash charges recorded during the year ended

December 31, 2020

related to these actions are below. These severance and

one

-time termination benefits, the impairment charge and the costs associated with subletting the facility in Mansfield are included in restructuring and other charges on our consolidated statement of operations for the year ended

December 31. 2020.

The other associated costs in the table below are included in general and administrative expense on our consolidated statement of operations for the year ended

December 31, 2020.

	Cash Charges		Non-Cash Charges		Total Charges
Severance and other one-time termination benefits	$	133	$	-	$	133
Other associated costs		381		-		381
Impairment of ROU asset		-		90		90
Costs related to subletting the Mansfield, MA facility		99		-		99
Total	$	613	$	90	$	703

Other Charges

In addition to the charges discussed above, during

2020,

we recorded cash charges for severance and other

one

-time termination benefits of

$46

and other costs of

$14

related to headcount reductions and employee relocation. The headcount reductions were primarily in our Thermal segment as a result of a slow-down in business activity early in the year. These costs are included in restructuring and other charges on our consolidated statement of operations for the year ended

December 31. 2020.

Consolidation of Ambrell

s European Operations

During the year ended

December 31, 2019,

we recorded

$240

of restructuring and other charges which were primarily related to the consolidation of Ambrell's European operations. These costs included severance and other

one

-time termination benefits of

$137

and other costs related to the consolidation of

$103.

Accrued Restructuring

December 31, 2020

and

2019

are as follows:

Balance - January 1, 2019	$	-
Accruals for severance and other one-time termination benefits		137
Accruals for costs related to the consolidation of Ambrell's European operations		103
Cash payments		(240	)
Balance - December 31, 2019		-
Accruals for severance and other one-time termination benefits		248
Accruals for costs related to subletting the Fremont, CA facility		153
Accruals for costs related to subletting the Mansfield, MA facility		98
Cash payments		(159	)
Balance - December 31, 2020	$	340

XML 25 R11.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Goodwill and Intangible Assets Disclosure [Text Block]

(

)

GOODWILL AND INTANGIBLE ASSETS

We have

two

operating segments which are also our reporting units: Thermal and EMS. Goodwill and intangible assets on our balance sheets are the result of our acquisitions of Sigma Systems Corp. ("Sigma") in

October 2008,

Thermonics, Inc. ("Thermonics") in

January 2012

and Ambrell in

May 2017.

All of our goodwill and intangible assets are allocated to our Thermal segment.

Goodwill

Goodwill totaled

$13,738

at both

December 31, 2020

and

2019

and was comprised of the following:

Sigma	$	1,656
Thermonics		50
Ambrell		12,032
Total	$	13,738

Intangible Assets

Changes in the amount of the carrying value of finite-lived intangible assets for the years ended

December 31, 2020

and

2019

are as follows:

Balance - January 1, 2019	$	8,201
Amortization		(1,257	)
Balance - December 31, 2019		6,944
Amortization		(1,233	)
Balance - December 31, 2020	$	5,711

The following tables provide further detail about our intangible assets as of

December 31, 2020

and

2019:

	December 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	10,480	$	4,912	$	5,568
Technology		600		477		123
Patents		590		570		20
Software		270		270		-
Trade name		140		140		-
Total finite-lived intangible assets		12,080		6,369		5,711
Indefinite-lived intangible assets:
Trademarks		6,710		-		6,710
Total intangible assets	$	18,790	$	6,369	$	12,421

	December 31, 2019
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	10,480	$	3,805	$	6,675
Technology		600		380		220
Patents		590		541		49
Software		270		270		-
Trade name		140		140		-
Total finite-lived intangible assets		12,080		5,136		6,944
Indefinite-lived intangible assets:
Trademarks		6,710		-		6,710
Total intangible assets	$	18,790	$	5,136	$	13,654

None

of our intangible assets have any residual value.

The following table sets forth the estimated annual amortization expense for each of the next

five

years:

2021	$	1,227
2022	$	1,167
2023	$	1,067
2024	$	980
2025	$	905

Impairment of Goodwill and Indefinite Life Intangible Assets

During

December 2020

and

2019,

we assessed our goodwill and indefinite life intangible asset for impairment in accordance with the requirements of ASC Topic

350

using a quantitative approach. Our goodwill impairment assessment is based upon the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The discount rate used in

2020

and

2019

for the discounted cash flows was

20.0%

The selection of the rate in each year was based upon our analysis of market-based estimates of capital costs and discount rates. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions including the selection of control premiums, discount rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge.

During the goodwill impairment assessment in both

2020

and

2019,

we compared the fair value of our Thermal reporting unit with its carrying value. This assessment indicated

impairment existed as the fair value of the reporting unit exceeded its carrying value in both

2020

and

2019.

During the indefinite life intangible asset impairment assessment in both

2020

and

2019,

we compared the fair value of our indefinite life intangible assets with their carrying values. This assessment indicated

impairment existed as the fair value of the indefinite life intangible assets exceeded their carrying values in both

2020

and

2019.

Impairment of Long-Lived Assets and Finite-lived Intangible Assets

During

2020

and

2019,

we did

not

review any of our long-lived assets for impairment other than the ROU assets related to the leases for our facilities in Fremont, CA and Mansfield, MA as discussed further in Notes

and

There were

events or changes in business circumstances that would indicate an impairment might exist other than the events identified and discussed in Note

related to these specific long-lived assets.

XML 26 R12.htm IDEA: XBRL DOCUMENT

Note 5 - Revenue From Contracts With Customers

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

(

)

REVENUE FROM CONTRACTS WITH CUSTOMERS

The following tables provide additional information about our revenue from contracts with customers, including revenue by customer and product type and revenue by market. See also Note

for information about revenue by operating segment and geographic region.

	Years Ended December 31,
	2020		2019
Net revenues by customer type:
End user	$	48,041	$	55,074
OEM/Integrator		5,782		5,586
	$	53,823	$	60,660
Net revenues by product type:
Thermal test	$	15,768	$	17,631
Thermal process		18,966		20,079
Semiconductor test		13,112		16,273
Service/other		5,977		6,677
	$	53,823	$	60,660
Net revenues by market:
Semi Market	$	26,870	$	30,953
Industrial		17,341		21,231
Defense/aerospace		6,314		4,842
Telecommunications		1,715		1,845
Other Multi Markets		1,583		1,789
	$	53,823	$	60,660

Changes in the amount of the allowance for doubtful accounts for the years ended

December 31, 2020

and

2019

are as follows:

Balance - January 1, 2019	$	233
Bad debt expense		3
Write-offs		(25	)
Balance - December 31, 2019		211
Bad debt expense		-
Write-offs		-
Foreign currency translation adjustments		1
Balance - December 31, 2020	$	212

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

+ Details

XML 27 R13.htm IDEA: XBRL DOCUMENT

Note 6 - Major Customers

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Concentration Risk Disclosure [Text Block]

(

)

MAJOR CUSTOMERS

During the year ended

December 31, 2020,

customer accounted for

10%

or more of our consolidated net revenues. During the year ended

December 31, 2019,

Texas Instruments Incorporated accounted

10%

of our consolidated net revenues. While both of our operating segments sold products to this customer, these revenues were primarily generated by our EMS segment. During the year ended

December 31, 2019,

other customer accounted for

10%

or more of our consolidated net revenues.

XML 28 R14.htm IDEA: XBRL DOCUMENT

Note 7 - Inventories

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Inventory Disclosure [Text Block]

(

)

INVENTORIES

Inventories held at

December 31

were comprised of the following:

	2020		2019
Raw materials	$	5,371	$	5,369
Work in process		1,085		949
Inventory consigned to others		45		54
Finished goods		975		810
Total inventories	$	7,476	$	7,182

XML 29 R15.htm IDEA: XBRL DOCUMENT

Note 8 - Leases

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Lessee, Operating Leases [Text Block]

(

)

LEASES

As previously discussed in Note

we account for our leases in accordance with the guidance in ASC Topic

842.

We lease our offices, warehouse facilities and certain equipment under non-cancellable operating leases that expire at various dates through

2031.

Total operating lease and short-term lease costs for the years ended

December 31, 2020

and

2019,

respectively, were as follows:

	Years Ended December 31,
	2020		2019

Operating lease cost	$	1,583	$	1,476
Short-term lease cost	$	47	$	51

The following is additional information about our leases as of

December 31, 2020:

Range of remaining lease terms (in years)	0.1	to	10.0
Weighted average remaining lease term (in years)		6.4
Weighted average discount rate		4.3%

Maturities of lease liabilities as of

December 31, 2020

were as follows:

2021	$	1,481
2022		1,405
2023		1,416
2024		1,395
2025		722
Thereafter		1,845
Total lease payments	$	8,264
Less imputed interest		(999	)
Total	$	7,265

Cash Flow Information

Total amortization of right of use assets for the years ended

December 31, 2020

and

2019

was

$1,294

and

$1,251,

respectively.

ROU Asset Impairment Charges

During the

fourth

quarter of

2020,

we recorded charges for non-cash impairments related to certain of our ROU assets as discussed further in Note

The total of these charges was

$612.

In determining whether our ROU assets were impaired, we considered the intended future use of the assets, including whether we expect to be able to sublease the related facilities. In both cases, we expect to eventually be able to sublease the facilities, but we currently do

not

expect to successfully negotiate a sublease for either facility in

2021.

Our projected future cash inflows from sublease income reflect this expectation. In order to determine whether an impairment existed, we compared all future cash outflows related to the lease for the underlying ROU asset and compared this with our projected future cash inflows from the sublease. We developed several scenarios to model the expected timing and amount of sublease income we expect to receive. In all cases, the future cash outflows exceeded the expected future cash inflows, resulting in the conclusion that the ROU assets were impaired. We then discounted the projected deficit in each scenario using our estimated cost of capital and probability weighted the results to determine the amount of the impairment charge to record. To the extent that our estimate of future cash inflows exceeds the amount we ultimately receive from any sublease we enter into for these facilities, we

may

need to record an additional impairment charge related to these ROU assets in a future period.

Lease Modifications and Additions

Supplemental cash flow information related to leases for the years ended

December 31, 2020

and

2019

was as follows:

Year ended December 31, 2020
Non-cash increases (decreases) in operating lease liabilities and ROU assets as a result of lease modifications and the execution of new leases:
Modification to lease for facility in Fremont, California	$	1,176
Modification to lease for facility in Mt. Laurel, New Jersey	$	2,051
Modification to lease for Ambrell's Netherlands facility	$	133
Additions to automobile leases	$	91

January 23, 2020,

we executed an amendment to the lease for our EMS facility in Fremont, California, which extended the term for a period of

months commencing on

November 1, 2020

and expiring on

November 30, 2025.

At the effective date of this modification, we recorded an increase in our ROU assets and operating lease liabilities of approximately

$1,176.

September 22, 2020,

we executed an amendment to the lease for our EMS facility in Mt. Laurel, New Jersey, which extended the term of the existing lease for a period of

120

months commencing on

May 1, 2021.

At the effective date of this modification, we recorded an increase in our ROU assets and operating lease liabilities of approximately

$2,051.

In addition, effective on

August 1, 2021,

the leased space will be reduced to approximately

33,650

square feet.

October 1, 2020,

the lease for Ambrell's Netherlands facility automatically renewed for an additional

three

years. At the effective date of this modification, we recorded an increase in our ROU assets and operating lease liabilities of approximately

$133.

During the

fourth

quarter of

2020,

we executed new leases for automobiles for certain of our employees in Europe. At the dates of execution, we recorded increases in our ROU assets and operating lease liabilities. The total increase recorded in

2020

related to these new leases was approximately

$91.

Year ended December 31, 2019
Non-cash increases (decreases) in operating lease liabilities and ROU assets as a result of lease modifications:
Modification to lease for Ambrell's U.K. facility	$	(486	)
Modification to lease for facility in Mansfield, Massachusetts	$	1,811
Modification to lease for Ambrell's Netherlands facility	$	(48	)

The lease for Ambrell's U.K. facility had an original term of

years, which extended through

August 2029.

The lease included the option to terminate the lease at specified points in time without penalty. We exercised this option in

March 2019,

and the lease expired in

September 2019.

At the effective date of this modification, we recorded a reduction in our ROU assets and operating lease liabilities of approximately

$486.

April 8, 2019,

we executed an amendment to the lease for our facility in Mansfield, Massachusetts that extended the term of the lease for an additional

forty

months to

December 31, 2024

and expanded the amount of leased space by approximately

6,100

square feet. The current rate per square foot that is in place through

August 31, 2021 (

the original expiration date of the lease) did

not

change. After

August 31, 2021,

there are predetermined fixed escalations of the rate as outlined in the amendment. As a result of this modification, we recorded an increase in our ROU assets and operating lease liabilities of approximately

$1,811.

During the

third

quarter of

2019,

the lease for a portion of Ambrell's facility in the Netherlands was modified to reduce the term of that lease to expire in

September 2019

as that portion of the space was

longer needed. At the effective date of this modification, we recorded a reduction in our ROU assets and operating lease liabilities of approximately

$48.

XML 30 R16.htm IDEA: XBRL DOCUMENT

Note 9 - Other Current Liabilities

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]

(

)

OTHER CURRENT LIABILITIES

Other current liabilities at

December 31

were comprised of the following:

	2020		2019
Accrued restructuring	$	340	$	-
Accrued warranty		235		334
Other		229		163
Total other current liabilities	$	804	$	497

XML 31 R17.htm IDEA: XBRL DOCUMENT

Note 10 - Debt

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Debt Disclosure [Text Block]

(

)

DEBT

Letters of Credit

We have issued letters of credit as the security deposits for certain of our domestic leases. These letters of credit are secured by pledged certificates of deposit which are classified as Restricted Certificates of Deposit on our balance sheets. The terms of our leases require us to renew these letters of credit at least

days prior to their expiration dates for successive terms of

not

less than

one

year until lease expiration. In accordance with the terms of our lease, the letter of credit related to our facility in Mt. Laurel, New Jersey was reduced from

$125

$90

April 1, 2019.

Our outstanding letters of credit at

December 31, 2020

and

2019

consisted of the following:

L/C

Lease

Letters of Credit

Amount Outstanding

Facility

Original L/C

Issue Date

Expiration

Date

Expiration

Date

Dec. 31

2020

Dec. 31

2019

Mt. Laurel, NJ

3/29/2010

4/30/2021

4/30/2031

Mansfield, MA

10/27/2010

12/31/2024

140

Line of Credit

April 10, 2020 (

the “Closing Date”) we entered into a Loan and Security Agreement (the “Agreement”) with M&T Bank (“M&T”) which was amended on

December 16, 2020.

Under the terms of the amended Agreement, M&T has provided us with a

$7,500

revolving credit facility under which our domestic subsidiaries, Ambrell, inTEST EMS LLC (“EMS LLC”), Temptronic Corporation (“Temptronic”) and inTEST Silicon Valley Corporation (“Silicon Valley”), are guarantors (collectively, the “Guarantors”). The revolving credit facility has a

364

-day contract period that began on the Closing Date and expires on

April 9, 2021 (

the “Contract Period”). The principal balance of the revolving credit facility accrues interest at the LIBOR rate plus

2.0%.

In the event the current LIBOR rate is

longer available or representative, the Agreement includes a mechanism for providing an alternate benchmark. Interest payments are due on a monthly basis, and principal payments are due, along with any accrued and unpaid interest thereon, on the earlier of (a) the expiration of the Contract Period, or (b) on demand upon the occurrence of an event of default that is continuing. As of

December 31, 2020,

we had

$7,500

available to borrow under this facility.

The Agreement contains customary events of default including, but

not

limited to, the failure by us to repay obligations when due, violation of provisions or representations provided in the Agreement, bankruptcy of inTEST Corporation, suspension of the business of inTEST Corporation or any of our subsidiaries and certain material judgments. After expiration of the Contract Period, or if during the continuance of an event of default, interest will accrue on the principal balance at a rate of

in excess of the then applicable non-default interest rate. Our obligations under the Agreement are secured by liens on substantially all our tangible and intangible assets. The Agreement includes customary affirmative, negative and financial covenants, including a maximum ratio of assets to liabilities and a fixed charge coverage ratio.

This facility was put in place to provide us with additional liquidity in response to the business environment, as a result of COVID-

19.

During the

three

months ended

June 30, 2020,

we drew down

$2,800

on our revolving credit facility. This amount was fully repaid during this same period. We did

not

borrow under this revolving credit facility at any other time during

2020.

Paycheck Protection Program Loans

As discussed more fully in Note

to our consolidated financial statements in our Quarterly Report on Form

-Q for the

three

months ended

March 31, 2020

filed on

May 13, 2020

with the Securities and Exchange Commission, during

April 2020

we applied for and received loans through the Paycheck Protection Program (the “PPP”) of the Coronavirus Aid, Relief, and Economic Security Act administered by the U.S. Small Business Administration totaling

$2,829.

We repaid the full amount of the PPP loans on

May 5, 2020

with the applicable interest.

XML 32 R18.htm IDEA: XBRL DOCUMENT

Note 11 - Income Taxes

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Income Tax Disclosure [Text Block]

(

)

INCOME TAXES

We are subject to Federal and certain state income taxes. In addition, we are taxed in certain foreign countries.

Earnings (loss) before income taxes was as follows:

	Years Ended December 31,
	2020			2019
Domestic	$	(2,017	)	$	1,804
Foreign		786			800
Total	$	(1,231	)	$	2,604

Income tax expense (benefit) was as follows:

	Years Ended December 31,
	2020			2019
Current
Domestic – Federal	$	(182	)	$	510
Domestic – state		53			101
Foreign		135			97
Total	$	6		$	708
Deferred
Domestic – Federal	$	(299	)	$	(413	)
Domestic – state		(7	)		(13	)
Foreign		(36	)		-
Total		(342	)		(426	)
Income tax expense	$	(336	)	$	282

December 31, 2020

and

2019:

	December 31,
	2020			2019
Deferred tax assets:
Operating lease liabilities	$	1,601		$	1,123
Inventories		321			247
Accrued vacation pay and stock-based compensation		252			279
Net operating loss (state and foreign)		241			280
Allowance for doubtful accounts		44			44
Accrued warranty		13			19
Acquisition costs		10			12
Tax credit carryforwards		5			112
Other		71			13
Total		2,558			2,129
Valuation allowance		(169	)		(234	)
Deferred tax assets		2,389			1,895
Deferred tax liabilities:
Net intangible assets		(2,697	)		(2,923	)
Right of use assets		(1,400	)		(1,066	)
Depreciation of property and equipment		(214	)		(169	)
Deferred tax liabilities		(4,311	)		(4,158	)
Net deferred tax liabilities	$	(1,922	)	$	(2,263	)

The net change in the valuation allowance for the years ended

December 31, 2020

and

2019

was a decrease of

$65

and

$7,

respectively. In assessing the ability to realize the deferred tax assets, we consider whether it is more likely than

not

that some portion or all of the deferred tax assets will

not

be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. In order to fully realize the total deferred tax assets, we will need to generate future taxable income prior to the expiration of net operating loss and tax credit carryforwards which expire in various years through

2040.

An analysis of the effective tax rate for the years ended

December 31, 2020

and

2019

and a reconciliation from the expected statutory rate of

21%

is as follows:

	Years Ended December 31,
	2020			2019
Expected income tax expense (benefit) at U.S. statutory rate	$	(259	)	$	547
Increase (decrease) in tax from:
Dividend from foreign subsidiaries		83			97
NOL carryforwards utilized		64			32
Restricted stock compensation		62			114
Global intangible low taxed income		35			30
Nondeductible expenses		8			4
Current year tax credits (foreign and research)		(82	)		(234	)
Domestic tax benefit, net of Federal benefit		(68	)		(184	)
Changes in valuation allowance		(65	)		(7	)
Foreign income tax rate differences		(34	)		(51	)
Section 250 foreign derived intangible income deduction		(9	)		(145	)
Other		(71	)		79
Income tax expense (benefit)	$	(336	)	$	282

In accounting for income taxes, we follow the guidance in ASC Topic

740

(Income Taxes) regarding the recognition and measurement of uncertain tax positions in our financial statements. Recognition involves a determination of whether it is more likely than

not

that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information. Our policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of

December 31, 2020

and

2019,

we did

not

have an accrual for uncertain tax positions.

We file U.S. income tax returns and multiple state and foreign income tax returns. With few exceptions, the U.S. and state income tax returns filed for the tax years ended

December 31, 2017

and thereafter are subject to examination by the relevant taxing authorities.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

XML 33 R19.htm IDEA: XBRL DOCUMENT

Note 12 - Legal Proceedings

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Legal Matters and Contingencies [Text Block]

(

)

LEGAL PROCEEDINGS

From time to time we

may

be a party to legal proceedings occurring in the ordinary course of business. We are

not

currently involved in any legal proceedings the resolution of which we believe could have a material effect on our business, financial position, results of operations or long-term liquidity.

XML 34 R20.htm IDEA: XBRL DOCUMENT

Note 13 - Stock-based Compensation Plan

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

(

)

STOCK-BASED COMPENSATION PLAN

As of

December 31, 2020,

we have unvested restricted stock awards and stock options outstanding which were granted under the inTEST Corporation Third Amended and Restated

2014

Stock Plan (the

"2014

Stock Plan"). The

2014

Stock Plan was originally approved at our annual meeting of stockholders held on

June 25, 2014

and permitted the granting of stock options, restricted stock, stock appreciation rights or restricted stock units for up to

500,000

shares of our common stock to directors, officers, other key employees and consultants. On

June 27, 2018,

our stockholders approved the amendment and restatement of the

2014

Stock Plan to increase the number of shares of common stock that

may

be delivered pursuant to awards granted under the

2014

Stock Plan from

500,000

1,000,000

shares. On

June 19, 2019,

our stockholders approved the amendment and restatement of the

2014

Stock Plan to increase the number of shares of common stock that

may

be delivered pursuant to awards granted under the

2014

Stock Plan from

1,000,000

2,000,000

shares. As of

December 31, 2020,

there were

1,067,979

aggregate shares available to grant under the

2014

Plan.

Our unvested restricted stock awards and stock options are accounted for based on their grant date fair value. As of

December

31,

2020,

total compensation expense to be recognized in future periods is

$1,353.

The weighted average period over which this expense is expected to be recognized is

2.6

years.

The following table summarizes the compensation expense we recorded during

2020

and

2019,

related to unvested shares of restricted stock and stock options:

	Years Ended December 31,
	2020		2019
Cost of revenues	$	-	$	-
Selling expense		12		8
Engineering and product development expense		42		35
General and administrative expense		617		841
	$	671	$	884

There was

compensation expense capitalized in

2020

2019.

Stock Options

We record compensation expense for stock options based on the fair market value of the options as of the grant date.

option

may

be granted with an exercise period in excess of

ten

years from the date of grant. Generally, stock options will be granted with an exercise price equal to the fair market value of our stock on the date of grant and will vest over

four

years.

The fair value for stock options granted during

2020

and

2019

was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

	2020			2019
Risk-free interest rate		0.46	%		2.35	%
Dividend yield		0.00	%		0.00	%
Expected common stock market price volatility factor		.44			.42
Weighted average expected life of stock options (years)		6.25			6.25

The per share weighted average fair value of stock options issued during

2020

and

2019

was

$1.48

and

$2.75,

respectively.

The following table summarizes the activity related to stock options for the

two

years ended

December 31, 2020:

	Number of Shares			Weighted Average Exercise Price
Options outstanding, January 1, 2019		264,400			7.54
Granted		249,460			6.25
Exercised		-			-
Canceled		(7,050	)		8.45
Options outstanding, December 31, 2019 (87,900 exercisable)		506,810			6.89
Granted		113,980			3.49
Exercised		-			-
Canceled		(182,590	)		6.31
Options outstanding, December 31, 2020 (204,630 exercisable)		438,200			6.25

Restricted Stock Awards

We record compensation expense for restricted stock awards based on the quoted market price of our stock at the grant date and amortize the expense over the vesting period. Restricted stock awards generally vest over

four

years for employees and over

one

year for our independent directors (

25%

at each of

March 31,

June 30,

September 30,

and

December 31

of the year in which they were granted).

August 24, 2020,

our new President and CEO received

two

restricted stock awards totaling

141,610

shares valued at

$650

as of the date of grant, which was also his hire date. Of the total shares awarded,

66,448

shares vest over

years (

25%

at each anniversary) and

75,162

vest on the

third

anniversary of the grant date at a vesting percentage that could range from

150%

of the number of shares awarded on

August 24, 2020.

The final vesting percentage will be based on the achievement of certain performance metrics, including net revenue compound annual growth rate and diluted earnings per share excluding amortization of intangibles, for specified time periods as determined by the Compensation Committee of our Board of Directors. As of

December 31, 2020,

we have estimated that these shares will vest at

100%

of the original amount awarded and are recording expense based on this estimate on a straight-line basis over the

three

year vesting period. Our estimate of the final expected vesting percentage will be reassessed and adjusted, as needed, at the end of each reporting period.

The following table summarizes the activity related to unvested restricted stock awards for the

two

years ended

December 31, 2020:

	Number of Shares			Weighted Average Grant Date Fair Value
Unvested shares outstanding, January 1, 2019		114,750			6.92
Granted		132,580			6.31
Vested		(69,974	)		6.60
Forfeited		(12,325	)		7.14
Unvested shares outstanding, December 31, 2019		165,031			6.55
Granted		229,110			4.24
Vested		(89,861	)		5.32
Forfeited		(67,125	)		6.03
Unvested shares outstanding, December 31, 2020		237,155			4.93

The total fair value of the restricted stock awards that vested during the years ended

December 31, 2020

and

2019

was

$357

and

$426,

respectively, as of the vesting dates of these awards.

XML 35 R21.htm IDEA: XBRL DOCUMENT

Note 14 - Stock Repurchase Plans

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Stock Repurchase Plan [Text Block]

(

)

STOCK REPURCHASE PLANS

July 31, 2019,

our Board of Directors authorized the repurchase of up to

$3,000

of our common stock from time to time on the open market, in compliance with Rule

10b

under the Securities Exchange Act of

1934,

as amended (the “Exchange Act”), or in privately negotiated transactions pursuant to a newly authorized stock repurchase plan (the

“2019

Repurchase Plan”). Repurchases

may

be made under a Rule

10b5

plan entered into with RW Baird & Co., which would permit shares to be repurchased when we might otherwise be precluded from doing so under insider trading laws and our internal trading windows. The

2019

Repurchase Plan does

not

obligate us to purchase any particular amount of common stock and

may

be suspended or discontinued at any time without prior notice. The

2019

Repurchase Plan is funded using our operating cash flow or available cash. Purchases began on

September 18, 2019

under this plan. During the quarter ended

March 31, 2020,

we repurchased

13,767

shares under the

2019

Repurchase Plan at a cost of

$74,

including fees paid to our broker. On

March 2, 2020,

we suspended repurchases under the

2019

Repurchase Plan. For the term of the

2019

Repurchase Plan through

December 31, 2020,

we have repurchased a total of

243,075

shares at a cost of

$1,216,

which includes fees paid to our broker of

$6.

All of the repurchased shares were retired.

In addition, on

July 31, 2019,

our Board of Directors terminated the

2015

Stock Repurchase Plan which had been authorized on

October 27, 2015

and under which we had repurchased a total of

297,020

shares at a cost of

$1,195.

The shares were repurchased between

December 2015

and

January 2017.

All of the repurchased shares were retired.

XML 36 R22.htm IDEA: XBRL DOCUMENT

Note 15 - Employee Benefit Plans

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Retirement Benefits [Text Block]

(

)

EMPLOYEE BENEFIT PLANS

We have defined contribution

401

(k) plans for our employees who work in the U.S. All permanent employees of inTEST Corporation, EMS LLC, Temptronic and Silicon Valley who are at least

years of age are eligible to participate in the inTEST Corporation Incentive Savings Plan. We match employee contributions dollar for dollar up to

10%

of the employee's annual compensation, with a maximum limit of

$5.

Employer contributions vest ratably over

four

years. Matching contributions are discretionary. For the years ended

December 31, 2020

and

2019

we recorded

$331

and

$382

of expense for matching contributions, respectively.

six

months of service, as defined in the Ambrell Plan. The Ambrell Plan allows eligible employees to make voluntary contributions up to

100%

of compensation, up to the federal government contribution limits. We will make a matching contribution of

50%

of each employee's contributions up to a maximum of

10%

of the employee's deferral with a maximum limit of

$5.

For the years ended

December 31, 2020

and

2019

we recorded

$62

and

$49

of expense for matching contributions, respectively.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

+ Details

XML 37 R23.htm IDEA: XBRL DOCUMENT

Note 16 - Segment Information

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

(

)

SEGMENT INFORMATION

We have

two

reportable segments, Thermal and EMS, which are also our reporting units. Thermal includes the operations of Temptronic, Thermonics, Sigma, inTEST Thermal Solutions GmbH (Germany), inTEST Pte, Limited (Singapore) and Ambrell. Sales of this segment consist primarily of temperature management systems which we design, manufacture and market under our Temptronic, Thermonics and Sigma product lines, and precision induction heating systems which are designed, manufactured and marketed by Ambrell. In addition, this segment provides post-warranty service and support. EMS includes the operations of our manufacturing facilities in Mt. Laurel, New Jersey and Fremont, California. Sales of this segment consist primarily of manipulator, docking hardware and tester interface products, which we design, manufacture and market. See Note

for information related to the planned closure of our manufacturing facility in Fremont, California.

We operate our business worldwide and sell our products both domestically and internationally. Both of our segments sell to semiconductor manufacturers,

third

-party test and assembly houses and ATE manufacturers. Thermal also sells into a variety of markets outside of the Semi Market, including the automotive, defense/aerospace, industrial, medical, telecommunications and other markets.

	Years Ended December 31,
	2020			2019
Net revenues from unaffiliated customers:
Thermal	$	40,209		$	43,823
EMS		13,614			16,837
	$	53,823		$	60,660
Depreciation/amortization:
Thermal	$	1,727		$	1,810
EMS		109			118
Corporate		27			14
	$	1,863		$	1,942
Operating income (loss):
Thermal	$	325		$	2,334
EMS		(1,113	)		1,725
Corporate		(429	)		(1,510	)
	$	(1,217	)	$	2,549
Earnings (loss) before income tax expense (benefit):
Thermal	$	306		$	2,370
EMS		(1,077	)		1,767
Corporate		(460	)		(1,533	)
	$	(1,231	)	$	2,604
Income tax expense (benefit):
Thermal	$	84		$	257
EMS		(294	)		194
Corporate		(126	)		(169	)
	$	(336	)	$	282
Net earnings (loss):
Thermal	$	222		$	2,113
EMS		(783	)		1,573
Corporate		(334	)		(1,364	)
	$	(895	)	$	2,322
Capital expenditures:
Thermal	$	371		$	501
EMS		284			46
Corporate		3			73
	$	658		$	620

	December 31,
	2020		2019
Identifiable assets:
Thermal	$	50,782	$	51,621
EMS		9,667		7,319
Corporate		1,581		775
	$	62,030	$	59,715

The following table provides information about our geographic areas of operation. Net revenues from unaffiliated customers are based on the location to which the goods are shipped.

	Years Ended December 31,
	2020		2019
Net revenues from unaffiliated customers:
U.S.	$	22,211	$	25,283
Foreign		31,612		35,377
	$	53,823	$	60,660

	December 31,
	2020		2019
Property and equipment:
U.S.	$	2,053	$	2,163
Foreign		297		257
	$	2,350	$	2,420

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

XML 38 R24.htm IDEA: XBRL DOCUMENT

Note 17 - Quarterly Consolidated Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Quarterly Financial Information [Text Block]

(

)

QUARTERLY CONSOLIDATED FINANCIAL DATA (Unaudited)

The following tables present certain unaudited consolidated quarterly financial information for each of the

eight

quarters ended

December 31, 2020.

In our opinion, this quarterly information has been prepared on the same basis as the consolidated financial statements and includes all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the information for the periods presented. The results of operations for any quarter are

not

necessarily indicative of results for the full year or for any future period.

Year-over-year quarterly comparisons of our results of operations

may

not

be as meaningful as the sequential quarterly comparisons set forth below that tend to reflect the cyclical and seasonal activity of the Semi Market. Quarterly fluctuations in expenses are related directly to sales activity and volume and

may

also reflect the timing of operating expenses incurred throughout the year.

	Quarters Ended
	3/31/20 (1)			6/30/20 (2)		9/30/20 (3)			12/31/20 (4)			Total
Net revenues	$	11,230		$	13,275	$	14,443		$	14,875		$	53,823
Gross margin		4,867			6,067		6,450			6,720			24,104
Earnings (loss) before income tax expense (benefit)		(1,393	)		183		433			(454	)		(1,231	)
Income tax expense (benefit)		(250	)		13		(25	)		(74	)		(336	)
Net earnings (loss)		(1,143	)		170		458			(380	)		(895	)

Net earnings (loss) per common share – basic	$	(0.11	)	$	0.02	$	0.04		$	(0.04	)	$	(0.09	)
Weighted average common shares outstanding – basic		10,220,853			10,252,490		10,269,995			10,282,903			10,256,560
Net earnings (loss) per common share – diluted	$	(0.11	)	$	0.02	$	0.04		$	(0.04	)	$	(0.09	)
Weighted average common shares outstanding – diluted		10,220,853			10,258,917		10,287,562			10,282,903			10,256,560

	Quarters Ended
	3/31/19		6/30/19 (5)			9/30/19 (6)		12/31/19			Total
Net revenues	$	18,062	$	14,352		$	14,632	$	13,614		$	60,660
Gross margin		8,836		6,719			7,205		6,465			29,225
Earnings (loss) before income tax expense (benefit)		1,462		(300	)		794		648			2,604
Income tax expense (benefit)		324		(113	)		147		(76	)		282
Net earnings (loss)		1,138		(187	)		647		724			2,322

Net earnings (loss) per common share – basic	$	0.11	$	(0.02	)	$	0.06	$	0.07		$	0.22
Weighted average common shares outstanding – basic		10,385,017		10,411,276			10,421,383		10,274,980			10,373,164
Net earnings (loss) per common share – diluted	$	0.11	$	(0.02	)	$	0.06	$	0.07		$	0.22
Weighted average common shares outstanding – diluted		10,414,330		10,411,276			10,429,536		10,298,535			10,391,975

	( 1 )	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
	( 2 )	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
	( 3 )	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
	( 4 )	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3
	( 5 )	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.
	( 6 )	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.

XML 39 R25.htm IDEA: XBRL DOCUMENT

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

inTEST CORPORATION

SCHEDULE II -- VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

	Balance at Beginning of Period		Expense (Recovery)		Deductions			Foreign Currency Translation Adjustments		Balance at End of Period

Year Ended December 31, 2020
Allowance for doubtful accounts	$	211	$	-	$	-		$	1	$	212
Warranty reserve		334		32		(131	)		-		235

Year Ended December 31, 2019
Allowance for doubtful accounts	$	233	$	3	$	(25	)		-	$	211
Warranty reserve		346		243		(255	)		-		334

XML 40 R26.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Basis Of Presentation And Use Of Estimates [Policy Text Block]

Basis of Presentation and Use of Estimates

Reclassification, Comparability Adjustment [Policy Text Block]

Reclassification

Certain prior year amounts have been reclassified to be comparable with the current year's presentation.

Subsequent Events, Policy [Policy Text Block]

Subsequent Events

We have made an assessment of our operations and determined that there were

material subsequent events requiring adjustment to, or disclosure in, our consolidated financial statements for the year ended

December 31, 2020.

Business Combinations Policy [Policy Text Block]

Business Combinations

third

Restructuring And Other Charges [Policy Text Block]

Restructuring and Other Charges

In accordance with the guidance in Accounting Standards Codification (“ASC”) Topic

420

may

be recognized upon notification or ratably over the remaining required service period of the employees. Plans to consolidate excess facilities

may

result in lease termination fees and impairment charges related to our right-of-use (“ROU”) assets that are associated with the leases for these facilities. Other long-lived assets that

may

842

(Leases), ASC Topic

360

(Property, Plant and Equipment) and ASC Topic

350

(Intangibles - Goodwill and Other).

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents

Short-term investments that have maturities of

three

may

exceed the federally insured limits. We have

not

experienced any losses related to these cash balances and believe the credit risk to be minimal.

Receivable [Policy Text Block]

Trade Accounts Receivable and Allowance for Doubtful Accounts

Trade accounts receivable are recorded at the invoiced amount and do

not

bear interest. We grant credit to customers and generally require

not

have any significant off-balance sheet credit exposure related to our customers. There was

bad debt expense recorded for the year ended

December 31, 2020.

We recorded bad debt expense of

for the year ended

December 31, 2019.

Cash flows from accounts receivable are recorded in operating cash flows.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value of Financial Instruments

Our financial instruments, principally accounts receivable and accounts payable, are carried at cost which approximates fair value, due to the short maturities of the accounts.

Goodwill Intangible And Long Lived Assets [Policy Text Block]

Goodwill, Intangible and Long-Lived Assets

We have

two

operating segments which are also our reporting units: Thermal and EMS. We account for goodwill and intangible assets in accordance with Accounting Standards Codification (“ASC”) Topic

350

fourth

quarter on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill

may

not

that the fair value of a reporting unit is less than its carrying amount. If, as a result of our qualitative assessment, we determine that it is more-likely-than-

not

that the fair value of the reporting unit is greater than its carrying amount, a quantitative goodwill impairment test is

not

required. However, if, as a result of our qualitative assessment, we determine it is more-likely-than-

not

that the fair value of a reporting unit is less than its carrying amount, or, if we choose

not

Indefinite-lived intangible assets are assessed for impairment annually in the

fourth

not

that an indefinite-lived intangible asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-

not

that the fair value of the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required; otherwise,

may

not

be fully recoverable or that the useful lives of these assets are

Revenue [Policy Text Block]

Revenue Recognition

We recognize revenue in accordance with the guidance in ASC Topic

606

may

Revenue is recorded in an amount that reflects the consideration we expect to receive in exchange for those products or services. We do

not

have any material variable consideration arrangements, or any material payment terms with our customers other than standard payment terms which generally range from net

to net

days. We generally do

not

provide a right of return to our customers. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

Nature of Products and Services

We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We sell thermal management products including ThermoStreams, ThermoChambers and process chillers, which we sell under our Temptronic, Sigma and Thermonics product lines, and Ambrell's precision induction heating systems, including EKOHEAT and EASYHEAT products. We sell semiconductor ATE interface solutions which include manipulators, docking hardware and electrical interface products. We provide post-warranty service and support for the equipment we sell. We sell semiconductor ATE interface solutions and certain thermal management products to the Semi Market. We also sell our thermal management products to various other markets including the automotive, defense/aerospace, industrial, medical and telecommunications markets.

We lease certain of our equipment under short-term leasing agreements with original lease terms of

six

months or less. Our lease agreements do

not

contain purchase options.

Types of Contracts with Customers

not

Contract Balances

We record accounts receivable at the time of invoicing. Accounts receivable, net of the allowance for doubtful accounts, is included in current assets on our balance sheet. To the extent that we do

not

Costs to Obtain a Contract with a Customer

The only costs we incur associated with obtaining contracts with customers are sales commissions that we pay to our internal sales personnel or

third

not

yet paid are included in current liabilities on our balance sheets.

Product Warranties

In connection with the sale of our products, we generally provide standard

one

- or

two

-year product warranties which are detailed in our terms and conditions and communicated to our customers. Our standard warranties are

not

offered for sale separately from our products; therefore, there is

not

See Notes

and

for further information about our revenue from contracts with customers.

Inventory, Policy [Policy Text Block]

Inventories

Inventories are valued at cost on a

first

-in,

first

-out basis,

not

been used in a work order during the prior

twelve

months and the quantity of material on hand that is greater than the average annual usage of that material over the prior

three

$444

and

$391

for the years ended

December 31, 2020

and

2019,

respectively.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

one

ten

years. Leasehold improvements are recorded at cost and amortized over the shorter of the lease term or the estimated useful life of the asset. Total depreciation expense was

$630

and

$685

for the years ended

December 31, 2020

and

2019,

respectively.

Lessee, Leases [Policy Text Block]

Leases

We account for leases in accordance with ASC Topic

842

may

be either explicitly or implicitly specified in the contract. In addition, the supplier must

not

have any practical ability to substitute a different asset and would

not

842.

not

currently have any financing leases.

None

may

not

obligated to pay rent. For these leases, our ROU asset and lease liability are calculated including any rent holiday in the determination of the life of the lease.

not

included in the calculation of the ROU assets and lease liabilities as they are based on actual charges incurred in the periods to which they apply.

We have made an accounting policy election

not

to apply the recognition requirements of ASC Topic

842

to short-term leases (leases with a term of

one

year or less at the commencement date of the lease). Lease expense for short-term lease payments is recognized on a straight-line basis over the lease term.

See “Effect of Recently Adopted Amendments to Authoritative Accounting Guidance” below and Note

for further disclosures regarding our leases.

Contingent Liability, Repayment of State and Local Grant Funds Received, Policy [Policy Text Block]

Contingent Liability for Repayment of State and Local Grant Funds Received

In connection with leasing a new facility in Rochester, New York, which our subsidiary, Ambrell, occupied in

May 2018,

we entered into agreements with the city of Rochester and the state of New York under which we received grants totaling

$463

2023.

If we fail to meet these employment targets, we

may

be required to repay a proportionate share of the proceeds. As of

December 31, 2020,

$423

of the total proceeds received could still be required to be repaid if we do

not

meet the targets. We have recorded this amount as a contingent liability which is included in other liabilities on our balance sheet. Those portions of the proceeds which are

$27

December 31, 2020.

As of

December 31, 2020,

we were

not

in compliance with the employment targets as specified in the grant agreement with the city of Rochester. We applied for and received a waiver of this requirement for the year ended

December 31, 2020.

We have until

December 31, 2021

to come into compliance with the targets as outlined in the waiver received for the year ended

December 31, 2020.

If we do

not

achieve compliance, we will need to apply for an additional waiver or we

may

be required to repay a proportionate share of the proceeds.

Share-based Payment Arrangement [Policy Text Block]

Stock-Based Compensation

We account for stock-based compensation in accordance with ASC Topic

718

13.

Research and Development Expense, Policy [Policy Text Block]

Engineering and Product Development

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Foreign Currency

For our foreign subsidiaries whose functional currencies are

not

December 31, 2020

and

2019,

foreign currency transaction losses were

$26

and

$3,

respectively.

Income Tax, Policy [Policy Text Block]

Income Taxes

not

that such assets will

not

be realized. See Note

for additional information regarding income taxes.

Earnings Per Share, Policy [Policy Text Block]

Net Earnings (Loss) Per Common Share

	Years Ended December 31,
	2020		2019

Weighted average common shares outstanding–basic		10,256,560		10,373,164
Potentially dilutive securities:
Unvested shares of restricted stock and employee stock options		-		18,811
Weighted average common shares and common share equivalents outstanding–diluted		10,256,560		10,391,975
Average number of potentially dilutive securities excluded from calculation		717,015		523,485

New Accounting Pronouncements, Policy [Policy Text Block]

Effect of Recently Issued Amendments to Authoritative Accounting Guidance

June 2016,

the Financial Accounting Standards Board (“FASB”) issued amendments to the guidance for accounting for credit losses. In

November 2019,

December 15, 2022.

first

reporting period in which the guidance is effective. We plan to adopt the amendments when they become effective for us on

January 1, 2023.

We are currently evaluating the impact the adoption of these amendments will have on our consolidated financial statements.

December 2019,

the FASB issued amendments to the accounting for income taxes, which add new guidance to simplify the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic

740

(Income Taxes) and changing the accounting for certain income tax transactions. The amendments are effective for us as of

January 1, 2021.

Early adoption is permitted. We plan to adopt the amendments when they become effective for us on

January 1, 2021.

We do

not

expect these amendments to have a material impact on our consolidated financial statements.

XML 41 R27.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Schedule of Weighted Average Number of Shares [Table Text Block]

	Years Ended December 31,
	2020		2019

Weighted average common shares outstanding–basic		10,256,560		10,373,164
Potentially dilutive securities:
Unvested shares of restricted stock and employee stock options		-		18,811
Weighted average common shares and common share equivalents outstanding–diluted		10,256,560		10,391,975
Average number of potentially dilutive securities excluded from calculation		717,015		523,485

XML 42 R28.htm IDEA: XBRL DOCUMENT

Note 3 - Restructuring and Other Charges (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Restructuring and Related Costs [Table Text Block]

	Cash Charges		Non-Cash Charges		Total Charges
Severance and other one-time termination benefits	$	69	$	-	$	69
Other associated costs		159		-		159
Impairment of ROU asset		-		522		522
Costs related to subletting the Fremont, CA facility		153		-		153
Total	$	381	$	522	$	903

	Cash Charges		Non-Cash Charges		Total Charges
Severance and other one-time termination benefits	$	133	$	-	$	133
Other associated costs		381		-		381
Impairment of ROU asset		-		90		90
Costs related to subletting the Mansfield, MA facility		99		-		99
Total	$	613	$	90	$	703

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

Balance - January 1, 2019	$	-
Accruals for severance and other one-time termination benefits		137
Accruals for costs related to the consolidation of Ambrell's European operations		103
Cash payments		(240	)
Balance - December 31, 2019		-
Accruals for severance and other one-time termination benefits		248
Accruals for costs related to subletting the Fremont, CA facility		153
Accruals for costs related to subletting the Mansfield, MA facility		98
Cash payments		(159	)
Balance - December 31, 2020	$	340

XML 43 R29.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Schedule of Goodwill [Table Text Block]

Sigma	$	1,656
Thermonics		50
Ambrell		12,032
Total	$	13,738

Schedule of Carrying Value of Finite-lived Intangible Assets [Table Text Block]

Balance - January 1, 2019	$	8,201
Amortization		(1,257	)
Balance - December 31, 2019		6,944
Amortization		(1,233	)
Balance - December 31, 2020	$	5,711

Schedule Of Intangible Assets [Table Text Block]

	December 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	10,480	$	4,912	$	5,568
Technology		600		477		123
Patents		590		570		20
Software		270		270		-
Trade name		140		140		-
Total finite-lived intangible assets		12,080		6,369		5,711
Indefinite-lived intangible assets:
Trademarks		6,710		-		6,710
Total intangible assets	$	18,790	$	6,369	$	12,421

	December 31, 2019
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	10,480	$	3,805	$	6,675
Technology		600		380		220
Patents		590		541		49
Software		270		270		-
Trade name		140		140		-
Total finite-lived intangible assets		12,080		5,136		6,944
Indefinite-lived intangible assets:
Trademarks		6,710		-		6,710
Total intangible assets	$	18,790	$	5,136	$	13,654

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

2021	$	1,227
2022	$	1,167
2023	$	1,067
2024	$	980
2025	$	905

XML 44 R30.htm IDEA: XBRL DOCUMENT

Note 5 - Revenue From Contracts With Customers (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Disaggregation of Revenue [Table Text Block]

	Years Ended December 31,
	2020		2019
Net revenues by customer type:
End user	$	48,041	$	55,074
OEM/Integrator		5,782		5,586
	$	53,823	$	60,660
Net revenues by product type:
Thermal test	$	15,768	$	17,631
Thermal process		18,966		20,079
Semiconductor test		13,112		16,273
Service/other		5,977		6,677
	$	53,823	$	60,660
Net revenues by market:
Semi Market	$	26,870	$	30,953
Industrial		17,341		21,231
Defense/aerospace		6,314		4,842
Telecommunications		1,715		1,845
Other Multi Markets		1,583		1,789
	$	53,823	$	60,660

Schedule of Changes in Allowance for Doubtful Accounts Receivable [Table Text Block]

Balance - January 1, 2019	$	233
Bad debt expense		3
Write-offs		(25	)
Balance - December 31, 2019		211
Bad debt expense		-
Write-offs		-
Foreign currency translation adjustments		1
Balance - December 31, 2020	$	212

XML 45 R31.htm IDEA: XBRL DOCUMENT

Note 7 - Inventories (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	2020		2019
Raw materials	$	5,371	$	5,369
Work in process		1,085		949
Inventory consigned to others		45		54
Finished goods		975		810
Total inventories	$	7,476	$	7,182

XML 46 R32.htm IDEA: XBRL DOCUMENT

Note 8 - Leases (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Lease, Cost [Table Text Block]

	Years Ended December 31,
	2020		2019

Operating lease cost	$	1,583	$	1,476
Short-term lease cost	$	47	$	51

Range of remaining lease terms (in years)	0.1	to	10.0
Weighted average remaining lease term (in years)		6.4
Weighted average discount rate		4.3%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

2021	$	1,481
2022		1,405
2023		1,416
2024		1,395
2025		722
Thereafter		1,845
Total lease payments	$	8,264
Less imputed interest		(999	)
Total	$	7,265

Supplemental Cash Flow Infomation, Lessee [Table Text Block]

Year ended December 31, 2020
Non-cash increases (decreases) in operating lease liabilities and ROU assets as a result of lease modifications and the execution of new leases:
Modification to lease for facility in Fremont, California	$	1,176
Modification to lease for facility in Mt. Laurel, New Jersey	$	2,051
Modification to lease for Ambrell's Netherlands facility	$	133
Additions to automobile leases	$	91

Year ended December 31, 2019
Non-cash increases (decreases) in operating lease liabilities and ROU assets as a result of lease modifications:
Modification to lease for Ambrell's U.K. facility	$	(486	)
Modification to lease for facility in Mansfield, Massachusetts	$	1,811
Modification to lease for Ambrell's Netherlands facility	$	(48	)

XML 47 R33.htm IDEA: XBRL DOCUMENT

Note 9 - Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Current Liabilities [Table Text Block]

	2020		2019
Accrued restructuring	$	340	$	-
Accrued warranty		235		334
Other		229		163
Total other current liabilities	$	804	$	497

XML 48 R34.htm IDEA: XBRL DOCUMENT

Note 10 - Debt (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Schedule Of Outstanding Letters Of Credit [Table Text Block]

L/C

Lease

Letters of Credit

Amount Outstanding

Facility

Original L/C

Issue Date

Expiration

Date

Expiration

Date

Dec. 31

2020

Dec. 31

2019

Mt. Laurel, NJ

3/29/2010

4/30/2021

4/30/2031

Mansfield, MA

10/27/2010

12/31/2024

140

XML 49 R35.htm IDEA: XBRL DOCUMENT

Note 11 - Income Taxes (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]

	Years Ended December 31,
	2020			2019
Domestic	$	(2,017	)	$	1,804
Foreign		786			800
Total	$	(1,231	)	$	2,604

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	Years Ended December 31,
	2020			2019
Current
Domestic – Federal	$	(182	)	$	510
Domestic – state		53			101
Foreign		135			97
Total	$	6		$	708
Deferred
Domestic – Federal	$	(299	)	$	(413	)
Domestic – state		(7	)		(13	)
Foreign		(36	)		-
Total		(342	)		(426	)
Income tax expense	$	(336	)	$	282

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	December 31,
	2020			2019
Deferred tax assets:
Operating lease liabilities	$	1,601		$	1,123
Inventories		321			247
Accrued vacation pay and stock-based compensation		252			279
Net operating loss (state and foreign)		241			280
Allowance for doubtful accounts		44			44
Accrued warranty		13			19
Acquisition costs		10			12
Tax credit carryforwards		5			112
Other		71			13
Total		2,558			2,129
Valuation allowance		(169	)		(234	)
Deferred tax assets		2,389			1,895
Deferred tax liabilities:
Net intangible assets		(2,697	)		(2,923	)
Right of use assets		(1,400	)		(1,066	)
Depreciation of property and equipment		(214	)		(169	)
Deferred tax liabilities		(4,311	)		(4,158	)
Net deferred tax liabilities	$	(1,922	)	$	(2,263	)

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	Years Ended December 31,
	2020			2019
Expected income tax expense (benefit) at U.S. statutory rate	$	(259	)	$	547
Increase (decrease) in tax from:
Dividend from foreign subsidiaries		83			97
NOL carryforwards utilized		64			32
Restricted stock compensation		62			114
Global intangible low taxed income		35			30
Nondeductible expenses		8			4
Current year tax credits (foreign and research)		(82	)		(234	)
Domestic tax benefit, net of Federal benefit		(68	)		(184	)
Changes in valuation allowance		(65	)		(7	)
Foreign income tax rate differences		(34	)		(51	)
Section 250 foreign derived intangible income deduction		(9	)		(145	)
Other		(71	)		79
Income tax expense (benefit)	$	(336	)	$	282

XML 50 R36.htm IDEA: XBRL DOCUMENT

Note 13 - Stock-based Compensation Plan (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Years Ended December 31,
	2020		2019
Cost of revenues	$	-	$	-
Selling expense		12		8
Engineering and product development expense		42		35
General and administrative expense		617		841
	$	671	$	884

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	2020			2019
Risk-free interest rate		0.46	%		2.35	%
Dividend yield		0.00	%		0.00	%
Expected common stock market price volatility factor		.44			.42
Weighted average expected life of stock options (years)		6.25			6.25

Share-based Payment Arrangement, Option, Activity [Table Text Block]

	Number of Shares			Weighted Average Exercise Price
Options outstanding, January 1, 2019		264,400			7.54
Granted		249,460			6.25
Exercised		-			-
Canceled		(7,050	)		8.45
Options outstanding, December 31, 2019 (87,900 exercisable)		506,810			6.89
Granted		113,980			3.49
Exercised		-			-
Canceled		(182,590	)		6.31
Options outstanding, December 31, 2020 (204,630 exercisable)		438,200			6.25

Schedule of Nonvested Share Activity [Table Text Block]

	Number of Shares			Weighted Average Grant Date Fair Value
Unvested shares outstanding, January 1, 2019		114,750			6.92
Granted		132,580			6.31
Vested		(69,974	)		6.60
Forfeited		(12,325	)		7.14
Unvested shares outstanding, December 31, 2019		165,031			6.55
Granted		229,110			4.24
Vested		(89,861	)		5.32
Forfeited		(67,125	)		6.03
Unvested shares outstanding, December 31, 2020		237,155			4.93

XML 51 R37.htm IDEA: XBRL DOCUMENT

Note 16 - Segment Information (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Years Ended December 31,
	2020			2019
Net revenues from unaffiliated customers:
Thermal	$	40,209		$	43,823
EMS		13,614			16,837
	$	53,823		$	60,660
Depreciation/amortization:
Thermal	$	1,727		$	1,810
EMS		109			118
Corporate		27			14
	$	1,863		$	1,942
Operating income (loss):
Thermal	$	325		$	2,334
EMS		(1,113	)		1,725
Corporate		(429	)		(1,510	)
	$	(1,217	)	$	2,549
Earnings (loss) before income tax expense (benefit):
Thermal	$	306		$	2,370
EMS		(1,077	)		1,767
Corporate		(460	)		(1,533	)
	$	(1,231	)	$	2,604
Income tax expense (benefit):
Thermal	$	84		$	257
EMS		(294	)		194
Corporate		(126	)		(169	)
	$	(336	)	$	282
Net earnings (loss):
Thermal	$	222		$	2,113
EMS		(783	)		1,573
Corporate		(334	)		(1,364	)
	$	(895	)	$	2,322
Capital expenditures:
Thermal	$	371		$	501
EMS		284			46
Corporate		3			73
	$	658		$	620

Revenue from External Customers by Geographic Areas [Table Text Block]

	Years Ended December 31,
	2020		2019
Net revenues from unaffiliated customers:
U.S.	$	22,211	$	25,283
Foreign		31,612		35,377
	$	53,823	$	60,660

Long-lived Assets by Geographic Areas [Table Text Block]

	December 31,
	2020		2019
Property and equipment:
U.S.	$	2,053	$	2,163
Foreign		297		257
	$	2,350	$	2,420

Asset [Member]

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	December 31,
	2020		2019
Identifiable assets:
Thermal	$	50,782	$	51,621
EMS		9,667		7,319
Corporate		1,581		775
	$	62,030	$	59,715

XML 52 R38.htm IDEA: XBRL DOCUMENT

Note 17 - Quarterly Consolidated Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Quarterly Financial Information [Table Text Block]

	Quarters Ended
	3/31/20 (1)			6/30/20 (2)		9/30/20 (3)			12/31/20 (4)			Total
Net revenues	$	11,230		$	13,275	$	14,443		$	14,875		$	53,823
Gross margin		4,867			6,067		6,450			6,720			24,104
Earnings (loss) before income tax expense (benefit)		(1,393	)		183		433			(454	)		(1,231	)
Income tax expense (benefit)		(250	)		13		(25	)		(74	)		(336	)
Net earnings (loss)		(1,143	)		170		458			(380	)		(895	)

Net earnings (loss) per common share – basic	$	(0.11	)	$	0.02	$	0.04		$	(0.04	)	$	(0.09	)
Weighted average common shares outstanding – basic		10,220,853			10,252,490		10,269,995			10,282,903			10,256,560
Net earnings (loss) per common share – diluted	$	(0.11	)	$	0.02	$	0.04		$	(0.04	)	$	(0.09	)
Weighted average common shares outstanding – diluted		10,220,853			10,258,917		10,287,562			10,282,903			10,256,560

	Quarters Ended
	3/31/19		6/30/19 (5)			9/30/19 (6)		12/31/19			Total
Net revenues	$	18,062	$	14,352		$	14,632	$	13,614		$	60,660
Gross margin		8,836		6,719			7,205		6,465			29,225
Earnings (loss) before income tax expense (benefit)		1,462		(300	)		794		648			2,604
Income tax expense (benefit)		324		(113	)		147		(76	)		282
Net earnings (loss)		1,138		(187	)		647		724			2,322

Net earnings (loss) per common share – basic	$	0.11	$	(0.02	)	$	0.06	$	0.07		$	0.22
Weighted average common shares outstanding – basic		10,385,017		10,411,276			10,421,383		10,274,980			10,373,164
Net earnings (loss) per common share – diluted	$	0.11	$	(0.02	)	$	0.06	$	0.07		$	0.22
Weighted average common shares outstanding – diluted		10,414,330		10,411,276			10,429,536		10,298,535			10,391,975

XML 53 R39.htm IDEA: XBRL DOCUMENT

Schedule II - Valuation and Qualifying Accounts (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Valuation Allowances and Reserves [Table Text Block]

	Balance at Beginning of Period		Expense (Recovery)		Deductions			Foreign Currency Translation Adjustments		Balance at End of Period

Year Ended December 31, 2020
Allowance for doubtful accounts	$	211	$	-	$	-		$	1	$	212
Warranty reserve		334		32		(131	)		-		235

Year Ended December 31, 2019
Allowance for doubtful accounts	$	233	$	3	$	(25	)		-	$	211
Warranty reserve		346		243		(255	)		-		334

XML 54 R40.htm IDEA: XBRL DOCUMENT

Note 1 - Nature of Operations (Details Textual)	12 Months Ended
Note 1 - Nature of Operations (Details Textual)	Dec. 31, 2020
Number of Operating Segments	2
Number of Reportable Segments	2

XML 55 R41.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Accounts Receivable, Credit Loss Expense (Reversal)	$ 0	$ 3
Number of Operating Segments	2
Number of Reportable Segments	2
Inventory Write-down	$ 444	391
Depreciation, Total	630	685
Deferred Grant Proceeds	27
Foreign Currency Transaction Gain (Loss), before Tax, Total	(26)	$ (3)
City of Rochester and State of New York [Member]
Contingent Liability, Repayment of State and Local Grant Funds Received	463
Covenant, Future Amount Receivable	$ 423
Minimum [Member]
Property, Plant and Equipment, Useful Life (Year)	1 year
Maximum [Member]
Property, Plant and Equipment, Useful Life (Year)	10 years

XML 56 R42.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies - Weighted Average Common Shares (Details) - shares

3 Months Ended

12 Months Ended

Dec. 31, 2020

^[1]

Sep. 30, 2020

^[2]

Jun. 30, 2020

^[3]

Mar. 31, 2020

^[4]

Dec. 31, 2019

Sep. 30, 2019

^[5]

Jun. 30, 2019

^[6]

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Weighted average common shares outstanding–basic (in shares)

10,282,903

10,269,995

10,252,490

10,220,853

10,274,980

10,421,383

10,411,276

10,385,017

10,256,560

10,373,164

Unvested shares of restricted stock and employee stock options (in shares)

18,811

Weighted average common shares and common share equivalents outstanding – diluted (in shares)

10,282,903

10,287,562

10,258,917

10,220,853

10,298,535

10,429,536

10,411,276

10,414,330

10,256,560

10,391,975

Average number of potentially dilutive securities excluded from calculation (in shares)

717,015

523,485

[1]	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3.
[2]	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
[3]	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
[4]	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
[5]	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.
[6]	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.

XML 57 R43.htm IDEA: XBRL DOCUMENT

Note 3 - Restructuring and Other Charges (Details Textual) - USD ($) $ in Thousands		3 Months Ended						6 Months Ended	12 Months Ended
	Dec. 28, 2020	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating Lease, Impairment Loss		$ 612							$ 612
Operating Lease, Right-of-Use Asset		6,387							6,387	4,842
Restructuring Charges, Total		1,078	$ 161	$ 38	$ 8	$ 17	$ 223
Lease Agreement, EMS Facility in Mt. Laurel, New Jersey [Member]
Operating Lease, Right-of-Use Asset		139							139
Severance and Other One-Time Termination Benefits [Member]
Restructuring Charges, Total									248	137
EMS Segment Restructuring and Facility Consolidation [Member]
Restructuring and Related Costs, Incurred Cost, Total									903
Operating Lease, Impairment Loss	$ 522								522
Operating Lease, Right-of-Use Asset		597							597
Other Restructuring Costs									159
EMS Segment Restructuring and Facility Consolidation [Member] \| Minimum [Member] \| Forecast [Member]
Restructuring and Related Costs, Incurred Cost, Total								$ 100
EMS Segment Restructuring and Facility Consolidation [Member] \| Maximum [Member] \| Forecast [Member]
Restructuring and Related Costs, Incurred Cost, Total								$ 150
Executive Management Changes [Member]
Operating Lease, Impairment Loss		$ 90							90
Restructuring Charges, Total									514
Share-based Payment Arrangement, Reversal of Expense									117
Other Restructuring Costs									381
Executive Management Changes [Member] \| Facility Size Reduction [Member]
Other Restructuring Costs									99
Other Restructuring Actions [Member] \| Headcount Reductions and Employee Relocation [Member]
Other Restructuring Costs									46
Other Restructuring Actions [Member] \| Employee Relocation [Member]
Other Restructuring Costs									$ 14
Ambrell European Operations Consolidation [Member]
Restructuring Charges, Total										240
Ambrell European Operations Consolidation [Member] \| Severance and Other One-Time Termination Benefits [Member]
Restructuring Charges, Total										137
Ambrell European Operations Consolidation [Member] \| Facility Closing [Member]
Restructuring Charges, Total										$ 103

XML 58 R44.htm IDEA: XBRL DOCUMENT

Note 3 - Restructuring and Other Charges - Restructuring and Related Costs (Details) - USD ($) $ in Thousands		3 Months Ended	12 Months Ended
	Dec. 28, 2020	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Impairment of ROU asset		$ 612	$ 612
EMS Segment Restructuring and Facility Consolidation [Member]
Severance and other one-time termination benefits			69
Other associated costs			159
Impairment of ROU asset	$ 522		522
Costs related to subletting the Fremont, CA facility			153
Total			903
Executive Management Changes [Member]
Severance and other one-time termination benefits			133
Other associated costs			381
Impairment of ROU asset		$ 90	90
Total			703
Costs related to subletting the Mansfield, MA facility			99
Cash Charges [Member] \| EMS Segment Restructuring and Facility Consolidation [Member]
Severance and other one-time termination benefits			69
Other associated costs			159
Impairment of ROU asset
Costs related to subletting the Fremont, CA facility			153
Total			381
Cash Charges [Member] \| Executive Management Changes [Member]
Severance and other one-time termination benefits			133
Other associated costs			381
Impairment of ROU asset
Total			613
Costs related to subletting the Mansfield, MA facility			99
Non-Cash Charges [Member] \| EMS Segment Restructuring and Facility Consolidation [Member]
Severance and other one-time termination benefits
Other associated costs
Impairment of ROU asset			522
Costs related to subletting the Fremont, CA facility
Total			522
Non-Cash Charges [Member] \| Executive Management Changes [Member]
Severance and other one-time termination benefits
Other associated costs
Impairment of ROU asset			90
Total			90
Costs related to subletting the Mansfield, MA facility

XML 59 R45.htm IDEA: XBRL DOCUMENT

Note 3 - Restructuring and Other Charges - Changes in Accrued Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended						12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2019
Beginning balance				$ 0			$ 0	$ 0
Restructuring Charges, Total	$ 1,078	$ 161	$ 38	$ 8	$ 17	$ 223
Cash payments							(159)	(240)
Balance	$ 340						340	0
Ambrell European Operations Consolidation [Member]
Restructuring Charges, Total								240
Severance and Other One-Time Termination Benefits [Member]
Restructuring Charges, Total							248	137
Severance and Other One-Time Termination Benefits [Member] \| Ambrell European Operations Consolidation [Member]
Restructuring Charges, Total								137
Facility Closing [Member] \| Ambrell European Operations Consolidation [Member]
Restructuring Charges, Total								$ 103
Subletting Costs of the Fremont CA Facility [Member]
Restructuring Charges, Total							153
Subletting Costs of the Mansfield MA Facility [Member]
Restructuring Charges, Total							$ 98

XML 60 R46.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Number of Operating Segments	2
Number of Reportable Segments	2
Goodwill, Ending Balance	$ 13,738	$ 13,738
Discounted Cash Flows, Discount Rate	20.00%	20.00%
Goodwill and Intangible Asset Impairment, Total	$ 0	$ 0

XML 61 R47.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets - Component of Goodwill (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Goodwill	$ 13,738	$ 13,738
Sigma [Member]
Goodwill	1,656
Thermonics [Member]
Goodwill	50
Ambrell [Member]
Goodwill	$ 12,032

XML 62 R48.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets - Changes in the Amount of the Carrying Value of Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Balance	$ 6,944	$ 8,201
Amortization	(1,233)	(1,257)
Balance	$ 5,711	$ 6,944

XML 63 R49.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Finite-lived, Gross Carrying Amount	$ 12,080	$ 12,080
Finite-lived, Accumulated Amortization	6,369	5,136
Net Carrying Amount	5,711	6,944	$ 8,201
Intangible Assets, Gross Carrying Amount	18,790	18,790
Net Carrying Amount	12,421	13,654
Trademarks [Member]
Indefinite-lived, Gross Carrying Amount	6,710	6,710
Net Carrying Amount	6,710	6,710
Customer Relationships [Member]
Finite-lived, Gross Carrying Amount	10,480	10,480
Finite-lived, Accumulated Amortization	4,912	3,805
Net Carrying Amount	5,568	6,675
Patented Technology [Member]
Finite-lived, Gross Carrying Amount	600	600
Finite-lived, Accumulated Amortization	477	380
Net Carrying Amount	123	220
Patents [Member]
Finite-lived, Gross Carrying Amount	590	590
Finite-lived, Accumulated Amortization	570	541
Net Carrying Amount	20	49
Computer Software, Intangible Asset [Member]
Finite-lived, Gross Carrying Amount	270	270
Finite-lived, Accumulated Amortization	270	270
Net Carrying Amount
Trade Names [Member]
Finite-lived, Gross Carrying Amount	140	140
Finite-lived, Accumulated Amortization	140	140
Net Carrying Amount

XML 64 R50.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets - Future Amortization Expense (Details) $ in Thousands	Dec. 31, 2020 USD ($)
2021	$ 1,227
2022	1,167
2023	1,067
2024	980
2025	$ 905

XML 65 R51.htm IDEA: XBRL DOCUMENT

Note 5 - Revenue From Contracts With Customers - Disaggregation of Revenues (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

^[1]

Sep. 30, 2020

^[2]

Jun. 30, 2020

^[3]

Mar. 31, 2020

^[4]

Dec. 31, 2019

Sep. 30, 2019

^[5]

Jun. 30, 2019

^[6]

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Net revenues

$ 14,875

$ 14,443

$ 13,275

$ 11,230

$ 13,614

$ 14,632

$ 14,352

$ 18,062

$ 53,823

$ 60,660

Semiconductor Market [Member]

Net revenues

26,870

30,953

Industrial Market [Member]

Net revenues

17,341

21,231

Defense/ Aerospace [Member]

Net revenues

6,314

4,842

Telecommunications Market [Member]

Net revenues

1,715

1,845

Other Multi Markets [Member]

Net revenues

1,583

1,789

Thermal Testing Products [Member]

Net revenues

15,768

17,631

Thermal Process [Member]

Net revenues

18,966

20,079

Semiconductor Production Test Products [Member]

Net revenues

13,112

16,273

Service and Other Products [Member]

Net revenues

5,977

6,677

End User [Member]

Net revenues

48,041

55,074

OEM and Integrators [Member]

Net revenues

$ 5,782

$ 5,586

[1]	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3.
[2]	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
[3]	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
[4]	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
[5]	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.
[6]	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.

XML 66 R52.htm IDEA: XBRL DOCUMENT

Note 5 - Revenue From Contracts With Customers - Changes in Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Balance	$ 211	$ 233
Bad debt expense		3
Write-offs		(25)
Foreign currency translation adjustments	1
Balance	$ 212	$ 211

XML 67 R53.htm IDEA: XBRL DOCUMENT

Note 6 - Major Customers (Details Textual)	12 Months Ended
Note 6 - Major Customers (Details Textual)	Dec. 31, 2020	Dec. 31, 2019
Number of Major Customers	0	0
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Texas Instruments Incorporated [Member]
Concentration Risk, Percentage		10.00%

XML 68 R54.htm IDEA: XBRL DOCUMENT

Note 7 - Inventories - Inventories Held (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Raw materials	$ 5,371	$ 5,369
Work in process	1,085	949
Inventory consigned to others	45	54
Finished goods	975	810
Total inventories	$ 7,476	$ 7,182

XML 69 R55.htm IDEA: XBRL DOCUMENT

Note 8 - Leases (Details Textual) $ in Thousands			3 Months Ended		9 Months Ended		12 Months Ended
Note 8 - Leases (Details Textual) $ in Thousands	Oct. 01, 2020 USD ($)	Apr. 08, 2019 USD ($) ft²	Dec. 31, 2020 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Sep. 22, 2020 ft²	Jan. 23, 2020	Mar. 31, 2019
Operating Lease, Right-of-Use Asset, Amortization Expense							$ 1,294	$ 1,251
Operating Lease, Impairment Loss			$ 612				612
Mansfield, Massachusetts [Member]
Lessee, Operating Lease, Renewal Term (Month)		3 years 120 days
Increase in Operating Lease Liabilities and Right-of-Use Assets, Non-cash		$ 1,811
Operating Lease, Increase in Area (Square Foot) \| ft²		6,100
Lease Agreement, EMS Facility in Fremont, California [Member]
Lessee, Operating Lease, Renewal Term (Month)										5 years 30 days
Increase in Operating Lease Liabilities and Right-of-Use Assets, Non-cash					$ 1,176		1,176
Lease Agreement, EMS Facility in Mt. Laurel, New Jersey [Member]
Lessee, Operating Lease, Renewal Term (Month)									10 years
Increase in Operating Lease Liabilities and Right-of-Use Assets, Non-cash							2,051
Area of Real Estate Property (Square Foot) \| ft²									33,650
Lease Agreement, Ambrell’s Netherlands Facility [Member]
Lessee, Operating Lease, Renewal Term (Month)	3 years
Increase in Operating Lease Liabilities and Right-of-Use Assets, Non-cash	$ 133						133
Decrease In Operating Lease Liabilities and Right-of-Use Assets, Non-cash				$ 48				48
Automobile Leases [Member]
Increase in Operating Lease Liabilities and Right-of-Use Assets, Non-cash			$ 91				$ 91
Lease Agreement, Ambrell’s U.K [Member]
Lessee, Operating Lease, Term of Contract (Year)											15 years
Decrease In Operating Lease Liabilities and Right-of-Use Assets, Non-cash						$ 486		$ 486

XML 70 R56.htm IDEA: XBRL DOCUMENT

Note 8 - Leases - Lease Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating lease cost	$ 1,583	$ 1,476
Short-term lease cost	$ 47	$ 51
Weighted average remaining lease term (in years) (Year)	6 years 146 days
Weighted average discount rate	4.30%
Minimum [Member]
Range of remaining lease terms (in years) (Year)	36 days
Maximum [Member]
Range of remaining lease terms (in years) (Year)	10 years

XML 71 R57.htm IDEA: XBRL DOCUMENT

Note 8 - Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Dec. 31, 2020 USD ($)
2021	$ 1,481
2022	1,405
2023	1,416
2024	1,395
2025	722
Thereafter	1,845
Total lease payments	8,264
Less imputed interest	(999)
Total	$ 7,265

XML 72 R58.htm IDEA: XBRL DOCUMENT

Note 8 - Leases - Lease Modifications (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2020	Dec. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019
Lease Agreement, EMS Facility in Fremont, California [Member]
Non-cash increases in operating lease liabilites and ROU assets				$ 1,176		$ 1,176
Lease Agreement, Ambrell’s U.K [Member]
Modification to lease for Ambrell’s U.K. facility					$ (486)		$ (486)
Lease Agreement, EMS Facility in Mt. Laurel, New Jersey [Member]
Non-cash increases in operating lease liabilites and ROU assets						2,051
Lease for Facility in Mansfield, Massachusetts [Member]
Non-cash increases in operating lease liabilites and ROU assets							1,811
Lease Agreement, Ambrell’s Netherlands Facility [Member]
Non-cash increases in operating lease liabilites and ROU assets	$ 133					133
Modification to lease for Ambrell’s U.K. facility			$ (48)				$ (48)
Automobile Leases [Member]
Non-cash increases in operating lease liabilites and ROU assets		$ 91				$ 91

XML 73 R59.htm IDEA: XBRL DOCUMENT

Note 9 - Other Current Liabilities - Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Accrued restructuring	$ 340
Accrued warranty	235	334
Other	229	163
Total other current liabilities	$ 804	$ 497

XML 74 R60.htm IDEA: XBRL DOCUMENT

Note 10 - Debt (Details Textual) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended	12 Months Ended
Note 10 - Debt (Details Textual) - USD ($) $ in Thousands	Apr. 10, 2020	Apr. 30, 2020	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Apr. 01, 2019
Proceeds from Lines of Credit, Total				$ 2,800
Proceeds from Paycheck Protection Program Under CARES Act		$ 2,829
M&T [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 7,500					$ 125
Letters of Credit Outstanding, Amount						$ 90
Line of Credit Facility, Current Borrowing Capacity				$ 7,500
Debt Instrument, Interest Rate, Stated Percentage	2.00%
Proceeds from Lines of Credit, Total			$ 2,800
M&T [Member] \| Revolving Credit Facility [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	2.00%

XML 75 R61.htm IDEA: XBRL DOCUMENT

Note 10 - Debt - Outstanding Letters of Credit (Details) - Letter of Credit [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Letters of Credit Amount Outstanding	$ 140	$ 140
Mt Laurel [Member]
Line of Credit, Issue Date	Mar. 29, 2010
Line of Credit, Expiration Date	Apr. 30, 2021
Lease Expiration Date	Apr. 30, 2031
Letters of Credit Amount Outstanding	$ 90	90
Mansfield [Member]
Line of Credit, Issue Date	Oct. 27, 2010
Line of Credit, Expiration Date	Dec. 31, 2024
Lease Expiration Date	Dec. 31, 2024
Letters of Credit Amount Outstanding	$ 50	$ 50

XML 76 R62.htm IDEA: XBRL DOCUMENT

Note 11 - Income Taxes (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (65)	$ (7)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	21.00%

XML 77 R63.htm IDEA: XBRL DOCUMENT

Note 11 - Income Taxes - Earnings Before Income Taxes (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

^[1]

Sep. 30, 2020

^[2]

Jun. 30, 2020

^[3]

Mar. 31, 2020

^[4]

Dec. 31, 2019

Sep. 30, 2019

^[5]

Jun. 30, 2019

^[6]

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Domestic

$ (2,017)

$ 1,804

Foreign

786

800

Total

$ (454)

$ 433

$ 183

$ (1,393)

$ 648

$ 794

$ (300)

$ 1,462

$ (1,231)

$ 2,604

[1]	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3.
[2]	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
[3]	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
[4]	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
[5]	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.
[6]	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.

XML 78 R64.htm IDEA: XBRL DOCUMENT

Note 11 - Income Taxes - Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

^[1]

Sep. 30, 2020

^[2]

Jun. 30, 2020

^[3]

Mar. 31, 2020

^[4]

Dec. 31, 2019

Sep. 30, 2019

^[5]

Jun. 30, 2019

^[6]

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Domestic – Federal

$ (182)

$ 510

101

135

708

(299)

(413)

Domestic – state

(7)

(13)

Foreign

(36)

Total

(341)

(426)

Income tax expense (benefit)

$ (74)

$ (25)

$ 13

$ (250)

$ (76)

$ 147

$ (113)

$ 324

$ (336)

$ 282

[1]	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3.
[2]	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
[3]	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
[4]	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
[5]	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.
[6]	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

XML 79 R65.htm IDEA: XBRL DOCUMENT

Note 11 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets:
Operating lease liabilities	$ 1,601	$ 1,123
Inventories	321	247
Accrued vacation pay and stock-based compensation	252	279
Net operating loss (state and foreign)	241	280
Allowance for doubtful accounts	44	44
Accrued warranty	13	19
Acquisition costs	10	12
Tax credit carryforwards	5	112
Other	71	13
Total	2,558	2,129
Valuation allowance	(169)	(234)
Deferred tax assets	2,389	1,895
Deferred tax liabilities:
Net intangible assets	(2,697)	(2,923)
Right of use assets	(1,400)	(1,066)
Depreciation of property and equipment	(214)	(169)
Deferred tax liabilities	(4,311)	(4,158)
Net deferred tax liabilities	$ (1,922)	$ (2,263)

XML 80 R66.htm IDEA: XBRL DOCUMENT

Note 11 - Income Taxes - Effective Tax Rate Analysis and Reconciliation of Expected Statutory Rate (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

^[1]

Sep. 30, 2020

^[2]

Jun. 30, 2020

^[3]

Mar. 31, 2020

^[4]

Dec. 31, 2019

Sep. 30, 2019

^[5]

Jun. 30, 2019

^[6]

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Expected income tax expense (benefit) at U.S. statutory rate

$ (259)

$ 547

Dividend from foreign subsidiaries

NOL carryforwards utilized

Restricted stock compensation

114

Global intangible low taxed income

Nondeductible expenses

Current year tax credits (foreign and research)

(82)

(234)

Domestic tax benefit, net of Federal benefit

(68)

(184)

Changes in valuation allowance

(65)

(7)

Foreign income tax rate differences

(34)

(51)

Section 250 foreign derived intangible income deduction

(9)

(145)

Other

(71)

Income tax expense (benefit)

$ (74)

$ (25)

$ 13

$ (250)

$ (76)

$ 147

$ (113)

$ 324

$ (336)

$ 282

[1]	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3.
[2]	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
[3]	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
[4]	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
[5]	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.
[6]	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.

XML 81 R67.htm IDEA: XBRL DOCUMENT

Note 13 - Stock-based Compensation Plan (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Aug. 24, 2020	Mar. 31, 2020	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Jun. 19, 2019	Jun. 27, 2018	Jun. 25, 2014
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total					$ 1,353
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)					2 years 219 days
Share-based Payment Arrangement, Amount Capitalized					$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value					$ 357	$ 426
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)					10 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)					4 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)					$ 1.48	$ 2.75
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)					229,110	132,580
Restricted Stock [Member] \| Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)					4 years
Restricted Stock [Member] \| Independent Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)					1 year
Restricted Stock [Member] \| Independent Directors [Member] \| Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		25.00%
Restricted Stock [Member] \| Independent Directors [Member] \| Share-based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			25.00%
Restricted Stock [Member] \| Independent Directors [Member] \| Share-based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage				25.00%
Restricted Stock [Member] \| Independent Directors [Member] \| Share-based Compensation Award, Tranche Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					25.00%
Restricted Stock [Member] \| President [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	141,610
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted, Fair Value	$ 650
Stock Plan 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)							2,000,000	1,000,000	500,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)					1,067,979
Restricted Stock Vesting in Four Years [Member] \| Restricted Stock [Member] \| President [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	4 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	66,448
Restricted Stock Vesting in Four Years [Member] \| Restricted Stock [Member] \| President [Member] \| Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	25.00%
Restricted Stock Vesting in Four Years [Member] \| Restricted Stock [Member] \| President [Member] \| Share-based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	25.00%
Restricted Stock Vesting in Four Years [Member] \| Restricted Stock [Member] \| President [Member] \| Share-based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	25.00%
Restricted Stock Vesting in Four Years [Member] \| Restricted Stock [Member] \| President [Member] \| Share-based Compensation Award, Tranche Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	25.00%
Restricted Stock Vesting in Three Years [Member] \| Restricted Stock [Member] \| President [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	75,162
Restricted Stock Vesting in Three Years [Member] \| Restricted Stock [Member] \| President [Member] \| Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					100.00%
Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights Percentage Lower Range	0.00%
Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights Percentage Upper Range	150.00%

XML 82 R68.htm IDEA: XBRL DOCUMENT

Note 13 - Stock-based Compensation Plan - Allocation of Share-based Compensation Expense (Details) - Restricted Stock [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Allocation of Share-based Compensation Expense	$ 671	$ 884
Cost of Sales [Member]
Allocation of Share-based Compensation Expense
Selling and Marketing Expense [Member]
Allocation of Share-based Compensation Expense	12	8
Research and Development Expense [Member]
Allocation of Share-based Compensation Expense	42	35
General and Administrative Expense [Member]
Allocation of Share-based Compensation Expense	$ 617	$ 841

XML 83 R69.htm IDEA: XBRL DOCUMENT

Note 13 - Stock-based Compensation Plan - Stock Options Valuation Assumptions (Details) - Share-based Payment Arrangement, Option [Member]	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Risk-free interest rate	0.46%	2.35%
Dividend yield	0.00%	0.00%
Expected common stock market price volatility factor	0.44%	0.42%
Weighted average expected life of stock options (years) (Year)	6 years 91 days	6 years 91 days

XML 84 R70.htm IDEA: XBRL DOCUMENT

Note 13 - Stock-based Compensation Plan - Stock Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Options outstanding, number of shares (in shares)	506,810	264,400
Options outstanding, weighted average exercise price (in dollars per share)	$ 6.89	$ 7.54
Granted, number of shares (in shares)	113,980	249,460
Granted, weighted average exercise price (in dollars per share)	$ 3.49	$ 6.25
Exercised, number of shares (in shares)
Canceled, number of shares (in shares)	182,590	7,050
Canceled, weighted average exercise price (in dollars per share)	$ 6.31	$ 8.45
Options outstanding, number of shares (in shares)	438,200	506,810
Options outstanding, weighted average exercise price (in dollars per share)	$ 6.25	$ 6.89

XML 85 R71.htm IDEA: XBRL DOCUMENT

Note 13 - Stock-based Compensation Plan - Stock Option Activity (Details) (Parentheticals) - shares	Dec. 31, 2020	Dec. 31, 2019
Options exercisable (in shares)	204,630	87,900

XML 86 R72.htm IDEA: XBRL DOCUMENT

Note 13 - Stock-based Compensation Plan - Unvested Stock Activity (Details) - Restricted Stock [Member] - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Unvested shares outstanding (in shares)	165,031	114,750
Unvested shares outstanding, weighted average exercise price (in dollars per share)	$ 6.55	$ 6.92
Granted, number of shares (in shares)	229,110	132,580
Granted, weighted average exercise price (in dollars per share)	$ 4.24	$ 6.31
Vested, number of shares (in shares)	(89,861)	(69,974)
Vested, weighted average exercise price (in dollars per share)	$ 5.32	$ 6.60
Forfeited, number of shares (in shares)	(67,125)	(12,325)
Forfeited, weighted average exercise price (in dollars per share)	$ 6.03	$ 7.14
Unvested shares outstanding (in shares)	237,155	165,031
Unvested shares outstanding, weighted average exercise price (in dollars per share)	$ 4.93	$ 6.55

XML 87 R73.htm IDEA: XBRL DOCUMENT

Note 14 - Stock Repurchase Plans (Details Textual) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended		45 Months Ended	62 Months Ended
	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019	Jul. 31, 2019	Dec. 31, 2020
Stock Repurchase Program, Authorized Amount				$ 3,000
Stock Repurchased and Retired During Period, Shares (in shares)	13,767			297,020	243,075
Stock Repurchased and Retired During Period, Value	$ 74	$ 74	$ 1,142	$ 1,195	$ 1,216
Payments for Stock Repurchased Broker Fees					$ 6

XML 88 R74.htm IDEA: XBRL DOCUMENT

Note 15 - Employee Benefit Plans (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
401(k) Plan [Member]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	10.00%
Defined Contribution Plan Maximum Annual Employer Matching Contribution Per Emplyee Amount	$ 5
Defined Contribution Plan Employer Matching Contribution Vesting Period (Year)	4 years
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 331	$ 382
The Ambrell Plan [Member]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	10.00%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 62	$ 49
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	100.00%
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	50.00%
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount	$ 5

XML 89 R75.htm IDEA: XBRL DOCUMENT

Note 16 - Segment Information - Segment Information (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

^[1]

Sep. 30, 2020

^[2]

Jun. 30, 2020

^[3]

Mar. 31, 2020

^[4]

Dec. 31, 2019

Sep. 30, 2019

^[5]

Jun. 30, 2019

^[6]

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Net revenues

$ 14,875

$ 14,443

$ 13,275

$ 11,230

$ 13,614

$ 14,632

$ 14,352

$ 18,062

$ 53,823

$ 60,660

Depreciation/amortization

1,863

1,942

Operating income (loss)

(1,217)

2,549

Earnings (loss) before income tax expense (benefit)

(454)

433

183

(1,393)

648

794

(300)

1,462

(1,231)

2,604

Income tax expense (benefit)

(74)

(25)

(250)

(76)

147

(113)

324

(336)

282

Net earnings (loss)

$ (380)

$ 458

$ 170

$ (1,143)

$ 724

$ 647

$ (187)

$ 1,138

(895)

2,322

Capital expenditures

658

620

Corporate, Non-Segment [Member]

Depreciation/amortization

Operating income (loss)

(429)

(1,510)

Earnings (loss) before income tax expense (benefit)

(460)

(1,533)

Income tax expense (benefit)

(126)

(169)

Net earnings (loss)

(334)

(1,364)

Capital expenditures

Thermal Testing Products [Member] | Operating Segments [Member]

Net revenues

40,209

43,823

Depreciation/amortization

1,727

1,810

Operating income (loss)

325

2,334

Earnings (loss) before income tax expense (benefit)

306

2,370

Income tax expense (benefit)

257

Net earnings (loss)

222

2,113

Capital expenditures

371

501

EMS [Member] | Operating Segments [Member]

Net revenues

13,614

16,837

Depreciation/amortization

109

118

Operating income (loss)

(1,113)

1,725

Earnings (loss) before income tax expense (benefit)

(1,077)

1,767

Income tax expense (benefit)

(294)

194

Net earnings (loss)

(783)

1,573

Capital expenditures

$ 284

$ 46

[1]	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3.
[2]	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
[3]	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
[4]	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
[5]	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.
[6]	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.

XML 90 R76.htm IDEA: XBRL DOCUMENT

Note 16 - Segment Information - Identifiable Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Identifiable Assets	$ 62,030	$ 59,715
Corporate, Non-Segment [Member]
Identifiable Assets	1,581	775
Thermal Testing Products [Member]
Identifiable Assets	50,782	51,621
EMS [Member]
Identifiable Assets	$ 9,667	$ 7,319

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

XML 91 R77.htm IDEA: XBRL DOCUMENT

Note 16 - Segment Information - Net Revenue From Unaffiliated Customers (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

^[1]

Sep. 30, 2020

^[2]

Jun. 30, 2020

^[3]

Mar. 31, 2020

^[4]

Dec. 31, 2019

Sep. 30, 2019

^[5]

Jun. 30, 2019

^[6]

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Net revenues

$ 14,875

$ 14,443

$ 13,275

$ 11,230

$ 13,614

$ 14,632

$ 14,352

$ 18,062

$ 53,823

$ 60,660

UNITED STATES

Net revenues

22,211

25,283

Non-US [Member]

Net revenues

$ 31,612

$ 35,377

[1]	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3.
[2]	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
[3]	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
[4]	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
[5]	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.
[6]	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.

- Definition

Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

XML 92 R78.htm IDEA: XBRL DOCUMENT

Note 16 - Segment Information - Long-lived Assets by Geographical Area (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Property and Equipment	$ 2,350	$ 2,420
UNITED STATES
Property and Equipment	2,053	2,163
Non-US [Member]
Property and Equipment	$ 297	$ 257

XML 93 R79.htm IDEA: XBRL DOCUMENT

Note 17 - Quarterly Consolidated Financial Data (Unaudited) (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019
Restructuring Charges, Total	$ 1,078	$ 161	$ 38	$ 8	$ 17	$ 223

XML 94 R80.htm IDEA: XBRL DOCUMENT

Note 17 - Quarterly Consolidated Financial Data (Unaudited) - Quarterly Consolidated Financial Data (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

^[1]

Sep. 30, 2020

^[2]

Jun. 30, 2020

^[3]

Mar. 31, 2020

^[4]

Dec. 31, 2019

Sep. 30, 2019

^[5]

Jun. 30, 2019

^[6]

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Net revenues

$ 14,875

$ 14,443

$ 13,275

$ 11,230

$ 13,614

$ 14,632

$ 14,352

$ 18,062

$ 53,823

$ 60,660

Gross margin

6,720

6,450

6,067

4,867

6,465

7,205

6,719

8,836

24,104

29,225

Earnings (loss) before income tax expense (benefit)

(454)

433

183

(1,393)

648

794

(300)

1,462

(1,231)

2,604

Income tax expense (benefit)

(74)

(25)

(250)

(76)

147

(113)

324

(336)

282

Net earnings (loss)

$ (380)

$ 458

$ 170

$ (1,143)

$ 724

$ 647

$ (187)

$ 1,138

$ (895)

$ 2,322

Net earnings (loss) per common share – basic (in dollars per share)

$ (0.04)

$ 0.04

$ 0.02

$ (0.11)

$ 0.07

$ 0.06

$ (0.02)

$ 0.11

$ (0.09)

$ 0.22

Weighted average common shares outstanding – basic (in shares)

10,282,903

10,269,995

10,252,490

10,220,853

10,274,980

10,421,383

10,411,276

10,385,017

10,256,560

10,373,164

Net earnings (loss) per common share – diluted (in dollars per share)

$ (0.04)

$ 0.04

$ 0.02

$ (0.11)

$ 0.07

$ 0.06

$ (0.02)

$ 0.11

$ (0.09)

$ 0.22

Weighted average common shares outstanding – diluted (in shares)

10,282,903

10,287,562

10,258,917

10,220,853

10,298,535

10,429,536

10,411,276

10,414,330

10,256,560

10,391,975

[1]	The quarter ended December 31, 2020 includes $1,078 of restructuring and other charges which are discussed in Note 3.
[2]	The quarter ended September 30, 2020 includes $161 of restructuring and other charges which are discussed in Note 3.
[3]	The quarter ended June 30, 2020 includes $38 of restructuring and other charges which are discussed in Note 3.
[4]	The quarter ended March 31, 2020 includes $8 of restructuring and other charges which are discussed in Note 3.
[5]	The quarter ended September 30, 2019 includes $17 of restructuring and other charges which are discussed in Note 3.
[6]	The quarter ended June 30, 2019 includes $223 of restructuring and other charges which are discussed in Note 3.

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

+ Details

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

XML 95 R81.htm IDEA: XBRL DOCUMENT

Schedule II Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
SEC Schedule, 12-09, Allowance, Credit Loss [Member]
Balance at Beginning of Period	$ 211	$ 233
Expense (Recovery)		3
Deductions		(25)
Foreign Currency Adjustment	1
Balance at End of Period	212	211
SEC Schedule, 12-09, Reserve, Warranty [Member]
Balance at Beginning of Period	334	346
Expense (Recovery)	32	243
Deductions	(131)	(255)
Foreign Currency Adjustment
Balance at End of Period	$ 235	$ 334

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

TK%1D27.P\9DS!L3O&;3%A J5N3- MV4*=R%Z7&JLM-2J@QGS%4)=C>X\S]=WQ'3 *75.J#30HJ[CV.&^<(MPB7:RS MC^EB.%I4>20Z5'02@J\W/ 54,(^33E:(B'-I\#@B A-Q.K:X'!&)#0%TR)N_ MT*@(%0^KSG',@,B&!^0]S2B_=2[7>1H+_5=.W;S41F".PO&974O/(73CBYCM M!>%O8]7AXE[+E4R1WQB"YH:R<\F/R[("_]Z4S(Q_B9&5_AG=.W ;J,:R86L! M>)E(MXMY+;(PP4=,@[9^+;?Y.+C]<]WY.+V M^A.YOCF_/;F_O/J1G)S>7_YT>7]Y?A?$Y#'8&V:/X(%C'_D/S>_.OT"397I+ MP9$CWGY.XKA81UGY"P2UL(6F%ZTG^B_?O?LSW.M&[E9#'Z&N4_N3N69)#NW- MKV_%K=S@SF2.-,:PV;M)B1#FI' MP-3-%[IQK8Z. M.=9):WYS48D6/QIE8-2A5 7HW+,81\&9KC0<_^[$Z[M/!I M@XYA_HKL427I,+9-U;3!W=RN/,REX,S^]:-FH$ MR"\2;O 35IW@A_425*GHV99LJLY^3'-ZR7\<.O6&/\1:@ <3^N@54G<' 9A$ M UDJ@U3DZF3R"^KJ*7FR'S[(<\S:@XD@VG!.YW@)TY4'/^D=MI^?GW#4X$J\7[:-<[4T9 MTC&3WV,?9X?F]<7K@PA@1-WB:C UW@1T\!ZV\(G::EP])T\R#=.FG6>S\\"@ M@,?M<2M380C6J!R9VGEP71$EM*\DP!'):05,-U5%@'_RO]Z_>R_.5_[#NR,^ M2;FB$ Q LS#%:93VBF$V((PVEXYRP$M1G0\/,-3GAQ/[5NB'&)AH=!OK,5+I M6P3FH=-'.*='J4^1S[-63Q+A"HLR: =WF9]&J[2*LB&%/OXU5I?WS^K<%="" MY7>=-#E.CS>;E"#XYS[KD\OR4E5%>G#6NJRBI&;J!!N4:5X$W>&@.9.,&/R^O:UL_C7 M)Y8E_!""E)1J,Q&G.ST [7L?FMB]#WX+^;>B($^U^6,@%_PD<9D^Q6:2RZ?V M?J@[W'96G^?7Q(F#5-.U_VZ 8]4& MF91]&IS<>0TV49N@[N7\!JINA\FY5"3Q?KDF1;IY/G'W@M?.VC*,DU&1ZB.Q M9_ T!/?5"O8C'+=(D%]"*T"=+6 &= W_%'G*_YU6IU%1;!:L>(F*1.>=<62T MQ4?$'BC._9W1%Q(+L/R"W($[FQ>M,.G-*?%IFO ]NH'LT>.F79VE?NEXY*O^DFP;' 3RFA; KE#@0 I M5VA6958VP;.36BB2^I%RPNE\4BMO*%OD(FK.W,Y-]9;>$9IJX8X.RABMT4J3&9J/TI:6*\8-J1\+ME[Q$>!+8CF_#*QI4M\+ MN'DY<)*'0 %I(/A$U=<]U>>:,%?[>=.<#TU92!/J9Y#DX2?O.0(+Y6TIWGFHU71PD'/0X42>;(E ZBS=@<]MSOP=6V/5%[ MPI_Z''D@#$WKK;G-[)[C)PG-=*GGEZ_.%PL:5]>+\[JO\VU4T>M\!F;2?!!# MRDKX!3AO%R16*-('VK;@'#3EO\G%<15$(L/3O4_VPV/U:J]=-\*ZX:LM:%32 M,RK_VZZ^2U%)91<7+S02(:Y>VLB^BLN7]JJ\WR$\T+UB593I/T.+R\.J+OL* M-K"&!.LW?0G(8B=JZKZ_O$H&73%O7",-M#QS2P=ECXNU)98BMH(W.U*Z5 M4@.;5-&7H,]12O0=BT48))IQ XLO$3HH7".+ MJ=G=-[/@&) ."J2+@TE'"_LK0U;P%RM,.RM,NRM<"F2"M*M0YBR&).HL2O=? MI'F4QSOUV =4L_X$=DOU]P#REDVLC!$JN]CA>DULN-IL(XL&D="V&X(#IQL2 M3)+9KYA^3*.'-!N3PYXOD(+6FH4?*16N0DQ5&8%T:PS,[#SK;@A9O:3O R9LK5E'R M[GV8Q"H5@C,$%4V#?-I2W]?KJJPXU2#6F590*N-Z(?,41'WSH:D Y.I$8*?BW1TBX6'VCYN M%MWX^ZY AJ\G ?UUG]-2U!X *#X!A MB# F/,\R2SMA*+N?JH_1NJ#9\!V]_PN,S.W.Y%J>/E5$@L-?LTT1=A"PQU>5 M"9P"&/,#?3(-4L'%T]C0?U'%TC$SCO21G8T=6#D45'EY7UVG^L MW*;3SM/M-<:/J#Z<=NW"*"\7*CJ'QE+7M(LX^A>"]^A!V4%[05$ ME\O!8(.>;]#A!9VYW <4E*),4B'!!0J;[Z4>4R*)H2=)>I4Y7T+[TCSFG"E\ M%G5&V/4"ZBMU"Z1Q7E4J:.EFN* M8_X/JE5W(#2?X+R-$F%Q82MV4"9TF\^9'Y:N!(N[&BB]&L W:5]),+<[ZO?T M_;'@F-T4;)$.W1M[OD">O)V9?)G&'9 8(]<(8T2S* &/+*/B4:^NI!U\]5T[ MZO@Z,FWZF),IT,/0K.$&=YI3$54I&N% 4W9.F+H]:/$IJJ"6Y&/W[S])]ZK, M >RS9FS-B3%B3&%[L5U,D=0^LOU3!:$R:B1)%PO1H(0T>)(&T=UO:E2)Q)6\ M^0N-"JUXH4 TPEDS#9GB+@E60";:D&G9D&GGF^;11]9."F# 6-,+S,F6&9DK M95%U3!7^KWTSA?^*WT[7.1>,5514FZMH24^^I/O7P:G/-'7BT'3NO05;F 2 MDE\ K-^*19.T9*H$5CN'#46P43*, )P ME@3LG[?TZD>[[H2 M^7P 2 3B<"IND*],A5J "D3\7 M:<45YLL^XTQ_:%H4LIW00U./Y[0$AH%^]O1+3&O_)'O@^T(K*H*Z!$X8;XN- M!2%N?"U8(N >)QQPV)J6AQS25\UR@$HV&B-$V7U]0RE8LHZKJ28)$]^C&R8, MS.NE>4*4D?OF2E]#-VRE8&TUKMHJ0 OT9JEZE'7M:/%,R^EL?LQXC,[5@>.:CUI[8&01L.AAG44% M2;:]7]F"1*3LY/)'#;J"(H7$ET1Q#/?WDKQP_4>%YGYNJ0@?_GT=9>EB(V/N MZV\C_B5-141G#HGR"8F@!UE9B?%Q'6\3Y3+(B[Q)<\**A']=,3$[M_DJ*(F? M\KG$VS3,+O[PEG_()^%_X[*1T9A_UEY7-X3K9D[>M'R"BRR#(T8>3B+4%(H] MDL6Z@L4#"B$>NE%"QXP9:PZQIH/]RB?<+9JS6(TC'806-FIT$"U[,:(V5FX< MV7,&\AO7 2W0&J-&:K?+X8Q"1*>Y6)_G.T M7/WIWB!+%(VHB_10N9H0R:'[>\Y&Z>.Y8M]NK9U.%9Z3)=@; P>(ZC!L;;^) MZ5VS_L=MN:6ZZI2$VRU-A:H :'U="/?9X>(Z>!S5*PU3*E"5JQB6I',PUK3J MB(^/LVJ0A:HHWGD1"UY6?(+0A MJ5&"4[1%'+BFAFC'% AB:$]^I-T7__-/=Q=1+*[DE_E% ?W9JU/P$K B3T>: MS>)GP=BH^M#<'^D<(]*B=$0X4J3!"LH;U'@=D2UF>-/7Q_J-C>1,D"3:)7G/ZM*Z] (<\GO[=W_X M4TD^?_-G6U)GOC;[$M:SW. 2-'*ZOT[%=#'OC]. M3>UCY,G9TN.* UEAL%2 5&+[N*$K(H+H4NUDE)DV9+2&Z M-2;B[O_N3_R*PG$*4PY)B[V8$34#' T#X;JCW]E0\SZ"=7N5>9A@W7%Z#BEL MRTFRZ"?9'1YN$]N4M#-F"L.'6A50OL/F5' RB9ESL^;7K;E1K-?S:*U/6[]2 M>@^-X=?%1GB^1J^((U\B9:YG1N=:O09)!,RP-\,Q@C(-*GEP.@$3@]>T\7(, M'/RCWV%<3GWS^?-*ACGMQXG(E"D3Y!(&[J_T,=>\?DV-,KMX#RA"'=0T\Y+UJDF\.;U1J) MC*=>XX6QDM<&&UO$X$-]V\3@V)A:Q[76^ M,O'2Y*D>LU>'@'Z%[21)4O!A1ME-E":7^6FT2JNHOR^MUABD:(W.[5JBML ) M0#].T03JC^GKP.W0?A[WYW%>*$+%5,W!2#).2*=/'+Y,( M-+:A73<%>RRBYF(%E-.7R4KO!EA'KYD%07#= C3&L@/8EC1EMA2;=_ M*Y9#N^ M&*AZL[60?D^_XRQ M3T.VHB';NFRZDP;4AV8*85])6M@\0\VY"W^+UPG_;Y]B5/D>H_?&YO5B<8TA MH"V<=E>#T$M[NNB(=!458$'>W/U]#?4B+QBK]%L;V5V@%>42R3),;+&C7<1? M8+VR\.6^LND89,&:&"F)%-,FO&FINB@O%RG-DD]H@B>2J_ M06'):L/O02N6PQ[T1"9JC4$[]$?F=BU7$B;9 @T1NJA'988BG5\>V\.G-]]1 MZ5LD3_7.Z9N7PB0PJI&5:=$J2-R'WBN'VB"SJ(_ KQKC6!C$?-A[Q=#O37P/ M0T+&=V@\5>B0RZ_(2)2@??D%7R/T!$WS-;>?:AN=Y>4'RNTKVJ).RSK,<$"< MS"=$BAH>L"\QQ&.(ZU[ECQZO+-36 H\R^X2>O>"??ZF*B!5)FD?%1G2FN>*T MAC;"+./X/5Y"KTY:#AVT'B#Z4QVJF,U8MZ@NP9/R<4=1A''1EK%YD_$UO"4/ M EOPRG%T15EG*H]P\N9!'N(3_L?Y:#)MF3)3=;AMG;TN;&)H[.FZ_1G]Z;(& M\HQU58.B)UV$IXA!.-9K42 'C&JF(/II[3E,,BVCQ\<""G1R'*\7M_29YFLZ MV@D/-18;)*D"PWE7@QTDX#&J1D.[\YVK4$*MG6!&Y/5=5E @U,@4]%^ TF"G MZ[+BTE-,L:CN<'3I034P[HL12K8$[B -)N2%HT(:7#C+!F96[3UAIH3V[(N- MRJ>3/('_@)_X.>&&96F\F>)7K;%8SZP*#.D7NG!Z UI]#$[O7F WDV3"< I69/NG\LM:/ M-(?,!,[^)\DRS5/HG%2ES[1V_X^F4VJ-13*<$@S7O% M1C CZGJNRB![+D-+>I 9"-@<;]PV/0!;CV%P8N?%&%K(I %-?FF !ZK#,$UE MID\ZSZ%"Z6.>+M(8&M$>(#AUP.H-Q@8/*0%Q7O=LBP7I9<70Q[#F7C S ONN M;,"7GU?2,76;EK^>M2WN)V\H&D/1]0^F0;@OB=#!@0 29(M%>.;4V@5F0EH= MQBP;SBQI_,TC>_XVH2E?VKL?X(=C^*'#B_Q7?Y4UW<5#"%?;W$(XBZJH#AG9 MXS_5SS5Y;FI:YP%P C;I "< G=3@O3*7,HF9+MT\'\%4O*]Q\_-35/Q*0?NJ MW#M4AV&/W8GIG1^X$KZX;;08S..BH4QYAB6GY^M%EK&7B"_[@A5G;/U0+=99 M;0F4V_LZ_XD]TX+;!$.7#N0TV*N()CC7#/LA2DA"'ZHFX"#,E02[!\P687W[ M!%=UQ[KKQ6=.])A;!LD9WX5!E^#$]VB/X,"\OI[J!Q' /,3;6(UA+\4:/CQ> MWD2;^(G&OT)!HHK&PL*M2_B0C$7Y1*JW,[?G%"&I*\>__FX2UIP'LW2 =)R%3H,L=S_V>.+KU>+,R._8-9 MG)[Z+31?ZE<3+8Q2=K=R$U4MX!VSR34%M7<.F4_;W!F@JV\_6%E=+T1MFXD* MGP/?H3U<>_.Y=V>5(KE>@ Q=XG.(EDR90+YMXI)R6/"8?T:?:<96(G]4P:6@ M,1)M)T]"AL 3.@JU^6_"G*UL*'VRI;47*&(UT\\Q^3 MOZW+2IC' XRI/1[)GLIP7#-IG7=4^U7C#=G"#L*6^AO C*DZ)Q;]$&7P*Q1[ M[HUUPIHU#%_FKA(R&"/7T2IEN9V[*BHJ/?.VADBBBGR@CVDN*I: 3T),.+L5 MGN>:YGMG?7RLZLJ"*)E],5)6,+TTG9-R.7V*BD>:W#,P(_GOZV,;I6PFYG*B M? 9@.G^+;!+[:E?T)DQFG]E^*'.Q$I%#9..U%6J@B:= ?[C(D,((HVRZWIE= M\Z$$35K8I $>LM"0"J4/TL$4R.>7PVX*%E.:B!RUR[)<@U"H/?1HC$1RG ($ MUYS7H" 3:.;Y3J*S$QA,V>H=HJ1A MO=D/49F6UXL;69I4@L^3SR4_8L[+*EWR'9C(,3.=!E.=%@'.?= 31XE<+T@7 M*<*Q(E!WGO^^14P_7RT4!7"%;B4EV(*LNI2 -P8H)<]_3UM*K"0A*B#$ ^ 8 MH,ZM">LR6[MA*,5<250%5P^BK#:'?%T]T4+>DU6D%S$<([4:8#P\?6U1$5(J MD"$U-E9$U.ERL36HN\L&D61BV7&][#G((X89F2G) U6E_K NTYR6Y1U]7*I6 MI1X;8UJ5NF]N]^'M$M8LBE&/$K>O&/4TQ7RG4 @\1J_?O=^@DR,Z<_ECE9"W MZ7[R,26:A*A,7@=:IK2\S),U5Y";T= 7M4%&M8IT>ZF,Z<[&2[/YR.8'M>+TX(F@[T")K^WD.>S M,V^(/)\=!$SS?+"KL9?G4]!GECW#%2T62)!%%$-_.K])'.H<-)#?,T)(OS+S M,X66?C2I->254)#7BS/0 S01@EU>KZNRXC=B3O4!24+.@I0O36CZ4L?G?6"Z MA5\;K$A4'S;0+9>1Z-$8ZOVQVQ?+/ MXWE*/5\@&:@SDVMN@2;*G^_"9HGT$8XI4"-<]):*T3[YO85(+:]&^VY\%M*^ M=;XF1"7\W84)^&#!2PR.2+B.7],L-!!CYLIJ+XNJ(S#\7_O"PG_UU[OXB2;K MC%XOMM$0>?)?ZRA+%QMXTZG34:?+GEF:35/0#*$Z=Z"?GY(&O2/R[OWQ=S\< MM;\ OFTQ%A;L%N>FTE\YBV)JMO:66=ZP0*^(HNC_U+/ASD>F[X1B,N?,VD91 MRF8-@9\&=PG8]Q;80Y5 ''&]N$CS*(_3*+MA92HX>KQ.KLY04^X9 >&/I[BR M:[$@#1JAZ^AJ[4(?"RJ3UO,]>\^-7OL"AB[8XU]C;];]LWIRG%W1BM"]#FTK MB+SI.HGZG$$)R_[_ZHYLR7$;]RM\V=JDRE-[ONRCQ].==%4?L].=Y%F6Z+9V M9-&KHR>]7[\$11T>2Z((7LI#DAF' D 0 $$0!+*H*,5@,0H5/;,V>EMO66S@WKJJ7'<[3C#VYJ9-F M? %OPYMK^&-!Z6P*\^+O+)KP"_@AC/F&M#2$S5Q=SGR%B9_A:+# &73]N\W8 M-U5CJ26?F ?*KD![#9")%H\"_8H"8]/<'@^(*5CH5]#N:532M@%J'64OM#C- M&CKU!T@AFP;L6L0$9C) 30!W6).V@,U,GW?!C-ASQ>*O1Y8E_(3;I,4LMV;J M;\W-VC0.K_9M2,:?24/(BBS=@I48-WE+V1O>]LV:UQ2R F]^KVB11]FN+BM.?%%^?/^)0D6] M\S&-MP7?'D3VB[H1O3%$]'LU-&;WQ4@$:4T*:4L8U;MS[2QMSP!W-L\\ M!YB[=Q+_KOD62XOLO8;G1_=/_#]EQ;> /)&MJC3EWPBJL2:@L#N_I!F\ M2).ASKV@L/T;IW%#6BK%4[6V3=CJU,5L>4<5Q\*:&=:;E9O1?1KMX=UN2N=] M9:UO,)5E5;!="ZS$3P8$:$NBEVGARL9RK'46%23IWWYRS8SEI+.>O #E8A>+ M%4,Q-:#C+HJ_9U!+"AH=<44'PL6?ESCQZJ]M./336()$H*;),0[HV)PIXN'! M=>5F20T!$LH-:2D2?P]9>$!7"J?./4L9'LH;A"L=EC>5SKI=6/8B^TAS>D@K M34\0#='8"]3&[-,#[(D;^(.*"@O M)[:)G7'=7NH[6H)FK"):6'VJ1TN84 D9AX7]P<07=:X7N#4' M W2E>^M/;U_X/@?-.W.H@X2)HN%!&FN&/FJ?ZM%1-]PY@$!R2>'Z=,1@24<5 MQ72= AZ%/O/EG4D5G1UKXYC3PO3;E@:PADP0G6?KE-\^SJO PC/[QD(QVI8 M^7E=,29"(5]6J)@[)T;AWU3Z?<2F:R!^9\[PS%<.Q;X FPKF6IQ4MZ MQ&&K?2KYRW299A@([[?2BVWT$Z4GFGQ*W]*$YJ*K@(S)/]?[,DW2J.">Z5B0 MW 8\3 #=!*]K*30F4#ON[I<;B&A@2T.3,GJ0=U_E'V?.N'N(IOL&>/75D9(D MY0YM0;G1('M:?:,T)P4]LP*"HFGCZU?@%PD?M MWTET/F>B%*; W=X]'FA"BR@C)9]*S?7M?0BP$$TN*P:=,.'O\G_)^@)-TQ66 M5VE> UQVYI!$AU<2#1+!X?N()&(=^)Q5"Q_@"L:*T6+6Y="OI_#"L3T=+ER8 M6:=3.1[I*TS"=6VF 3&HYJ4#&M3W5/.8:3/.KU3=RL+8.VXR.$&SSN?L6*0T MC<)T+4DM4B*QAO4YY]G*M'@5*N X<[%6+H\Q:D$Q#BLNPN;W-'UU[;J^H*'> M&HW&"1&,#QC= ;($D2)+=FF0:^A^Y51LQ6L)',ZP>BKVH^*?X:'] MY4B+4Y2)I@?E>%\6Y3C,(7L,GG.OK,%))-*%6ZDSXK%MR_D!JA09 )6/_WV3&Z_/#V0V[O'[>/N[O$GLMV]W/UZ]W)W M\QRFFQ=^;9@]AH[BIZF7%L,"*."-\M0^4H!UJ$)DP?L M=LZ(\+_ '+#0CZ:D757_P;#2\[WO@ER9;77;!/^?V]C_Q>"I*V)[D+&WR>84 M^-)L"Z2B2E"'X!#"#BS-;=N0J"*27-+1^_U'&_*9RG5MC@E5FXRF#SC/V^Z-<";JW"U=P=.;NY M@EQE4O?M$+.,?8/Z,GH.* *P7;=4@X# SJH&I19=6*?\06QH#3TE27/RUGJ;\?26 M%G5)MFFR@42DE!Y$3M(--T;LE,;DF?)3)F3._2!X_B,P'9SI!VXPC@3,00!+ M:& MF"4Y\'O,YDMU9I#[S4_]S_05A&LV<5,Y'GDHGH3K_'ZQ1;PA'/4'B3ML M&J>:R4R;<\:/AQ)ZIOQ?>?6)>S(Q7]R9;"3U:-S#GRFH[GM8=)A)AQI_"+,Y M$2M9'NE@?DE+49#7&4JY89H\]!P#;][%Y*^B"N$ M_XF5DH50IB+C2##8>+DF.E_Q1UVZ,-%&]W/'7)JW1!%!%7>@@*X/[/"!4]84 M3MF0(7%D$0=<73=@I9796@;/;Q6N6I9-J/'T0.R+@RN OE3Q&C-&V6S07T&U M.#UU$@7FFFA+UT&/!IT$OOL#ON>#/;K_4!T?9I20+6>.:7BW+XL6%04\S85; M$O[7VS1/*RH:$]QQ)RY_3?=98_06E*FU!Q45*C;&[K4RGZ21""+AEX9,V12B M)[2M2V:A)FX(#MFLFEN)P)'DVUO+M\.0;VG/MTC0'R)\;4\-F*.5,ZUA#>_9 MY-NV%_9</A7P"63&H M/"#)$8(M"=J0W98<)$WZ5:^=3MC*V3Y&\"%$;6R,B#+C93!6S#>:1WEU6U?< M9C8U/[Z(\#H8@W%57/(%3OGF('NY9YHG :%==F>$R?*1)&Q(0P21=5U6-"N< ME9#3B9KI%!U^DA[(-VXU"@JYN7!C W4E*OX/*<\T3@\IMR(9?:.9*'%,1>4J M$3+G(\">#$:U=;BJ8\'JUR-W(?CIH2Y)(FK-T.;**87'\0/Q: ?8D-E MS4UKW- 40J@GI8(MXYFAZ#ZR?)'TSHW#"/ 8/-&=N38#O6V13GGOP06 MYUDQ88NYMXK<=4YFPD^5<05GQOD+( 0$N]GH8Y@"IYV/D60QO]S.C!$NY@7B MMK!?F(O[_H;[GV G=UE4ED\'$?N=J<:C'(^^S9F Z]SW GS@ MO3<9MP&K[ZA9R[3Y9>C ;$_[@F;935VP,XWRIZ[2Y8[_P[(TF2ZMC/X>X_#H MX'$M4)(6TA)#>FK(!3EX#\GM=&U[3E<,&11,C8<$!W"I4 +*C)=AM2[8,W<; MZ<>HA+)Q)_BE>=XTW;O.*FSW;MLT#2MTZ*:)=>SJV>02MF=>*JH\-Z]"X@$5 M:_<%%T@YSDM M%,('AP!9&GP))+OEP>MGKIP^/(E"27] MOU'(B*?)%C;95_I8@V(^'81_K-N3%@'+6 ,TTUFH\S/[0@B#UO2=2/!'Z[3QD MLG"TZ8/&2ZC.J_]US_9:O&'?D:N8._;^;HYCCK+8,9GK+K/5UY*AWJGW9FBY MK.6HKS@O?85YZ-JYYT[RS45D[:'.JO0A*K[2N7BT8BA&829 ^BFJ*O 2B1CO MX%B;@]48<1,5/HDIGAJZ LB^2F28#@]-\TCE>>0A^@\K=G59L1,M1OL0SX]$ MY9*.0O3R@F( %QX;0*@Z1JCNOATQC55>1*\)_V!4T M22O-5B;7W]G-\>CA!\[?Z FQF)N!FMV_FMGE]%5X88AG7DW!<_).HT*TPXX; M&L@/;=]JN/P!>P#5Z7Y<4T+&B+BIDRVFN+P*Q1-YGML\N><*DW5CJ*8:JJ#8 M5I!7".>X,C*HM(J"9V+22]:AE5L,[?- MSG[1/^=3>CA0\ 32*-/;;I9"L[OMJ+ &]A!5Y%GT&^US G'VE43 $0ZZ5<&> M#)5922()B=?UKFNQS*HW8SWV6V@! BU'?BJBO&KK+8]MO[,#L0U K@!Z"0R- M8D:U_[! /T(U6LQ$H":A9V E)B2+9_#]/&EG]RIF=Y9T!6II,BWR;#D7O]?1 MX53N^9_XC^U/_%_[J*3\E_\#4$L#!!0 ( (R"=U*1A5,\5F( ,S@" 5 M :6YT="TR,#(P,3(S,5]P&UL[;UK<^,XLB;\?2/V/_3;^YG377WO M$V=VP]=:G['+/K:K>^?3!$Q"$J8I0@V2=JE__0N0DBS+!)C@!0 A1)PS7;8! M,#.1 #*?3"3^\_]\6:9?/6.6$YK]_>L/?_OVZZ]P%M.$9/._?_WY(3IY.+NZ M^OJKO$!9@E*:X;]_G=&O_\___I__XS__ORCZB#/,4(&3KY[67STNRBS![)PN M\5?_[_3^^JOHJV]__H\/W]W=?/7Y\>RK[[[][D/T[??1=]]'T?_^SY1D?_R' M^)\GE..O.!%97OWX]Z\71;'ZCV^^>7EY^=N7)Y;^C;+Y-]]]^^WWWVQ;?[UI M+OZ:%+L.^XU__*;^XZ[INZ%?OJ_:?OCUUU^_J?ZZ:YJ3IH9\T _?_+^;ZX=X M@9:;)"MP7OPMIDL^YG???OCN^P_?B';?<)H+ MO,19$0F*DS+%$2'1,TK+BO"(SW'T9XE2,EOS^8]0'-,R*W+.9/7-!<.SOW_- M1R^B[;B"K/_5<]ABO>):E9/E*L5??[/'XXKAG(]:#7+-?[%I+U@QPF]-&/Y2 M8*[7&^EO:4MI_$8J@IQ\JX4YCO\VI\_?))APBC[\*OX1B7]$WW[8S.7_XK_Z MUT56D&+-%PPBV?:C*7K"Z=^_EOVYIBD5JD;91EJ#TG2-YRBMOWSRA>0-9$E: MZ%#V7H?$;_[UB?*)?*27).-KBZ#T83M_^9S2O&3X MD>O8*2?@CP/V!AJM-]ME'LT16NVQOOG-(?N;7_^K@1C)#&KTF#@;T7?V&-DM M";Z-XBO^S\-UW=[0(M&/Z"G%;02_::0B=O]4.6'Q5Y1QH^7O7W/#A_]EAAG# MR77]#>DA71TN%2'\@Y6A\1]BUG'R]Z\+5NZH0"Q^=U:]'6C3XIL58N*4BAH M/P48,6 1?)BJ"*#[O2_* #$OZ, &UZOL_O.;1G]F.'2 MS2A;5A^".V^ 04RX:F R@F,6'#,W3'M/V+#JH=2K_1ZO*"OX+MON''?H&1RO MX'@%QRLX7L'Q"HY7<+Q<%G!RW+1R^IPG)OVLWZ-:+' +(I+5C&?$O1$4E)P"G7=+2+&(XC(OZ)+OP)KNE.:HQARM M3G0%%RRX8&[X+IZP8=,%NZ_7_R5?_F>;U?\[7_MGFZ7?YH[I=@^N67#-@FL6 M7+/@F@77++AF+KIFW4YT@VY:0N.R^HY6I ,XD EG3(N4$?VO$TY$ M(@BY3-&\P=-I_/OH'M@FK'K)%1FE_\2(763).1== X%M34>G]7PSDS4%=Y@1 MFESRWS7YC:UM#5,KY 6C]5U+8Y1>O:X*F4$/;6Z#YB9['M+4&*VU%LH7F+*= M,2H?^8<4Q.W_>72::DOJ#(NS,KWB&_.7?^"U%+R2M#-%)5TN:?90\//[8<$M MA_RV+*IZU"1KVN[AG4S17V_ONSOMPH9KW*X@S0W1[!::67_T@EMR,Y$8Y*5GQ"RZ;]7M7,$(T/"YRF;0NHJ9$I M^I8H34_+G!L_N7RC;&QEB,+?:%IR+XK5BU=.HZ2=(2I_YS/XCXR^9 \8Y33# MR56>EYA)J6UI[T?4JA-E#S@N&?_HA^^>'DG1: W+FHQ.VR-#PJIY6"^?:-I M6./?_4'&+@M$#)<'IY8 MN6UX,%P@GABX\I M7!2>F+: T#I<)IX8M:"T$[A4/+%K@8E#<+EX8M0JTM/@ MLO#$CE7'4 SF:\8TRVE*$O&V>?2$4O'6=Y0O,"[RJ&9W@0O"]5CC4IW^F":R M.+M2%2[4'9 U4&BR_SVQQC\BR"(LVI'KW& M,,_JGA-SA]@MJ]+C$_%N(^8'3.772!C4Z&F5K=HW.RF+!67D+YRTLR/KX0 ; M%88%9N%M:_/DWVT/U"[ZI=?9-G- +8-U[RYAW-265NJZ]*ZW3UYF[N.,0^,HSRDJWW5%I"L:*E/PE.G33,^KWBD/QE M7C&.+^TKW)SM=KF^AW_GGD1F)D:@V6,/4))M'*YJ26/^=L"Y#&_.NNA,7?"YC/M<9'_)V=D_C!9]3 MS$ZRI-I5;F>?\,L_*?OC!B^?WM59Z=#S&-S#G!5[!C+_Z= XYK_ZUYE0?L15&"AAEO:V:&T!OTA2S+9:,"2/]NB#22J4EK^KL9TNY1-I?-Z;N_&21) M*JN&OQHB"Z]*%B]0CD_F#%=+\E#I&[?I3GTGCIEXPH;5I]A?#9"3G?UQMS$_ MVM[9T.L<(*( $06(*$!$ 2(:@_EF2XJV6#,^<*WT"6@ORVCJXFD'S10&^-01 M0^6*4/A"4\_N4_,M=T^G/M\P96]'$*8N!\B>V!FJFOKB,!E)F4J.:XBDZ$52 MNKB]IJ,KWT=\?"ZON"B9B"B()YQHL<",RP&QN79(!3R>L3B*)D4A>') UGC! MDY/E$\-I>E$RNL(H>PTXGNU*4?"?Y"&4+OT'(/OBYN$!SX6"W>\K%C\6+U%, MTJJD&HC^7@,-P<@7')>B)-X-RM"\=G86PB#,%30#^PQ WE8(#^0OOLTE7#Q* M:0*:#T#4_\4HJ;;RW2=R/E\7?!>C:\R_6PVNI+/;" .0?HWWW=J+9;Z5V%5V M4UPC?JJEW*#[+P%0K>7D=Q_%LQBFA,1;<;2\7<_U),M%"NPR '$/^)GOD5F, MN<957[W-<$&6W)QA2RX=\=%3G.$9*13D=AXD!%Y#X'7Z@=>'&&>($7I)&8Y1 M7D@I5# MT;S@]AK_'6;/30>]9B_+[%PM5X@PL?MOC5!A,C^3@N"\84."\-IQ2,N"N$M1 M!IW-P[8.D*Y<5"VM0YZ0AQ6_^!=O9V\F7JDBK>U#JE-(=3H41TAUVDHDI#KY ME^H$._JIYC'KI504YBW5/F.F+J%V3(5JX413EP?8.Z7Z;J OLFE/#0$X(%// MHP)ON$,%?7T16,@V/>39XVQ3V*0#0'T?%$#KG%7%CZ:N%:/G(#O*M^:9H95T MC%Y>%%A 4ZD^*]4;6,#)%X6!.#"#I';YLO' -F6MK"TO MSRO YM,GV=%+=8)!3@,+R/$-&[;>NF=[>RDGP.+KF:@)%IOC)=<[K#] /HTO MTC%QP6TJ1>?#!3>]"V[#Y<^8OO;V0S2G-'DA:5K=!^/=N#M-^.Q'*,_%B[=; M\H#7WL#C&;OVIDE1N/9V0%:HTQYRGZ>:^_QQL_+Y1GRU6_9 %6J3UQE,64KRL3CC_+[^/!>IB[@PP,9F M0WI'G/*^.+#7Q"$X3]BP6O8?I3B_Q\\X*_$GW%SK!-0VX((!%PRX8, % RXX M5AJ]PJ.B6G[,U(6A8T_3#N:=Q_)I]IU40E(ZD+Y(JAUK!OMNOL#ONHM+Q^'P M14:=U$8!7_@BERX;#\"Y\"7'7GU#L@TXG;J2M)LRG4!O7RX3F(C\.IX&'R*_ M'2._^H"LZ7CO+U$J[J#IAGD/NQF+[C9_. 1U#\@:\0F)DI\1](FDN+J\J*A: MKFXY>'G]S6VEG-LJ"\Q2E"6[VY30VOK@(48C_O,_=&D][#'\LP4W#Z^W4B\9 M7M*L.$,IF5&6$01^MD!CE/#R@OCX#%ZI$ 2'O/DCJZ M)R-L"@)]Q'3.T&I!8I3*J[2WM35<*&S3ACJ!CN0L7P M:YSG&&]N5F?SVE!J2_. =0KQWQ#_#?'?$/\-\=_1:\I)K2RJ94%.729@6R'4 M;PVELC1T91 XP9=85:@M9D9@FEB@+Z$>L+0@Z"Y8*(Y7[.FI0LT0K2\[.+"\ ML!J)FKHPP.:@)E3KRZEE(HCN^#D4@N@=@^@Z<)?I\/F';Z,$/^W(!D;/#WH9 M"YXW?C?$S@_(&B]V?O.H"-\]'E^H3O_N'=_02+&UPU4W.Z4-;1.MOO"H:&HA MUL7W"OCETY;6$P_5><*&U8@CMVIN9^ EW-;<#0:NQ=G97,A MYL%AFB6T.R* M6P_L"65_W,ZXR8B3>[[?7U^=WMXK[YYJ]37/VCU^INFS*#_\1NY*ED!]0EC5 MOS=P?T.," J$]BIV)%DSNP0K]QYYPQ"\#L'K0W&$X/4^*N5O\!K@)5$=I\07 M>4@W> K?47V11:OY3;M:N+Y("!#*![DP4X]]Z&B, NKR10R .\A'HA"PS4/# MZ_(_&@9S-7Q1$,AYVP%G\#]B&&X>AZ"I.F@*0N.-1TL_1"3CK7!4H"]8^\D? M67=S\5,E 2&0>D#6<526=C#*XPD;-H-55]4Z?T1?X %02)<0/0B7L@*N'7#M M@&M/W7%RW+4.CE-'QPE^BAOWGKZ/\H)3\82XO"+>?(6SO/I8M$K1;BE#G2G8 M:.9\*QUZ@JMES-6ZX#-/UUA5Z$G29("/7_%)7HF9SHISPG#,!U+0T=[:,]=3 M0F+U2#2)"YP\B!7U&_]1O!:=7=*2_1,CE0@UNXY(["/OA3M2*^L[ +D/"W[@ MG(H]ZFQOBSIY02QY9'QN%UB(2DYRE_Y#D"WD<\?W4?Z''Q34R9N9*7)TQT\5 M(A9P(XV*%F;(>R1%BF]G?*,ASR0II?67E.TLD?H[*1;W.*WT+5^0U2-5''4] M1C"/%M2K9ZU\ZJFQC4U\[':VOP%48A5[0E[DKUO$'5I79T1KZOTPHTX<+O2$ M#9NHY]:2J\Z!VY70(67&=&M[\RR(TTL\NZ'8"YJ:V"-4F;_;W,A&.OT;2ZLE MC5[1U@*6W&QQ,6YMS6L3_'3];G.LCHO7,R-+0+,UYJ><$=R>J7J;8?7[9/HC MN,AFY4[T9+1A#"=9?:%]&3T<(82\/+PP4WO:JKLR[UM8(U-]0Z:I30@BAB#B MH3A"$'$KD>,((C8C!M2DM>>+*)L. PK:@GV10*/+26%^WM1ET Z(T@$ QZE+ M"1ZXE\,7OB0OR%8++$;ABQ3:-4$!:OLBA-93& A!^G)UJ%4> /3-%UFH*T\" M8G!37R2@D[4]16/J^@ 7 S1#Q/\;9*TXS=37!M#WZ Q13WW1#"8?">#KRQ+J M+Q\9\N_+'4V)A'JF.TU=?\!>KS*AR9==1NG1=4HZG+I^])*,.L'1EXW%Q#4. MQU\>"-5[M9QS-WN@%$2[G4< MD'4<5^A52>OW.X41)Z4L$Q;!/4BIYPAF>DZ.8CM8UCSD>"41)\I. CO9+XN, _ M?/OA'V)ARJ_U2AL-0\#FG,*&3:?L#F>Y.$2SY%8\MWM'.4FX M(*Q:-Z?U9IC#2['U'<[&!;LM>8 +C.K&+A"OO'+1UCQ@ @$3")A P 0")C"F M5K0<(E1WO_9%+NU >3X]04V:=<2B(?A2QH+7!HMOHXOZF$"6'1<)P*PV#%% M8Q@GS3CN^'/T9XD8-^/2=133+*D1F)$?\WBF-:9N)*3;3B#DQ,<+[[ M!]QITQW1A)/6C:;@E!ESRDY13O+;V=W^CI EGW-\.[O("\)7"\[OQ"2ME2GO M/889@(DS6JE5M06BI^K9WGN\JN_2W,ZJ_9%3<\T_D7YD7!4ORRS)[W&,R3-. M:K( /([WE0%$\)'2Y(6D?(\K4#8G_*BH:,GFU^+K)WF."\@\]AAFJ#<8RK@H MF;C'N\'CSA:(S4%*V*'[ $3O;7:=M[U]+H88ST+M^QU5=QM:6B"$]@[FF3@M M4:I<#+5RZ=37PME MX1'+N,+D=YA5=R9A3 %[F6?G$A'V&TI+?(.1,&NK>![@-.KX[GGD1[!YR@W'8UMP& \]5[9H)5SE_R[S NA-.VMVMY$@+;Q1 20"-\+V#E;>@,&(Q<)0/>>C+H[*YX";.ES\ MY+FZSJ=VM'J,%"*U_KW[\5 ^Y?C/4BS>9UW[1ZNO9T'H0;"E$)Z6A:>!-MS4 M W(A-!U"TR$T_:9X8HOO2?5Q;U]$ ^"7#A5$]&5AP60VC'_MR_4'/9EU, +! M@G*\T*N>H* 1+K!T'*_UJK%==0XW@V7E>%%8/4WJ$%L$"^HGGP0%Q=S TOG9 M)^ET#'J"A?6+#$:)I<'++-??9!91SP5;G-Z8:CK17GAPO',(N\2"((+RRM3 M'!QKA\O'"PO<2,XI7*9>V.V#A9/@25"=\OQ)?&FM((^DYBVQ68893$:))*O,!)*1[>^YT; XL")R?/ MF*$Y_E2*0ES5JC.,.NB ZP M9WRZ?N04B>>.\Z(CRY"1@E<;O-K@U=JWO ;>NX,K&US9X,H&5S:XLCJN; ># MT1>%Z2PFN)%IVM__(9IOK\Y+L$G@C5&7M=G/W-4P/QL8'X+OL!P?I6=I"E]05F,+RD[I^53,2O3S2VK_+5DB1;P-\30 M8$IW905A*KU60MSDJ/YG'%%JVY(SS;5,4!.MU;?@",%'"G@2/8-LE&V MK0 G!3@IP$D!3@IP4KN?V\%J\D5-X,#2<)Z#:>?_YXAL2J=U+N>@&L*8(]]. M1'#7C;GK4GM--4L@/[5]FNVD>NSJ#]8UE@K-*@JP[L$G#3YI\$GMVP<]MJC@ M>0;/,WB>P?,,GJ=.(H..>63:@?HE2JM:P=U\)TEO8VZ3\OO!8S+F,3V4*S[5 M8EY0*IZDN$SIRU4VXP*H9KJJ20V(978>94RG3Z)C(']/J9\F3=^J('AU)PMB M [>TMD&^F/O;%69(5.ZJZ-N5\+Y!X@9:L0:RUGFDX+\&_S7XK_9-L&Y;;G!= M@^L:7-?@N@;7M=UU!=E_OB@&1!P];<9CR;GOZ;^9QCY^W=9.JF&9*-W,:>=0 M,GQ 8PB)+DD!-#$&FFS0P.O7&6F'2*!]Q@1$X"H%PDAT-30XX,$!GPZQQ^> M:ZSGX),'GSSXY,$G#SYYBV>E9_:9]J,^?!LE^*GHYC,U=S;F'ZD^'WPA8[[0 M:[+$;5GP*T>6*9IS07*30"Q(?T9=- ;)3G.%9BTLXX(@V MQ7"^V<$YJ755MI,L@<8,!QK-)OL7LQF."_*,=Q-VS_7W'LS'5ET6O4 $0$("( $?8MZEXG? D M B 1 (D 2 1 0N].;V^[R1<%TA%;3P_,_T3J03TVL+B\*6?>W[DS#AM^S^TU M3L43XB*,>'.Q%JJ/1:L491UA1*U!S<&*'<@*,*,#,*/6O,%@QPZJ8 F XLN" MKC%^P.R9Q/AAP;>K4T'UV1[1HG)BO"LQ&=-Y1O["R1UFA$J>C96C4^-\SZ8( M/]'LF6\0.*F8.1';,_2^?K=!;#+;/&$/0MEO5^*?>4 M$$OV:1>OVM2JG>?ELOY=9P'U_TB -@.T&:!-^R[ H%9$@#H#U!F@S@!U!JA3 M"U$9TR'Q1;5T!#J\G7J,N.@P[M Q0J3ZGK1Q4/2G*,?SZF>2S2BK*XATQ$(A M8YF#0.'4!.33&/)9!59N\/()LR84L^'/H\*M$!V!H:QP;3/IVU[3;%X].%L' MM$[7'S&=,[1:D/B$803#?;H-8I[9S8M#EWR[ON KFF4H/=N^[-:-\P%&M(H% MUAIYCU?B7>%L?O6JF:?KS1\U0+\NHUE@OZ:D<"\GQ#5]ZP M+6OU"9AJP%0#IFK?9QC"9@A0:H!2 Y2J/.THZ&3W3B;MV&J[C> +*@A6%+6; MZ9TX1@Q!.(YPAA!$)ZRWNY/GR]II%]=@L( O:ZU=9'TP)..8^,_1GR5B?&+3 M=133+*(/W?#ROM\QAZ4/0VG V8WA['*G ML^]4PN#P813&#FSZWUO*+[>T[IV"FIF2'<8*X%T [P)X9]^X&7N'"\!> /8" ML!=R) - H0-0=#:H#'J1^8;:B)#H>9M@&*$L$4=&2F9KDLTC%,>TS K]\G5] M1C?A,?:G+_B)QOS$U_S7-*4O?$%A<>O]GBL#>X8\D]2E_TCN;1^]:W-J^^MT M\.>"/S<=8H_*G^NUN(,7%[RXX,4%+RYX<2U5QKM;BL;C?U$FGAK&$9U%M'Z+ MF&9YE. "D90? )Q*?B[H!ONT!C47V>M 5G#/C+EGG_@3_-&Z:=29%_=SG:/?6\3MB3VJ;0]S%0=EXDZ749L84 NWG>PR4;P M%Z=Z]G99ZM8]EF"@.V"=!@/= 0/=6=\=?-J.IR7.RZ;]##?MN'P7Y>5RB=A: M6/,YF6=D1F+$_[H!KP2.M:(IB<4+X?WP3?ODG97_(BPCH]1R"5%KI$'Y]-WK--X>ZXLSMK/JX*"7- M/Y%^9%SO+LLLR>]QC$5"=",'?0;LYDE(67O&6?4%@1*<+,5RJ3_48'4#>@Q* MW+9@=R6#.T9CC)/&D%YCPT%)F8RCGK-BS\?B/QWZ5_Q7? [YI&'&3\QB_0DM M<GO9DB[1WQOD8FUIQ7:I?@J#L-[&)46V>^3@K M^3Z>Q>M'OI/G*!94?>0BO*9Y7C\1\HB^2#C1&"'*+')ZE?$#E']L_3LC!5>1 M%]G4O&_H A8: %W[;' 3ATNU6-^EW-[AEN+%GR59":H^YWA6IM=D)@-, 3TM M,_9,P#= ^@>0/=AF&\VGVF+">L#UTI' MD/8RAZZU]Y'G)>-3NA^Z!W&6>&TPXE@H?S@ MC5 ZX&%@*?WHC91400*P.'Z:O#B&C]V#A?>S+\+321X 2^<7/Z0#2F, "^77 MR0MEB,B>Z1R][R,^/A=7S!6\NE>:)1$M%IAQ,2 V[YV8UWE\8]EX/2D,*7@' M9(WX6,_RB>$TO2B%$82RV]W]L+-=O2O^D^(UGP[]!R#[XN9A5\9V3]'XJ7N) MXNI !M+?:Z A&/F"X[+@=L$-RM"\ALP7 E;,%30#^PQ WE8(#^0OOBTF9:R6 M)J#Y $3]7XR2N#8;-I\0UTRW+RO>XW3S>**KNMZLN6B!789@+@'_,SWRBP6 MKD+UU=L,%V2)'S%;D4)#;>9 A&! /'C[MO[S)F-B%ZLV4TY6C M]'9V\44\)]F81JPUP(!Y'"'M-*2=6D\[?8BY%\P(%8Y-C/+F!Q/;&YHE]G.6 MKW!,9@0GTIS8UK:&2-Z>+EMZ)%JI;&<^^PIHQ4";6TCBW9K-*6<;54_0R-II;VV3@T,'G>Z8H MYBWHNLIB 2Q6_Y8P!.SM#(-G-= &X6;3U!W2N1Q?ZT8I=F!@+\OLB+@BE(G# MM@Z0KCQ 6EJ'E'L/ZZ+R+XKTBKV)5ZI(:_MP:R#<&@BW!OR[-0 [X*CF8>*E M5!2V"]7>2:/+V[!)AT0%O!! ;3.654$:NI:,?IU/D?YUCPSM#*/CN<*EQ80.?5] MHX,'HY<<-MX=%-?T!A9"]$5A( [,(/EMOFP\L$U9*V7-R_,*L/GTR?CT4IU@ MD-/ G)\PX:MM^XI[U[*";#X>F:ICG?;TEFQ:61(^2(=$[4BM.^?NB*"4"M" M>C.P8V+.>$:ULY+229,;STZR>V< ML#330E\E8^;&]@_1G-+DA:1I=569=^.32$0Y B06?]\+VUV'-W9?NQ^!X;KV M 5GC7=<^)WF%8G";!N6+RY2^Y-M?W?,9/: %TN4XG\C0SGK\N%D?![0?_MEF M#O66!FX#7^T6<&6\O)IZ+>2KNKI0LST4GK?/1LBPGFJR5$A/#NG)MA$XQT.4 M 8%SHARI/YC;".5(_4'<9%;S$8%K75RT(P+9^C@HID&DGZ(E^C=E45SF!5UR M2?9$C<#C&8.)-"D*N) Q7,A%X$5&ZN9$O!&J=+;5I$;2&EL."EAQ]E!^E0D\ MNCJ4K[*8,GY2BPBBO.H6O)>I6E7[ I(4NI$W,D.D>"#C8"ZE-81:VYI'$,YH M%F.1NB@VTWN2_W&*LWBQ1.P/Y>UG:#<7&%KO:%.4*X!V9^ 6:XP]0/O:ZV(0*W]$EI*NW7-[WL,#&9@MZ1YRRN!6PEP4L%*4X%\'I MK,2?<'/A.5#;@#T'[#E@SP%[[GOO3F&94BU[<.K"T+%+:(=#TV/Y--N@*B$I M#7%?)-4>SP#;P+Z$>'07EXX9YXN,.JF-P@WT12Y=-AZ ">W+I3QU284V &KJ M2M)NRG0"#WVY?6@BN\#Q>W,ANT W,@H+ 1QA7H$.Y&)> PX:&^6&"902.BL!K/4:<%#6WA88V5SHS[EUOL L M15FR*S@"?8,+/,1HQ'_^ARZMAST&)^WBYN&U<,LEPTN:%6T&9?F,X#2Y07F.X@5?2H7J$3%(^^/*43FX*;W;MT[X?YL(5+4W M_7#9)K_T(Z9SAE8+$J-4_E936UM#)&\G=)^0MO>:9&W-!_C$+(L,7V[M5);C M]D%Y2:A/UMQFI#X\?>3"TT?7F%L\^* . <[P2TV>E!-E+[MJ]9XT0=/M;"MY M#9[>=G3G72=_GZ@Z65)6D+\J1[KY'<^NPX0+C"&))"21#"B:HT\B:;<+J9;- M.W69@$VU\&I$*-"KH2N#(#2^!+Q#16,S M.$5WV)%X.E!0ES@(7B>)W0GBK4 MC'K[LH,#'S518V=3%P;8'-1$OWTYM4QDXCA^#H5,G*$+I ) GB-,TPDE=Y7B MT82NQ]M]G)/0\ D3XQG%S@E/-](VGFGLK&CT RQ@(6D7V7=.2,,G8H&%][,? MPM-)B#"=GOKAVRC!3T7/[-2648PEIX+H"+FI!V2-EYMZ\ZA(M'H\YJ0J?OK& M&"?Y)=],[M Z7N#X#_Z[ E?/AV*IN8)/^<;X>O-JE.4D_R![[UDB M7OA9BK*($N;:NEEEB1M+6$ &T);4_7$[X\X43L0&=WUU M>GNO+'>DU=<\:_NVCYB.W48G84?:WN;\W.-GFCX+97FK2JIY ?4)F80V,PG' M(7;?[E(\;OLBBU?^A M7>UN7R0$R%X%^9!33_?1T1@%#.N+& "UNXY$(6";AX9OX7\"&,R@]D5!(.=M M!TC _R2Y4+$KY DJ8 M- B.)QQ;KF#_I!3C27 ?(I+Q5C@JT)?>I1J!HYE+BM.A)R3''9!U7,_4#1/W MN>!^(5_LSR+7E>O=(_HBSI!['--,G,'UOE=<8KX%U-27G++UF\:20-$ (X=J M*W['2-.RUH(TI2]\?>#SS8G*I[_*2C];H&PNLJ]5N5.ZPT092*NFA:V'B&6( M6-J&Q!P'30,DUL%SZKVY'B$N-H+A8]S+^C[*"QK_\82X/"/>7-R+KCX6K5*4 M]?6ZNHUNS@OK0U_PRHQY91=<$^@:J^KH2YH,4F4^P2LQT]R^(HPO>,H4=+2W M]M1+E9!ZSQQTG[C/Y)L?I5=TI+]$R.5*#6[CDCL(^^%.U(KZSL MN0\+?I"=BKWK;&_K.GE!+'ED?((76(A*3G*7_D.1_?3NLXP)^Z(*GZQ?F]RA M=54<21!5_<]&L-6UYOP5_+ZF+YC=BQ&DG([WR4&??AB%UL^KE6GQO'[2#?%< M_%E6Y>QV[YK=BE)MC]RJO5V)(?*/? B^?"\18<(:'E92VE\?5FAB2[KC)@W_ MPP^*#4'>S$R=_3MNX!%Q=C;2J&AAAKQ'4J3X=L;/>/),DE+Z!("RG252?R?% MXAZGE;[F"[)ZI HKL\<(%EXWJ ZL]4IU_Z*QC040?F.E/F#V3&(L.8#3BB3^ M+U$:)J;SC/Q5Q7D)Y>WR(C]#*U*@5/Q6"9B.]#6;8#V(I4\T>^9G$JZ/I_R1 MP1JKS9UMS(QD73-RYCRP5315L+\;;UWH$I@>?*,[GRO[,$9*.-^2EG!+>'M-]F6&G_=1C! M13:K:$A/1AO&<)+5%]J7T<,1++$Y=&1 )9"AOV5]N^P4+/BR(JQJW&[:#S%^ M2+_U.OVV7AFJZD3O6U@C4UV3J*E-2.X-R;W'D=S;',6B)JUF7T39M.51T$;C MBP0: 7L*0\FG+H/V(#T=( @^=2G!$^KEP1]?+A7(5@LL;\87*;1K@B+1PAL3]U?8"+ 7IAP/^:7:UH MQ-37!M#WZ SU3WW1#"8?"7#NRQ+J+Q]9!,67JG@2"?6\]3)U_0%[OU]V M&:5'U^GNV=3UHY=DU/? M@>>L:(U=>QGOR#P^V8(NOHQW$$];X/VOP8UWOCLKV=$2D,"RG'YY5A/77<#B MG/[C[HYD98,E_HM?$A\[?1,LUU_]DJN%"UQPCV+Z;IKEVAYP44_?>[-1CP0X3*MB^6>#Y)655@M?]3J>2 M4T;_P.P2XT8G!=0Q5!IPPV8>B]@W\[YY5O(U::D.G$L+_L%ZVU6AMXI]DB7W MW-KFI_]YR7;QUSJO",:E<@CW6546QH*/ &-T6D98*.80/+7@J4W64W,W\-3M MF#S&!.$>1^T1)OWV.*^/*(VWNZ]C' CY,<*;U-?H"6=X1HIA@!#=<6 M),3U: O$(QT..795&BV_JBWJ8"-@YKA,A8-0S4>X?\Y^K-$C$LX74XJ/*JSA:(S:7YXDU-PRV* )('D#R Y-/#MR8+\05\2VI'0TXHTY;Q]Q'; MIRI"61)146>)LUL3R/^;B?\244-Y(Q(JGD<6C(GOSKER8K>T] M@R1-VE4!SSP>/%-].LL +-E)Z*54%(87U=Z0?)$0)"E:PWCU!1O74)PA\!A? MQ*:I3A"_":-V2>Z*0ON19=]BD :#,>.F:SDJG'[PZ7GKF] 0&!'9]68$F M@N&.+S.7@^&KNG17@5CA?$A<@D\=T66.;ID"@VT@O]9BR?BB+39M'1,,."8Q MWMY2KZB+S$GY0$!3TRDF/T1S2I,7DJ85,,6[H6Q.^$X9H3S'15Z]WD$ST9[. M7MMV2RL9YF/&4DF&)#>DCQR0-7KZ2&M^R/"I"&2^1(I$@_=_'J;Z%N,^ (D5 M226R-F-F,0RS>$"9"T.N4Y,AE=.2^[@XST_B/TN25R_=5_]D6%US!MS/#9;D MD>>6UN;)_[C1#0F]AW\.<DR\K)-1&<:5WN(^@ M,.XG&6G:<^/A,DZG&NF95<[!%;.R*%EU].[F.L)?5CC+\5A(A,8GW0$9M(D. M^,$$\ .-61T&&M!6(T?Z'#LO]!0M39 4L8A M*9T#.J!- 6T*:),3:).S5]B&-7^/\ [@(*;#>-B43W)KLCC'R[WS2')-OLIX MM0!\$ER#CVL:(OTQ8O@99R6.!,_BR9>"H9B;@B^D6$1QF1=TR27^IG98FM(7 M4:HFFE$6);1\*F9E*DJ*B0!FUQ2N\0DQ!J>:8B6 K,9 UI/M_%Q2=KZ9G9/- MY-SC&)-G817R/V(RS\Y*OIME\?J1H2Q/*[5JPE'[CMD-(=!%D<=79A"V;&I- M&* NIT0F@WO\TTZOE+E&*4<\MNB425O()O&>**1?7+*"7H251L M%;_LAF5V'=X80MF/P( [&L,=I2Y,UQD$@6W]U,.DLWN-\QSC3 M$+C>U@D]+V5N,+1[]+W[+)[,^,':DH?9:2R;F6A0@H'IN%V'FX((!IKZ*YS3[ON"+.> M>QO_1P3Z#^4D'F&FQ3R M'081 (ONEXF8JTJ9@5 &T^')]J?,!SL5#?O$IXDB6[)YCESU3OT]]KH"$8^8+CLN!6V0W*T+S: M>L[J]& %S< ^ Y#WB6:@%:1J-\33= W/V#\V/V/?1%V'[F,F60Q^JH"R+T8Z MR^Q%>JZ6*T1898K17!8T@72QP(B0^[L'P:4\J%N;)Q_XE/D!&] 'T.VS ^8@ MMYG!\X::NQ2IGBI4MG6 =.6#D2VM0\C69LAV'&(?^1=O9V\F7JDBK>V/)>H\ M_"D?PM''$XY6'Q.RM^!E6[*74E$8+E1[/_)%0NTQ?"WCSY?4!@W%@>!0OHA% M4UN:S55?A-&ZY0X%4XV7N."DP+0P,B]E ]APVF$[7R1C(M'.\9=R74ZTR0J;+ 5D6[O3KS1LHEMQ% M%4R&#ZXV%*U%]>1\@1/QSKUX.J["Y(0[)(O8:/2TR);\0>+])C:#DSLZ[M'+ M#=<=1E"J-P&M'2TR]3ME?UQE=XR*A%&#PYG&1T'@-C9-3M"Z%#E_IG&QG[=)IY554V+-S5/ MY'_I!ID-\BUC2-J U : S3[ -LAT@G"W 17'.,!P$L=\:TRN7PFKRQTK$836 M3I:8T>/B?6N;T!PWR)(R+GY'C*&,KQ(A8I2>I2C/R8S@1,V09F_+=PLVAH&: M)4"/@$0%)&H8)&J8+3P 5 &@"@!5 *@@&22J$\T[!5&*I9/M2\%WHGFNGS!$W]5U/1/H;%6^RB:1CTT)M M_O+$Q7I/\C\N&<97_+@610E,"57U70=%FLMX>]V LT3<@_R$EEA9)&/,3UD2 MW%.[3CSI+#1QO>N#2GRC?C"@S %E'@9E'L,*#9CS\6#.S<8]-7F6^"+*=NQ: MX4GY@L^VZA/0+?-%'B9B.E/!HT-,!P0]&_:!O%MIYH3;#H5XMX;-"U<%B1Q7 M7K0IO]3EH%:$XH*OMF)M((PE_9:3@:L6:D.H:EJA*NET#AZ<:E$'!OQ/]$(2F+[0?O1":A3,%^'5/M-)A ;NLP5)@OG'O'T/(PU%@ M]5 *H=/1B>7>R%6>ES@YKZL]5PI1Z4Z^%RC(MSHA-22U!P+:B=/"FTWXAB%( M?#Q!XG QR>D@UJK>Y K$"A>O4HSN;(VG8\LC[(&("WC M1;.F+-?QG(CQR@:Y+._^)C)8;MI%R5V6FP&,&BS8GX)@QXFO@&?@YVZFQ$66 M^#@'K= N6*Z_!+GVAR%=2^ HLV<^#O]3#2V,G,(!_)HS21Q:](8TC@.R'$SC M $[H((D<6LH3;A;+"XD1D0Q7V;_*6\7*M@X&@60'S,6?)5>3JTR4CZF\K*K@ MQ>,"96_-*IR,E;NA3T&4_>*QI(4!>W#(5Z[M.=\/=@FW5L"'>GS:8H^T8V9,4Z"D.[W)YG7,CDANYS;TI])]_89.&F> MZ_^DI\;+5?-;Q;PU*^CMYSUU ]XRZ=X:Z$B?@U,4"NV$1,5J&4&0PPI M?\>3\A?JPH2Z,$;U"0"L^R*+4!,FI--:R"GHB[*%-%N'()^0@VLPSG*$96;< MBZ2,D*W[:ST)&3]Q"^Q7 EE?3&V\'-_C4OE>J-D(^<#'K/+M"27CI?\>E]9W MSQH)B<)FH[I@>?\:Y#URJ-!@UG;,":4I25"-^FY^G4=T%L4H7T2SE+[D$3PO M6V\\$YG772@*N=4'9(V76WU:YGQYYCE??4\DJR;\C/(/\=67%?Q?.>&;SCM$ M>;,0;V<7B&6T+/@Q<\48J&-2U)]6HOB M@[[1=Z,2O-/N:_'SWC.),)I;NP] -)_"&.,DO^36@1#.[>P&<;,APVPMK@GR MA;H2Z_@3YDOYX_M=N=<8%FY;)/\N\Z+:H+9+4)@^C_0>\Y,P)BGF1/*)H$M\ M37/^^S/>A+,GZE8GI^O/N7"*&O:LDR>^PE$L>U#=U&?-"U00*OY?3/(SGWK. MX>MN)_[ %>#M+_9:(]^,]Q=<3P%;MAFY\S$N&: M),%F1N&QB=IBAF O/FO,Y/UNON'^XDN\$%:2J-)^,9MAZ:9AEHC#%WM-BOM\ MXR_7.^ C^B**KFVYS1S8E]PAS/RD<,<#DWE6/[P=KQ^Y"Y:+U#2:"5-+ MF!.G>,;;\ 4BD9[&"%9SBK?4W&:UD/TRI\*04>N@SA MULP*""WCG]?A;:^/8PMRY^.?H14I4-J"*^@/X 23(A146QM%%]64]'=++RLB M!=A3TWF2Y[C09/&PMV.Z>L?PBAL@6S=LXWUQ"[DB7I-AR&!.\;^/ZM @9QANCTDK3^ @W.K'T'J/I 5IE]C67)^7MO8 MK->CBL170;JVB='M;Y[%MV'DJR4WM%B5^26?'E47F[.UR2H1B9/W>%6R>%$9 M4R*@3[,JN4+"4'M'J[;7EKQ'6N7&,/P&GMP/HK?PUSY E/UJD<^]3 %17)NO MDRI?)L?M:Y$LQ36+$R4-7;6VM\M" T(.44']$6S4L%QM M5LKM##)3TO96MXM]JB"+1]K>P1HQ$A::&]O$?*9=!H3K,3=;+D5Z;XN% ^GB M33V3L8C=/2;Q04KJ:Q.K]2O+U2JM9(;2[71?93/*EG6*;XNNZ/7VI[*,UF() M!6*.IT!,>!/.Z2(6+MXW[(OUC"HB# @$G[U::4K_,9J/[LG:-26UO MIO330B1BO](R_"O]JT&O<6?.N MB*G2*^V:RSR"?VES(^@@!J40 7=01O 9?9*@ZK: 9_[?T*+KE-4]@DOFCTRA MB>.>^5Y#*R;L?H57'M18!XODOM]X;I$'LH-?KANOTJ85/+>;(/L5H?+%7QE: M"35NLXY7_7(RB[E763&XA>UX$&Q0V0'+F\&%IQW3FHSV*8]AV 5\N!BUX00/ MQ B\4PP7HG:\J*"<#7\D8'N![-+]\>,MF3;(]++[YD M_ PDR*Y7-\:#J"ULA\/(LONEXQ$PF^EMB^";Z+[DE?60@V0%@Z['>0;Z#R-% M^#TI7V)SPVO?M?P^HV?(_O Z=ZV\8>@9IC^0ZNE?[!X1UG?&:-&48O,,+:X[ .3$O/*O[CA3XUP2GI^MZ:'^]J M=KDV[8L#K,O\6QQ?7@O;%\L$"*=TJT,UGA+9N2NJ+84WMY#E)1B\P8N[",C0 M V>O,A[]8<>,%CCZ\"$BU082%6('B9+-M(D?(U2GA*$LB=*]>&"""T32'>'M M3SX.]243CT$.2VMX)O* K/&>B=PFV/*3L$YEW+L%>4;S=V6)89T&? M9G_ *#SH,Q:!>PD ]^)Q6K[AY;BQH+5&SXYU]R34OB[:X9?O/F]C?L>!AZ;: MR\^KND29R->RS&LK#K8+->UCNJN.\-98 W M=6H&.#TM];T@71Q@Y/6[O!WL'5I_V+Y-PEVES[S+?W ;8_:TB@VP=7YH>F)[;?D:B;4JRW?QI45(># M.R6>WU!:ULM@.Z%0WM_WM%HSN]F]:&?&14-UCZ:/E"8O)$VY/EUE!$V\80J"/06%0#EAPM.O_+,!)6K(5W!._ "ZK)# MH/<1_':7EEV+"%KEUB=0,X+>34NT?1(/1W#]IR6\H2)-([CZ!X*T>DKH"Q*6 M)#F"GS]ML<$%9NABQ+=1(HI>T++@?\G$+;XHQ84H\Q;16137Y0DZ7H7H,K:Y MRP_=J0O7'0[(&N^ZPPW*\AG!:7*#ET_O\A]538;X>'&-2H93Q;<;6XR:]-]% M;6%I_MT7A,F4AAI+N41Q5;RV02';&]HFNG%Y0YK:R/-Y*JXR?JZ50E$4TI8W MM$WT)[3$2HFW-3?/0!7PO/BR(O65^7.^3F6/B:N:VB!<[!?;LD:-^R:DJ2W" M=P69;E_WP).E"+ HF6CO9H$ADN$M6=O-!*A1\)YNL'65<6.Z$UN2GB&Y,"07 M#I1[YEFZ_C2_ &IAGMIJ4O M\FC7C#:_S!=)J/?15K!FO!Q)]\2@PLM\D8.)+/VI/%D1LO1!(7]M!]&7K;.[ M>)2P@'=;B5H\K3B<=_M*BSQTD#'38<]?N!=>W2FI_A,M:4)F)-[4)^T6[=09 MTEB04Y^H$-L\(&N\V.9)6= E?2(IKB\XR<.,ZI:#5$1K?:E/5 ^2#?Z1*MZ MYTT4]QKP71G_7KQM2W@#2*&S$L#;( ,.P%CUT9,YP]6"/UD^<=\F%8DH"\Q2 MOM?FVV-:KE@=AQB-^,__T*7UL,?@I%W/;[W@3_CEOT3R'E@[=$89BH5+RO:^N7-<49ZC>,&75E$H=LUN(XR9 MO*%S'(-R-O3/=^-A[.W;PR5*'S%;*E((VIJ[P8 RE:"]0X@MAMCB,+%%K;4? M0HK'$U)LW4Y,A(4=/\!"6!@6 MR!H:ZAW]'K/96Y X0T; S!^,_*@+BA&W+3-YGGTA+F5BP^+A@[Q5I3.)ZP] M$J5/9 @I'I U7D@17.569Q9AMP=[JXE)>+&^O2[*U(EW[,_J1THYN:^OE)Y6 M9.^].LFU2+QO%TNPR!XC1M]-2A#<"\%D+D/ NP\X,3'/YS<6 M1RA#Z3HG]:,H#,<) 2Q]T^\]1ZOFR^MQ]A% MI;GY[>P3+MY4_N>;'>BUSV$''_;1;0E9DE]_3.D32E]+F5[3%W$,;/9\#;9[ MC3\>VP]BBZ+9=S]^N]&U<\SXEK57S+7N>(Z3LFJIP;+VV(/J-MRA'6N?[H:N MCGMJF(?>N%ILWF78/+:BA,G>M;8):4GT^FS!U9?K;O?72OL/;!]2?4?]9I&_ M_I4KX3GAZBQL=8)2/5FTC>:@ "0:?%)<8NXWH?1ANS[?,*4GEG[?<$94GZ@P M7<6NST^!#2MZ@F@:P4&=:"+S8<'=UU/$_=_]UZG$4RO]12 ?VT'A5&^!['Z5 MS551 YTA'&2UPB.XA7O-24GWX 0];MM&<8;=G2&OR>!KO_ B<(AEC1_+&LW8 M#H&O$/@*@2\G E\NI9X:L.Z/* 8V.)@Z0@C,^J,ZW44X %([WO4GYY1Q5&?- MEUM1W95Q /Q\O-M2/BAC9Y6#WY9R?"_L[IN"9>7XB[B]Y ,#)\"BTGX/=VJ+ ML ?:#Q:B_GNY$Q.B;I@ ;AU//\%NU-@L7)#3]S.&P*#A\O(MO:XUI&L\%>[[ M*"]H_,>3L+RC>,_TCE8IRB*45DCH!O'+A9'>T!1OS*:.Z6]CTF NY6U\+D*: MVP%9-JX8CCG-L"R9\17-9*CFI"87)\T(@#H@#NML,P9Z(L"@1_Y914G QC86 MGF^D>7$[>T"II$AO:SOS)'_DIRA#XL7UDV1),B*>)A8QK,W$*]G0ZFLKFOQJ M7&S6M$*- #V<84-97Q+4QSPK]]Q@X/;9@FO,.7[&*:T>48>HFD9/*VP5C(A M[H,X5MH8D;>U$.;'J7 RN%AO$/L#"TP>,AW0;A88:CS&3A@3\$AU=^9T_=KF M#JVKTD_B^'@]0[+DCIL!K>_!COFID*42LE0&RE(9U=@-F2G'DYD"L8[>X34@ M&\07"36[(=3DD>&+*-MS@!0^GR^)4*WZ!+ F?9%%NT* O3=?1**Y(;>@#N/= MV'=:*GJNS'@I2$X+2=O]]B7%2%-.'1 Q7Y9=>$G5Z;QE9\/@W0(0QJ.\/T=_ MEHAQ*:9K[AEG.4U)(JB.9B1#62R20_C/*"HS5"9$_ '6OF/ UQ YYF*_1AD* M8> #LFR$@0W-."PB;%3]3"*D%YL"BW>8;3=8:6W:QK;1!W>(/R=IR84,)'_3 MVB8#'QG-\SM&Y84J]EK8OVA\+(5MK0NZ;QD3BPQ\PL6KD"5DOVECD]A[[JQF M)=YJE'CBY'=2+,[*O.#4,4YD6E9OC>UL<^A4!U"^]YJ]A!O-46R>91)2W]&HLC"TQH Q.ZWP MAB-F: C;'D_8-A04",!<%V!N (OGB*H' /RY\9!^9Z5AT:D[YF(!:F]QO-B< MLY)1.J3CW>3G5NX3=5,B(*QOA%O[[DNFEX\RWMU]AR4&!%['NZSOL&QZ.O@& MXYQO_,R M NADC9DJ"?*,+I>D(@[$2W,?JS=CX[A_Y9'"WJUB+]''A5@E'JLKCD_,]R/#OGFBV)*.JLH;(+6)XP=TC\HQ? M?0)1E&XFC_YT',4"NTE"BFJYW2'"W>,SM"*%M%I^2VL+Y%I2+5&/Q'[&+//.=EQ^+)W5Y2&XEBYI6 MLOB@5E\;)0+X 5(C5H+*"A&;XRQ^_[B31@\[;(@B;33^0SD9DF8V"'X/85\3 M]$12;N:J5S2DJ\W [+;DVP[^VQ+'-82?2!*N@+TL)'UQMY"N,7=EJ_-VCRSU M-('[64@#HS1Y(:GL&#[\LXVLI&VAMOHDX IP\643WVDA7J>K#<:>^UYR,ZM<6-FVC/3+XF5J= M3T*4F.5U=*F=^L9NCK"DWB??-W2+[!93M;V#>29N4+P@&6;K?;=7M7C;.YAG MXK4HN]A9@+81K),SS'RB6=R%G_?];+-T+\(*M[//>7WL@MB1]+' BL!0-N9" MZXRHVEHB';S7MK2V3SY,_,H.YIFXVP8'6_U/14LK9*\023;)&7SGWU-MM1II M]+3!E@3W;3G(P?T<8DEUIJL[V;2QI)3)G2)5%YNLO!8\:<;Y6O7VXSZ.YI709.6[4VG:[AJTT(LT#]W MRR-_3TVKRK1U,,]$E9,+2L!0M+1 -N,.3\G6K1;B^X; MV(G?AD$LBN%6T+A MEE"X)>3$+2%+DGC/YW[EGO:D 5\$HF9UO\:>?O:!+\L'+"-XFJ,OM=' HI'' M(GVID086A3;F->*U)O-/8L$7DRK=S)>M!78>:0**OIQ-<+;W9 4-0/JB09V$ M!$VQ&/%BK_F=IY.D]+#O$W4,#JN,#;&+\>[^3F!_T\@. M&.\F\ 3DU)S&.-Y5WPF(1#_K<[S;OQ,05]>H(UAHVD]S3T!H@,P?N'FJ7Y=G M(J==\ZTH7Y 3F.<'S0GUQ>4#\-N MZEB<[[X>7J2T;PRXLNBTE8?\%7N\5!* M*R4^] 35Y9Z85[68.ND5[%J]+WZ:GHATLNM]\=#T)-2:=.*+EZ:I.)"\\_$\ M,@NVLYY\VN] ^>)Y#;+A6'"_7):2UM5IN(R\,JVA]T;@XIE"\*3S+M0]C67GD5E=G*R;M?YQ&=173WT,&6.LT2RFW#&:^E#",H%%4^(&N\%U:K MW((R+DI6/V-?GTL+Q.;OJC"UMK=9QNZ,YOS0W+PZ^?J/UUI4 ME5TP9B,]&<'OVCE%=(N&M[:WR$*KJC2TM"I[8 M<]D05J<9#FRS@D.=FE"G)M2I"75JAGO(VG/%48I+@;&.ES1@)?RD^Y[W^-?8 M'58+H*/NR];2SBZ%.3&^;!Y: M%PQ'U)1-*2CU9 PK-+52!!:452R'M1 4'1SO'I;K MZJ>,0WIS\TI+)(!<&F^N6VD)I@=0/.(%+(<%!DIL\N82UA"Z!(NPN)%U&^]G MY4=X,]=1*C;2+;V]\G A'["3J'I U0*[N4"FQ[VZ7'-XL>9<@*^UA M,S-%.^_*'JFR:SV7W-(G\TU]DGC]R%"6\QVT+M59_936QT+R[S(O-N4F*\'? MB3*>_ ]%P4^;;3B'K"H$!.];)"+"-70A?"! MES2+\@JSB!)1X2#5N(@[-@4F$ (S/ 0(87@(07+=]W5JS4WR_O5A&]\W[_2< M<'H3@7CR'?$!QR6K"@_4)>YQ4L<#EZNR7J*WLT,X^60I.);X2H..;>4*(*NF M':6;$D/5G+T]6[?A&9S@/<$O,<)O,=9F*/7]NR=YBA%-;1IZ$O2>2]%T\WH.(9;+B/X M9J8ALQ^B^>8!MHC/9T1V+[5%J'XJZOUONB%C_3]D# ;BM2 <]G'N?K/)0C. M&DIE3.<+\2V=/=!9\8)$9OJ;5QIOL-CX%9E#X+X66-OZA*Y]PNRRM4, MM?]UUW' M49QC5_HVL1Z_[X:Q62_7%LL6TT5;:-78E'J,9(/MAF,!/K^0SG9+HL+?$F]A MKJFK3=;NN!&650\SQ(N,IG2^5IJL;(G8'P""&YH=2R!T *@CQ#N/)][9U2F@ YI?OLBR"[!!!_*M?9%A>_"Y M,WSD2Y2UIYJ!H51?XJH]Y06SXWV)K XBK'[JY/@;@WV7GWYH!BPY[9I?DY*< MVA7Q97=O/P![X;B^B&D NU7M*?IR^IE(:'3\3',YH='%O"F](*8O.TIOV8!" M]=YM*UVE]2Z@.MYNXVS2<-]PW7@FM95BPB,)K6MQX2E4T(6*K$O8$"RH:3S> MW450D!"DZ93@'R-6/^<0"0ZC>/,*1AZ]D&(1Q1MT)X\2DJ/YG(G'Y#DAXEK4 MIE_7%.'A/VPL97@LTD,*\0%9XZ40G_,-)LOQ">9[UPK%N#$("&@Y "D76?(Y MQTQ.06.# 3[,CSZNJHR@](:[K9(<8$#+ 4BYO;@YR<3AB^=,C-(FJ [1L4_^.[VR'?.S4\* M>6EW'H1@]DQBO'TD D(DH,, A#WB%(NKPF5&XCIVTC:_L!Y#D,;Y7J*4LQ[C M7"$J5;OAR!#JP4VF]IF#M!_S_LGPA@'H/LI8]DB/?)R<%7NY./RGPSP<_JM_ MU:#JEKP&&T#=R R1(D1P.WM#1:,9!6IKAN2-XM^R[4[6+%E5,Z.$YGRKW="0 M2V7;VM9\#MG%GR6W3%_O@IZN-X92DSVKU\D^,UNJE.EQL$[FF3G69[5#GNM$ M0RK&#_B0E>E_5F;K(4^UCE8?Q*&P)JF6#3=U86B:([3;F>^+E.0Q?XB+,O68 M=OO":<,IIQZG!DH A$U.71M@:Z+=N9RZ'""GJR8JY<,RT1&) C><>K886!0= M(?&IYS]KR >,QD]]^< S#'5 I*GOL_J6JDXLS!>=T90.)*([]2VXHV@@ ?^I M[[X=1:,3?_3EFHFFB$ 9 ;ZL+!.W 1Q?0>$V@%Y.9.]XBND$R5^B%"-.2_V? M**9YYZJHD*&,)3'"B0EIB0=DC9>6N'N-^UI,RCT6C&]_>N0N\P$Q6GW&3'R! M*!,HE06NE>,GIWPARW+9&/Z6_MT0:7R"E:0U_=T,:?>BJKHDW^3=WPR2))55 MPU_-A\#?+N$SKO0'E+8WM$WT02'Y83IZ\>%#1#+>"D<%^H+SO1\B_&4E MXMS1$\[PC!0=8QK=/V LTM&7Q!#_."#+PLMNW><0%';HJR)FGSMC8B>[Q'Q/ M1>DC^G)14WA:$R@!CUIZV7RZ94L:97PSS709DO1R@*&K2HDT^9%TLOE2R8:R MZG@\R9)K_FE=M5/WM3E7YQM[9+,P].8,UMD)]NIETI$]96<7V.O&EX-K;4O: MFP73C3O($'9?[-+ARL&Y"I&FJ4)*HQF#(?[D?_S))#@]%1#207#:V3*]FI[8 M>+KBNH3TG(;QH&S7Y01U@%5A< M^J6O71>7'G0 %M3/WNQ0FE@$6$*_>",A;['D%H^ZH2UBI65CVYI:"*=1MJ*,*\-QH:RC<4X[VF9<^\ZS[=K1%&: M'M0GQ-E#G'V@.'MWERC$V?V/LP.<3:KCXTU='GJ[- 6=2-[)I#T1H?UL\RX[ MHTU1QJI2/!7Y-%ZEAN!<4Y<$;(O5\NU$(6CP2 'WJPM#3#R!0.76AF,S_ MF\KM4@?S_QQ^%F$#LM&&2,:+U'088ETCWDXDO)%$OX;,B/"!HH0/[ [%XCN_@';*5]@ M$D/*UP%9(>7+M90O@"[W2?D"+Y60\N5+RM=)-.]^>'0Y][\^E^?'P[\[/=_&!V*#^&!?K!X1SWK Y7W4NVQ$>F- M;?$1TSE#JP6)42J%I%O;&B)Y*_5]0B2@?VM;"WW, B(\#(&X_/ZC6V3AUF<#@'."IZP.B U(0F9\P=?0&+(!6RV;J MJF 2QW)4&:: 8UF2A!+"ZFT>.X)VI32;I^29FTV;H/K3.IKO[0D1EQ<:%NOJ M]$G;2%!6 M4[46#>ZV ;4*J%5 K0)J%5"K@%H%U&HRJ)6SV5N=\1 M8]S+6F\I4IH5ZL9'@)V/;5L&)-U_)+WCSD#[;)>^R*P=3NNRW_J"MW;7*+B_ MZ LPVUU6D$/0%XT*"+[3"/X*,T+%J^NL[=T>H@(Y,>.L-!^K066 M\?5=;-I.2FX*C]B[L@X]Q"3%\\!"TB[,7>]8%]D$E4J"H!D,0,:[,B\X>75* M\XC.^$\T_F-!TT3<*L15^?4('ECL.+")@&$OTN"!P &B-'%<+LM4T'E;+# [ MHTLNA@7?K\GSIGB^.F2CV]]"("KAC@&?4I3>(9)<96=H10J4JMF"]+'!RF[K M>Z02&A_XZ8N?$-^8Q%SPB:CT^5YH6DX*_,!W!1+CNVI'N\7Z5YR5.V@G?;VTS6C0, Q8C0O4[(4+- M:89;"A0KVUJXBJ#[Y+D]4F7'B:"*DW@[>T1?[L1K0=SP*0I&GLI"N+J/]*ZR MJR3,#32JC0HD!=<D;$EU:B.4"K ^P\Y*)RJ\U%%8=;-QCXQM.S"WIJMG)"V+) M)64SS,TGV>G8?4"K07=MLC\R^7G5;;##AX<<8+^RA0?B7CW6<3.?_6J9^WN\ M*EF\$,Y2A=04A#7IKHIIX!#V5WDKH2K'4V,$^YR^.1A5#+UI:-,3ZT.V1?_K MD6&4EVS=[K8K6OJ3]M/-4#N2G)T.\=!V?\,[H2A9IF 8S+L@*%0N&G"Q=PD& M4!E!, GOPIQ@!>H61ADOXNFXO%H/=K!DM!\B=EPR ,#9NVTZY#CIY@P PT+C M:8KC\FGWT[P[QY7R4,2$O#NSE8(8-'[DW?&M%)W9+(+Q#(!GS)ZHFR4HAH'" MP:+[R7_1Z>'H8,G]W#&I]='5XB?#(/%@^?WB45+P@#$\L/Q^]4U^7>,A< L7 M[@+X(K+FN I<8AV= D?3K(&):'#Q:#L&3HNG/40$23G?_$7\C[ "^6_^?U!+ M 0(4 Q0 ( (R"=U(*"_7.#8L! +6Q&P 1 " 0 !I M;G1T+3(P,C Q,C,Q+GAM;%!+ 0(4 Q0 ( (R"=U*ENN"]]QD '%0 0 1 M " 3R+ 0!I;G1T+3(P,C Q,C,Q+GAS9%!+ 0(4 Q0 ( M (R"=U+$YZEU 1, ,